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Abstract
a
The aim of this project is to establish Roseobacter marine bacteria and Trypanosoma brucei (T.
brucei) protozoa as synthetic biology chassis. This work addresses the gap within synthetic bi-
ology resulting from the limited choice of host cells available for use in practice. This was done
by developing synthetic bacterial and trypanosomal genetic regulatory networks (GRNs) which
function as an oscillator as well as by developing the necessary protocols and set-ups to allow for
the analysis of GRN dynamics within the host.
Roseobacter clade bacteria are naturally found in diverse oceanic habitats and have an important
ecological role in balancing global carbon levels. This makes Roseobacter an ideal chassis for fu-
ture efforts to apply synthetic biology to bioremediation and geo-engineering challenges. The aim
of this investigation was to establish straight-forward molecular biology procedures in Roseobac-
ter bacteria followed by characterisation and modelling of an E. coli oscillator in Roseobacter.
Results showed that Roseobacter synthetic biology is non-trivial.
Protozoa are exploited as host cells for industrial production of biotherapeutics due to fast doubling
times and host proteins’ mammalian-like post-translational glycosylation. As an established model
organism for studying protozoa, T. brucei provided a test case for establishing synthetic biology in
this phylum for the first time. T. brucei is highly divergent from eukaryotes commonly used in syn-
thetic biology and possesses a sophisticated genomic machinery to evade host immune systems.
The establishment of standard synthetic biology approaches in mathematical modelling and gene
network design in T. brucei will underpin application of synthetic biology to enhance the industrial
capability of the protozoa as a chassis and to probe its pathobiology. This investigation involved
design and assembly of a Goodwin oscillator, followed by characterisation and modelling of the
network and the development of a novel experimental set-up for live-cell imaging of single motile
trypanosomes. Results showed that T. brucei is a promising novel synthetic biology chassis.
a
a
a
a
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Chapter 1
Introduction
1.1 Synthetic biology and its application
A principal aim of synthetic biology is to build up our understanding of nature (Stephanopoulos,
2012). While this remains an integral part of the vision of synthetic biology, it has now evolved into
a much more ambitious enterprise which calls for increasingly complex, non-linear and layered
applications from the proof-of-principle networks (Elowitz & Leibler, 2000; Gardner et al., 2000)
which were developed at the dawn of synthetic biology.
Projects in synthetic biology are now looking towards industrialisation (Kitney & Freemont, 2012)
and the development of real-world applications in areas as diverse as bioprocessing (Peralta-
Yahya et al., 2012), therapeutics (Lienert et al., 2014), medicine (Ye et al., 2013; Ruder et
al., 2011), energy generation (Vetter et al., 2014; Peralta-Yahya et al., 2012) and biomateri-
als (Bryksina et al., 2014). Synthetic biology has the potential to optimise bioprocessing and
metabolic engineering methodologies in industry through the development of cell factories - ‘wet
nano-robots’ - (Hasty et al., 2002b) which can replace current culturing practices which are result-
ing in high production costs (Kim et al., 2012; Holtz & Keasling, 2010; Anesiadis et al., 2008).
The wide scope of research within synthetic biology has attracted the attention of public and pri-
vate funding bodies. For example, the UK government has listed synthetic biology as one of
eight main technologies to be invested in (Willets, 2013), resulting in an investment of over £130
million in multiple research centres, grants, training and collaboration schemes (BBSRC, 2014,
2012; Department for Buisness, Innovation and Skills, 2013). The Engineering and Physical Sci-
ences Research Council (EPSRC) alone has increased its funding almost six-fold since 2011,
increasing the value of the number of grants it funds from £12m in 2011 (ESPRC, n.d) to £71m
in 2014 (ESPRC, 2014). An analysis on patent applications related to synthetic biology reveals
a growing trend, pointing to the growing role industry is playing in this field (van Doren et al., 2013).
As synthetic biology develops and attracts more investment, the challenges it faces become in-
creasingly pressing. The research being carried out is not short on ambition. However, the field
is currently based on an ad hoc network design process (Tabor, 2012) and lacks a standard-
ised, modular practice which is prevalent in other engineering areas. This is fuelling research
towards building a solid foundation and the development of better tools, platforms and techniques
to work with (Cameron et al., 2014). For example, projects are being undertaken to establish the
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design, construction and use of standardised DNA-plasmids. The most successful of these is
the Registry of Standard Biological Parts project (www.partsregistry.org/). This is a database
of DNA-plasmids known as BioBricksTM which satisfy specific design requirements (Muller &
Arndt, 2012). Other public registries include the ATCC (www.lgcstandards-atcc.org/) and Ad-
dgene (www.addgene.org/) databases. However, as of yet, none of these appear to be used by
the majority of academia and research bodies (Kahl & Endy, 2013).
Other challenges which are being tackled include the development of alternative host cells (McIsaac
et al., 2014), financially competitive products (Church et al., 2014), orthogonal and consistent net-
works which avoid molecular crosstalk (Arkin, 2013) and quicker development processes. More-
over, developments are being made in order to be able to modify network parts with minimal
effort (Arkin, 2013; Kwok, 2010) and for synthetic biology to gain acceptance by the public and
favourable and permissive policies from administrative bodies (Hayden, 2014; Erickson et al.,
2011), to name but a few. Multiple administrative and funding bodies are now coming together
to draw up strategy frameworks (ERASynBio, 2014; Khalil et al., 2012; Board, 2012; Win et al.,
2009; Endy, 2007). A search of available literature shows an increase in the past three years on
the awareness of, discussion of and funding for dealing with challenges in synthetic biology.
1.1.1 Synthetic biology adopts a multidisciplinary approach: The role of
wet lab and mathematical analysis in synthetic biology
Synthetic biology aims to manipulate molecular systems on which available knowledge is often
limited. There can be missing information on the parameter rates being used, the stability, optimal
culturing conditions, strength, range of function and component compatibility, amongst others. In
order to address these gaps, synthetic biology seeks to draw knowledge from multiple fields via
collaborations with biologists, chemists, biochemists, mathematicians, computer scientists and
engineers (Vinson & Pennisi, 2011) in order to enrich the field with a diverse problem-solving
skill-set. Since it is in essence an engineering principle, synthetic biology aims to incorporate
theoretical with practical work to complement and inform the other.
Mathematics, in particular, is utilised to develop realistic theoretical models of Genetic Regula-
tory Networks (GRNs) and to carry out quantitative and qualitative analysis, such as time series
simulations, steady state analysis and sensitivity analysis. Multiple hypotheses and different con-
ditions can be tested out mathematically, which would otherwise be infeasible to carry out practi-
cally (Chandran et al., 2008). Kaznessis (2007) proposes that modelling should be done on two
levels; that of network topologies, where modules in a GRN and their interactions are modelled
quantitatively, such as in Stricker et al. (2008), and that of qualitative molecular sensitivity and
characterisation analysis, as seen in Francois and Hakim (2004). Endler et al. (2009) suggest
that a study which is based on an iterative designing-testing-validation cycle which includes mod-
elling will tend to lead to an economic practice.
The role of mathematics within synthetic biology has been described as “indispensable” (Zheng
& Sriram, 2010) and has been shown to bring an element of rational design when dealing with
complex, layered cellular systems (Gramelsberger, 2013). A clear example of this can be found
in Stricker et al. (2008). Here, the authors develop an oscillator and analyse it mathematically.
When carrying out standard time-series simulations, they found that, non-intuitively, oscillations
occurred in two different regions of parameter values, rather than the expected single region. The
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necessity of mathematical models becomes increasingly evident when looking at studies which
show that even when dealing with simple synthetic networks, complex, rich and unexpected dy-
namics evolve due to non-linearities within the system and results in the whole being greater than
the sum of its parts (Borg et al., 2014).
1.1.2 The democratisation of synthetic biology and the DIYbio movement
As public awareness of synthetic biology has increased, a different development has been taking
place (Kean, 2011) in parallel to the increased interest from the government, industry and fund-
ing bodies. This is the evolution of the do-it-yourself (DIY) synthetic biology movement, which is
the participation of citizen scientists in synthetic biology. Citizen scientists have participated in
astronomy (Littmann & Suomela, 2014), conservation (Jordan et al., 2011) and ecology projects
(Hochachka et al., 2012), and this approach to science has more recently spread to other fields,
including biology and genetics (Kawrykow et al., 2012).
Known as ‘bio-hackers’, ‘garage scientists’ and ‘DIYbiologists’, they take advantage of readily-
available online software, easy-to-use technology such as the Arduino prototyping platforms, new
advanced technology such as 3D-printing (Pearce, 2012) and cheap and second-hand equipment
(Ledford, 2010) to build improvised machinery and set up ‘community’ laboratories at minimised
costs outside of an academic or industrial setting. The community laboratories, of which there
were 37 registered as of 2013 (Landrain et al., 2013) such as the London Hackspace (www.
london.hackspace.org.uk), San Francisco’s BioCurious (www.biocurious.org) and New York’s Gen-
Space (www.genspace.org), are non-profit organisations which offer a space for citizen scientists
to pursue their scientific interests.
The DIYbio movement has resulted in a variety of ongoing projects, from genetic disease testing
(Alper, 2009) to the designing of water quality monitoring devices (Jorgensen & Grushkin, 2011).
Few such initiatives have led to publications or influenced policy-making (Freitag & Pfeffer, 2013).
That being said, citizen scientists can bring a different outlook and problem-solving skill set to the
field precisely because they are not conventionally trained and are not constrained with deadlines
and grants and thus have the freedom and creativity to carry out experiments in a way academics
tend not to. Comparisons are often made between synthetic biology and computer science. Many
suggest that just like citizen computer scientists revolutionised their field through creativity, the
participation of many and an enterprising spirit, so can citizen synthetic biologists contribute to
and enrich their respective field (The Economist, 2010).
One step towards the democratisation of synthetic biology which would greatly benefit citizen sci-
entists is the move towards a more open source practice (Nelson, 2014; Pearce, 2012). This
remains a controversial topic as the overall benefit of it to synthetic biology is open to questioning
(Saukshmya & Chugh, 2010). Moreover, this highlights the ethical issues and biosecurity fears
concerning DIYbio and the development and release of mutant strains by individuals, either due
to malicious intent (Jorgensen & Grushkin, 2011) or due to a lack of education (Seyfried et al.,
2014) which leads to sub-standard handling and disposal of strains.
The importance of having a standardised, modular synthetic biology practice in line with engineer-
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ing principles has been mentioned previously. The benefits of this progress will be felt nowhere
more strongly than in the DIYbio movement, as this will allow citizen scientists to follow proto-
cols and construct plasmids with ease, in turn allowing for an increase in the quality of DIYbio
based science. Projects such as the 3A assembly technique (Shetty et al., 2011) which is a stan-
dardised cloning method using BioBrickTM cassettes, OpenPCR (http://openpcr.org/) which is an
open-source thermocycler which can be assembled in a lab, online funding campaigns (Scudel-
lari, 2013), accessibility to the Registry of Standard Biological Parts (Kean, 2011) and the popular
iGEM competition (www.igem.org/) are a step in the right direction towards democratisation of
synthetic biology.
1.2 The choice of chassis for synthetic GRNs
Within synthetic biology, networks tend to be developed on a chassis to chassis basis (Danchin,
2012), and networks developed for use in a specific chassis tend to function differently in an-
other host cell (Heidorn et al., 2011). The chassis is defined as the compartment within which
the synthetic plasmid is placed and which provides “a metabolic environment, energy sources,
transcription, and translation machinery, as well as other minimal cellular function” (Kelwick et al.,
2014). Choice of chassis is important since it determines the level of protein complexity which can
be synthesised along with downstream processes required. It also influences the rate of output,
range of potential applications and stability of the network, as will be seen below.
The use of chassis-specific GRNs has resulted in synthetic biology being at risk of becoming
limited by the platforms available for use. Looking at synthetic GRNs being developed, it quickly
becomes clear that while the scope and function of synthetic GRNs is not lacking, the choice of
host cell to integrate the network in is more restricted.
1.2.1 First generation synthetic biology chassis
Within this thesis, the standard, established chassis within synthetic biology are considered to be
bacterial Escherichia coli (E. coli), mammalian and yeast Saccharomyces cerevisiae cells. E. coli
was the first platform to be widely employed within the field, with mammalian and yeast synthetic
networks being developed at a later date. A case-in-point is the development of proof-of-principle
synthetic toggle-switches and oscillators: the first networks in E. coli cells were developed in
2000, but the first mammalian toggle switch device was constructed in 2004 (Kramer et al., 2004)
while the first mammalian oscillator was presented in 2009 (Tigges et al., 2009).
E. coli was and remains a very common platform (Markson & Elowitz, 2014) for the development
of both basic components and advanced networks. For example, over 100 regulatory parts hav-
ing been established for E. coli (Nielsen et al., 2013a) and advanced systems such as pathogen
biosensing-and-destroying E. coli cells (Gupta et al., 2013) have also been constructed. E. coli
is a common host cell choice due to several reasons, including but not limited to, well-established
cloning techniques (Voigt, 2011), extensive troubleshooting know-how (Cameron et al., 2014),
rapid doubling time (Markson & Elowitz, 2014) and strain robustness (Liu et al., 2013).
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However, as synthetic biology moved from the development of proof-of-principle networks towards
real-world applications and more complex functions were demanded of the host cell, the restric-
tions of E. coli became increasingly apparent. Of the more prominent of these limitations is the
inability to carry out post-translational modifications of many eukaryotic proteins, the lack of com-
partments allowing for sophisticated function (Liu et al., 2013) and incompatibility with potential
human hosts (Bacchus et al., 2013).
The use of mammalian chassis has gained momentum more recently (Leonard, 2014) for the pro-
duction of clinically relevant complex proteins (Lienert et al., 2014; Bacchus et al., 2013; Aubel &
Fussenegger, 2010). This is because higher eukaryotes, in contrast to prokaryotes, can produce
complex proteins, make use of advanced regulatory tuning of network dynamics (Cameron et al.,
2014) and can be used to insert multicomponent network systems (Auslander & Fussenegger,
2013).
However, mammalian cells present a considerable set of challenges, especially in a bioprocess-
ing and pharmaceutical industry where product demand and drive for profit is consistently high.
Cultures are expensive to maintain (Hirokawa et al., 2013), protein production is a lengthy pro-
cess and the available parts toolbox is much more limited than that for E. coli (Markson & Elowitz,
2014). Moreover, mammalian cells have low growth rates; while E. coli double every 20 minutes
in optimal conditions, Chinese Hamster Ovary (CHO) cells only double every 14-17 hours given
optimal conditions. Research & Developments projects are also time-consuming, with cell line
selection processes taking up to one year (Birch, 2005). Throughout the practice of mammalian
synthetic biology to date, there remains a lack of standardisation and engineering practices (Aus-
lander & Fussenegger, 2013).
In parallel to the proof-of-principle studies carried out in mammalian cells, yeast (especially S.
cerevisiae) based networks were also developed. Attempts to construct proof-of-principle sys-
tems (Becskei et al., 2001) and cell-cell communication networks (Chen & Weiss, 2005) have
been successful, with studies looking into the manipulation of the chassis prior to any mammalian-
based studies (Park et al., 2003). Moreover, there is an ongoing project for the development of a
synthetic yeast genome, Sc2.0 (http://syntheticyeast.org/). Notably, the production of the synthetic
artemisinin based anti-malarial medication has been implemented within S. cerevisiae (Paddon
et al., 2013). However, the use of yeast chassis does not appear to have become as popular as
the use of bacterial or mammalian platforms, except for use within genome engineering studies
(David & Siewers, 2015) and metabolic engineering studies related to biofuel production (Nielsen
et al., 2013b).
Yeast chassis are favoured because culturing and cloning methods, based on the homologous
integration of foreign DNA into the genome, are well-established and robust strains are avail-
able for use (David & Siewers, 2015). Moreover, yeast is insensitive to phage contamination,
has a low growth temperature and high by-product tolerance (Liu et al., 2013). Yeast cultures face
limitations because their post-translational modification processes diverge from mammalian ones,
making them unsuitable for the production of complex, higher-eukaryote proteins and applications
within therapeutics (Kelwick et al., 2014). Moreover, production rates remain low when compared
to bacterial counterparts (Liu et al., 2013) and the integration of synthetic pathways is reported to
require extensive remodelling of native systems (David & Siewers, 2015).
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1.2.1.1 Gene structure, expression and regulatory mechanisms in prokaryote and eukary-
ote chassis
First generation synthetic biology platforms are used to maintain and express plasmids encoding
GRNs, which typically feature many types of genes, associated promoters and other modules
such as operators and binding sites. GRNs are self-regulating and can be designed so as to
interact with other GRNs and pathways through positive and/or inhibitive feedback. Basic GRNs
function as a toggle switch (Gardner et al., 2000), amplifier (Nistala et al., 2010) or oscillator
(Elowitz & Leibler, 2000). Their basic structure, expression patterns which allow for a gene to be
transcribed to RNA which in turn is translated into protein, and regulatory patterns which control
protein quantities vary depending on whether they are placed within a prokaryotic or eukaryotic
platform, as will be discussed below.
1.2.1.1.1 Initiation of transcription and transcription. Transcription involves the process of
reading and copying a gene sequence of DNA in order to make single-stranded RNA. This pro-
cess is carried out by RNA polymerase enzymes which catalyse the formation of phosphodiester
bonds between RNA nucleotides (Alberts et al., 2010).
Initiation of transcription differs between eukaryotes and prokaryotes. In prokaryotes, an RNA
polymerase recognises the promoter via the use of a sigma factor protein to which it is attached.
The promoter is a short conserved sequence found at the -35 and -10 positions of the start of the
transcription site, taken to be the start of the gene. The sigma factor is released after this function.
Given recognition, the polymerase binds to the gene’s DNA downstream of the promoter, serving
to unwind the double helix and initiate transcription of one of the DNA strands which acts as a
template. Transcription occurs one nucleotide at a time. The polymerase serves to bind an incom-
ing ribonucleotide (adenine (A), guanine (G), cytosine (C) or uracil (U), the latter which replaces
the thymine (T) nucleotide in DNA). The bound ribonucleotide is complementary to the nucleotide
being transcribed in the DNA strain. Thus, the single-stranded RNA chain is elongated one nu-
cleotide at a time. Following transcription of a DNA nucleotide, it it released by the polymerase,
allowing the DNA strand to wind back with its complementary DNA strand. This continues until the
polymerase encounters a stop signal at which point both the DNA and RNA strands are released
and the polymerase can attach to another free sigma factor to start the transcription process all
over again. Multiple transcripts can be in development at the same time, at different sections of
the DNA template.
In eukaryotes, transcription initiation is similar but includes extra features. For example, eukary-
otes have three different types of RNA polymerases, of which RNA polymerase II transcribes
genes which lead to protein, while the remainder transcribe genes which lead to tRNA, rRNA
and other RNAs which have catalytic functions. Moreover, the RNA polymerase is not enough for
transcription to be initiated within eukaryotes. Alongside it, a body of general transcription factors
must assemble to form the transcription initiation complex on the promoter. This complex serves
to recognise a sequence of T and A nucleotides upstream of the transcription start site known as
the TATA box, bind to it and in turn bind the polymerase to the promoter, allowing for initiation of
transcription. After attaching the polymerase to the DNA strand, the complex disassembles via a
phosphorylation reaction of the polymerase. Following transcription the polymerase goes through
a dephosphorylation reaction which enables it to start another round of transcription.
30
1.2.1.1.2 Post-transcriptional modification. Unlike prokaryotes, genes in eukaryotes tend to
be fragmented with sequences of non-coding DNA known as introns placed between the coding
parts of a gene which lead to protein, which are known as exons. This means that the two sets
of chassis undergo different post-transcriptional processes prior to translation. In prokaryotes,
mRNAs transcribed from genes in plasmids are free to begin the translation process even while
transcription is ongoing. The ribosome latches on to the free end of the mRNA strand and initiates
the translation process simultaneously.
In eukaryotes, transcribed mRNA is not yet mature and undergoes several reactions while tran-
scription is ongoing. RNA processing for mRNA transcripts includes capping, polyadenylation and
splicing. Capping is the addition of a guanine nucleotide having a methyl end to the 5’ end of the
RNA which facilitates transportation of the RNA chain to the cytoplasm. Polyadenylation, on the
other hand, involves the processing of the 3’ end. Two enzymes serve to cut off the RNA at a spe-
cific sequence towards its 3’ end and then add a tail which is composed of hundreds of adenine
nucleotides. These modifications help to stabilise the mRNA, flag it up for translation and also
aid its transfer out of the nucleus. Thirdly, following capping, the introns are removed via splicing
which also serves to attach the remaining exons together. This is carried out via a spliceosome
which is a complex of small nuclear ribonucleic proteins (snRNPs). Finally, given that the network
of interest was inserted within the genome, post-transcriptional processing involves transportation
of the mature and processed mRNA from the nucleus via pores in order for ribosomes, which are
found in the cytoplasm, to have access to it. Transport of mRNA is only enabled when certain
proteins recognise and bind parts of the mRNA, such as the 5’ cap, and flag up the structure for
transport.
Note that following transcription, RNA can also be modified via folding. This means that RNA
is not only an important middle step in the development of proteins to act as a template during
translation but that it can also function as an end in itself by folding into a 3D structure to act as a
catalyst. For example, ribosomal RNAs (rRNAs) are the backbone of the ribosome while transfer
RNAs (tRNAs) are important to the translation process and in the handling of amino acids for
attachment to a protein chain as it is being synthesised. Other small RNAs are used for house-
keeping duties.
1.2.1.1.3 Initiation of translation, translation and post-translational modifications. Given
the above, translation of the mRNA goes ahead to lead to protein. While in prokaryotes, one
mRNA can code for several proteins (polycistronic mRNA), in eukaryotes one mRNA codes for
one protein (monocistronic mRNA). At this stage, nucleotides on the mature mRNA are read in
sets of three to lead to the addition of a single amino acid to the protein chain. This process is car-
ried out via the ribosome. Prokaryotic and eukaryotic ribosomes are similar. They are a complex
made of proteins and rRNA. The RNAs form the core while the proteins are found on the surface.
The ribosome is made of a small and larger subunit, with each serving a different purpose. The
smaller subunit matches tRNAs to the codon triplet being read while the larger subunit develops
a covalent bond between amino acids. The ribosome contains three principal sites to which the
tRNA binds in succession; the A-, P- and E- sites. Whereas in prokaryotes, circa 20 amino acids
are read per second, the rate of translation is lower in eukaryotes, with circa two amino acids
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being read per second. tRNAs are important at this stage because they allow the amino acid to
bind to the tRNA’s 3’ end and the corresponding triplet of RNA nucleotides to bind to the tRNAs
anti-codon site, as explained further below.
Translation is initiated at a start site, represented by the codon AUG. In prokaryotes, upstream
of the start codon is a ribosome binding site (RBS) to which the ribosome can bind directly and
initiate translation. In eukaryotes, an initiator tRNA is required. The tRNA binds tightly to the
middle P- site on the small ribosomal subunit, along with a set of initiation factor proteins. The
mRNA is then bound to the ribosomal subunit from its 5’ end which is flagged up by the mRNA’s
cap and the AUG site located. At this stage, the initiation factors unbind, making way for the larger
ribosomal subunit to assemble and form the ribosomal complex.
This allows for the progression of translation which involves reading the mRNA, capturing tRNAs
and elongating the polypeptide chain. A tRNA initially binds to the A- site by pairing with a triplet of
nucleotides, leaving no empty nucleotides between the previously translated nucleotides and the
present ones. Only a tRNA which has the correct amino acid which corresponds to the nucleotide
triplet in the A-site can bind. The polypeptide chain then uncouples from the tRNA on the P- site
and instead forms a bond with the amino acid on the A- site’s tRNA. The large subunit then shifts
onwards, moving this tRNA from the A-site to the P- site. As the small subunit also shifts onwards,
the process is repeated and at the end of the next round the tRNA would be at the E- site, at which
stage it is ejected. Thus, the polypeptide chain is developed from the N- to the C-terminus.
The end of translation is similar in prokaryotes and eukaryotes. The stop codon is not bound by
any tRNA but instead binds to a release factor protein which catalyses the addition of a water
molecule to the polypeptide chain and hence the release of the chain. At this stage the mRNA is
also released, as are the large and small ribosome subunits. Following release, the protein is still
not complete and often requires folding and other post-translational modifications. There are over
a hundred covalent and non-covalent modifications which can be carried out, the most common
being glycosylation and phosphorylation.
1.2.1.1.4 Transcriptional regulatory mechanisms in prokaryote and eukaryote chassis.
Regulation of protein production can occur at any of the transcription, translation and post-translation
steps discussed above, although the use of transcriptional regulatory remains the more common
method.
In prokaryotes, transcriptional regulation makes use of regulatory DNA sequences known as op-
erators, which are located upstream of the transcription initiation site. The operator can vary in
size up to thousands of nucleotides, with eukaryote sites tending to be larger in size. Transcrip-
tional regulator proteins can bind to the operator at multiple locations, resulting in a strong bond. A
common DNA binding motif in eukaryotes is zinc fingers. The transcriptional regulator can act as
a repressor or as an inducer, either inhibiting or allowing for transcription to take place. A repres-
sor blocks the binding of RNA polymerase. Activators, on the other hand, work by enabling the
binding of RNA polymerase which otherwise would not recognise the promoter site. An operator
can be bound by both repressor and activator proteins.
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In eukaryotes, a regulatory protein can be bound several thousand nucleotides upstream of the
promoter. This is possible because the DNA sequence appears to bend to allow easier contact
between the bound protein and promoter. Moreover, eukaryotic cells tend to require combinations
of proteins to regulate gene expression, known as combinatorial control, as opposed to regulation
in prokaryotes wherein one protein can perform the function. Moreover, due to the structure of
prokaryotic genes, a single regulatory protein can have an effect on the expression of multiple
genes by having these genes within the same operon. This level of co-ordination of expression
of multiple genes can also be implemented in eukaryotes but requires the use of combinatorial
control which makes use of a common trigger protein.
Positive and negative transcriptional feedback loops can be used for autonomous regulation of
a gene being expressed or for exerting an influence on other genes being expressed. Alberts
et al. (2010) describe feedback loops as a memory mechanism within cells, because they can
propagate specific expression patterns indefinitely.
1.2.1.1.5 Post-transcriptional regulatory mechanisms in prokaryote and eukaryote chas-
sis. Post-transcriptional regulation can also be implemented in order to regulate the amount of
protein which is synthesised. There are multiple mechanisms in place for this purpose, starting
with processes used during the mRNA maturation stage. In prokaryotes, mRNAs can be reg-
ulated autonomously by containing riboswitches. These are sequences of RNA which change
structure in the presence of certain metabolites, leading to a stop in the transcription process, re-
sulting in incomplete mRNA. Alternative splicing within eukaryotes, as another example, is a form
of post-transcriptional regulation which can lead to a transcript maturing into different products
depending on the splicing pattern.
Moreover, the half-life of different mRNAs affects the quantity of protein translated, with mRNAs
with short half-lives allowing for only a small amount of proteins to be translated prior to degra-
dation when compared to mRNA with similar length but longer half-lives. The mRNA half-life is
in part regulated by the 3’ end untranslated region (UTR) lying between the end of the coding
sequence and the polyadenylation tail.
Regulation can also occur at the initiation of translation. At this stage, a protein which blocks the
RBS can be utilised to prevent translation. In other cases, proteins which bind to RBS can serve
the opposite purpose, wherein translation can only be initiated if a protein is bound to the site,
allowing the ribosome to locate the AUG site. Moreover, in eukaryotes, the same principle can
work by having proteins bind to the 5’ cap on mRNA chains and inhibit or activate translation by
blocking or aiding the ribosome.
RNAs, for example, micro RNAs (miRNAs) can be used instead of proteins to regulate translation.
miRNA can bind to a set of proteins to form the RNA-induced silencing complex (RISC complex)
which in turn binds to mRNA. The miRNA in the complex can only bind to complementary mRNA,
with the complementary sequence tending to be located in the mRNAs’ UTR. This results in the
mRNA being degraded by nucleases present in the complex, at which stage the RISC body is
released. This results in the cell having no template to use for translation.
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RNA interference is a mechanism which draws from the above process and is nowadays engi-
neered to control translation. It is naturally employed to remove viruses. The mechanism works
via the use of a nuclease which cleaves double stranded RNA into small interfering RNAs (siRNA)
which are then incorporated into a RISC complex, which discards one of the strands. The remain-
ing siRNA strand then acts as a template for other RNA, serving the same purpose as the miRNA
described above. Thus, siRNA which recognise any of a number of templates can be used to
control gene expression.
Given mature protein, regulation can be carried out via the protein’s half-life and stability. Pro-
teases serve to degrade proteins by cutting the peptide bonds between amino acids. Eukaryotes
use whole complexes of proteases to degrade proteins, known as proteasomes, which recognise
ubiquitin proteins which are covalently linked to other proteins. The process of ubiquitin getting
attached to the protein is known as ubiquitylation, wherein enzymes add a ubiquitin train to the
protein on recognition of certain motifs. They serve to flag up the proteins for the proteasome to
break down.
1.2.1.2 Transcriptional and post-transcriptional regulation mechanisms in GRNs in com-
monly used synthetic biology chassis
1.2.1.2.1 Transcriptional regulation mechanisms. Systems which regulate transcription in
prokaryotic DNA-plasmids and prokaryotic/eukaryotic operons are based on the principle that reg-
ulatory proteins and transcription factors (TFs) bind to corresponding operators and DNA-binding
domains (Khalil & Collins, 2010), on the same (Gardner et al., 2000) or neighbouring (Elowitz
& Leibler, 2000) operons. This serves to activate or repress transcription by either allowing for
or hindering the recruitment or binding of RNA polymerase at the promoter. The effects of the
regulatory proteins can often be reversed through signals or chemicals to which the proteins has
a greater affinity than the operator (Hillen et al., 1983).
For example, the tet operon to which the family of Tetracycline Repressor (TetR) proteins bind is
widely employed in synthetic transcriptional control, as are the bacterial λ phage operon, inducible
lac operon, repressible trp operon and inducible/repressible ara operon which is equipped with
two promoters (PC and PBAD). Although many of these simple regulation mechanisms are based
in prokaryote organisms, they have also been implemented in eukaryotes (Khalil et al., 2012; Wu
et al., 1997; Hu & Davidson, 1987).
Apart from the use of single operon systems, combinatorial systems have also been engineered,
wherein operators and promoters from different operons are placed together to form a ‘mosaic’
operon, as developed by Lutz and Bujard (1997). For example, Elowitz and Leibler (2000) use the
‘PLlac01’ promoter-operator system, which combines the strong PL promoter from the λ phage
with the lac operator to which LacI binds and inhibits transcription. This strategy can be seen in
multiple other studies, such as Stricker et al. (2008), Basu et al. (2004) and Gardner et al. (2000).
Thus, with the manipulation of a limited number of promoters and operators acting either as one
unit or as a cascade, a variety of devices, including logic gates, have been developed (Moon et al.,
2012; Tamsir et al., 2011).
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1.2.1.2.2 Applications of transcriptional regulation. In the Registry of Standard parts, three
of the top ten most widely used parts from the database are TetR- and LacI-controlled promoters
(Registry of Standard Biological Parts, 2014). Similarly, of the ten most used promoters, seven are
inducible and only three are constitutive. Moreover, of the synthetic proof-of-principle oscillators
which are discussed later on, the majority use LacI, CI, TetR or Ara-based transcriptional control
(see Section 1.2.1.4 for further information). This occurs in spite of a wide variety of options for
alternative post-transcriptional regulation mechanisms which are available.
Developments have led to more diverse methods of regulating transcription via add-on features
to the relatively simpler operon systems. For example, Ye et al. (2011) use extracellular light
signals to power protein production via transcriptional pathways while Weber et al. (2009) use
an electronic current as the input signal in a transcriptionally-controlled network. More recently,
the construction of synthetic zinc fingers (Khalil et al., 2012; Beerli et al., 2000) and transcription
activator-like effectors (TALEs) (Moore et al., 2014) has allowed for more tailored transcriptional
control while CRISPR (clustered regularly interspaced short palindromic repeats) DNA has been
re-purposed to interfere with gene transcription (Larson et al., 2013).
Transcriptional regulation mechanisms have also enabled cell-cell communication efforts, known
as quorum sensing, to be implemented across a population of cells (Danino et al., 2010; Basu
et al., 2005; Kobayashi et al., 2004). A popular transcription-based quorum sensing mecha-
nism is the well characterised system extracted from the Gram-negative bacterium Vibrio fischeri,
based on the lux operon, which allows for these marine bacteria to bio-luminesce when popula-
tion density is high (Gray et al., 1994). This is just one example of a prokaryotic quorum-sensing
mechanism, with several other systems based on AHL (N-Acyl homoserine lactones) and non-
AHL based quorum sensing systems having been uncovered (Hong et al., 2012; Pappas et al.,
2004; Whitehead et al., 2001), although their use in synthetic biology remain limited. Eukaryotic
transcription-based cell-cell communication phenomena have also been developed via synthetic
biology techniques (Chen & Weiss, 2005; Neddermann et al., 2003; Weber et al., 2003). Intracel-
lular signalling systems have been used in cellular pattern formation (Liu et al., 2011), logic gates
(Brenner et al., 2007), population regulation (You et al., 2004) and virus biosensors (Tabor et al.,
2009; DeAngelis et al., 2007).
1.2.1.2.3 Post-transcriptional regulation mechanisms. Post-transcriptional regulation mech-
anisms which can occur at the mRNA maturation, translational or post-translational level vary
widely in their scope. A common approach in translational mechanisms is to regulate protein
production via mRNA stability and splicing (Auslander & Fussenegger, 2013), the use of riboreg-
ulator/riboswitches molecules (Carothers et al., 2011; Bayer & Smolke, 2005; Isaacs et al., 2004)
and synthetic RNA designs to prevent the binding of the ribosome (Na et al., 2013). Others use
another form of RNA molecules; antisense RNAs, which can be released via the use of trigger
molecules to bind to mRNA and inhibit translation (Tigges et al., 2009; Wagner & Simons, 1994).
Post-translational regulation, on the other hand, can be effected through synthetic scaffolds pro-
tein (Park et al., 2003) to regulate signalling pathways or proteolysis repression, wherein a pro-
tease rapidly degrades an expressed protein, causing a decrease in protein levels (Maldonado et
al., 1999). To this, Lienert et al. (2014) add the manipulation of signal pathways, wherein protein
receptors are modified so as to respond differently to intra- and extra-cellular signals, as seen in
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Dueber et al. (2003).
Research is now at the stage where hybrid regulatory mechanisms with both transcriptional and
post-transcriptional control features are being developed, such as the study in Auslander et al.
(2012). In fact, the mammalian oscillators discussed further on (see Section 1.2.1.4) use a hybrid
approach by employing a combination of anti-sense expression, siRNAs and inducible promoters
(Tigges et al., 2010, 2009). However, as Auslander and Fussenegger (2013) discuss, whilst this
diverse custom-made regulatory toolkit appears to enrich the field of synthetic biology, it is also
representative of the fact that the field still lacks a set of standardised, modular methods to regu-
late product synthesis post-transcriptionally.
1.2.1.3 Synthetic GRNs in commonly used synthetic biology chassis
Synthetic GRNs are developed via wet lab techniques and mimic and optimise GRNs found in the
natural world. Studies on natural networks date back to the 1950s, when it was argued that the
body houses ‘internal’ mechanisms (Menaker, 1996). Although theoretical studies on synthetic
networks followed shortly afterwards (Goodwin, 1963), the first synthetic GRNs were designed,
constructed and characterised at a much later stage with the development of a bistable toggle
switch (Gardner et al., 2000) and oscillator (Elowitz & Leibler, 2000), both of which are based on
transcriptional regulatory mechanisms.
Following this, multiple proof-of-principle synthetic GRNs were constructed, some as simple as
the single-gene auto-inhibiting, stabilising GRN (based on the Tetr and Lac transcriptional regula-
tory loops) (Becskei & Serrano, 2000), others more complex such as the inverter network (based
on the Lac regulatory loop) (Yokobayashi et al., 2002), the mammalian oscillator (Tigges et al.,
2009) and the ‘calculator’ GRN (Friedland et al., 2009). With the maturation of different branches
of synthetic biology, applications based on synthetic GRNs, such as biosensor capsules used for
artificial insemination in cows (Kemmer et al., 2011), a partially synthetic pathway for producing
the anti-malarial drug artemisinin (Paddon et al., 2013) and a light-controlled cascade for control-
ling glucose levels in mice (Ye et al., 2011), also saw fruition.
1.2.1.4 Oscillatory synthetic GRNs in commonly used synthetic biology chassis
GRNs which function as oscillators are networks wherein protein is produced periodically, based
on the interaction of negative feedback loops between the network’s components. Several natural
systems are known to function as oscillators, although underlying design principles remain only
partially understood (Agapakis & Silver, 2009). The most widely studied system is the circadian
rhythm, which is the body’s natural clock. The circadian rhythm is a dual-feedback GRN with a
24-hour period that is responsible for wake-sleep cycles in mammals, bacteria and plants (Mc-
Clung, 2006). It is of interest, especially to synthetic biologists, because of its robust (consistent)
behaviour in spite of functioning within a noisy environment (Sayut et al., 2007). Other natural
biochemical oscillations are found in insulin secretion (Koseska et al., 2011), ATP concentrations
during glycolysis, mitosis processes (Novak & Tyson, 2008) and AMP production (McKane et al.,
2007) to name but a few. Improper function of these networks is associated with health problems
such as diabetes, epileptic seizures, and sleep disorders (Aziz et al., 2010; Danino et al., 2010;
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Weldemichael & Grossberg, 2010; Menolascina et al., 2012).
Synthetic biology comes into play because it can be used to gain knowledge and understand clock
mechanisms by constructing synthetic networks which function as clocks, as seen in the repres-
silator design (Elowitz & Leibler, 2000), which is a three-gene network based on the circadian
rhythm (which also has three central clock-keeping genes) (Khalil & Collins, 2010). The drive for
the forward-engineering of synthetic oscillators as a means of understanding natural systems is
echoed by Fung et al. (2005) in the development of the first metabolic oscillator, by Tigges et al.
(2010, 2009) in the construction of the first mammalian oscillators and by Danino et al. (2010) in
the design of the first quorum-sensing oscillator, amongst others. See Figure 1.1 for a list of the
main proof-of-principle synthetic oscillators which have been developed in-vivo and Figure 1.2 for
an overview of the network designs used in these studies.
Prior to this, the first oscillator which was widely studied, albeit in silico, was the Goodwin os-
cillator (Figure 1.2a) through which the basic design principles required for oscillations to occur
in a molecular network were deduced. The Goodwin oscillator is a single gene network which
auto-represses gene regulation (Goodwin, 1963). It has often been employed in the study of cir-
cadian rhythms, as seen in Gonze et al. (2005) and Ruoff et al. (2001), amongst others. In spite
of its simplicity, there were no efforts to develop a Goodwin oscillator in vivo prior to Stricker et al.
(2008).
Different synthetic oscillators developed to the proof of principle devices presented above include
those by Perry and Ninfa (2012) wherein the synthetic oscillator was integrated into the bacterial
chromosome. This is different to the approach usually taken in synthetic GRN integration in bacte-
rial hosts, where the network is introduced as a plasmid via chemical or electrical transformation.
Chromosomal integration increased plasmid stability and allowed authors to keep track of plasmid
copy number, which can not be done accurately if the network exists as a circular DNA-plasmid.
Kim and Winfree (2011), on the other hand, constructed a synthetic oscillator in vitro, bypassing
the use of host cells and making use of just two commercially-available enzymes (bacteriophage
T7 RNA polymerase and ribonuclease H). Mondragon-Palomino et al. (2011) developed on the
work by Stricker et al. (2008) by focusing on the entrainment of a population of engineered cells
into which the oscillator developed by Stricker et al. was inserted. The study is unusual in that
it chooses to build on the developments of a previous project. The majority of other studies are
original and isolated designs.
There is also a large number of in silico studies available on oscillators, focusing on design al-
gorithms (Chang et al., 2013; Chen & Chen, 2010) and specific oscillator features, such as the
impact on the network of cell division (Gonze, 2013), growth rate (Osella & Lagomarsino, 2013),
nutrients available, intra- and extra-cellular conditions (O’Brien et al., 2012) and quorum sensing
Figure 1.1 (following page): Synthetic proof-of-principle oscillatory GRNs which have been
constructed and modelled mathematically within synthetic biology using first generation
chassis. ‘Org’ stands for the organism in which the network was inserted, ‘Osc’ stands for per-
centage of oscillating cells, ‘Amp’ is amplitude of oscillations, ‘Dur’ is the duration of time over
which oscillations were observed, ‘CHO’ stands for Chinese Hamster Ovary cells, ‘S.G’ is sys-
tematic growth, ‘Var’ stands for varying, ‘f.u’ stands for fluorescent units, ‘r.a’ is relative amplitude,
‘a.u.’ stands for GFP arbitrary units, ‘Ref.’ stands for Reference.
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(a) Goodwin Oscillator as devel-
oped by Goodwin (1963)
(b) Repressilator as developed by Elowitz and Leibler (2000)
(c) Amplified Negative Feedback Oscillator as de-
veloped by Atkinson et al. (2003), Tigges et al. (2009,
2010)
(d) Amplified Negative Feedback Oscillator with
Additional Negative Regulation as developed by
Stricker et al. (2008) and Danino et al. (2010)
(e) Metabolator as developed by Fung et al. (2005)
Figure 1.2: Diagrams representing abridged versions of positive and negative regulatory pathways
used within proof-of-principle synthetic oscillators developed: a) Goodwin Oscillator as proposed
by Goodwin (1963), b) Repressilator as developed by Elowitz and Leibler (2000), c) Amplified
Negative Feedback Oscillator as developed by Atkinson et al. (2003), Tigges et al. (2009, 2010),
d) Amplified Negative Feedback Oscillator with Additional Negative Regulation as developed by
Stricker et al. (2008) and Danino et al. (2010) and e) Metabolator as developed by Fung et al.
(2005). Red pathways represent negative regulation while green pathways represent positive
regulation. Grey pathways in 1.2e represent metabolic flux.
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(Chen & Hsu, 2012; Lang et al., 2011; Garcia-Ojalvo et al., 2004).
Most oscillators are constructed using non-standardised parts. Moreover, characterisation and
analytical work is not consistent across the networks. For example, some authors chose to report
on oscillatory quantitative dynamics such as the amplitude (Danino et al., 2010; Tigges et al.,
2010, 2009) whereas others do not (Stricker et al., 2008; Fung et al., 2005). Even when ampli-
tude readings are given, different units of measurement are used such as ‘GFP arbitrary units’
and ‘fluorescence units’, making comparison between them difficult. Having no consistent quan-
tification of the amplitude also means that there is no information available on the strength of the
GRN. Progress of synthetic biology as an engineering field will require that genetic networks have
the same set of characterisation data available, similar to the data information sheets proposed
by Canton et al. (2008), which show that abstraction and modularity is important not only in the
construction stages but also in the data communication process.
Throughout, noise plays an important role within synthetic oscillators. In spite of mimicking the
circadian rhythm which is extremely robust, the synthetic copy by Elowitz and Leibler (2000) is
prone to stochasticity and a varying amplitude (Drubin et al., 2007) and other oscillators similarly
exhibit damped or varying dynamics which are attributed to noise (Fung et al., 2005; Atkinson
et al., 2003). As it became clear that the role of noise within natural and synthetic oscillators could
not be left out of the equation, there was an increase in the number of studies which analyse and
debate the role of noise within networks (such as Raser and O’Shea (2005, 2004) and Elowitz
et al. (2002) to mention but a few).
1.2.1.4.1 Characteristics of proof-of-principle synthetic oscillator GRNs. The majority of
synthetic oscillators constructed have been developed for E. coli chassis. Moreover, proof-of-
principle networks tend to be relatively simple constructs, both in terms of the size and number
of genes used and the type of feedback implemented. In spite of this architectural simplicity, re-
sulting dynamics can be very diverse. As a case in point, proof-of-principle oscillators have been
constructed with periodic cycles lasting from 13 minutes (Stricker et al., 2008) to 26 hours (Tigges
et al., 2010). In addition, the oscillations have different profiles, from non-sinusoidal relaxation
oscillations characterised by a steep amplitude rise and gradual decrease (Tigges et al., 2010;
Atkinson et al., 2003) to standard sinusoidal oscillations (Danino et al., 2010; Stricker et al., 2008).
1.2.1.4.2 The scope of mathematical models in the development of synthetic oscillator
GRNs. For most synthetic oscillator constructs, deterministic or stochastic mathematical models
were developed in tandem. A deterministic model ignores random events and is simpler, since it
avoids use of probability measures. However, this can result in shortcomings since variability can
have significant effects on the system. In fact, studies where both a deterministic and stochastic
model were developed generally resulted in different observations being made. In both bacterial
(Purcell et al., 2010) and mammalian (Tigges et al., 2010) dual feedback networks, oscillations in
the stochastic model occurred over a larger set of conditions and replicated in-vivo dynamics more
faithfully than deterministic counterparts. As with choice of characterisation experiments carried
out, depth and scope of mathematical analysis varies between studies. Danino et al. (2010),
Tigges et al. (2009), Fung et al. (2005) and Elowitz and Leibler (2000) use their model to carry
out parameter space analysis while Atkinson et al. (2003) use modelling to scan multiple GRN
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designs and select those networks which function as oscillators. It appears that only the minority
of studies (Tigges et al., 2010; Stricker et al., 2008) employ mathematical models in an iterative
cycle of designing and testing GRNs. Stricker et al. (2008) are one such case, using mathematical
analysis to locate a second region in the parameter space where oscillations occur to extract a
minimal oscillator from their original device, based on a singular dominant negative feedback loop.
In summary, proof-of-principle synthetic oscillator GRNs which have been developed for use within
first generation synthetic biology host cells have been discussed with respect to the variety of dy-
namics displayed, mathematical models developed, the stochastic environment and standardisa-
tion efforts, amongst other. The data shows that proof-of-principle networks are simple in structure
and predominantly use transcriptional regulation which has nonetheless led to a rich variety of os-
cillatory dynamics.
1.2.1.5 Design principles for oscillatory synthetic GRNs
The following section adopts a more theoretical viewpoint and discusses design principles re-
quired to construct an oscillatory synthetic GRN which is also autonomous. Networks that can
only be made to function as an oscillator via an external periodic input are classed as non-
autonomous. Even though there is little in terms of standardisation and the synthetic GRNs
presented so far vary in their use of parts, choice of parameters and environment conditions,
certain basic theoretical considerations are common to all oscillatory synthetic and natural GRNs.
This section will show that fundamentally, oscillations occur due to a series of activation and inac-
tivation biochemical regulatory processes (Novak & Tyson, 2008).
Of the features discussed, the combination of negative feedback, time-delay and non-linearity
is necessary and sufficient to cause instabilities which result in oscillations, or in mathematical
terms, a Hopf bifurcation (Erneux, 2009). Positive feedback is an optional design feature which
can make oscillations more robust (Stricker et al., 2008). It remains unclear as to whether noise
features within the systems have a constructive effect on oscillations. These design considera-
tions can not be considered in isolation without reference to each other.
Although theoretical, this section will not adopt a strong mathematical undertone. Mathematically,
the design principles backing the development of oscillations have long been elucidated (Tyson &
Othmer, 1978; Griffith, 1968). It was only more recently that these started being incorporated in
in vivo biological studies. For a detailed review of mathematical work on oscillators, see Purcell
et al. (2010) and Novak and Tyson (2008).
1.2.1.5.1 The role of negative feedback. Synthetic oscillators have a dominant negative feed-
back loop which acts at the transcriptional or translational level. Mathematically, it is defined as
follows:
aaaa
aaaaIf there is a path from the ith node, pi, of an interaction graph to itself, p(i, i) = (i = p1)
ep2,p1−−−−→
p2 . . . pl−1
epl,pl−1−−−−−→ pl = i for l > 2, where epk,pj is the interaction between the nodes pk and
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pj , then this path is said to be a feedback loop. In addition, this feedback loop is said to
be negative if
∏l−1
m=1 sm+1,m =-1 where sk,j = 1 if the interaction between the jth and kth
component is positive and sk,j =-1 if the interaction between the jth and kth component is
negative (Wang et al., 2005)
aaaa
It has been proven mathematically that a system without negative feedback can not perform os-
cillations and moreover, the negative feedback must be dominant for a system to perform stable
oscillations, as shown in Muller et al. (2006) who looked at n-gene repressilators. These are a
generalisation of the three-gene repressilator by Elowitz and Leibler (2000), which can be defined
as a ring of genes where gene l inhibits the expression of gene l + 1 and the last gene n inhibits
gene 1.
In addition to the strength of the negative feedback within the GRN, the type of negative feedback
used (whether it is transcriptional or post-transcriptional) influences network dynamics, as seen
in Guantes and Poyatos (2006), where two dual-feedback oscillators were developed, with sig-
moidal translational repression and linear post-translational repression respectively. Oscillations
occurred in both models, but were triggered by different biochemical processes. In spite of similar
parameter choices, the network with translational repression had larger amplitudes, more tunable
frequencies and increased sensitivity to external stimuli than the oscillator with post-transcriptional
repression.
1.2.1.5.2 The role of time-delay. Delayed negative feedback (Tigges et al., 2010, 2009; Stricker
et al., 2008) prevents a synthetic oscillator from attaining homeostasis (mathematically referred
to as a stable steady state), which occurs if plain negative feedback is present in the system.
A time-delay within a negative feedback pathway can be defined as the time interval τ between
when a reaction r in the pathway is initiated and terminated. For example, a time-delay within
a synthesis pathway can be defined as the time interval τ between when a gene a starts be-
ing transcribed and when the product protein A starts exerting an influence on genes within the
GRN. This delay occurs due to the time taken for transcription, translation, post-translation and
translocation processes. Thus, time-delay is implemented naturally and automatically in in vivo
networks, especially in eukaryote platforms. In fact, Purcell et al. (2010) attribute the robustness
of oscillations in the mammalian devices by Tigges et al. (2009) and Tigges et al. (2010) to natural
time-delay caused by synthesis in eukaryotic platforms.
It has been proved mathematically (through use of the Bendixson’s Negative Criterion) that no
two-gene network can produce sustained oscillations without a sufficient element of time-delay or
equivalent (Xiao & Cao, 2008). A time-delay prevents protein levels from converging to a stable
steady state and instead introduces an element of instability, acting as a bifurcation parameter and
forcing the system to undershoot and overshoot the homeostatic state. This forms a loop around
this state known as a limit cycle, which represents oscillatory dynamics (Wang et al., 2005).
If insufficient time-delay is present in the GRN architecture, additional time-delay can be gener-
ated by introducing supplementary genes within the feedback path so as to generate a negative
feedback cascade (Novak & Tyson, 2008). This has the additional advantage of making the net-
work more insensitive to noisy fluctuations, since effects of noise are averaged out along the
cascade (Andrianantoandro et al., 2006). An alternative way of generating sufficient time-delay is
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to modify protein synthesis by, for example, slowing protein folding (Orosz et al., 2010).
Time-delay can have additional benefits such as increasing robustness of oscillations (Orosz et
al., 2010; Fung et al., 2005). It can be used to tune period and amplitude (Wang et al., 2005;
Chen & Aihara, 2002) and prevent damped oscillations (Tigges et al., 2010). However, time-delay
can work against network stability if it is too long. It can cause oscillations to become irregular or
even to stop altogether (Fung et al., 2005). This can be explained by the fact that the time-delay
is inherently related to the value of biochemical parameter rates (for example, the longer the time-
delay in transcription, the lower the transcription rate). Thus, suboptimal time-delay values can
result in corresponding parameter values which fall outside the parameter range which represents
the range of possible values of the k parameters in a GRN region which allows for oscillations and
Hopf bifurcations to occur. In fact, it has been shown that different parameter combinations within
the same network architecture can cause damped oscillations, undamped oscillations and bista-
bility (Atkinson et al., 2003).
There is an equivalent way of considering time-delay; via ratios of activator modules’ to repressor
modules’ biochemical reaction rates. The activator module refers to the set of genes which source
products which activate synthesis. Similarly, the repressor module is the set of genes which when
expressed, produce proteins which inhibit expression. Research has found that for oscillations
to occur, the timescales of activator synthesis and degradation rates should be higher than the
respective repressor rates (Guantes & Poyatos, 2006; Hasty et al., 2002a). This allows for an
accumulation of activator molecules and proteins prior to inhibitive proteins becoming dominant,
thus introducing instability and non-linearity. This accumulation produces the same effect as a
time-delay. Zhou et al. (2008) suggest that the main difference between having a time-delay and
specific activator-to-repressor ratios is that whereas a time-delay leads to sinusoidal oscillations,
fast-activator-slow-repressor dynamics lead to relaxation oscillations. In order to ensure correct
ratios, several modifications can be carried out. One of the more common is the fusion of proteins
to small stable RNA A (ssrA) tags to shorten decay rates, as seen in Goodwin (1963) and Elowitz
and Leibler (2000).
1.2.1.5.3 The role of non-linear dynamics. A third design requirement for an oscillator de-
vice is to have a source of non-linearity within the network (Purcell et al., 2010; Chen & Aihara,
2002) which prevents the system from achieving equilibrium, in line with the role of time-delay.
Non-linearity is best described and assessed mathematically (Teschl, 2012): aaaa
iiiiiiiiiIf protein level variations of a system of gene products x = (x1, x2, . . . , xn) are represented
by the set of first-order, differential equations
dx(t)
dt
= f(t − τ,x), the system is said to be
linear if for i = 1, . . . , n it can be represented as
dxi(t)
dt
= gi(t− τ) +
∑n
j=1 ai,j(t− τ).xj , and
is said to be non-linear otherwise.
aaaa
It is manifested via feedback and the level of co-operativity within the GRN (Kaern et al., 2003;
Goldbeter, 2002). Several synthesis and metabolic processes, such as substrate and product
inhibition and diffusion are non-linear reactions wherein, in abstract terms, the output is not pro-
portional to the amount of causative agent which is present. This means that products of reactions
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do not vary at a constant rate. This is often represented by the Michaelis-Menten enzyme theory
(Wilkinson, 2011), with corresponding reactions being represented as a biochemical rate by using
the Hill equation (Bernot et al., 2013).
Non-linear reactions are also found within bistable systems (Goldbeter, 2002). This highlights
how the different design requirements must be combined together to lead to the required oscil-
latory output. In fact, Becskei and Serrano (2000) developed a 1-gene repressilator which led to
homeostasis in spite of dominant negative feedback. Stricker et al. (2008) developed a similar
design, but based the negative loop on the lac operon, repressed by the LacI tetramer rather
than the tetR operon, repressed by the TetR dimer. Their network exhibited oscillations. Purcell
et al. (2010) attribute the onset of oscillations in the Stricker et al. design to a stronger element of
non-linearity within the system due to the extra polymerisation reactions required. Non-linearity,
although implicitly present in the choice of genes, time-delay and feedback within the network, is
rarely discussed by authors.
1.2.1.5.4 The role of positive feedback. A positive feedback loop activates gene expression
and results in increased protein levels. Similarly to negative feedback, it can act at the transcrip-
tional or post-transcriptional level. Although direct positive feedback is not a necessary component
for oscillations to occur (see Stricker et al. (2008) and Elowitz and Leibler (2000)), many choose to
incorporate it into the GRN design (Danino et al., 2010; Tigges et al., 2010; Atkinson et al., 2003).
Positive feedback loops and pathways are found in several natural systems, including circadian
clocks (Guantes & Poyatos, 2006), cell cycles and pacemaker neurons (Pomerening et al., 2005).
This suggests that positive feedback has distinct benefits on network dynamics and system sta-
bility. In fact, in E. coli (Stricker et al., 2008) and Xenopus laevis (Tsai et al., 2008) synthetic
oscillators, positive feedback allowed for a more tunable frequency, increased robustness and
more regular oscillations.
1.2.1.5.5 The role of noise. GRNs function within a noisy environment caused by extrinsic
sources (neighbouring cells, temperature gradients, metabolites, ribosomes, cell-cycles) and in-
trinsic sources (biochemical synthesis and metabolic processes, protein leakage) (Strelkowa &
Barahona, 2010). The effects of noise is felt strongly when gene copy numbers are low (Tigges
et al., 2009; Yoda et al., 2007). Larger numbers of gene and mRNA copies, on the other hand,
even out the effect of noise. Some suggest that extrinsic noise sources have a larger impact on
gene networks since they cause fluctuations which are not synchronised with the network (Andri-
anantoandro et al., 2006).
The role of noise is not well understood, particularly as to whether it has a constructive or destruc-
tive role on network dynamics. Bates et al. (2014) show that different levels of noise can have a
varied effect on GRN dynamics, with optimal noise levels leading to stochastic resonance in the
intracellular genetic perceptrons being analysed. In a study showcasing how noise can have a
constructive role, Bratsun et al. (2005) carried out both deterministic and stochastic analysis on a
time-delayed negative feedback network and showed that while no limit cycles were observed in
the deterministic case, the instabilities caused by noise resulted in oscillations. In multiple other
GRNs, noise has led to stochastic coherence (Borg et al., 2014; Purcell et al., 2010). Guantes
and Poyatos (2006) claim that stochasticity increases survival chances of cells within a constantly
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changing environment. This is exhibited in the analytical work of Stricker et al. (2008), wherein a
noise component retains oscillations mostly stable by preventing damping of oscillations.
Noise can also have a detrimental effect and result in a varying amplitude and loss of uniform
distribution of genetic material during cell division, as seen in Fung et al. (2005) and Elowitz and
Leibler (2000). Robustness in the presence of noise remains a major challenge within synthetic
biology (Tigges et al., 2010), partly because it is unintuitive (Guantes & Poyatos, 2006). As Elowitz
and Leibler (2000) postulate, progress needs to be made to at least distinguish between noise and
unknown intrinsic causes, including chaos. For example, only a minority of cells transformed with
Elowitz’s repressilator showed oscillations, which they only account in part to stochasticity (Purcell
et al., 2010). Similarly, Fung et al. (2005) are hesitant in their conclusions regarding noise, saying
that noise may account for dynamics observed. Although there are multiple papers looking at
sources and effects of noise, fewer discuss options on how to control them. Danino et al. (2010)
offer one solution, arguing that quorum sensing has the potential to lessen and overcome effects
of internal stochasticity. To this, Purcell et al. (2010) and Barkai and Leibler (2000) add that the
effects of noise can be minimised by selecting specific parameter rate combinations.
In summary, dynamics and dynamic features in networks, such as oscillations, robustness, sen-
sitivity, amplitude, period and tunability depend on the optimal combination of the design require-
ments discussed above (delayed negative feedback within a non-linear system) and the levels of
noise which are present.
1.2.1.6 Construction and characterisation of oscillatory synthetic GRNs
1.2.1.6.1 Construction of oscillator plasmids. The first step in the development of GRNs
prior to insertion into a first generation chassis, is to design a DNA plasmid consisting of promoter
sites, operators, genes, selective markers plus additional features such as restriction sites. The
layout of the plasmid allows for the implementation of the theoretical considerations discussed in
the previous section. For example, Stricker et al. (2008) use a higher copy number of the activa-
tor cassette than the repressor cassette, to enable an increase in protein levels before inhibition
becomes effective, in line with time-scale and non-linearity requirements.
Preliminary work often requires other modifications to strains, genes and backbones which are to
be used. These include altering synthesis and degradation rates such as fusing of the short 11
amino acid ssRA tags which flag up the protein for degradation. This was seen in Danino et al.
(2010), Stricker et al. (2008), Fung et al. (2005) and Elowitz and Leibler (2000), who used the
same machinery to destabilise both functional and reporter genes. Other common modifications
include replacing the start codon GTG with ATG in order to increase transcription efficiency (as
seen in Stricker et al. (2008), Fung et al. (2005), Elowitz and Leibler (2000)).
1.2.1.6.2 Insertion of oscillator networks into cells. Transformation processes are not dis-
cussed in detail by any of the authors and therefore it is not possible to deduce the reasons for their
choice of transformation. It appears that standard transformation (Elowitz & Leibler, 2000), co-
transformation of multiple plasmids (Stricker et al., 2008), electroporation (Atkinson et al., 2003)
45
or transfection (Tigges et al., 2009) procedures are employed. Fung et al. (2005), on the other
hand use the CRIM (conditional replication integration and modular) method by Haldimann and
Wanner (2001) to integrate their plasmid into the bacterial chromosome using site-specific recom-
bination. For bacterial oscillators, the use of plasmid ensures a high copy number. This is useful
because high copy numbers of a GRN may reduce the effect of noise (Yoda et al., 2007; Tigges
et al., 2009). For oscillatory GRNs within mammalian and yeast cells, chromosomal integration is
the most straightforward route for gene insertion, which helps to lead to a more stable construct
which is more feasible to maintain than cells transformed with plasmid DNA which require a con-
stant supply of selective agents (Gu et al., 2015). Moreover, chromosomal integration allows for
tighter control over the copy number.
Following plasmid insertion with any of the methods mentioned above, cells which were success-
fully transformed were selected using antibiotics, with Kanamycin and Ampicillin being the most
widely used, followed by Chloramphenicol and Gentamycin. Culturing of cells is not discussed
in depth, either, with authors mentioning use of media, culturing conditions and equipment only
briefly. Culturing conditions are important because they can be used as a tuning measure. For
example, a different source of carbon can result in varying oscillation characteristics, as seen in
Fung et al. (2005). Only Atkinson et al. (2003) make specific reference to the turbidity, stirring and
aeration conditions of the cell culture in the chemostat used.
1.2.1.6.3 Characterisation, microscopy and cell imaging. By looking at oscillator charac-
terisation efforts, it is evident that emphasis is placed on live single cell phase contrast and
fluorescent microscopy and subsequent analysis of images acquired during this step. Authors
do not provide detail on characterisation assays, choosing instead to discuss microscopy and
flow cytometry efforts and whether oscillations are observed during this stage. This is relatively
easy to do via fluorescent microscopy due to the use of fluorescent reporters as the GRN output
(Shaner et al., 2005; Kain et al., 1995) which make for simple visual detection of oscillations in
the protein quantities. The reporter gene is set up within the plasmid or system, such that while
it does not influence regulatory genes, they affect its expression via the use of feedback loops
and environment-responsive promoters. Thus, the reporter protein is able to reflect activation or
inhibition events occurring within the plasmid. In the case of the oscillators, variants of the green
fluorescent protein (GFP) are the most widely employed reporter protein, with only Tigges et al.
(2010) (from the studies reviewed above) using a variant of the yellow fluorescent protein (YFP).
In order to detect oscillations in protein levels, authors use a combination of time-lapse fluores-
cent (Tigges et al., 2010), bright-field (Fung et al., 2005) and phase contrast (Stricker et al., 2008)
microscopy to observe cells. Preparation, mounting devices, exposure times and frequency vary
from study to study, however, it is interesting to note that images were taken every 2-5 minutes
in all cases with the exception of Tigges et al. (2010) where images of CHO cells bearing the
synthetic oscillator were taken every 20 minutes. Apart from single-cell microscopy, Stricker et al.
(2008) also carry out flow cytometry to extract population-level information on the oscillations.
The number of cells/colonies observed and the duration of observations varies. For example,
Elowitz and Leibler (2000) observed more than 100 cell lineages in each of three micro-colonies
transformed with the repressilator. Tigges et al. (2010), on the other hand, transfected 35,000
cells but carried out studies on less than 600 cells in each case. Authors tend to not provide
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the rationale behind their decisions. Efficiency of cell transformations, percentage of cell viabil-
ity and the type of cells analysed (for example, all cells or viable cells only) is frequently not stated.
Moreover, few discuss replication and validation issues although Fung et al. (2005) mention that
triplicate measurements were carried out, while Stricker et al. (2008) develop a device to allow
for parallel analysis of three isolated colonies. Fung et al. (2005) and Elowitz and Leibler (2000)
report using a reporter-only plasmid, using different promoters and adding inducer molecules,
amongst others, to analyse control plasmid dynamics.
1.2.1.6.4 Microscopy imaging set-up. Authors emphasised the importance of retaining a
closed system with stable conditions and insulation throughout the duration of live cell imaging.
Danino et al. (2010) placed the microscope within a plexiglass incubation chamber, Elowitz and
Leibler (2000) used a Peltier device, which is a device wherein heat is transferred between two
different materials, while Fung et al. (2005) use an objective heater.
Interestingly, whereas most authors mount cells on glass slides in some form or another, Danino
et al. (2010) and Stricker et al. (2008) make use of a microfluidic devices to culture and observe
cells. In the Stricker et al. (2008) design, the device has a well with a height of 1µm which allows
a monolayer of E. coli to grow while being constantly supplied with nutrients. By developing three
such wells, three populations could be analysed simultaneously. The authors also incorporated
heater channels in the device through which to pass heated water to maintain temperatures and a
switch to allow for induction experiments to be carried out. The design, based on a yeast chemo-
stat device, takes into account how to remove cells on the edge of the growing population which
are spilling out of the well. The device was built using standard soft litography techniques and
polydimethylsiloxane (PDMS) material.
The design of Danino et al. (2010) was based on that of Stricker et al. (2008), with modification
such as a higher well height (1.65µm instead of 1µm) to allow for better nutrient supply. In their
review, Gulati et al. (2009) describe how microfluidics has the potential to be a foundational tech-
nology in synthetic biology, and proof of this can be seen in the above smart designs which allow
for the culturing of populations of cells and single-cell imaging within the same set-up.
1.2.1.6.5 Post-imaging analysis. Following the imaging process, analysis had to be carried
out to quantify the fluorescence observed. Again, one can see a variation here in the methods
described and the software programs used by the authors. Stricker et al. (2008), Fung et al.
(2005), Atkinson et al. (2003) and Elowitz and Leibler (2000) chose to analyse cells manually by
picking a number of cells on the last image and back-tracking through the previous images to build
the cells’ fluorescent trajectories. Elowitz and Leibler (2000) then analyse their data using Fast
Fourier Transforms. Tigges et al. (2010) develop their own custom-built software within MATLAB
to segment, track and select oscillating cells.
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1.2.1.7 Mathematical modelling of oscillatory synthetic GRNs
Mathematical modelling of GRNs is a powerful tool and encompasses a wide variety of theories
and techniques with which countless studies have been carried out. This section will focus on
those techniques which are made use of for the modelling of synthetic genetic oscillators. These
methods serve three purposes; carrying out quantitative analysis, qualitative analysis and param-
eter estimation. Quantitative analysis leads to the development of a deterministic or stochastic
mathematical model from which time series profiles of protein expression dynamics within the
GRN can be simulated. Qualitative analysis, on the other hand, can be used to analyse a net-
work’s innate properties such as stability and robustness. Parameter estimation is used in the
deduction of biochemical rates, which are often unknown and which often are the foundation for
the models.
In the study of network dynamics, a mathematical model serves the purpose of describing pro-
tein turn-over due to feedback signals under different environmental conditions (Chandran et al.,
2008; de Jong, 2002; Smolen et al., 2000). This reduces the need for time- and cost-expensive
experiments and provides a “rigorous, systematic, and quantitative linkage between molecular
and microscopic phenomena on one hand and macroscopic process performance on the other”
(Bailey, 1998). A model can be either deterministic or stochastic. The former ignores all sources
of noise within and surrounding the GRN under consideration. The latter, although more biolog-
ically relevant, is more tasking to solve and analyse. Non-linear, first-order ordinary differential
equations (ODEs) are often used to represent synthetic gene oscillators, although alternative
representations can be used. These include discrete representation techniques such as directed
graphs (Yongling & Su-Shing, 2006), Bayesian and boolean networks (Saadatpour & Albert, 2013)
which make use of logic networks to represent network topology and dynamics, and continuous
representation techniques such as partial and stochastic differential equations (Das, 2009).
1.2.1.7.1 Deterministic modelling of network dynamics.
1.2.1.7.1.1 Ordinary differential equations. Deterministic, non-linear, first-order, continuous
ordinary differential equations (ODEs) are often used to represent protein and mRNA kinetics
in synthetic gene networks as seen in Danino et al. (2010), Tigges et al. (2010, 2009), Stricker
et al. (2008) and Elowitz and Leibler (2000). A differential equation shows the interplay between
production rates and consumption rates of a product (protein or mRNA) xj , based on feedback
and biochemical processes within the network such as transcription, translation and degradation
(Smolen et al., 2000). ODEs which represent gene oscillatory networks often incorporate a time-
delay τ to take into account time taken up by ‘long’ biochemical processes such as transcription
and translation. In general, a first order non-linear ODE with time-delay τ for a gene product xj is
represented by:
dxj
d t
= f(t− τ,x)− g(t− τ,x); τ > 0
where x = (x1, ..., xn) represents the concentrations of n gene products S1, ..., Sn, t represents
the independent variable (often taken to be time), d xjd t is the change in xj over time, f(.) is the
function representing rate laws which lead to an increase in xj and g(.) is the function represent-
ing biochemical rate laws which lead to a decrease in xj quantities. By incorporating a delay τ ,
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Danino et al. (2010) call the system of ODEs a system of delay differential equations (DDEs).
Technically, the system can be solved through integration or numerical methods to give a solution
xj(t), however, this is often a very complex process and simulations are used instead to visualise
the products’ trajectories over time without having to solve the ODE. These are discussed later on.
Mass action kinetics, first-order and second order rates, and Michaelis-Menten kinetics are used
to represent f(t−τ,x) and g(t−τ,x) in terms of the different biochemical reactions occurring in the
GRN. Michaelis-Menten equations, in particular Hill functions (Figure 1.3), are used to represent
positive and negative regulatory reactions (Danino et al., 2010; Tigges et al., 2009; Fung et al.,
2005) and binding reactions (Chandran et al., 2008). Given a gene product xj , the Hill function
for positive feedback is defined as:
h+(xj , θj , n) =
xnj
xnj + θ
n
j
where θ is the disassociation constant/threshold which represents the value xj for which the Hill
function has value 1/2 (Cinquemani et al., 2008) and n is the Hill coefficient, also referred to as
the steepness/co-operativity coefficient, which influences the gradients of the Hill curve (de Jong,
2002). For n < 1, the system is said to have negative co-operativity, indicating lack of affinity.
For n > 1, there is positive co-operativity or multimerisation, depending on the context (Chandran
et al., 2008). At n = 1, there is no co-operativity. In order to model negative feedback, the function
1− h+(xj , θj , n) is used (de Jong, 2002).
Figure 1.3: Hill function for different values of the hill coefficient, n = 2, 5, 10, 50. The x-axis
represents the value of the input x, while the y-axis represents the value of the Hill function, h+.
The dissociation constant is set at 1.
Authors use ODEs, one for each product of interest, to represent the GRN system to a different
degree of complexity. Elowitz and Leibler (2000) choose to model proteins and their respec-
tive mRNA in terms of the transcription, translation and degradation rates. Fung et al. (2005),
on the other hand, choose to model transcription and translation as one main synthesis rate.
Stricker et al. (2008), at the other end of the spectrum, develop a very detailed model, account-
ing for transcription, translation and post-translation processes such as folding, dimerisation and
tetramerisation of the proteins involved. Both Tigges et al. (2010) and Elowitz and Leibler (2000)
develop second generation models which incorporate a greater level of complexity than the basal
simpler model they start with. For example, Elowitz and Leibler (2000) choose to model the bind-
ing and unbinding of the protein to the operator in their second model, while Tigges et al. (2010)
distinguish between whether the regulatory molecule (tetracycline) was intra- or extracellular. This
allowed them to extract a previously undetected relation between oscillation frequency and gene
dosage.
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1.2.1.7.1.2 Simulating deterministic ODEs. As a system of ODEs increases in complexity
and size, direct integration to solve the equation becomes infeasible. Instead, analytical meth-
ods such as numerical integration can be used to simulate product trajectories indirectly without
explicitly solving the equation. One option is to use the family of single-step, finite difference meth-
ods, where the continuous time domain [0, T ] is discretised and broken down into a set of small
time-points ti. The value of the ODE is then calculated in iterations. At a time ti, the value of
the ODE (i.e. the change in product quantity) is calculated based on its values at time ti−1. One
such example is the Runge-Kutta method as used in Fung et al. (2005). Other methods include
the Forward and Backward Euler methods. Alternatively, multi-step finite difference techniques
such as the Adams-Bashfort algorithms can be utilised, which use concentration levels at multiple
previous time steps. However, care needs to be taken when using these methods because they
are less stable than single-step ones (Schwartz, 2008).
As an alternative to discrete methods, spectral methods can be used to represent a system of
ODEs, as seen in Fung et al. (2005) and Elowitz and Leibler (2000). A Fourier series can be used
to represent the concentration of a gene product, x(t), in terms of the frequency ω, rather than
time. However, this technique is mathematically demanding.
1.2.1.7.1.3 Assumptions of deterministic ODEs. The representation of GRNs by determin-
istic non-linear, first-order ODEs is based on a set of assumptions which serve to simplify the
system that is under consideration. This is necessary within a biological setting, where explicit
modelling of the intra- and extracellular environment, cell cycle and metabolic and regulatory pro-
cess complexity would quickly render a mathematical model infeasible to design and analyse.
The most common assumption is that there is spatial, thermal and structural homogeneity across
the cell and the cell population (Zheng & Sriram, 2010). This allows for simplification of the cell
system, since processes such as diffusion can be ignored. It also means that the system is as-
sumed to have only one independent variable, which in most cases is taken to be time (Schwartz,
2008). When this assumption fails, partial differential equations have to be used instead to repre-
sent both time and volume as independent variables. Thus, for example, in tissue and embryonic
development and diffusion processes, a set of PDEs is used to represent the dynamics and to
study pattern formation across both time and space (Zheng & Sriram, 2010; de Jong, 2002). A
second common assumption is the ‘continuum assumption’ which states that product concentra-
tions vary continuously and deterministically over time (de Jong, 2003). This allows for changes
in protein quantities to be represented by ODEs, which are continuous functions. In actuality,
gene product numbers vary discreetly and non-deterministically, which is why discrete stochastic
modelling is considered to be more biologically relevant (albeit more challenging).
Other assumptions made to reduce degrees of freedom and variables are specific to the model
under consideration. For example, Atkinson et al. (2003) assume that “the rate of translation is
directly proportional to the concentration of mRNA”, while Guido et al. (2006) assume that chem-
ical rates, such as transcription factor binding and releasing rates are at equilibrium with each
other. Whereas assumptions appear to cast doubt on the validity of the model and its connection
to the biological world, Danino et al. (2010), Tigges et al. (2009), Stricker et al. (2008) and Fung
et al. (2005), to mention but a few, have reported good agreement between results obtained in
experiments and modelling. This shows that assumptions can serve the purpose of simplification
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while remaining loyal to the molecular model.
1.2.1.7.2 Stochastic modelling of network dynamics. Stochastic modelling is used instead
of deterministic modelling to model network dynamics while introducing an element of random-
ness and noise to the network to represent intra- and extracellular noise sources (Zheng & Sriram,
2010). Stochastic models represent biological systems more accurately, especially when each cell
harbours the network in low gene copy numbers such that natural biological inconsistencies are
felt more strongly than in large populations when the impact of noise is averaged out (El Samad
et al., 2005). This is known as the ‘finite-number effect’ and is considered to be the main source
of intrinsic stochasticity (Kaern et al., 2005, 2003).
Deterministic models can be considered as average representations of stochastic network dynam-
ics in a unitary stable-state system (Kepler & Elston, 2001; Stricker et al., 2008). The stochastic
model becomes equivalent to a deterministic one at the hypothetical thermodynamic limit or in
systems of a large size (Gillespie, 1976). This does not imply that stochastic models can be
bypassed in favour of deterministic ones. In their stochastic model, Elowitz and Leibler (2000) ob-
serve variable oscillation amplitudes and a finite autocorrelation time between oscillations, which
features were not observed in deterministic simulations. Similarly, in Tigges et al. (2009), deter-
ministic and stochastic simulations yielded trajectories with the same trends but different values.
A crucial difference between a deterministic and stochastic model is that the former considers
protein concentration levels over time, whereas the latter considers the probability of protein val-
ues varying over time. More specifically, a stochastic model represents how the probability of
being in a (discrete) state X, P [X(t)], changes with time, where a state X = [X1, X2, . . . , Xn]
represents the number of molecules of products/species S1, S2, . . . , Sn (which can be proteins or
mRNA molecules). Moreover, deterministic models are reproducible. Stochastic models, on the
other hand, are unlikely to follow the same trajectory twice even when starting from the same
initial starting point (de Jong, 2003), although they still tend to follow a general trend.
A selection of the most relevant stochastic modelling terms are defined below:
• the set of possible reactions, R1, . . . , RM , which can occur in the GRN. An example of a
reaction is the translation or degradation of a protein.
• the vector vi = (vi1, vi2, . . . , vin), given a reaction Ri, which represents the changes in
molecular numbers occurring to the n species being modelled. If reaction Ri occurs, the
state X = x becomes x+vi. The M×n matrix, v, is referred to as the stoichometric matrix.
• the propensity function, ai(x), which is defined such that ai(x)dt = P [Ri occurs in [t, t +
δt)|X(t) = x] (Gillespie, 1976).
1.2.1.7.2.1 Master and Langevin equations. The Master Equation is the equivalent of the
deterministic ODE and models the probability of a Markov process X(t) being in a state x at time
t. Thus, instead of a system of n deterministic ODEs for each species in the network under con-
sideration, one Master Equation is used to represent the entire network system state. The Master
Equation, same as a set of ODEs, can be solved through direct integration or Stochastic Simula-
tion Algorithms (SSAs). Alternatively, approximations such as the Fokker-Planck equation can be
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used to simplify and solve the Master Equation. However, the Master Equation representation is
rarely used in studies because it is not practical to work with due to its complexity. An alternative
stochastic representation of the GRN dynamics is the Langevin Equation.
The Langevin equation, unlike the Master Equation, does not model probabilities explicitly and
instead models the discrete number of molecules of a species S over time. It is a stochastic
differential equation, in that a normally distributed stochastic term is added to a first-order, non-
linear (deterministic) ODE, in order to represent intrinsic and extrinsic fluctuations (Fung et al.,
2005). The Langevin equation can be derived from the Master Equation or independently. The
Chemical Langevin equations for each gene products S1, . . . , Sn with X1, . . . , Xn molecules are
given by:
dXi(t)
dt
=
M∑
j=1
vjiaj(t) +
M∑
j=1
vji
√
aj(t)Wj(t)
where the first term represents a drift term proportional to the time increment dt, while the second
term represents a diffusion term proportional to
√
dt. W (t) represents white noise as a theoretical
notion of stochasticity.
Effectively, the Langevin equation is the summation of deterministic terms with an additional
stochastic summation. Thus, the Langevin equation deals with a continuous, Markov process,
as opposed to a (discrete) jump, Markov process, which is generally the case in a Master Equa-
tion. The Langevin formula is effective given that a time increment dt is chosen such that the
propensity function aj(t′) ' aj(t) for t′ ∈ [t, t+ dt] is true i.e. dt is small enough so as to not affect
propensity values aj significantly and so that events occur independently of each other according
to a Poisson distribution. Moreover, it is assumed that there are multiple occurrences of each
reaction Ri in the time interval [t, t + dt] such that the Central Limit Theorem can be employed
to approximate the Poisson distribution by a Normal one. These assumptions are satisfied if the
system is large, but may be incompatible otherwise (Gillespie, 2000).
The Langevin equation can be solved through numerical algorithms such as the Euler-Maruyama
algorithm or simulated using SSAs (Mistry, 2007; Tuttle et al., 2005). The latter are a much more
powerful and intuitive tool to use. In fact, studies on synthetic GRNs often bypass the develop-
ment of a Master and Langevin Equation, and use SSA profiling directly to generate time series
trajectories of the products without solving equations directly. Fung et al. (2005) is one excep-
tion, using the Langevin equation to represent the metabolator stochastically via the addition of a
Gaussian white noise element to the parameters within the system. The equation is then solved
directly via the analytical weak Euler scheme.
1.2.1.7.2.2 Stochastic Simulation Algorithms. As already mentioned above, SSAs are used
in order to simulate trajectories of a set of species S1, . . . , Sn for which the change in quantity over
time is represented by differential equations showing the biochemical processes which cause the
variation. SSAs make use of Monte Carlo (MC) sampling and simulation techniques to map a
species Si’s trajectory over time. This bypasses the use of integration to solve the differential
equation.
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MC algorithms work by iteratively generating random numbers which in this case are taken to rep-
resent change in the dependant and independent variables. This serves to build the time series
profile of the species incrementally, using time as the independent variable. When run several
times from the same initial condition, an average trajectory output can be extracted (Gillespie,
1976). In addition, statistics such as the mean number of proteins and the autocorrelation func-
tion can be generated to give an overview of protein kinetics.
1.2.1.7.2.3 The Gillespie Stochastic Simulation Algorithm. The most widely used family of
SSAs in simulation of oscillator GRNs is the Gillespie algorithm and its derivatives. They have
been used in Tigges et al. (2009), Stricker et al. (2008), Guantes and Poyatos (2006), Fung et
al. (2005) and Elowitz and Leibler (2000) with good agreement with experimental results, even
though the original Gillespie algorithm does not take time-delayed reactions specifically into ac-
count.
The Gillespie algorithm is based on the ‘inversion method’ MC simulation technique. Given that
it can be assumed that the system has thermal and spatial homogeneity, a pair (τ, j) is randomly
generated. Given the system is at a time t, τ represents when the next reaction, taken to be Rj ,
will take place at time t + τ . The protein and mRNA numbers are then updated with vj from the
stoichometric matrix at this time-point according to the reaction Rj which takes place, and the
iteration is repeated until an upper time limit T is reached. The Gillespie SSA makes use of a joint
probability density function (pdf), p(τ, j|x, t) for the time increment τ and reaction Rj . This is a
normalised, continuous function over [−∞,∞]. The pdf is defined as the probability that a reaction
Rj will be the next and only reaction to occur in [t+τ, t+τ+δτ) (Gillespie, 1977) where δ is a small
increment. The probability has value equal to ajexp[
∑M
i=1 aiτ ]. Thus, the number of molecules
X1(t), . . . , Xn(t) of species S1, . . . , Sn which are dependant on the reactions R1, . . . , Rm can be
simulated over time.
The algorithm consists of the following steps (Gillespie, 1976):
Step 1: Given thermal and spatial homogeneity, set the time variable t = 0. Store initial values for
the n variables X1 = x1, X2 = x2, . . . , Xn = xn. Store M propensity values a1, a2, . . . , aM
of the M reactions. Calculate the probability density function p(τ, j). Define the final time
point, T .
Step 2: Randomly generate a pair (τ, j) using the Direct Method (see below). This entails gen-
erating two numbers r1 and r2 from the uniform distribution U(0, 1) and calculating the pair:
τ =
1
a
ln(
1
r1
)
j ∈ {1, . . . ,M} s.t.
j−1∑
i=1
ai < ar2 ≤
j∑
i=1
ai
Step 3: Update t to t+ τ and xi to xi + vji for i = 1, . . . , n. Recalculate the probabilities aj .
Step 4: Store new values X1, X2, . . . , Xn. If t > T or aj = 0 for all possible j, Stop. Else Repeat
from Step 2.
aaaa
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In Step 2, the Direct Method is used to first generate τ , then j, based on the fact that p(τ, j) =
p1(j|τ)p2(τ) where p2(τ) = aexp(−aτ) and p1(j|τ) = aj/a, using a =
∑M
j=1 aj (Gillespie, 1976).
1.2.1.7.2.4 Variations of the Gillespie algorithm. The Gillespie algorithm assumes that pro-
cesses (reactions) have similar time-scales (El Samad et al., 2005). It has been suggested that
a biological system can have fast-slow dynamics (Cinquemani et al., 2008) and that ‘fast’ dynam-
ics, such as dimerisation cause the Gillespie algorithm to become inefficient (Tuttle et al., 2005).
These and computational efficiency issues have been addressed through the development of
modified algorithms which are based on the original Gillespie algorithm and are either more com-
putation and time efficient or more precise.
Alternative exact (where it is assumed that only one reaction occurs per iteration) and approxi-
mate (where it is assumed that more than one reaction occurs per iteration) simulation algorithms
have been developed. These include the Next Reaction Method (Gillespie, 1977) which assesses
when each and every reaction will next take place and then picks the one which occurs closest to
the current time, the Tau Leaping Method which uses a pre-defined time-step τ (Gillespie, 2001),
the Next Reaction Method which can be used when rates are time-dependant (Gibson & Bruck,
2000), the Optimised Direct Method and the Slow Scale SSA which takes advantage of fast-slow
reactions to simplify the set of reactions under consideration (Cai & Wang, 2007). The Delay
Stochastic Simulation Algorithm (DSSA) (Barrio et al., 2006) and the binomial Tau-leap DSSA
(Leier et al., 2008) are used when the system is non-Markovian and take into account time-delay
due to biochemical reactions.
Alternatively, hybrid SSAs can be used (Salis & Kaznessis, 2005). In these algorithms, both de-
terministic and stochastic techniques are implemented. One such hybrid model, developed for
prokaryotic biological systems, models biochemical processes such as transcription as stochastic
processes while others such as degradation are represented by deterministic processes (Cin-
quemani et al., 2008). Similarly, in another hybrid model, faster reactions are assumed to be
continuous and are modelled using Langevin equations while the slower reactions are modelled
using differential Jump equations (Tuttle et al., 2005).
1.2.1.7.3 Qualitative analysis of dynamics. Following quantitation of network dynamics, in-
depth qualitative analysis is often carried out in order to assess network properties such as sta-
bility and robustness. The three main methods used in analysis of oscillatory GRNs are briefly
discussed.
1.2.1.7.3.1 Bifurcation analysis. Bifurcation analysis is the study of bifurcation parameters
and the changes in network dynamics which they cause. A bifurcation of equilibrium occurs when
there is a qualitative change in the dynamics of the system such as the onset of oscillations or
bistability due to a change in stability or the type of equilibrium. This is the result of a change in
the value of a key parameter known as a bifurcation parameter which crosses a threshold value
and, for example, causes the GRN to start exhibiting oscillations as in the case of a supercritical
Hopf bifurcation. In synthetic GRNs, a common bifurcation parameter is time-delay. In light of this,
it is easier to understand why changing time-delay within a GRN’s architecture influences protein
expression: it can push the system towards or away from stable equilibrium and can be used in
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order to tune GRN dynamics (Guantes & Poyatos, 2006). Thus, bifurcation analysis is carried out
in order to understand how critical parameters affect protein dynamics.
In order to study bifurcations it is necessary to study the equilibria (steady-states, critical points)
of the network. Mathematically, an equilibrium is defined as a trajectory or point, φ ∈ C+, where
φ = x for some x ∈ R+n satisfying f(µ, x) = 0 which is a system of non-linear first order ODEs for
species S1, . . . , Sn with quantities represented by x1, . . . , xn (Wang et al., 2005). Multiple analysis
techniques such as vector fields (Leite & Wang, 2010), Poincare maps and use of the centre man-
ifold approach (Kuznetsov, 2004) are available to analyse equilibria. However, a more standard
practice is to analyse the system’s characteristic polynomial and eigenvalues. The latter can be
deduced by using the Jacobian matrix, J or through use of the Taylor series (Xiao & Cao, 2008).
Based on the values of the eigenvalues, the type of bifurcation which takes place can be deduced.
1.2.1.7.3.2 Hopf bifurcations. There are multiple bifurcations which bring a qualitative change
in network kinetics, including a saddle node, pitchfork and flip bifurcations. A Hopf bifurca-
tion causes a non-linear system to transition to or from oscillations as seen in repressilators
(Strelkowa & Barahona, 2010; Elowitz & Leibler, 2000), the one-component Goodwin oscillator
(Goodwin, 1963), dual-feedback oscillators (Guantes & Poyatos, 2006; Atkinson et al., 2003) and
the metabolator (Fung et al., 2005). It should, however, be noted that in theoretical work, oscil-
lations have been found to occur through other bifurcations, notably the saddle node bifurcation
(Guantes & Poyatos, 2006). In order to define a Hopf bifurcation mathematically, the following
theorem is used (Seydel, 1994):
Theorem 1. In a two-dimensional system, a birth of a limit cycle occurs at equilibrium (x, µ) if, at
the critical value
dx
dt
= 0, also known as the Hopf bifurcation point/threshold:
1. a pair of the Jacobian matrix’s simple conjugate eigenvalues σ1 = σ2 = ε + iη for j = 1, 2
have ε = 0, with no other eigenvalue having zero real part
2.
dε
dt
6= 0.
This is known as a Hopf bifurcation. The initial period is t0 =
2pi
η
.
aaaaaaaa
In an n-dimensional system, for n > 2, a Hopf bifurcation occurs when, in addition to the above
conditions, the remaining eigenvalues have negative real parts. Bifurcations can be visualised
using bifurcation diagrams (Stricker et al., 2008) and phase portraits (Fung et al., 2005). Note
that given non-zero real parts, the system would result in a stable or unstable focus for negative
and positive real parts respectively, wherein the trajectory either spiral towards or away from a
node. When the real part has value 0, the spiral transforms into a limit cycle (Lakshmanan &
Rajaseekar, 2012; Izhikevich, 2007).
There are two types of Hopf bifurcation; supercritical and subcritical (Byrne et al., 2014). In a
supercritical bifurcation, a stable equilibrium bifurcates to a stable limit cycle, while in a subcritical
bifurcation, an unstable limit cycle disappears in the equilibrium. The difference between a super-
and subcritical bifurcation is whether the system is non-linearly stable or unstable at ε = 0. In
order to analyse the onset of limit cycles following a Hopf bifurcation, it can be more convenient
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to represent the system of differential equations using the normal or polar-form representation,
although this approach is less conventional.
1.2.1.7.3.3 Stability and robustness analysis. Stability analysis complements bifurcation anal-
ysis when studying equilibria. In the case of synthetic oscillators, stability analysis serves to as-
sess whether limit cycles and periodic solutions are stable (unchanging over time) or sensitive to
changes in parameter values. Thus, stability analysis is concerned with the long-term dynamics
of the model under study and the likelihood of the model changing dynamics following small per-
turbations. This translates to the study of homeostasis and robustness. Mathematically, a solution
x(t) is stable if for each ε > 0 and t0 ∈ R there exists δ = δ(ε, t0) > 0 such that if x(t) is a solution
and |x(t0) − x(t0)| < δ then |x(t) − x(t)| < ε for all t > t0 (Grant, 1999) i.e the path does not
diverge, irrespective of small perturbations within parameter values.
The simplest form of steady state analysis can be carried out by solving for d xjd t = 0 in a set of
ODEs. This was done in Elowitz and Leibler (2000) to assess the stability of different parameter
values, including the basal translation rate and the level of co-operativity in the Hill equation for
gene transcription. Floquet theory is also widely used to assess the stability and quality of periodic
solutions. It has been used in studies by Strelkowa and Barahona (2010) and Fung et al. (2005)
to deduce quality of oscillations in the n-gene repressilators and the metabolator respectively.
In conjunction, or as an alternative, Poincare maps can be utilised to deduce results on stability.
As with bifurcations, analysis is carried out on the model’s eigenvalues. In this case, the eigen-
values of the Monodromy matrix (which will not be defined here) are calculated and analysed.
Using this technique, by varying one parameter (the glycolytic rate), Fung et al. (2005) were able
to assess the glycolytic conditions under which the network is more stable. The authors do not
develop this analysis further, stating that it may not help in the explanation of network dynamics.
This highlights the importance of using mathematical analysis as a means to an end, rather than
an end in itself.
In line with stability analysis, the aim of robustness analysis is to check whether oscillatory dy-
namics are maintained for all parameter combinations. In most studies, analysis is carried out
by simulating time-series wherein a parameter is perturbed by a small amount, , which can be
random or pre-defined. By assessing the generated time-series using the modified parameters,
a deduction can be made as to whether the network is susceptible to changes in a particular pa-
rameter or not (Tigges et al., 2009; Stricker et al., 2008).
Another technique for the analysis of robustness uses temporal logic to represent network be-
haviour as a set of conditions and check whether combinations from the parameter space lead
to oscillations which satisfy these conditions. In the method developed by Batt et al. (2007),
robustness conditions, φ, are represented by a set of atomic propositions for each species Si
in terms of quantities xi (xi > a(t), xi < b(t)) and logic operators (and, or, not) (for example,
φ = xi > a ∨ xj > b). Then, given an n-dimensional parameter space P , which represents the
ranges within which parameters can vary, a system is said to be robust if P is valid for φ, meaning
that every parameter combination in P satisfies the condition (behaviour) φ. In order to carry out a
validity check, numerical methods are used. The first step is to discretise the n-dimensional state
space P , based on the solutions of the differential equations and to divide it into sections (Batt
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et al., 2007). Afterwards, points from each section are selected and sampled, and if each sample
satisfies the conditions, the network is said to be robust.
1.2.1.7.4 Parameter estimation of GRN biochemical reaction rates. Prior to the develop-
ment of a model based on counteracting biochemical rates, all biochemical rate parameters being
used in the model must be defined. It is rare for all of the model’s rate parameters such as the
transcription rate, folding rate and degradation rate to be known. Often, researchers use reported
values and assumptions in literature sources to select parameter values (Stricker et al., 2008;
Atkinson et al., 2003). Alternatively, parameter values can be determined via experiments, al-
though this is a time-costly exercise.
As a more efficient measure, parameter estimation can be carried out through the use of iterative
algorithms. Once the observed dynamics are quantified, computational protein trajectory data
generated from the estimated parameter values can be compared to them via a difference mea-
sure, and if the two trajectories are sufficiently agreeable, the selected parameters are retained.
Otherwise, a new parameter set is selected iteratively until the generated dynamics only differ
from observed dynamics by a pre-specified difference, .
Tigges et al. (2009) initially make use of assumptions to minimise unknown parameter values,
such as assuming that the degradation rates of all mRNA molecules are the same. Following this,
an MC-based parameter estimation algorithm is applied to find parameter values which result in
oscillations of a specific period (15 hours). The algorithm is based on an evolutionary strategy
based on weighted least squares of the difference between observed and computational data. In
cases where knowledge on parameters is very limited, substitute approaches such as the black
box approach (Zheng & Sriram, 2010) can be used, wherein parameters are rendered dimension-
less and abstract and no longer represent biochemical kinetics.
There is a wide range of parameter estimation algorithms available, including evolutionary al-
gorithms, gradient search optimisation algorithms and scatter searches (Zheng & Sriram, 2010;
Dasika & Maranas, 2008; Feng et al., 2004). Algorithms based on Bayesian parameter estima-
tion are a more recent development (Liepe et al., 2014; Filippi et al., 2013; Barnes et al., 2011b,
2011a). These are MC based searches which, rather than inferring one value for an unknown
parameter, estimate a range of values for each parameter, making the estimated data set more
biologically realistic. Bayesian statistics are based on the proviso that a probability density func-
tion is fitted to the parameter of interest. Over subsequent iterations, this density function is
refined and narrowed until a range of probable values for the parameter is extracted. In particu-
lar, the Barnes group use the sequential MC Approximate Bayesian Computation algorithm (ABC
SMC), which they use to estimate parameter values in toggle switches, oscillators and large-size
networks.
1.2.2 The value of broadening the range of synthetic biology chassis
As synthetic biology gains momentum, research is being carried out to address the lack of choice
there is with regards to network chassis via two main approaches. The first is the engineering and
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manipulation of established chassis in order to perform required functions and make for a more
efficient culturing process (Church et al., 2014; Xiao et al., 2014). This requires extensive chassis
engineering. The second option is to look beyond the traditional hosting platforms towards the
rich domain of life in the natural world and search for organisms which may already posses more
desirable physiological features which allow for the desired function than established host cells.
This implies that less genetic manipulation is needed to achieve greater robustness and optimal
performance within the cell (Zhu et al., 2012).
With regards to optimising traditional host cells, research is looking into the minimisation and
‘stripping-down’ of organisms by deleting long stretches of the genome to leave only the essential
components and machinery (Xiao et al., 2014; Gao et al., 2010a; Keasling, 2008; Glass et al.,
2006). However, due to the lack of knowledge which is available on genome structure and func-
tion, the process of genome minimisation remains empirical (Hirokawa et al., 2013).
An alternative approach is the development of cell-free systems, such as the in vitro cell-free os-
cillator by Kim and Winfree (2011). The driving principle is to pick the required replication and
metabolic machinery (enzymes and molecules) from cells and use them within an in vitro setting
(Forster & Church, 2006). Proponents of this approach suggest that this allows for more direct
and easier control of the GRN (for example, adding inducer molecules) and bypasses the use of
host cells which gain no evolutionary advantage by incorporating the synthetic network (Hodgman
& Jewett, 2012; Kwok, 2010). The use of cell-free networks has a long history in biocatalysis, and
has been used in the production of hydrogenases (Boyer et al., 2008) (which are of interest in
biofuel research) and vaccine fusion proteins (Kanter et al., 2007). However, cell-free systems
are not financially feasible when compared to in vivo systems, due to the necessity of providing
expensive energy sources and metabolites (Smith et al., 2014).
With regards to the diversification of the choice of available host cells, there has recently been de-
velopmental work on the use of plant chassis within synthetic biology for application in medicine,
biofuel and bioprocessing (Medford & Prasad, 2014; O’Connor & Brutnell, 2014). Efforts have
also been made to establish a standardised practice within plant hosts using BioBricks (Boyle
et al., 2012). There are multiple other ongoing studies to establish novel organisms as syn-
thetic biology chassis. These include the minimal mycoplasma Mesoplasma florum (Baby et al.,
2013; Panke, 2005) and Mycoplasma genitalium (Heinemann & Panke, 2006), the minimal plant
species Marchantia polymorpha (http://synbio.org.uk/marchantia/), the gram-negative bacterium
Pseudomonas putida (Nikel et al., 2014), the gram-positive bacterium Bacillus subtilis (Radeck
et al., 2013) and microalgae strains (Gimpel et al., 2013) and cyanobacteria strains (Berla et al.,
2013) for the generation of biofuel. There has even been an iGEM project looking into the use
of the frog species Xenopus tropicalis (http://2012.igem.org/Team:Evry) as a host. Thermophile
organisms such as the Thermoanaerobacter and Clostridium species have recently garnered at-
tention for the production of proteins which would be toxic in other hosts and for their ability to
withstand extreme bioprocessing and environment conditions (Menezes et al., 2015; Berla et al.,
2013).
All of the organisms discussed above face challenges and shortcomings. For example, ther-
mophiles retain a low protein yield (Lin & Xu, 2013), cyanobacteria present challenges on how to
gather (solar) energy efficiently (Berla et al., 2013) and plant cells may be very sensitive to the
networks inserted (Yang et al., 2013a).
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There is no definitive list of requirements which a host cell should be able to meet, although
Smith et al. (2014) suggest five different criteria; enabling control of GRN and host cell behaviour,
straightforward monitoring of synthetic pathway dynamics, withstanding high-throughput optimi-
sation techniques, broad application and cost-competitiveness, the latter of which is emphasised
in several reviews (Medford & Prasad, 2014; Berla et al., 2013). As further research is carried out,
Kelwick et al. (2014) propose that since extensive data has been gathered on model organisms
from across all the tree of life, these could be tested as host platforms within synthetic biology.
1.2.2.1 The Roseobacter marine bacteria genus
Despite the vast bacterial diversity in the world’s oceans, the majority of identified marine bac-
teria fall into nine major clades (Buchan et al., 2005). The Roseobacter clade comprises 20%
of coastal and 15% of mixed-layer ocean bacterio-plankton communities (Buchan et al., 2005;
Gonzalez et al., 1999). Roseobacter bacteria are extremely versatile and have been detected
in the most diverse of marine environments, from oceanic upper mixed layers to deep sea, polar
sea ice, hypersaline lakes, saline soil and even gold mines (Brinkhoff et al., 2008; Buchan et al.,
2005). The genomes of the species vary from 3.1Mbp to 5.4Mbp and plasmids range in size from
4.3Kb to 821.7Kb (Brinkhoff et al., 2008). Petersen et al. (2013) report that over 40 strains in this
clade have had their genome sequenced, and work in this area is ongoing (Buddruhs et al., 2013;
Riedel et al., 2013). In fact, these bacteria are so diverse and flexible that studies are still looking
to establish a solid taxonomic ranking (Newton et al., 2010).
In spite of the diverse environments these organisms have been found in, strains share over
89% of the 16S rRNA gene and there are common physiologies pertaining to the majority of the
Roseobacter strains, as summarised by Moran et al. (2007) and Buchan et al. (2005) and on
which information is also still being gathered (Hahnke et al., 2013; Lenk et al., 2012). These com-
mon traits include but are not limited to: the ability to generate energy via an aerobic, anoxygenic,
phototrophic process which gives them a competitive advantage over neighbouring organisms;
the ability to break down organic and inorganic sulfur compounds which may have an impact on
global sulfur cycles; the ability to oxidise carbon monoxide and degrade aromatic compounds to
use as primary growth substrates; the ability to survive as free-living organisms but also to form
symbiotic relations with algae, cephalopods, fish and dinoflagellates (note that they have also
been implicated as pathogens in oyster and coral diseases); and the ability to produce secondary
metabolites such as poison, antibiotics and quorum sensing signals for defence and cell-cell sig-
nalling purposes. The Roseobacter clade use quorum sensing based on the luxI-luxR mechanism
(Zan et al., 2014), which is also widely used in synthetic biology.
1.2.2.1.1 Novel capabilities Roseobacter offers as a synthetic biology chassis. The above
highlights how, compared to traditional synthetic biology platforms, Roseobacter use a different
set of pathways and mechanisms in several metabolism and energy-generation processes, even
bypassing the Calvin cycle in some strains (Swingley et al., 2007). This results in the ability of
Roseobacter batch cultures to flourish and use mixotrophic metabolism in spite of substrate limi-
tations (Sato-Takabe et al., 2014; Swingley et al., 2007).
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This has led to interesting research developments which showcase the potential of the Roseobac-
ter clade in biotechnology and bioengineering. Roseobacter are among the most widely studied
marine bacteria, are easily cultivated and cultured and are naturally programmed to uptake for-
eign DNA and integrate it into their own genome (Brinkhoff et al., 2008; Buchan et al., 2005).
Commercially available culturing medium is on the market, and culturing conditions for the model
strain Roseobacter denitrificans require a 30°C temperature (Piekarski et al., 2009). This strain
has a doubling time of 2.2 hours with the doubling time of other strains such as Parvularcula
bermudensis as low as 1.2 hours (Christie-Oleza et al., 2012). The versatility of Roseobacter and
ability to survive in extreme and non-replete conditions gives them an advantage over the widely
used E. coli bacteria.
Following the 2010 Deepwater Horizon oil spill in the Gulf of Mexico, research carried out on bacte-
rial communities showed Roseobacter strains to be resistant to oil poisoning since cells contained
hydrocarbon-degrading genes (hydrocarbons are predominantly found in crude oil) (Lamendella
et al., 2014; Lu et al., 2012). Research has also highlighted the ability of Roseobacter bacteria to
form homologous biofilms (Mitra et al., 2014; Elifantz et al., 2013) and they have been shown to
precipitate phosphate through the formation of crystals from waste waster (phosphate purification
is a necessary and costly process in waste water treatment) (Rivadeneyra et al., 2014).
The role which the Roseobacter clade and marine bacteria in general can play within biopro-
cessing and biotechnology is starting to garner more attention within academia and industry.
There are discussions pertaining to the use of marine bacteria in therapies to tackle infectious
diseases (Williams, 2009), the production of antibacterial compounds (Bruhn et al., 2007) and
the production of bioenergy via hydrogen gas generation (Mirza et al., 2013). Moreover, due to
the natural marine and extreme habitats and their various metabolic properties of Roseobacter,
they can be used to address both ocean bioremediation challenges which synthetic biology is
seeking to tackle (Zhang & Nielsen, 2014; Dash et al., 2013; Schmidt, 2010), and challenges in
geo-engineering, a nascent field (Calvert et al., 2014) which aims to moderate climate change via
the use of technology (Rayner et al., 2013). Discussions on the potential benefits and impacts
of geo-engineering are gaining momentum (Hardman-Mountford et al., 2013; IPCC, 2012). For
example, the 2012 iGEM project by University College London (UCL) (http://2012.igem.org/Team:
University College London) focused on the bioremediation of oceans. 50-80% of sea-debris
stranded on beaches, floating on the ocean surface and on the seabed is made up of plastic
(Hidalgo-Ruz & Thiel, 2013; Barnes et al., 2009). The team proposed that this issue be tackled
by engineering Roseobacter marine bacteria to host polyethylene degradation enzymes such as
laccase (Santo et al., 2013), enabling the organisms to function as detection-and-degradation
ocean patrollers.
The above discussion on innate processes and features of Roseobacter strains serves to bring to
attention the potential of Roseobacter bacteria as chassis within synthetic biology. As of yet, this
potential has not been tested.
1.2.2.1.2 The challenges of using Roseobacter bacteria in synthetic biology. Protocols
have been established to allow for cloning (Irie et al., 2010), transfection (Piekarski et al., 2009)
and genome modification of strains (Jaschke et al., 2011). However, in consideration of the poten-
tial application of Roseobacter organisms within synthetic biology and the principles of the field,
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the applicability of these protocols across the Roseobacter spectrum is unknown. Moreover, no in-
vestigations have been carried out into whether these marine bacteria will stably uptake synthetic
plasmids and retain them over subsequent generations, although it appears that Roseobacter can
integrate DNA into their genome to enable adaptability (Brinkhoff et al., 2008).
Since research being carried out on Roseobacter stems from the field of marine biology, there
are currently no engineering principles governing Roseobacter research. Thus, for example, the
origins of replications used in GRNs which are compatible with Roseobacter are unknown, as is
the plasmid size threshold for synthetic plasmids which can be stably inserted, the orthogonality of
synthetic plasmids with respect to the cell, and whether protocols can be simplified and abstracted
as to be applicable to all strains within the clade. Moreover, there appears to be no quantitative
or qualitative modelling of Roseobacter systems. These questions need to be answered before
Roseobacter bacteria can be established as a synthetic biology platform.
1.2.2.2 The Trypanosomatida order
Trypanosomatida are a highly divergent eukaryote order consisting of diverse unicellular proto-
zoan species (Calvo-Alvarez et al., 2015). The order includes genera of parasites found in hu-
mans, animals, insects, birds and even plants (Jackson, 2014).
1.2.2.2.1 Leishmania tarentolae in bioprocessing. Leishmania tarentolae (L. tarentolae) is
a member of the Trypanosomatida order which is pathogenic to gecko lizards (Raymond et al.,
2012) and which has been commercialised as a host cell in bioprocessing. It combines the ro-
bustness of E. coli with the complex post-translational processes of higher eukaryotes (Sugino
& Niimi, 2012). The commercialised L. tarentolae expression system is a product of Jena Bio-
science GmbH, and can be used to express recombinant ‘constitutive or inducible, intracellular
or secretory ... proteins’ (Jena Bioscience GmbH, n.d). Since L. tarentolae is not pathogenic to
mammals, it has a Level 1 Biosafety grading and does not require specialised apparatus. Sup-
pliers claim that the whole process from construction to purification of protein takes six weeks
(Breitling, 2013). The system has only been tested with LEXSY plasmid vectors, which are also
developed by the company. These are expression systems which are L. tarentolae oriented and
can be used in vivo or even in vitro (Jena Bioscience GmbH, n.d).
The LEXSY platform has been used in several projects which include the expression of antibody
fragments (Jorgensen et al., 2014), the expression of the FVII protease which has blood coagu-
lation functions (Mirzaahmadi et al., 2011) and the expression of a Trypanosoma cruzi (another
strain within the Trypanosomatida order) apurinic/apirimidinic endonuclease within a T. cruzi host
(Sepulveda et al., 2014), showing that the LEXSY system may be applicable across the Try-
panosomatida spectrum. LEXSY plasmid vectors have also been used in research on how the
immune system responds to Leishmania parasites (Chamakh-Ayari et al., 2014), how Leishmania
parasites respond to environmental cues (Dacher et al., 2014), on the use of L. tarentolae as a
vaccine-producing alternative host to hen eggs (Pion et al., 2014) and proof-of-principle projects
to clone a tetracycline-dependent system into the Leishmania mexicana strain (Kraeva et al.,
2014) and to use fluorescent reporters for facilitated and rapid screening purposes (Vacchina &
Morales, 2014). Although these were done primarily with the aim of being applied within the field
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of immunology, they pave the way for use within bioengineering.
L. tarentolae and Trypanosomatida have characteristics and culturing properties which makes
them amenable to bioprocessing. Protocols and GMP guidelines have already been developed
for Leishmania strains (Melville, 2010). Additionally, protozoa benefit from growth to high cell den-
sities (up to 1× 109 cells), control of a neutral internal pH while experiencing pH 5-7.4 externally,
low shear stress sensitivity (Fritsche et al., 2007), a rapid growth rate (circa 6.7 hours) both in
liquid media and on agar plates (Basile & Peticca, 2009) and the use of cheap fully-defined media
supplemented only with hemin (Simpson et al., 1991).
Cultures produce up to 500mg/l of recombinant protein (Breitling, 2013). In addition, cultures
are capable of retaining stability for more than 50 passages (Fritsche et al., 2007). Several Try-
panosomatida strains have been shown to have mammalian-like and homogeneous glycosylation
processes (Basile & Peticca, 2009), which allows for mammalian recombinant proteins and phar-
maceutical quality level proteins to be expressed (Breitling et al., 2002; La Flamme et al., 1995).
1.2.2.2.2 Trypanosoma brucei as model Trypanosomatida. Trypanosoma brucei (T. brucei)
is a unicellular, motile, protozoan species with a single flagellum which moves in a corkscrew-like
motion (Langousis & Hill, 2014). They belong to the Trypanosomatida order, which has ten dif-
ferent genera (Podlipaev, 2001) including Leishmania, discussed above, and Trypanosoma, to
which T. brucei belongs. T. brucei brucei is non-pathogenic to humans due to the presence of
trypanosome lytic factor (TLF) in human blood, but is pathogenic to livestock (Samanovic et al.,
2009).
T. brucei are considered to be a model organism for the research of biological processes (Ser-
ricchio & Butikofer, 2011) since they are the most widely studied organism within the Excavata
eukaryote superdomain (one of the six to have been classified) in which the Trypanosomatida
are nested. Forward and reverse genetic techniques have been successfully used on T. brucei
(Verner et al., 2010). Trypanosome parasitology has also resulted in established protocols to
culture and manipulate T. brucei via standard genetic engineering cloning techniques (Clayton
& Shapira, 2007; Clayton, 1999). An efficient trypanosomal cloning system has recently been
developed to facilitate quick plasmid construction (Batista et al., 2010), along with techniques for
genome modification, gene over-expression and RNA interference (Bouvier et al., 2013; Mans-
field & Paulnock, 2008).
Trypanosomes are distinct from higher eukaryote and mammalian systems, both in their structure
and the expression mechanisms used (Daniels et al., 2010; Basile & Peticca, 2009; Gruszynski
et al., 2006; Palenchar & Bellofatto, 2006). This was made clearer with the completion and
publication of the T. brucei genome (Berriman et al., 2005).
1.2.2.2.2.1 The life cycle of T. brucei. T. brucei switches between two predominant morpho-
logical forms, depending on whether they are within their insect carrier or host, as seen in Figure
1.4. T. brucei switches between a proliferating short, stumpy form known as the procyclic form
when it exists in a benign form inside the (carrier) insect host gut, and a second long, slender and
proliferating bloodstream form when it exists as a pathogen within blood vessels and the central
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Figure 1.4: The life cycle of T. brucei, which changes morphology depending on the host (insect
vector or mammalian host) and the state (proliferating or not) it is in. When in the insect host’s mid-
gut, the trypanosome is in its proliferative procyclic form, which morphs into a non-proliferative,
metacyclic form as the trypanosome moves to the insect’s salivary gland in preparation for transfer
into the mammalian host’s bloodstream when the vector insect bites the host. Once in the host, the
trypanosome changes to a proliferative, bloodstream form which then switches to a non-dividing,
stumpy form as it prepares to be transported back to another vector host via the bloodstream
when the vector bites the human host. The image is reproduced from Lee et al. (2007).
nervous system in its host (Langousis & Hill, 2014). During the differentiation process between
procyclic and bloodstream forms, T. brucei also differentiates into two intermediate forms (referred
to as metacyclic and non-dividing forms) as it prepares to either pass from the host to the vector
while in the blood vessels or vice-versa as it prepares to be transported from the vector to the
host by relocating to the vector’s salivary glands (Clayton, 1999). In both cases the transfer from
host to vector or vice-versa occurs when the vector bites the host. Trypanosomes can replicate
both during the bloodstream and procyclic form stages, but not during the intermediate stages
(Gruszynski et al., 2006).
The two main life stages not only lead to a different morphology but also to the expression of differ-
ent sets of protein. Thus, whereas metabolic enzyme expression increases during the procyclic
stage, expression of surface immune-evasion proteins is up-regulated during the bloodstream
form stage (Jensen et al., 2014). Whereas bloodstream form trypanosomes express variant
surface glycoproteins to coat themselves, procyclics express EP and GPEET proteins to coat
themselves (Matthews, 2005). Moreover, bloodstream form cells makes use of quorum sensing
mechanisms in preparation of transmission into the carrier host (Langousis & Hill, 2014) and as
the number of cells increase to prevent over-population (Matthews, 2005). Energy generation
is also based on different sources and mechanisms; whereas bloodstream form trypanosomes
use glycolysis, procyclic trypanosomes used a respiratory system based on the mitochondrion
(Matthews, 2005).
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1.2.2.2.2.2 Transcription in T. brucei. Transcription in trypanosomes is polycistronic, allowing
for the transcription of multiple genes, similarly to prokaryotes (Breitling et al., 2002). Mammalian
cells, by contrast, tend to have monocistronic gene clusters (Blumenthal, 2004). T. brucei genes
within the same cluster do not necessarily share the same patterns (Clayton, 1999) or expression
levels (Jensen et al., 2014), unlike bacterial counterparts. This is indicative of post-transcriptional
regulatory processes, discussed below.
Whereas protein-coding genes in higher eukaryotes are generally expressed using RNA poly-
merase II (Palenchar & Bellofatto, 2006), trypanosomes use a combination of RNA polymerase
I, II and III. Most importantly, the former transcribes proteins specific to the life cycle stage and
all variant surface glycoproteins (VSGs) (Park et al., 2011) which are surface proteins which coat
trypanosomes as part of the immune evasion strategy, as discussed below. The use of RNA poly-
merase I is believed to enable the rapid switching of these surface coats, giving it an advantage
over the host’s immune system (Park et al., 2011). Unique to T. brucei is an Expression Site
Body (ESB) which is primarily involved in the polymerase I mediated transcription of trypanosome
surface proteins and which allows for strict and rapid switching of proteins being expressed (Pa-
lenchar & Bellofatto, 2006). By contrast, RNA polymerase II transcribes mRNA and polymerase
III transcribes tRNAs, 5S RNA and snRNAs, as seen in other organisms (Palenchar & Bellofatto,
2006).
Transcription is generally followed by 5’ trans-splicing (Breitling et al., 2002) and 3’ polyadenyla-
tion (Freire et al., 2014) to allow for the division of pre-mRNAs from the polycistronic transcribed
bodies into monocistronic mature mRNA. Note that in S. cerevisiae and higher eukaryotes, co-
transcriptional splicing is more common than 5’ trans-splicing (Park et al., 2011).
1.2.2.2.2.3 Translation in T. brucei. Post-transcriptional reactions are important within try-
panosomes since protein regulation occurs predominantly at this level (Bouvier et al., 2013).
Translational efficiency also varies between the different life stages of the trypanosome, further
implying that translational processes play an important role (Jensen et al., 2014) in the regulation
of protein synthesis. Thus, whereas transcription mechanisms are similar to those in prokaryote
systems, translation mechanisms are more similar to eukaryote systems (Vasquez et al., 2014).
Gene regulation within trypanosomes is governed by a combination of mechanisms. For example,
upstream ORFs within 5’ UTRs, some of which include an ATG codon, have been shown to
regulate translation (Siegel et al., 2011) while RNA stability regulating motifs have also been
identified (Jensen et al., 2014), as has a pattern in codon usage which is implicated in translational
efficiency (Vasquez et al., 2014). In addition, transcripts have half-lives which differ over an order
of two magnitudes due to the influence of the 3’ UTR (Siegel et al., 2011) and several proteins
which control translation initiation have been identified (Freire et al., 2014).
1.2.2.2.2.4 Variant surface glycoproteins as an antigen variation mechanism in T. brucei.
Trypanosomes use an antigen variation mechanism to avoid detection by the host (Rudenko,
2011). Trypanosome cells are covered with a mono-layer of a variant surface glycoprotein (VSG).
A mono-layer can have over 5×106 dimers (Smith et al., 2009). The VSG is chosen from a
reservoir of over 1000 VSGs and pseudo-genes at the disposal of the trypanosome. The VSGs
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are similar in structure but antigenically different (Hutchinson et al., 2007). The reservoir is much
larger in size than that of other organisms which employ antigen variation mechanisms (Stockdale
et al., 2008), accounting for over 10% of protein within T. brucei (Breitling et al., 2002). The try-
panosomes can even piece together parts of different pseudogenes in order to synthesise novel
functional genes known as ‘mosaic’ genes (Marcello & Barry, 2007).
The VSG mono-layer is continuously replaced through a low frequency selection process, in or-
der to repeatedly avoid neutralisation by the host’s immune system (Hutchinson et al., 2007). A
selection of the VSGs are placed in expression sites found at the telomere via recombination or
transcription-based switching (Morrison et al., 2009; Stockdale et al., 2008). However, it appears
that only one of these sites is active and bound to the ESB extranucleolar site which contains
transcription and RNA processing machinery (Aitcheson et al., 2005). When bound, the site ac-
tively represses the remainder of the sites such that only one VSG is fully expressed (Horn &
McCulloch, 2010). The polymerase I mediated transcription mechanism transcribes VSG genes
approximately 50 times more quickly than β tubulin genes (Park et al., 2011), which goes towards
explaining why T. brucei can switch its coating so efficiently. The VSG coat is crucial to the viability
of the cell such that inhibition of expression results in cell cycle arrest (Smith et al., 2009).
1.2.2.2.3 Novel capabilities T. brucei offers as a synthetic biology chassis. T. brucei are
highly divergent eukaryotes that make use of mechanisms which are found in both prokaryotes
and eukaryotes. This combination may give T. brucei a competitive edge over more traditional
chassis in terms of doubling times, yields and ability to synthesise complex proteins. While re-
search has mainly focused on the parasitic nature of trypanosomes, the work carried out on L.
tarentolae within bioprocessing has shown that Trypanosomatida are worth investigating as chas-
sis for the synthesis of complex proteins within industrial and biotherapeutics.
T. brucei, as a model organism about which information available is more detailed than for other
strains within the order, would be the first organism to be tested. Moreover, the tools and tech-
niques which will allow for the necessary investigative studies are already in place. Research
has led to the development of protocols to culture and manipulate T. brucei via standard ge-
netic engineering cloning techniques (Clayton & Shapira, 2007; Clayton, 1999), thus allowing for
genome modification, gene over-expression and RNA interference (Bouvier et al., 2013; Mansfield
& Paulnock, 2008) during the investigation. Work has also been done to streamline the cloning
and protein production process as seen in Batista et al. (2010) and Dortay and Mueller Roeber
(2010). Calvo-Alvarez et al. (2015) and Bouvier et al. (2013) developed a series of modular fluo-
rescent and tagging proteins to bypass antibody technology, while Ma et al. (2012) developed a
vector to allow for rapid degradation of fused genes. The T. brucei genome has been sequenced,
which will allow for better selection and manipulation of genes (Berriman et al., 2005). Insights
from these studies may be applied in synthetic biology and bioprocessing. For example, the VSG
and ESB regulatory mechanism, which allow for the transcription of a number of VSG genes but
only the full synthesis of a single protein, can be applied within genome engineering.
A step towards the systematic study of trypanosomes has been the development of TrypanoCyc
(www.metexplore.fr/trypanocyc/), which is a database of metabolic pathways for T. brucei built
using algorithms based on literature and genome sequence data. Plans have also been drawn
to develop an in-depth in silico mathematical model of a trypanosome, a project known as the
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‘silicon trypanosome’ (Bakker et al., 2010). Moreover, a metabolic pathway of bloodstream form
trypanosomes has been developed (Bakker et al., 1997) and used to model the effect of drugs
and compounds on the pathway and the glycosylation process, leading to effective ‘model-driven
experimental design and hypothesis-driven systems biology’ (Bakker et al., 2010).
The above has also shown that trypanosomes have unique innate mechanisms which positions
them as prime candidates for use within biotechnology, bioengineering and bioprocessing. Try-
panosomes use polycistronic transcription and sophisticated post-transcriptional capping and reg-
ulation, have a two-stage life cycle which allows for the up-regulation of different sets of genes,
different culturing conditions and antigen variation mechanisms based on switching between VSG
coat mono-layers. Several other interesting features can be found. For example, glycolysis
within trypanosomes occurs in a specialised organelle, known as the glycosome, resulting in
a metabolism pathway which is unique to these organisms (Lee et al., 2007).
1.2.2.2.4 The challenges of using T. brucei as a chassis in synthetic biology. Trypanosomes
have not yet been used as host cells in synthetic biology projects. For trypanosomes to become a
viable platform option within synthetic biology, a lot of groundwork will need to be laid. Important
technical data and techniques which are required in synthetic biology is missing. As of yet, try-
panosome mathematical models still need to rely heavily on parameter estimation, due to a lack
of data regarding biochemical parameters. The robustness of trypanosome strains has not been
established. Previous work on trypanosomes which used fluorescent proteins did not require live,
single-cell analysis, as is often necessary in characterisation processes in synthetic biology. Thus,
there are no protocols in place to track single cells.
The establishment of T. brucei as a novel synthetic chassis will require both developments to the
existing technology and increased and more in-depth knowledge of T. brucei mechanisms.
1.3 Aims and Objectives
The aim of this project is to establish Roseobacter clade marine bacteria and T. brucei as
synthetic biology chassis. This work addresses the gap within synthetic biology resulting from
the limited choice of host cells which are available for use in practice. Specifically, this will be
done via three main channels: by developing synthetic bacterial and trypanosomal GRNs which
function as an oscillator, by developing the necessary protocols and set-ups to allow for the char-
acterisation of the GRN within the organism, and by analysing the GRN’s dynamics within the
host. This will set the foundation for the use of the two organisms as chassis.
Roseobacter marine clade bacteria are naturally found in various diverse oceanic habitats, mak-
ing them an ideal chassis for the application of synthetic biology to bioremediation challenges in
the world’s oceans. Roseobacter also have an important ecological role in balancing global car-
bon fixation levels and as such, hold potential to be used as a tool in geo-engineering activities.
Protozoa are beginning to be exploited as host cells for industrial production of biotherapeutics
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due to their fast doubling times and mammalian-like post-translational glycosylation of host pro-
teins. As an established model organism for studying the protozoa, T. brucei provides a useful
test case for establishing synthetic biology in this phylum for the first time. T. brucei is highly diver-
gent from eukaryotes commonly used in synthetic biology to date and possesses a sophisticated
genomic machinery to evade host immune systems by rapid switching of surface antigen expres-
sion. The establishment of standard synthetic biology approaches in mathematical modelling and
synthetic gene network design in T. brucei will underpin the future application of synthetic biology
to both enhance the industrial capability of the protozoa as a class of host chassis and to probe
the pathobiology of this organism.
1.3.1 Aim 1: Establishing Roseobacter clade marine bacteria as a syn-
thetic biology chassis by identifying reliable molecular biology pro-
cedures for construction of a synthetic gene network.
The objectives of this investigation take a bifocal approach, namely to:
1. Establish straight-forward molecular biology procedures in Roseobacter clade bacteria.
The objective is to investigate the tractability of Roseobacter marine bacteria and to estab-
lish whether different strains from the Roseobacter marine prokaryote clade can be mod-
ified, cloned and chemically/electrically transformed via the use of standardised synthetic
plasmids, BioBricksTM and via reproducible, standard protocols which are applicable across
the whole clade. Moreover, the objective is to ensure that the developed protocols are easy
to follow and allow for the involvement of both professional and citizen scientists in synthetic
biology.
2. Characterise and model an E. coli oscillator plasmid in Roseobacter. Upon establishment
of robust molecular biology techniques, a plasmid encoding the standard Goodwin oscilla-
tor, following the scheme reported by Stricker et al. (2008), is used to transform competent
Roseobacter cells. The oscillatory phenotype will then be characterised and modelled math-
ematically.
This investigation will lead to insights on the potential of Roseobacter to be used in addressing
challenges in bioremediation and geo-engineering. Secondly, the development of standardised
cloning techniques will enable the participation of do-it-yourself research communities (DIYbio)
and foster the democratisation of synthetic biology.
1.3.2 Aim 2: Establish T. brucei as a synthetic biology chassis by design-
ing, modelling, constructing and measuring a Goodwin oscillator en-
coded by a novel synthetic gene network.
The objectives of this investigation take a multi-focal approach, namely to:
1. Design a synthetic trypanosomal Goodwin oscillator. Develop a synthetic network based
on the autonomous TetR negative feedback loop (Hillen & Berens, 1994). The network uses
modified Green Fluorescent Protein (eGFP) as a fluorescent reporter output. The network
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incorporates the main design features which are required for oscillations: dominant negative
feedback as per the TetR loop, and an element of time-delay and non-linearity, implemented
in the synthesis process.
2. Assemble DNA fragments to encode a synthetic trypanosomal Goodwin oscillator. Con-
struct a trypanosomal synthetic auto-inhibiting tetracycline-inducible oscillator which mimics
the Goodwin oscillator. This will be done through standard and Gibson cloning (Gibson &
Bruck, 2000) techniques within E. coli. The network will then be inserted via transfection
into both bloodstream and procyclic form T. brucei.
3. Parameterise gene network components and network dynamics to inform modelling
and characterise the network via live cell imaging. Characterise the GRN with initial
preliminary analysis carried out via protein detection techniques in order to confirm function
of individual network components. Following this, live single cell imaging using fluorescent
and brightfield microscopy will be carried out to determine whether the GRN functions as an
oscillator and to quantify observed dynamics.
4. Develop an experimental set-up for live-cell imaging of single motile trypanosome cells.
Develop a mechanical set-up to allow for live-cell imaging of single motile trypanosome cells,
as no solution is currently available on the market and in literature sources. Due to the motil-
ity of cells, a movement-constricting device needs to be developed without compromising
cell viability and which allows for the tracking and imaging of a single cell over a large span
of time. This work will draw from microfluidics, plant and parasite biology.
5. Mathematically model the synthetic Goodwin oscillator. Develop a mathematical model of
the GRN which complements characterisation work. Prior to analytical characterisation
efforts, a system of differential equations which represent protein production patterns will
be developed and sensitivity analysis carried out via stochastic time-series Gillespie sim-
ulations in order to generate protein production trajectories and establish the likelihood of
observing oscillations and the feasibility of going ahead with characterisation studies. Fol-
lowing live cell imaging, qualitative analysis will be carried out in order to assess stability
within observed dynamics.
This investigation will provide insight into the establishment of T. brucei as a synthetic biology
platform which can be exploited in the industrial and biotherapeutic sectors.
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Chapter 2
Materials and Methods
2.1 Roseobacter marine bacteria strains and culturing condi-
tions
2.1.1 Roseobacter bacterial strains
Three different marine bacteria strains from the Roseobacter clade were used; Roseobacter den-
itrificans OCh114 (Allgaier et al., 2003), Oceanobulbus indolifex HEL-45 (Wagner-Dobler et al.,
2004) and Dinoroseobacter shibae DFL 12 (Shiba, 1991). The strains were obtained from NCIMB
Ltd. (Aberdeen, Scotland).
2.1.2 Roseobacter culturing conditions
For the culturing of all Roseobacter strains, Marine Broth (MB) and MB agar (both Becton, Dick-
inson & Company, Le Pont de Claix, France) were used for liquid and static cultures respectively,
as per supplier instructions. Some protocols required the use of half-concentrated MB agar. This
was prepared by dissolving 18.7g of MB powder (instead of the standard 37.4g) in one litre H2O,
adding agar (Sigma-Aldrich, Munich, Germany) to a concentration of 1.5% (w/v), and sterilising
the solution by autoclaving (Piekarski et al., 2009).
If required, the solutions were supplemented with antibiotic as detailed below. Shaker cultures
were incubated in a Kuhner ISF-1-V Climo-Shaker Incubator (Adolf Kuhner AG, Basel, Switzer-
land) at 30-37°C at a speed of 200rpm, while static cultures were incubated at 30-37°C in a
Memmert High Precision Incubator (Memmert GmbH, Schwabach, Germany) with the petri dish
upside down to avoid condensation droplets compromising the cells.
2.1.3 Glycerol stock preparation for Roseobacter strains
6ml of sterile MB was inoculated with 6µl of the Roseobacter strain of interest from a previous
glycerol stock or with a colony picked from an MB agar plate on which the strain had been spread
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and grown for 12-16 hours at 37°C in an incubator. Following inoculation, the solution was incu-
bated for 12-16 hours in a shaker-incubator at 37°C and rotation of 200rpm, after which it was
supplemented with sterile 80% glycerol (Fisher Scientific, MA, U.S.A) at a ratio of 1:4 for glyc-
erol:culture. This was then divided into 380µl aliquots and stored at -80°C.
2.1.4 Antibiotics used for culturing of Roseobacter strains
Throughout all Roseobacter investigations, the following selective agents were added to the me-
dia at the appropriate working solutions. 100mg/ml Ampicillin (Fisher Scientific, MA, U.S.A) was
prepared by dissolving 1g Ampicillin in 10ml 0.33M NaOH, filter-sterilising the solution and storing
in 500µl aliquots at -20°C. It was used at a working concentration of 100µg/ml. 34mg/ml Chlo-
ramphenicol (VWR International Ltd., Leicestershire, U.K) was prepared by dissolving 0.34g of
Chloramphenicol in 10ml 100% ethanol and storing in 500µl aliquots at -20°C. It was used at a
working concentration of 17µg/ml. 50mg/ml Kanamycin (Sigma Aldrich, Munich, Germany) was
prepared by dissolving 0.5g of Kanamycin in 10ml dH20, filter-sterilising the solution and storing
in 500µl aliquots at -20°C. It was used at a working concentration of 25µg/ml.
2.2 Recombinant DNA techniques in E. coli
The following section lists E. coli strains, recipes and cloning techniques used in the construc-
tion of the plasmid encoding the Goodwin oscillator and all studies related to the investigation of
Roseobacter as a synthetic biology chassis which also required the use of E. coli strains.
Throughout all of the cloning processes, plasmid sequences were analysed using ApE - A plasmid
Editor(version 2.0.38) (ApE, 2012), which can be used to create graphic maps, analyse restriction
digest sites and align sequences, amongst others. All recombinant DNA techniques were carried
out at the Department of Biochemical Engineering, UCL.
2.2.1 Plasmids used for construction of the oscillator networks
The pHD1313 and pRPeGFPSIR2rp3 plasmids were provided by Dr. Sam Alsford and Dr. David
Horn from the London School of Hygiene and Tropical Medicine (LSHTM). The pHD1313 se-
quence data was provided via private correspondence by Prof. Christine Clayton from the Center
for Molecular Biology, Heidelberg. Commercially prepared plasmids were ordered from Eurogen-
tec Ltd. (Hampshire, U.K).
2.2.2 E. coli strains used in Roseobacter investigations and the construc-
tion of the oscillator networks
Three different strains of E. coli were used throughout cloning. The first is the K-12 W3110 non-
commercial strain (Hayashi et al., 2006). The second and third strains were two commercial
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brands of highly efficient chemically competent E. coli cells. These were the E. coli One Shot®
TOP10 cells (Life Technologies Ltd., Paisley, U.K), with a transformation efficiency of 1×109cfu/µg
plasmid DNA (Life Technologies Ltd., n.d) and the E. coli XL10-Gold® Ultracompetent cells (Ag-
ilent Technologies U.K Ltd., Chesire, U.K) which have a transformation efficiency of over 5×109
transformants/µg pUC18 DNA (Agilent Technologies UK Ltd., n.d).
2.2.3 E. coli culturing conditions
For liquid cultures, E. coli cells were grown in LB medium in tubes or flasks which had at least
five times the capacity of the culture volume, due to aeration requirements. One litre of LB was
prepared using 10g tryptone, 5g yeast and 5g NaCl (all Sigma-Aldrich, Munich, Germany). The
solution was then autoclaved. Cultures were grown at 37°C in a shaker-incubator at an agitation
of 200rpm.
For static cultures in petri dishes, cells were streaked or spread on solidified LB agar and incu-
bated at 37°C, with the petri dish upside down to avoid condensation droplets affecting the cells.
One litre of LB agar was prepared by using 10g tryptone, 5g yeast, 5g NaCl and 15g of agar. The
solution was then autoclaved.
If required, the solutions were supplemented with the correct antibiotic, detailed below.
2.2.4 Glycerol stock preparation for E. coli strains
E. coli glycerol stocks were prepared as per Section 2.1.3, replacing MB with LB.
2.2.5 Antibiotics used for culturing of E. coli strains
Ampicillin was used as a selective marker for all E. coli strains. Ampicillin was prepared as per
Section 2.1.4.
2.2.6 Generating chemically-competent E. coli W3110 cells
Non-competent W3110 cells were streaked from a glycerol stock onto a minimal agar plate and in-
cubated for 16 hours at 37°C. 50ml of minimal agar was made using 1ml filter sterilised 20% (w/v)
glucose (Sigma Aldrich, Munich, Germany), 50µl filter sterilised 2mg/ml thiamine (Sigma Aldrich,
Munich, Germany), 5µl filter sterilised 1M CaCl2 (Sigma Aldrich, Munich, Germany), 100µl 1M
MgSO4 (VWR International Ltd., Leicestershire, U.K), 10ml sterile 5X M9 salts and 39ml sterile
1.4% (w/w) agar. 500ml of 5X M9 salts was prepared by using 32g of Na2HPO4 (Sigma Aldrich,
Munich, Germany), 7.5g of KH2PO4 (Sigma Aldrich, Munich, Germany), 1.25g of NaCl and 2.5g
of NH4Cl (Sigma Aldrich, Munich, Germany).
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Following incubation, one colony was picked from the minimal agar plate into 5ml LB media. This
was supplemented with 100µl 1M MgSO4 and then incubated for 12-16 hours at 37°C in a shaker-
incubator and an agitation of 200rpm. From this solution, 1ml was used to inoculate 100ml LB,
which was then placed in a 37°C shaker-incubator and shaken at 200rpm until cells were at early
log phase of growth and the optical density at 600nm measured 0.3. At this point, the solution
was placed on ice for a further 10 minutes and then centrifuged at 4000rpm for 5 minutes at
4°C. As with all medium-volume (larger than 2ml) centrifugation steps, the Avanti J-E Centrifuge
(Beckman Coulter, High Wycombe, U.K) was used. The supernatant was discarded and the pellet
was resuspended with 10ml ice-cold 0.1M filter sterilised CaCl2/15% sterile glycerol and placed
on ice for 30 minutes, after which the centrifugation was repeated, the supernatant discarded and
the pellet resuspended in 1ml 0.1M CaCl2/15% sterile glycerol. The volume was divided into ten
100µl aliquots which were stored at -80°C.
2.2.7 Chemical transformation of chemically-competent E. coli cells
In all transformations detailed below, following the final incubation step, the number of colonies
on each plate were counted, and individual, clear, round colonies were picked into separate 2ml
Ampicillin-selective LB and shaken for 12-16 hours at 200rpm and a 37°C temperature. From
each of these, glycerol stocks were prepared as per Section 2.2.4, while a purification and ana-
lytical digest was carried out on the remaining 1.5ml culture as per sections 2.2.8 and 2.2.10.1
respectively in order to analyse plasmid identity.
Two controls were used to ensure a correct transformation procedure was followed. To check
whether cells are viable, a positive control where no selective marker is added to the LB agar
was used. To check whether cells were contaminated with antibiotic resistant strains, a negative
control where no plasmid DNA is added to the competent cells was used.
2.2.7.1 Transformation of chemically competent E. coli W3110 cells
A vial of chemically competent W3110 cells was taken from storage at -80°C and thawed on ice.
1-8µl of plasmid DNA/ligation mix was pipetted onto the surface of the frozen cells and the mixture
was incubated on ice for 45 minutes. This was followed by a heat-shock for 10 minutes in a 37°C
water bath. After this, 1.3ml LB was added to the cell solution, the volume was transferred to a
15ml tube and placed in a 37°C shaker with an agitation of 200rpm for one hour to allow for cell
membrane repair and antibiotic gene expression. The solution was then centrifuged for two min-
utes at maximum speed at room temperature using a Microcentrifuge 22R Centrifuge (Beckman
Coulter, High Wycombe, U.K). After, the supernatant was removed and the pellet re-suspended
with 100µl LB and spread on two Ampicillin-selective LB agar plates at a 1:9 ratio. The plates
were inverted and incubated for 12-16 hours at 37°C.
2.2.7.2 Transformation of chemically competent E. coli One Shot® TOP10 cells
A 50µl vial of TOP10 cells stored at -80°C was thawed on ice and 1-5µl of plasmid DNA/ligation
mix pipetted onto the cells. The solution was mixed gently and incubated on ice for 30 minutes.
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The heat-shock was carried out by placing the vial in a 42°C water-bath for exactly 30 seconds.
Following this, the vial was placed on ice, without mixing or shaking. 250µl pre-warmed S.O.C
media supplied with the cells was added to the mixture. The vial was then placed on its side in a
shaker-incubator and agitated for one hour at 200rpm. Finally, 10µl and 90µl of this mixture were
spread onto two selective LB agar plates. The plates were inverted and incubated at 37°C for
12-16 hours.
2.2.7.3 Transformation of chemically competent E. coli XL10-Gold® cells
One litre of NZY+ broth was made using 10g of casein hydrolysate (Sigma Aldrich, Munich, Ger-
many), 5g of yeast extract and 5g of NaCl. The solution was then autoclaved. Prior to use, the
solution was supplemented with 12.5ml filter sterilised 1M MgCl2 (Sigma Aldrich, Munich, Ger-
many), 12.5ml filter sterilised MgSO4 and 20ml of 20% (w/v) filter sterilised glucose.
A vial of XL10-Gold® cells was taken from -80°C and thawed on ice. A 100µl aliquot was pipetted
into a pre-chilled 15ml Falcon tube (Fisher Scientific, MA, U.S.A) to which 4µl β-mercaptoethanol
supplied with the cells (concentration not specified) was added. The tubes were swirled and
placed on ice for 10 minutes with further gentle swirling every two minutes. Afterwards, 2µl of
plasmid DNA/ligation mix was added, the solution mixed and the tubes incubated on ice for 30
minutes. The heat shock was applied by placing the vial in a 42°C water-bath for exactly 30 sec-
onds. The tube was then placed on ice for two minutes and supplemented with 0.9ml of preheated
NZY+ broth, after which it was incubated for one hour at 37°C, shaken at 200rpm. A 10µl and
90µl aliquot was then spread onto two selective LB agar plates. These were inverted and placed
in a 37°C incubator for 12-16 hours.
2.2.8 Plasmid DNA elution and purification from E. coli cultures, plasmid
DNA digests, PCR reactions and gel electrophoresis runs using com-
mercial kits
This section lists all the different commercials kits used to purify and elute plasmid DNA.
The KeyPrep Spin Plasmid DNA Mini Kit Pk100 (Anachem Ltd., Luton, U.K) was used to elute
less than 20µg of plasmid DNA (miniprep) from E. coli cultures, following the miniprep protocol as
supplied with the kit. In order to elute 20µg-1mg plasmid DNA from E. coli cultures, the Qiagen
Plasmid Maxi Kit or HiSpeed Plasmid Maxi Kit (both Qiagen, Crawley, U.K) was used as per sup-
plier instructions.
Following DNA preparative digests, dephosphorylation reactions and PCR runs, DNA was puri-
fied from enzymes and reagents using the QIAquick PCR Purification Kit (Qiagen, Crawley, U.K),
which can purify DNA strands between 100bp and 10kb in size, as per supplier instructions. If
DNA was to be purified from a gel, the fragment was first extracted using the White/UV Tran-
silluminator (UVP LLC, CA., U.S.A) and then purified from the encasing gel using the QIAquick
Gel Extraction Kit (Qiagen, Crawley, U.K). The protocol supplied with the kit was followed without
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modifications.
Following all purification protocols, plasmid concentration and purity were determined through
spectrophotometry, using the Thermo Scientific NanoDrop 1000 Spectrophotometer (Fisher Sci-
entific, MA, U.S.A).
2.2.9 Plasmid DNA purification from plasmid DNA digests using phenol-
chloroform extraction in preparation for T. brucei transfection
Prior to transfection of the oscillator plasmid into T. brucei, the (digested) plasmid was purified
using phenol-chloroform methods to ensure sterility and prevent the accumulation of salts which
ensue from the use of commercial kits. This in turn served to avoid arcing during the transfection
process.
The first step was to add an equal volume of phenol-chloroform (Phenol:Chloroform:Isoamyl Al-
cohol 25:24:1 Saturated with 10mM Tris, pH 8.0, 1mM EDTA; Sigma Aldrich, Munich, Germany)
to the volume of digested DNA. This was vortexed for five seconds using the Vortex-Genie® 2
(Scientific Industries Inc., NY, U.S.A). The solution was then spun for one minute at 10,000rpm
using a table-top Eppendorf Centrifuge 5415D (Eppendorf, Stevenage, U.K), the top aqueous
layer was pipetted to a fresh tube and 400µl ice-cold 100% ethanol (Fisher Scientific, MA, U.S.A)
was added to it. A five minute centrifugation at 10,000rpm was then carried out, after which the
supernatant was discarded and replaced with 1ml ice-cold 70% ethanol. The centrifugation was
then repeated, after which the supernatant was discarded and a final one minute centrifugation
at 10,000rpm was carried out to remove residual ethanol. After removing the supernatant and
air-drying the pellet for 10 minutes, 10µl of dH20 was added and the pellet stored at -20°C.
2.2.10 Plasmid DNA digests
In both digests detailed below, in order to determine whether the digest had been successful, a
control was used during the gel electrophoresis stage, wherein 5µl of the uncut plasmid being
analysed was run alongside the digested samples in order to assess whether a difference can
be noted between the two. All enzymes, enzyme buffers and Bovine Serum Albumin (BSA) were
supplied by NEB.
2.2.10.1 Analytical DNA digests of less than 1µg of plasmid DNA
Analytical digests using up to 1µg of DNA (volume of 10µl) were run to confirm plasmid identity. A
10µl analytical digest was set up using 5µl plasmid solution, 10% (v/v) restriction enzyme solution,
10% (v/v) enzyme buffer, 0.5µl BSA and, if required, 10% (v/v) of the second restriction enzyme.
This was topped up to 10µl with dH20. The solution was incubated at the enzyme’s specified in-
cubation temperature for 3 hours in an Eppendorf Thermomixer® comfort (Eppendorf, Stevenage,
U.K). If necessary, this was followed by a 25 minute heat-inactivation period, also using the Ep-
pendorf Thermomixer® comfort. The heat-inactivation temperature used in this stage depended
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on the enzyme being applied. Following this, the digest was analysed via gel electrophoresis
(Section 2.2.12).
2.2.10.2 Preparative DNA digests of 1-10µg of plasmid DNA
Preparative digests using 1-10µg of DNA (volume of 50-200µl) were run to prepare cassettes for
subsequent cloning steps, such as ligation. A preparative digest was set up using 50-150µl of
DNA, 10% (v/v) restriction enzyme, 10% (v/v) enzyme buffer, 10% (v/v) of the second restriction
enzyme (optional) and 1-3µl BSA, rounded to a specific volume with dH20. Following preparation,
the same incubation and heat-inactivation procedure as an analytical digest was followed. After-
wards, if the digest was to be gel-purified, the whole volume was run on a gel (Section 2.2.12) and
purified (Section 2.2.8). Otherwise, a 5µl sample was analysed via gel electrophoresis in order to
confirm success of digestion and purified as per Section 2.2.8.
2.2.11 Dephosphorylation of 5’-ends of plasmid DNA
In all dephosphorylation procedures detailed below, following treatment, gel electrophoresis was
carried out as per Section 2.2.12 to confirm DNA was not degraded during the reaction. This was
followed by a plasmid purification as per Section 2.2.8.
2.2.11.1 Dephosphorylation using Calf Intestinal Alkaline Phosphatase enzyme (NEB)
The NEB CIP kit consists of the CIP enzyme at a concentration of 10,000u/µl and 1X NEBuffer 3.
Two different methods were used to carry out this reaction. In the first protocol, DNA was mixed
in an eppendorf tube with 20µl of 1X NEBuffer 3 and 0.5 units of CIP per µg of DNA. This was
then briefly centrifuged, incubated at 37°C for one hour and heat-inactivated for 25 minutes at
a 65°C temperature. As an alternative more time-efficient procedure, and given that incubation
temperatures and use of buffers permitted, a preparative digest and CIP-treatment were carried
out simultaneously by loading digestion and CIP reagents into the same eppendorf tube. The
solution was then incubated at 37°C for three hours and heat-inactivated for 25 minutes at 65°C.
2.2.11.2 Dephosphorylation using Calf Intestinal Alkaline Phosphatase enzyme (Promega)
For CIAP, a 50µl dephosphorylation reaction was prepared. The 1u/µl phosphorylation enzyme
was diluted to a concentration of 0.01u/µl and added to 10µg digested, purified DNA at a rate of
0.01u CIAP per pmol of DNA. Following this, 10X Alkaline Phosphatase Reaction Buffer supplied
with the enzyme was added to a final concentration of 1X and if required, the volume was rounded
to 50µl with dH20. Once prepared, the mixture was incubated for 30 minutes at 37°C, after which
the volume was topped up again with the same amount of CIAP as added previously, and incu-
bated for a further 30 minutes at 37°C.
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2.2.11.3 Dephosphorylation using Shrimp Alkaline Phosphatase (NEB)
For dephosphorylation using the Shrimp Alkaline Phosphatase (SAP) enzyme, digest and de-
phosphorylation reactions were carried out simultaneously. The SAP kit was supplied with 10X
Antarctic Phosphatase Reaction Buffer. 2µl of this was mixed with 10µg DNA, 10%(v/v) restriction
enzyme, the appropriate NEBuffer for digestion to a final concentration of 1X and 5µl of Antarctic
Phosphatase. The solution was topped up to 20µl with dH20 if necessary. The mixture was incu-
bated for 15 minutes at 37°C and heat-inactivated for five minutes at 65°C.
2.2.12 Agarose gel electrophoresis
2.2.12.1 Preparation and electrophoresis of agarose gel
One litre of 10X TAE buffer was prepared from 48.5g of Tris base (Sigma Aldrich, Munich, Ger-
many), 11.4ml of glacial acetic acid (VWR International Ltd., Leicestershire, U.K) and 3.7g of
EDTA, disodium salt (Sigma Aldrich, Munich, Germany). The gel was prepared by adding 1.5g
agarose (Sigma-Aldrich, Munich, Germany) to 150ml 1X TAE in a conical flask. The solution was
heated to dissolve the agarose. Once cooled to c. 40°C, the solution was stained with 20µl Ethid-
ium Bromide and poured into the gel cast to solidify.
HyperLadder I (Bioline, London, U.K) was used as a DNA size marker, while the 5X Sample Load-
ing Buffer supplied with it was used as a tracking dye as per supplier instructions. The Power Pac
Basic (Bio-Rad, CA, U.S.A) equipment was used to run the gel at 100V for 70 minutes until the
tracker dye line was assessed visually to have migrated 90% across the length of the gel.
2.2.12.2 Electrophoresis analysis
Gels were imaged using the Gel Doc 2000 camera (Bio-Rad, CA, U.S.A). The Quantity One Ba-
sic software (Bio-Rad, CA, U.S.A) was used to manipulate the exposure and light settings when
imaging the gel.
2.2.13 Polymerase Chain Reaction
To amplify DNA fragments using either complementary or mutagenic primers, 50µl Polymerase
Chain Reaction (PCR) were carried out using Phusion® High-Fidelity DNA Polymerase (NEB,
MA, U.S.A). The polymerase was part of a kit which also contained 5X HF Phusion Buffer, 5X GC
Phusion Buffer, DMSO and 50mM MgCl2. In addition, 10mM Deoxynucleotide Solution Mix (NEB,
MA, U.S.A) was used.
Following recipe preparation as per Table 2.1 and a brief centrifugation to collect all volumes at
the bottom of the tube, reactions were run in a Veriti 96-Well Fast Thermal Cycler (AB Applied
Biosystems, CA, U.S.A), as per Phusion® kit recommendations and as outlined in Table 2.1.
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Ingredient Amount
1ng/µl DNA template 1-3µl
10pmol/µl Forward primer 2µl
10pmol/µl Reverse primer 2µl
Phusion® Polymerase 0.5µl
5X HF Phusion buffer 10µl
10mM Deoxynucleotide Mix 1µl
DMSO 1.5µl
dH20 to 50µl
Total 50µl
(a) Recipe used for PCR
Step Description Temperature Duration
1 Initiation 98°C 30s
2 30 cycles of:
aaaDenaturation 98°C 10s
aaaAnnealing 55-72°C 30s
aaaExtension 72°C 30s/kb
3 Final extension 72°C 10 mins
4 Hold 4°C ∞
(b) Thermocycling conditions
Table 2.1: Set-up and thermocycling conditions used for the PCR-amplification of DNA template
using either complementary or mutagenic primers.
A list of all primers used in PCR reactions can be found in Appendix B.
2.2.13.1 Controls used in Polymerase Chain Reaction
As a positive control, a plasmid having a SEAP insert and PCRBlunt2TOPO backbone was am-
plified using the forward primer (5’-3’)CAGGAATAGGCTGGCGAAGCGC and the reverse primer
(5’-3’)CAGTCAGTGCCCGGTAAGCCC. This served to amplify a segment of the SEAP sequence,
which results in a fragment of size 292bp. As a negative control, a reaction was run using a blank
instead of DNA template. This served to assess whether the enzymes and buffers being used
were contaminated.
2.2.14 Ligation of two or more DNA fragments
2.2.14.1 Directional, non-directional & three-fragment ligations using Quick T4 DNA ligase
Directional and non-directional two-way ligations were carried out using both a 3:1 and a 1:1
insert-to-backbone ratio. Three-fragment ligations were similarly prepared using 3:3:1 and 1:1:1
insert-to-insert-to-backbone molar ratios. Molar values for DNA were estimated using the formula
mols =
weight in ng
length in kilo base pairs
The Quick Ligation™ Kit (NEB, MA, U.S.A), which consists of Quick T4 DNA ligase enzyme and 2X
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Control A Control B Control C Control D Control E
10mol dephos., cut, pur.
8kb backbone at a con-
centration of 20ng/µl
- - - 4µl 4µl
10mol cut, pur. 8kb back-
bone at a concentration of
20ng/µl
4µl 4µl - - -
10mol uncut 10kb back-
bone at a concentration of
20ng/µl
- - 5µl - -
Quick T4 DNA Ligase 1µl - - 1µl -
2X Buffer ligase 10µl 10µl 10µl 10µl 10µl
dH20 (to 21µl) 6µl 7µl 6µl 6µl 7µl
Table 2.2: Controls used in standard, non-directional and three-fragment ligations. Each
control is prepared using a combination of dephosphorylated cut purified backbone OR cut puri-
fied backbone OR uncut backbone, Quick T4 DNA Ligase (optional), 2X Buffer Ligase and dH20
to add up to 21µl volume. In this example, all backbone aliquots are assumed to have a concen-
tration of 20ng/µl. The cut backbone is assumed to be 8kb in length, while the uncut backbone
is 10kb long. 10 mols of backbone is used in each case. ‘dephos.’ is short for dephosphorylated
while ‘pur.’ is short for purified.
Quick Ligation Reaction Buffer, was used to carry out ligations of volume 21µl, using at least 50ng
of purified backbone. Recipe variations of all ligation reactions are listed in Chapter 4. Following
preparation all mixtures were briefly centrifuged, incubated at room temperature for five minutes
and then either placed directly on ice prior to transformation as per Section 2.2.7 or stored at
-20°C.
2.2.14.1.1 Controls used in ligation. Several controls were carried out in order to validate
ligation results. An example of the controls carried out is found in Table 2.2. In all other cases a
similar set-up was followed with the volumes of the backbone and dH20 aliquots differing depend-
ing on the mass, length and concentration of plasmid used. The same molar value of backbone
plasmid needs to be used throughout the ligation and control reactions to ensure comparability of
results.
If the backbone was dephosphorylated, as when carrying out a non-directional ligation, all five
controls A-E were carried out. Otherwise, as when carrying out a standard directional and three-
fragment ligation, only controls A-C were used. The colony counts of controls A and B (which
use digested purified backbone with/without ligase respectively) can be compared to those of the
ligation reaction to quantify the amount of re-ligated plus undigested backbone and undigested
backbone respectively. Control C, using uncut backbone vector, was used to assess the com-
petency and viability of cells. Controls D and E which used dephosphorylated digested purified
backbone vector with/without ligase were compared to the ligation reaction plates to assess the
efficiency of the dephosphorylation reaction.
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2.2.14.2 Gibson assembly®
The Gibson assembly method (Figure 2.1) developed by Gibson et al. (2009) improves on the
standard method in that ligations do not require ends of the insert and backbone DNA to be restric-
tion sites. In addition, due to the nature of the primers used throughout, the assembled plasmid
does not run the risk of having the insert in reverse direction, as can happen in non-directional
ligations. The assembly method involves less steps than the standard assembly method. The
Gibson Assembly® Master Mix (NEB, MA, U.S.A) was used.
The insert was prepared via PCR amplification using 20-40 base pair long primers, which also
serve to attach overhangs (Figure 2.1a). The forward primer attaches overhangs which are com-
plementary to the 15-25 nucleotides upstream of the insertion site on the backbone to be used
for the construct. Similarly, the reverse primer attached overhangs which are complementary to
15-25 nucleotides downstream of the insertion site on the backbone to be used for the construct.
In addition, primers can have mutagenic or additional inserts such as restriction sites placed be-
tween the backbone-complementary and insert-complementary sequences. The backbone itself
was prepared either via digest (Section 2.2.10.2) or via amplification (Section 2.2.13) using com-
plementary primers (Figure 2.1b). Both insert and backbone were purified as per Section 2.2.8.
The ligation was carried out by mixing the insert and backbone DNA with the Gibson Assembly®
Mix, which has three main components; 5’ exonuclease, DNA polymerase enzymes and DNA
ligase(Figure 2.1c). The exonuclease serves to chew back the 5’ ends of both the backbone
and insert, leaving 3’ overhangs and allowing for complementary overhangs to anneal. The poly-
merase then fills in nucleotide gaps. Finally, the ligase creates a phosphodiester bond between
the annealed fragments, removing any discontinuities and resulting in a continuous DNA strand.
In order to effect the ligation, 0.02-0.5pmol of backbone and a 2-3-fold molar excess of insert were
mixed with the Gibson Assembly® Master Mix for a 20µl reaction as per supplier instructions as
discussed in Chapter 4. The DNA in pmol was calculated using the formula
pmol =
(weight in ng)× 1000
base pairs× 650Da
Following a brief centrifugation, the recipe was left to incubate at 50°C in a thermocycler for 60
minutes. The samples were then either placed on ice in preparation for a transformation as per
Section 2.2.7 or else stored at -20°C.
2.2.14.2.1 Controls used in Gibson assembly®. Several ligation controls were used, an ex-
ample of which is listed in Table 2.3. In all other cases a similar set-up was followed, although the
volumes used differed depending on the length of the backbone, the concentration of the aliquot
and the pmol used. Throughout, the same amount of pmol of backbone was used in both ligation
and control reactions in order to ensure comparability of results.
Colony counts from the transformation plates corresponding to the ligation reaction were com-
pared to colony counts from control reactions A and B (which use purified backbone with/without
the Master Mix respectively) to assess the amount of uncut plus re-ligated vector and uncut vec-
tor respectively. Colony counts for control C, which consists of uncut backbone taken through the
ligation and transformation processes, were compared to the ligation reaction colony counts to
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(a) The insert is prepared via PCR amplification which also
serves to add overhangs which are compatible to the back-
bone in which the insert will be assembled.
(b) The backbone is prepared for Gibson assembly via either a preparative digest
which serves to retain the required DNA backbone fragment or via PCR which serves
to amplify the required DNA backbone fragment.
(c) The three main steps and enzymes used in the Gibson assembly method to ligate the prepared insert into the prepared
backbone. The insert and backbone are mixed together with the Gibson Assembly mix and then consecutively go through
a cleaving reaction which uses 5’ exonuclease to chew back the 5’ overhangs, allowing for the fragments to anneal (Step
1), followed by an extension reaction using DNA polymerase to fill in any nucleotide gaps (Step 2) and a final reaction
using ligase wherein the nicks between the fragments are sealed by the formation of a phosphodiester bond, resulting in
a continuous DNA fragment (Step 3).
Figure 2.1: Gibson Assembly Method. Diagram explaining the main steps involved in the prepa-
ration and Gibson ligation of two or more DNA fragments: a) Preparation of insert via PCR which
adds backbone-compatible overhangs to the insert, b) Preparation of backbone via digest or PCR
and c) Steps and enzymes used in the Gibson assembly method wherein the insert and backbone
are mixed together with the Gibson Assembly mix and then go through a cleaving, annealing, ex-
tension and ligation reaction to assemble the final construct. ‘bb’ stands for backbone.
80
Control A Control B Control C
0.02pmol amp./cut, pur. 8kb back-
bone at a concentration of 25ng/µl
4.2µl 4.2µl -
0.02pmol uncut 10kb backbone at a
concentration of 25ng/µl
- - 5.2µl
2X Gibson Assembly Master Mix 10µl - 10µl
dH20 (to 20µl) 5.8µl 15.8µl 4.8µl
Table 2.3: Controls used in a Gibson Assembly. Each control is prepared using a combination
of PCR-amplified/cut, purified backbone OR uncut backbone, 2X Gibson Assembly Master Mix
(optional) and dH20 to add up to 20µl volume. In this example, the cut backbone is taken to be
8kb long, while the uncut backbone is taken to be 10kb long. Both aliquots have a concentration
of 25ngµl. 0.02pmol of DNA is used in all three controls. ‘amp.’ is short for PCR-amplified, while
‘pur.’ is short for purified.
asses cell competency and viability following ligation and transformation.
2.2.15 Sequencing Plasmid DNA
As a means of plasmid identity confirmation, sequencing of plasmid DNA was carried out by the
Scientific Support Services at the Wolfson Institute for Biomedical Research and the UCL Cancer
Institute, UCL.
As per service requirements, 10µl of plasmid at a minimum of 100ng/µl or PCR product at a mini-
mum of 1ng/µl per 100bp were submitted per reaction. Primers were submitted at a volume of 6µl
at a concentration of 5pmol/µl per reaction. Results, consisting of a base sequence and an elec-
tropherogram, were given in .fsta and .ab1 format respectively. All primers used for sequencing
can be found in Appendix C.
2.3 T. brucei strains and culturing conditions
All work concerning T. brucei was carried out at the London School of Hygiene and Tropical
Medicine (LSHTM) at the laboratory of Dr. Sam Alsford.
2.3.1 T. brucei strains
The bloodstream form (BSF) T. brucei brucei Lister 427 MITat 1.2 (Clone 221a) (Carrington et al.,
1991) strain and procyclic form (PCF) T. brucei brucei Lister 427 monomorphic (Cross, 1975)
strain were used throughout T. brucei investigations. The BSF 2T1 cell line (VSG221 expressing
Tagged cell line, clone 1) was used as a control strain (Alsford et al., 2005). All strains were pro-
vided by Dr. Sam Alsford at the LSHTM. Unless differentiated, the strains retain their respective
form, either bloodstream or procyclic.
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2.3.2 BSF T. brucei culturing conditions
BSF cells were grown in HMI-9 media (Hirumi & Hirumi, 1984). 4.5 litres of media was prepared
using HMI-9 powder (Life Technologies Ltd., Paisley, U.K) supplemented with 15g of sodium bi-
carbonate (Sigma Aldrich, Munich, Germany), 50ml of Pen-Strep (Life Technologies Ltd., Paisley,
U.K) and 70µl of β-mercaptoethanol (Sigma Aldrich, Munich, Germany). The solution was filter-
sterilised and stored in 450ml volumes at 4°C. Prior to use, 50ml FBS (Sigma Aldrich, Munich,
Germany) was added to each 450ml volume for a final concentration of 10% (v/v). The media was
then stored at 4°C and pre-warmed to 37°C prior to use.
Cells were incubated in NuncTM Cell Culture Treated Flasks with Filter Caps (Fisher Scientific,
MA. U.S.A) in a Revco Ultima II series CO2 incubator (Fisher Scientific, MA, U.S.A) at a tempera-
ture of 37°C and 0.5 CO2 level. Cells were maintained at a density below 2.5×106 cells/ml.
2.3.3 Cryopreservation and revival of BSF T. brucei
In order to cryopreserve BSF T. brucei cells, 100µl of 100% glycerol was added in a cryovial to
900µl of culture grown to a density of over 1×106 cells/ml. This was then stored at -80°C for 24
hours and then transferred to liquid nitrogen for a staggered freezing profile so as not to damage
cells.
In order to thaw cryopreserved BSF cells, a 1ml vial was taken from storage in liquid nitrogen,
allowed to thaw and added to 5-10ml of pre-warmed media. The volume was mixed gently and
incubated in 37°C in a CO2 incubator. Following a 24 hour incubation period, in which cells are
given time to recover, selective antibiotic, if appropriate, was added to cells.
2.3.4 PCF T. brucei culturing conditions
In order to culture procyclic cells, semi-defined SDM-79 media (Schonenberger, 1979) was used.
4.5 litres of media was prepared using SDM-79 powder (Life Technologies Ltd., Paisley, U.K),
supplemented with 10g sodium bicarbonate and 50ml Pen-Strep (Life Technologies Ltd., Paisley,
U.K). This was then filer-sterilised and stored at 4°C in 450ml volumes. Prior to use, 50ml of 56°C
heat-inactivated FBS and 1.5ml 2.5mg/ml hemin (Sigma Aldrich, Munich, Germany) were added
to each 450ml volume. The media was then stored at 4°C and pre-warmed to 28°C prior to use.
Cells were kept at a density between 1×106 and 2×107cells/ml. PCF cells kept at lower densities
do not survive. The cells did not require flasks with filter caps to be cultured in and were grown in
non-ventilated flasks (Fisher Scientific, MA. U.S.A) at an incubation temperature of 28°C using an
LMS Series Two Cooled Incubator (LMS Ltd., Kent, U.K).
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2.3.5 Cryopreservation and revival of PCF T. brucei
In order to cryopreserve PCF cells, 100µl of 100% glycerol was added in a cryovial to 900µl of
culture at a density of over 1×107 cells/ml. Storage was the same as for BSF cryopreserved cells.
In order to thaw cryopreserved PCF cells, a 1ml vial was taken from storage in liquid nitrogen, al-
lowed to thaw and added to 10ml of pre-warmed media. This was then centrifuged for 10 minutes
at 2000rpm using a table-top Eppendorf Centrifuge 5804 (Eppendorf, Stevenage, U.K) in order to
remove traces of glycerol. The cells were then resuspended in 2ml media to ensure high density
and incubated at 28°C. Following a 24 hour incubation period, in which cells are given time to
recover, selective antibiotic, if appropriate, was added to cells.
2.3.6 Antibiotics used for the culturing of T. brucei strains
In order to select for BSF and PCF trypanosomes transfected with the oscillator plasmid, Hy-
gromycin (Sigma Aldrich, Munich, Germany) was used at a concentration of 2.5µg/ml. It was
prepared at a stock solution of 5mg/ml in dH20, filter-sterilised and stored at -20°C.
2.3.7 Tetracycline induction of T. brucei cells transfected with the oscilla-
tor plasmid
In order to induce T. brucei cells transfected with the oscillator plasmid with tetracycline (Sigma
Aldrich, Munich, Germany), a 1mg/ml tetracycline stock solution was prepared by dissolving 10mg
of tetracycline in 10ml of dH20, filter-sterilising the solution and storing at -20°C. The antibiotic was
used at a working concentration of 10pg/ml-1µg/ml, depending on the study as discussed in Chap-
ter 7. Unless otherwise specified, the culture was then incubated in the appropriate conditions for
24 hours prior to harvesting or analysis, in order to allow for the tetracycline to become effective.
2.3.8 Blocking of T. brucei protein synthesis using cycloheximide
In order to determine the half-life of proteins within the oscillator plasmid, cycloheximide was used
as per Leung et al. (2011) in order to block translation processes. Cycloheximide (Calbiochem,
Nottinghamshire, U.K) was prepared as a 50mg/ml stock solution in ethanol, to enable solubility,
and stored for up to three months at -20°C.
Two induced BSF pUnstable clone cultures were grown to 1×106cells/ml. Cycloheximide was
added to a concentration of 100µg/ml to one of the cultures. An equal volume of ethanol was
added to the other culture to act as a control. Both flasks were then swirled gently and incu-
bated. For both cultures, a protein sample was taken and protein prepared (Section 2.5.1) at
the required time-points post-incubation. Following this, protein was analysed via a western blot
(Section 2.5.3) and coomassie stain (Section 2.5.4).
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2.4 Recombinant DNA techniques in T. brucei
2.4.1 Stable DNA transfection of BSF T. brucei
Prior to transfection, 10µg of insert DNA was linearised using the NotI (NEB, MA, U.S.A) enzyme
as per Section 2.2.10.2 and purified using phenol-chloroform techniques as per Section 2.2.9.
2×107 BSF T. brucei cells were spun down at 2000rpm for 10 minutes (Alsford & Horn, 2012). The
supernatant was then removed, cells were resuspended in 0.5ml PBS (Sigma-Aldrich, Munich,
Germany) and centrifuged for one minute at 10,000rpm. The supernatant was again removed
and replaced with 10µl of the phenol-chloroform purified, digested DNA and 100µl of Cytomix.
Cytomix was prepared as per the following recipe: 120mM KCl, 25mM HEPES at pH7.6, 0.5%
glucose, 100µg/ml Albumin bovine serum, 150µM CaCl2, 2mM EGTA at pH7.6, 1mM Hypoxan-
thine, 5mM MgCl2.6H2O and 10mM K2HPO4/KH2PO4 at pH7.6. Note that 100 X Hypoxanthine
was prepared using 0.4g NaOH, 100ml H2O and 1.36g Hypoxanthine and stored at -20°C. 10X
K2HPO4/KH2PO4 at pH7.6 was prepared using 8.66ml 1 M K2HPO4, 1.34 ml 1M KH2PO4 and
90ml H2O and stored at room temperature. All chemicals were supplied by Sigma Aldrich (Mu-
nich, Germany). The pH was adjusted to 7.6, the Cytomix filter sterilised and then stored at 4°C.
The cell, DNA and Cytomix mixture was then transferred to an 0.2cm cuvette and the transfec-
tion was carried out using the AmaxaTM NucleofectorTM II (Lonza Group Ltd., Basel, Switzerland)
transfection device, using nucleofection programme X-001. Following transfection, 1ml of pre-
warmed media was added to the cuvette and this was transferred into 60ml pre-warmed media.
The flask was then incubated for six hours to allow for expression of Hygromycin resistant protein,
after which a further 140ml pre-warmed media was added to dilute cells and Hygromycin selective
antibiotic was applied. 1ml volumes were then aliquoted into two 48-well plates at a neat and 5-
fold dilution or into four plates using a neat dilution. The plates were incubated for five days, after
which positive clones were identified, transferred to 10ml pre-warmed media with Hygromycin and
incubated for 24 hours prior to analysis.
2.4.2 Stable DNA transfection of PCF T. brucei
Transfection of PCF cells follows the same protocol except for the required use of conditioned
media, which is media in which PCF T. brucei have been previously cultured (Archer, 2009b).
Conditioned medium was freshly prepared prior to each transfection carried out. 200ml of PCF
cells were grown to a density of 1×107cells/ml. This volume was then divided into 50ml aliquots
and centrifuged at 2000rpm for 10 minutes to pellet and separate the cells from the medium,
excreted proteins and chemicals. After this, the supernatant was retained, transferred to a new
tube and the centrifugation repeated. Again, the supernatant was retained, after which it was
passed through an 0.2µm filter (Acrodisc® Syringe Filters with 0.2µm Supor® Membrane, Pall Life
Science, Portsmouth, U.K) and stored at 4°C prior to the transfection process.
Following this, the same transfection process as that used for BSF cells was carried out (Section
2.4.1), with one main difference. Following transfection, the use of pre-warmed media for BSF
cells was replaced with pre-warmed conditioned media supplemented with 10% (v/v) 56°C heat-
inactivated FBS. This allows for PCF cell growth even though cell density is below 106cells/ml,
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which usually results in cell death (Archer, 2009a).
2.4.3 T. brucei immobilisation using chemical agents and microfluidic de-
vices
2.4.3.1 Microfluidic laser cage devices
This work was carried in collaboration with Dr. Brian O’Sullivan at UCL. For the development
of microfluidic cage devices, the devices were initially designed in Adobe Illustrator software (v.
CS6)(Adobe Systems Inc., CA, U.S.A), after which they were imported into WinMark Pro Laser
Marking Software (v. 6.0)(Synrad Inc., WA, U.S.A)
In order to manufacture the devices, slides measuring 24×60mm were cut from 1.5mm thick poly-
methylmethacrylate (PMMA; RS Components, Northants, U.K) using a CO2 Synrad 48-Series
laser marking head (Laserlines, Banbury, U.K) with a maximum power of 25W at 50% power
(12.5W) and a mark speed (laser tracking speed) of 10mm/s. Following this, square chambers
with a width of 50-150µm were ablated on the slide using a power of 12.5W and a mark speed of
200-300mm/s.
2.4.3.2 Agarose block trap devices
Live cells were immobilised by placing an agarose block on them (Figure 2.2) (Huang et al., 2014).
PBSG was prepared by supplementing PBS with 6mM D-glucose. Following this, agarose was
added to 20ml of PBSG for a final concentration of 1% (w/v) and dissolved by heating. After allow-
ing to cool to a tepid temperature, 12ml was poured into a 9.2cm diameter petri dish to a thickness
of 2cm and allowed to solidify for at least 30 minutes. 1cm-by-1cm agarose blocks were then cut
(but left in the petri dish, to avoid drying out). If necessary, the dish was sealed and stored at 4°C.
Prior to use, the agarose blocks were left to set at room temperature.
Prior to cell preparation and analysis, a glass slide and cover slip set-up was prepared by clean-
ing the microscope glass slide (Fisher Scientific, MA, U.S.A) with 70% ethanol and lining a
24mm×60mm cover slip (Fisher Scientific, MA, U.S.A) with blu tack (Figure 2.2). 1ml of cells
at a density of 1×106cells/ml were then centrifuged at 1000rpm for one minute. The supernatant
was discarded and the cells were resuspended with an equal volume of pre-warmed PBSG. The
centrifugation process was repeated, the supernatant discarded and the cells resuspended in
50µl pre-warmed media.
Immediately after this, 5µl of cells was pipetted onto the glass slide, covered gently with a 1cm-
by-1cm agarose block and the cover slip which is kept in place by the blu tack which attaches to
the glass slide. The set-up was then inverted, so that the cells are on top the agarose block.
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Figure 2.2: Agarose block trap device: Main components of the agarose block trap device used
to immobilise viable and motile T. brucei cells. The device consists of a glass slide, 1cm-by-1cm
1% agarose block and cover slip with blu tack attached to the bottom. 5µl of cells are pipetted
onto the glass slide, on top of which an agarose block and the cover slip with blu tack are placed.
The set-up is then inverted.
2.4.3.3 Agar and agarose solutions
Agar and agarose were both prepared by adding the required % (w/v) of powder to HMI-9 media,
dissolving the powder by mixing and then autoclaving the solutions. Prior to use, both solutions
were heated in a microwave and if required, aliquots were diluted with HMI-9 media.
2.4.3.4 Xanthan gum
Xanthan gum solutions were prepared by adding the required % (w/v) of xanthan powder (Sigma-
Aldrich, Munich, Germany) to HMI-9 media and mixing the solution at a heated temperature of c.
30°C using the Bibby Scientific HB502 heated magnetic stirrer (Bibby Scientific Ltd., Staffordshire,
U.K). Prior to use, the solution was mixed to ensure homogeneity. If required, the solution was
diluted using HMI-9 media.
2.4.3.5 CygelTM thermoreversible gel
CygelTM (BioStatus Ltd., Leicestershire, U.K) is a thermoreversible product which is liquid below
room temperature and solid at temperatures above. It was stored at 4°C, as per supplier instruc-
tions. If required, CygelTM was diluted using dH20 prior to use. 40X PBS supplied with the gel
was then added to a final concentration of 2.5% (v/v).
2.5 T. brucei protein analysis
2.5.1 T. brucei protein isolation
To prepare protein from T. brucei cells, 10ml of 1×106 cells/ml culture was pelleted at 2000rpm
for 10 minutes. The supernatant was removed, the pellet resuspended in 10ml PBS and the
centrifugation repeated. Following this, the supernatant was removed and the pellet was resus-
pended in 500µl PBS. This was followed by a two minute centrifugation at 5000rpm, after which
the pellet was resuspended in 1X SDS sample buffer to a final concentration of 1×105cells/µl.
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The SDS sample buffer was prepared by dissolving 62mM Tris at a pH6.8, 10% glycerol, 2.3%
SDS (Sigma Aldrich, Munich, Germany), 5% β-mercaptoethanol and 0.002% bromophenol blue
(Sigma Aldrich, Munich, Germany) in rH20. A SIGMAFASTTM Protease Inhibitor tablet (Sigma
Aldrich, Munich, Germany) was added and dissolved via vortexing, after which the sample was
stored at -20°C.
Following resuspension in the SDS sample buffer, the cell solution was vortexed for two seconds
in order to ensure homogeneous breakdown of the cell wall and inhibition of protease activity. The
solution was stored at -20°C.
2.5.2 SDS-PAGE gel analysis of T. brucei proteins
2.5.2.1 Preparation of resolving and stacking gels
Following protein isolation (Section 2.5.1), an SDS-PAGE gel (Laemmli, 1970) was run in order to
separate proteins. The Bio Rad Mini-PROTEAN® Tetra System (Bio-Rad, CA, U.S.A) set-up was
used as per kit instructions to prepare and run gels.
Once the casting frame was assembled using a glass plate and 0.75mm spacer plate, the 12.5%
resolving gel was prepared using 2.08ml 30% Acrylamide (Sigma Aldrich, Munich, Germany),
1.38ml Lower Gel Buffer (1.5M Tris at pH8.8 and 0.4% SDS, 1.75ml dH20, 500µl 10% Ammonium
Persulfate (APS) (Sigma Aldrich, Munich, Germany) and 2µl N,N,N’,N’-Tetramethylethylenediamine
(Temed) (Sigma Aldrich, Munich, Germany). The Temed and APS were added in the end to pre-
vent premature gel polymerisation. 3.5ml of this solution was set to solidify in the casting frame
and on top of it, 0.5ml dH20 was pipetted to help remove bubbles along the gel’s surface. The gel
was allowed to polymerise for one hour, after which the top layer of water was removed by tipping
over the casting frame and using blue paper towel to absorb water.
The 5% stacker gel was prepared using 250µl 30% Acrylamide, 375µl Upper Gel Buffer (0.5M Tris
at pH6.8 and 0.4% SDS), 875µl dH20, 12.5µl 10% APS and 1.25µl Temed. The Temed and 10%
APS were added in the end to prevent premature polymerisation of the gel. After the addition of
the stacker gel to the casting frame on top of the resolving gel, a 10 well comb was inserted on
top to form wells. This was followed by a further one hour polymerisation period.
2.5.2.2 Running the SDS-PAGE gel
Prior to running the gel, 1X SDS-PAGE running buffer was prepared. A one litre 10X running
buffer solution was prepared using 144g glycine (Sigma Aldrich, Munich, Germany), 1% SDS and
30g Tris. When running one or two gels 700ml of 1X running buffer was used, while when running
three or four gels one litre was used. The gels were then slotted into place in the tank, the inner
buffer chamber filled with 1X running buffer, the combs removed and the wells cleaned using a 1ml
pipette. The samples and ladder were then thawed on ice and 10µl of each sample was loaded
into the wells. The PageRuler Prestained Protein Ladder (Fisher Scientific, MA, U.S.A) or the
Precision Plus Protein™ WesternC™ Standard (Bio-Rad, CA, U.S.A) ladder was loaded into one
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of the wells. After this, the outer buffer chamber was filled with the remainder of the 1X running
buffer, the lid placed and connected to the mains and a voltage of 200V was run for approximately
one hour through the gels using an Electrophoresis Power Supply (Fisher Scientific, MA, U.S.A).
The tank was placed in a tray filled with ice to avoid over-heating due to the high voltage being
used.
When the run was completed, the voltage was stopped and the mains switched off. The gel was
then removed from the glass plates holding it in place, and immediately placed into the appro-
priate solution, depending on whether the gel was to be taken forward to a western blot (Section
2.5.3) or a Coomassie stain (Section 2.5.4).
2.5.3 Western blotting
2.5.3.1 Semi-dry protein transfer
In order to detect proteins of interest, a western blot was carried out following an SDS-PAGE
run using the semi-dry transfer method. The Trans-Blot® Turbo™ Blotting System (Bio-Rad, CA,
U.S.A) was used to transfer protein from the gel to a nitrocellulose membrane. Assembly instruc-
tions were followed throughout.
One litre of transfer buffer was prepared using 5.83g Tris, 2.93g glycine, 200ml methanol (VWR
International Ltd., Leicestershire, U.K) and 0.375g SDS. Following an SDS-PAGE run, the gel was
placed in Western Transfer buffer for 15 minutes while being rotated at 20rpm using the Stuart
Mini See-Saw Rocker SSM4 (Bibby Scientific Ltd., Staffordshire, U.K).
During this equilibration period, the materials to be used for the semi-dry transfer sandwich were
assembled. This consisted of wetting two extra thick filter papers (Extra Thick Blot Paper; Bio
Rad, CA. U.S.A) in transfer buffer for at least 10 minutes, with no agitation. In addition, a ni-
trocellulose membrane (Amersham Hybond ECL Nitrocellulose Membrane; GE Healthcare Life
Sciences, Buckinghamshire, U.K) was placed in transfer buffer for 30 seconds, transferred to rH20
for a further one minute and then placed again into transfer buffer for 10 minutes, this time with
20rpm agitation.
Once the membranes and filter paper were equilibrated, the transfer sandwich was prepared by
placing an extra thick filter paper at the bottom, on top of which the nitrocellulose membrane was
placed, then the SDS-PAGE gel and finally the second extra thick filter paper. At each addition,
any bubbles and excess liquid were removed using a roller. The transfer sandwich was assem-
bled on the base anode cassette, with the cathode cassette placed on top, locked into place and
slotted into the apparatus bay, as per manual instructions. The Bio Rad pre-defined Standard SD
program was used, where a voltage of 25V and a current of 1A were run through the transfer
sandwich for 30 minutes.
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2.5.3.2 Blocking of non-specific binding at the membrane
Following transfer, the membrane was placed in blocking solution for a minimum of 30 minutes
in agitation in order to prevent non-specific binding. The blocking solution was prepared using
5% milk powder (Marvel, Premier International Food (U.K) Ltd., Lincolnshire, U.K) and 0.05%
TWEEN®-20 (Tween) (Sigma Aldrich, Munich, Germany) in TBS or PBS buffer, depending on the
antibody being used. One litre of TBS was prepared using 50ml of 1M Tris at pH8.0, 36.4ml 4M
NaCl (Fisher Scientific, MA, U.S.A) and topped up with rH20.
2.5.3.3 Addition of antibodies for protein detection in western blots
After blocking, the membrane was placed in the primary antibody solution for one hour in 20rpm
agitation. The primary antibody was prepared in the blocking solution, and diluted as per antibody
supplier instructions. For the detection of the eGFP gene, the GFP Rabbit IgG Polyclonal Antibody
Fraction (Life Technologies Ltd., Paisley, U.K) was used at a dilution of 1:5000. PBS was used as
a buffer in blocking and antibody solutions. For the detection of the tetR gene, the Anti-Tet Repres-
sor Antibody (EMD Millipore Co., MA, U.S.A) and the Anti-Tet Repressor Antibody (Sigma Aldrich,
Munich, Germany), both produced in rabbit, were used at a dilution of 1:1000. TBS was used as
a buffer. For the detection of the Myc tag protein, the Mouse IgG1 Monoclonal Antibody to c-Myc
(Source BioScience, Nottingham U.K) was used at a dilution of 1:2000. TBS was used as a buffer.
Following incubation, a rinsing process was carried out to remove excess antibody. This consisted
of placing the membrane in the same buffer as the one used to prepare blocking and antibody
solution but supplemented with 0.05% Tween and agitated for 10 minutes at 20rpm. The solution
was discarded and the rinse process was repeated.
After discarding the solution, the membrane was placed in a TBS-T (TBS + 0.05% Tween) solution
for a final 5-minute rinse, agitated at a speed of 20rpm. The membrane was then placed in TBS-
T plus 0.5% milk powder containing the secondary antibody diluted as per supplier instructions.
Following use of the anti-GFP and anti-TetR antibodies, the Goat Anti-Rabbit IgG (H+L)-HRP
Conjugate (Bio-Rad, CA, U.S.A) was used at a dilution of 1:12000. Following the use of the c-Myc
antibody, which had a Mouse host, the Goat anti-mouse IgG(H+L) Peroxidase Conjugated Anti-
body (Fisher Scientific, MA, U.S.A) was used at a dilution of 1:12000.
This was then incubated at 20rpm for a further one hour. Following this, the membrane was rinsed
in TBS-T for five minutes and agitated at 20rpm, after which the solution was discarded. The rinse
process repeated for another two times.
Following the final rinsing process, the membrane was prepared for visualisation and analysis
using the Amersham™ ECL™ Western Blotting Analysis system kit (GE Healthcare Life Sciences,
Buckinghamshire, U.K) which is used to detect tagged proteins. The detection reagent prepa-
ration and applications instructions plus post-handling of the membrane were carried out as per
manual instructions. Following preparation, the set-up was transferred to a dark room and an au-
toradiography film (Amersham™ Hyperfilm ECL, GE Healthcare Life Sciences, Buckinghamshire,
U.K) was pressed onto the membrane for an exposure of 15-60 seconds. The Compact X4 (Xo-
graph Healthcare, Gloucestershire, U.K) X-Ray film processor was used to visualise and print
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results.
2.5.4 Coomassie stain for protein visualisation following SDS-PAGE
Following an SDS-PAGE (Section 2.5.2), a Coomassie stain was carried out in order to obtain a
protein profile of the sample being analysed. The gel was placed into Isopropanol Fixing Agent
solution and rotated at 20rpm for 15 minutes. The Fixing Agent solution was prepared using 25%
(v/v) isopropanol (VWR International Ltd., Leicestershire, U.K), 10% (v/v) acetic acid (Fisher Sci-
entific, MA, U.S.A) and 65% rH20. This was followed by a one hour staining procedure using a
Coomassie G-250 stain (Sigma Aldrich, Munich, Germany). The staining solution was prepared
using 10% (v/v) acetic acid, 0.006% (w/v) Coomassie brilliant blue G-250 and 90% rH20. Again,
the gel was rotated at 20rpm to ensure homogeneous application of the stain. Finally, the gel was
placed in a destaining solution consisting of 10% acetic acid and rotated at 20rpm for at least 30
minutes.
In order to image the stained gel, the GeneGenius Bio-Imaging System (Syngene, Cambridge,
U.K) apparatus was used along with the image acquisition software GeneSnap (v. 6.08, Syngene,
Cambridge, U.K.) which was used to control exposure and light conditions.
2.5.5 Densitometry plot
Densitometry graphs based on western blot signal intensities were plotted using ImageJ v1.48
(Schneider et al., 2012). Given a ‘.jpg’ image of the western blot output, the density profile of
each band in the blot was calculated via ImageJ. After controlling for background noise manually,
the area under each density profile was calculated again using ImageJ. Following this, the relative
density readings xi were extracted for each band i by using either the data point of a positive
control or the data point of the band intensity at time zero xr as a reference point and calculating
xi/xr.
2.5.6 Immunofluorescence assay
2.5.6.1 Cell fixation process
In order to carry out an immunofluorescence assay to detect fluorescence levels in fixed cells, cells
were grown to a density of 1×106 cells/ml. 0.5ml 4% (v/v) paraformaldehyde (Sigma-Aldrich, Mu-
nich, Germany) was added to 0.5ml of culture. The mixture was inverted gently and placed on
ice for 15 minutes. It was then centrifuged for one minute at 5000rpm, 950µl of the supernatant
removed and the cells resuspended in the remaining solution. 1ml pre-chilled PBS was added
and the process of centrifuging, discarding the supernatant and resuspending in 1ml PBS was
repeated twice, although in the resuspension step of the last run, 0.5ml of pre-chilled PBS was
added instead of 1ml. A final centrifugation step was carried out, and the supernatant removed
except for a residual 20µl, in which the cells were resuspended. 2µl of cells was pipetted onto a
5mm 12-well slide (Fisher Scientific, MA, U.S.A), and the density of the cells was checked using
a 25X or 40X objective on a SP-95-1 Inverted Microscope (Brunel Microscopes Ltd., Wiltshire,
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U.K) having 10X widefield eyepieces for a total magnification of 250X or 400X. If too sparse, an
additional 2µl of cells was pipetted onto the cells.
2.5.6.2 Addition of antibodies for protein detection in immunofluorescence assays
If antibody was to be added in order to detect specific proteins, following the air-drying process,
instead of staining the cells, 40µl of 50% (v/v) FBS in PBS was added and left to act as a blocking
solution for 10 minutes. The blocking mixture was removed by softly dabbing a paper towel on the
well. 40µl of primary antibody diluted 1:200 in 3% (v/v) FBS in PBS were then pipetted onto the
well and left to incubate for 45 minutes in a humidity box. The excess solution was then removed
by tipping over the slide, which was thrice washed in 50ml PBS for five minutes per wash (with
no agitation). 40µl of the secondary antibody at a dilution of 1:50 in 3% (v/v) FBS in PBS was
then pipetted onto the well and the slide was left to incubate for 45 minutes in a humidity box. The
excess solution was removed by tipping the slide, which was then thrice washed in 50ml PBS for
five minutes per wash. The slide was then allowed to air dry for at least 30 minutes in the hood.
Following this, 1µl of DAPI in Vectashield (Vector Labs, Peterborough, U.K) was pipetted onto the
cells, a cover slip was placed on top and the edges were sealed with nail varnish.
2.5.6.3 Visualisation
Images of fixed and stained cells were captured using the AxioPlan2 microscope set up with the
QImaging® Retiga-2000R Fast 1394 digital camera. Prior to imaging, the surface of the cover
slide over each sample was covered with a drop of immersion oil (Sigma Aldrich, Munich, Ger-
many). In order to acquire both brightfield and fluorescent images of the cells, the Volocity® 3D
Image Analysis Software, Version 6.3.0 (Perkin Elmer Inc., MA, U.S.A) was used.
2.6 T. brucei live cell imaging via fluorescent and brightfield
microscopy
2.6.1 DEFRA licensing for T. brucei live cell imaging
In order to be able to carry out authorised work with T. brucei organisms and carry out live-cell
imaging, a Specified Animal Pathogens Order 2008 (SAPO) License, number PATH/151/2010/1
was issued by the Department for Environment, Food and Rural Affairs (DEFRA).
2.6.2 Imaging set-up using live T. brucei cells
In order to be able to image viable and motile T. brucei cells via fluorescent and brightfield mi-
croscopy, cells were embedded in 40% CygelTM in order to restrict motility. Cells were initially
grown to over 1×106cells/ml. An 0.5ml aliquot was taken and centrifuged for one minute at
5000rpm, after which the supernatant was removed and the cells were resuspended in media
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Channel Brightfield Fluorescent
Exposure 2ms 2.0s
Colour Format Monochrome Monochrome
Zeiss Fluo Turret Filter 1 Screen
Zeiss TL Voltage 5.4V 0.0V
Gain 1.8x 0.0x
Offset 46 levels 0 levels
Table 2.4: Camera settings used in brightfield and fluorescent microscopy to acquire consecutive
images of viable cells.
to a concentration of 5×107cells/ml. 5µl of this solution was then taken and mixed with an equal
volume of 40% CygelTM. 4µl of this mixture was pipetted onto a 5mm 12-well slide, on top of
which a cover slide was placed and sealed with nail varnish in order to comply with Health and
Safety regulations.
2.6.3 Imaging conditions
The AxioPlan2 microscope, set up with the QImaging® Retiga-2000R Fast 1394 digital camera
was used to acquire consecutive fluorescent and brightfield images over time. Prior to imaging,
the surface of the cover slide over each sample was covered with a drop of immersion oil. In order
to acquire both brightfield and fluorescent images of the cells, the Volocity® 3D Image Analysis
Software, v. 6.3.0 was used in order to set up automated image capturing protocols. Camera
settings such as exposure times and colour format were set up as per Table 2.4. Images were
captured every two minutes for a duration of two to four hours.
2.6.4 Background correction
Following image capturing, images were analysed using the Volocity 3D Image Analysis. Back-
ground correction was carried out on fluorescent microscopy images in order to better distinguish
between fluorescent cells and background noise. This was done by using a blank well as the con-
trol. A cover slip was put on top of the blank, a drop of immersion oil was placed on the cover and
a fluorescent image acquired using the same settings as for the other wells. This blank image was
then selected as the Dark Reference Image when setting up background correction to manipulate
the images.
2.6.5 Quantification of fluorescence intensity profiles
Following image acquisition and background correction, the next step was to extract fluorescent
trajectories at the single cell level. In order to quantify fluorescence intensities of individual cells,
Volocity Quantitation was used to detect and measure fluorescent spots at each time-point via
the Measurement view. Objects were excluded by size, with only fluorescent spots of size 20-
10,000µm2 being measured.
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Following this, results were confirmed visually by tracking a cell of interest manually over each
image acquired to ensure that the software had measured the correct object in each case.
2.7 Mathematical Modelling of the Goodwin oscillator GRN in
a T. brucei host
2.7.1 The Gillespie Direct Method stochastic simulation algorithm
The Gillespie Direct Method stochastic simulation algorithm (SSA) as developed by Gillespie
(1977) was used to generate stochastic time series simulations of the quantity of molecular com-
ponents/species within the oscillator GRN over a span of 500-1000 minutes. The algorithm works
by selecting an initial time-point t0 and simulating when a biochemical reaction next takes places
and also which reaction takes place. Species’ molecule numbers and timings are then updated
accordingly and the process is repeated. The decision of when the next reaction takes place and
also which type of reaction takes places is based on the generation of two random numbers from
the uniform distribution with parameters 0 and 1. This generates a trajectory of the molecular
components. The algorithm scheme runs as follows:
Step 1) Given thermal and spatial homogeneity
• Set t0 and tfinal. Set t = t0.
• Store initial molecule numbers for the N species, Xi(t0) for i ∈ 1, ...N
• Store reaction rate values of the M reactions, cj for j ∈ 1, ...M
Step 2) Calculate the propensity values aj(t) = hj .cj for j ∈ 1, ...M where hj is the number of
available molecules of the reactant species in reaction j
Step 3) Calculate a0 =
M∑
j=1
aj
Step 4) Generate a random pair (r1, r2) from the standard uniform distribution U(0, 1)
Step 5) Calculate τ =
1
a0
.ln
1
r1
Step 6) Calculate k such that
k−1∑
j=1
aj < r2.a0 ≤
k∑
j=1
aj
Step 7) Update t = t+ τ and Xi(t) for i ∈ 1, ...N to reflect the changes in the population from the
execution of reaction k.
Step 8) Go to step 2 and repeat until t > tfinal
The Gillespie algorithm was implemented via the ABC-Sysbio algorithm, as discussed in Section
2.7.1.2.
2.7.1.1 Copasi 4.12.65 for coding the oscillator GRN in SBML format
To carry out time series simulations, the network was represented as a set of molecular species
and biochemical reactions. This information was coded in Copasi 4.12.65 (Hoops et al., 2006)
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which was used for debugging the mathematical model and for translating the data into Systems
Biology Markup Language (SBML) (Keating & Le Novere, 2013)
2.7.1.2 ABC-Sysbio 2.05 for running the Gillespie stochastic simulation algorithm
In order to simulate dynamics of the GRN components using the Gillespie SSA, the ABC-Sysbio
2.05 (Liepe et al., 2010) Python-based program was used as per developers’ instructions. In or-
der to run the program, the Ubuntu 12.04 (www.ubuntu.com) Linux platform was used to access
a Dell PowerEdge C6100 server plus C410X GPU chassis. The system uses the centOS 5.8
operating system using a Tesla M2050, M2090 and K20 GPU. This remote system was used with
the permission of Dr. Chris Barnes at the UCL Research Department of Cell and Developmental
Biology.
Two scripts; abc-sysbio-sbml-sum and run-abc-sysbio, were used. The former was used by run-
ning the command abc-sysbio-sbml-sum –files file.xml in a terminal window, where file.xml is the
SBML model of the Goodwin oscillator. This command serves to parse and translate the GRN
model’s SBML file into an ABC-Sysbio compatible input ‘.xml’ file (input file template.xml). Ad-
ditionally, it also inserts default settings in the file, to be used for the simulation of the species’
quantity profiles.
The file was then manually edited in order to specify the following algorithm and simulation condi-
tions:
1. 〈particles〉 This represents the number of time series simulations to carry out.
2. 〈data〉 〈times〉 The time points at which to print molecule numbers of the species which
have been simulated.
3. 〈models〉 〈model1〉 〈type〉 The type of simulations to carry out. This was consistently set
to Gillespie.
4. 〈models〉 〈model1〉 〈parameters〉 The distribution of the range of values which can be
used for each parameter during simulations. The parameter values are randomly picked
from these distributions at the beginning of each simulation. No simulation is carried out
using the same set of parameters.
5. 〈models〉 〈model1〉 〈initial〉 The initial number of molecules for each of the species within
the model.
In order to run Gillespie stochastic simulations, the run-abc-sysbio script is run as per the following
command: run-abc-sysbio –infile input file template.xml -f -of=res –timing –cuda –simulate where
input file template.xml is the file generated by abc-sysbio-sbml-sum and then edited manually, -f
asks the program to indicate when each iteration has finished -of specifies the name of the folder
in which to place simulation results (in this case, res), –timing asks the program to print timing
information, –cuda asks the program to use CUDA platform implementation and –simulate asks
the program to generate time series for the specified model. This script generates two text files.
particles.txt contains information about the parameter values which were selected from the user
defined range of values and used in each simulation. trajectories.txt lists the quantities of the
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different species at each of the specified time points in 〈data〉 〈times〉.
2.7.2 MATLAB R2012a for analysis of Gillespie simulations
Data generated by ABC-Sysbio was analysed using MATLAB (2012) R2012a. The software was
also used to plot time series, matrix plots and reconstructed phase space trajectories during quan-
titative and qualitative mathematical analysis.
2.7.3 Data smoothing by application of imputation or a moving average
filter
In order to impute or smooth data during the qualitative analysis process, a moving average filter
was applied to the data. Given a set of N data points x1, ..., xN , the moving average of data point
k, yk, using window size n is based on the value of data point k, the previous n raw data points xi
and the subsequent n raw data points xi, as per the following:
yk =
k+n∑
i=k−n
xi
2k + 1
a
given that k−n > 0 and k+n ≤ N . Else, each data point with the index out of bounds is ignored,
and the denominator subtracted by 1. This gives a set of N filtered data points y1, ..., yN . By
weighting each data point equally, the dominant trend is preserved while eliminating noise sig-
nals. This technique was implemented in MATLAB using a custom written algorithm, as seen in
Appendix D.
2.7.4 Cubic spline data interpolation
In order to fit a (smooth) curve to a set of data points, a spline was fitted. Given a dataset y with
values defined at independent points t1, ..., tN , a cubic spline serves to generate a stable piece-
wise function, f : [a, b] → R where [a, b] = [a = t1 < t2 < ... < tN−1 < tN = b], consisting of
cubic polynomials between each consecutive pair of data points. The polynomials are continuous
and continuously differentiable up to the second derivative, even at the interior boundary points
(De Boor, 2001).
A cubic spline was fitted to the dataset of interest using the MATLAB function yy = spline(t, y)
wherein yy is the output representing the coefficients of the spline’s polynomials, t is the data
array of independent variables taken to be time and y is the set of data points to which the spline
must be fitted. Following this, v = ppval(pp, yy) was used to generate values of the piecewise
polynomial function yy at time-points pp. The plot function was used to plot the fitted spline.
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2.7.5 Fitting of linear growth trends
In order to fit a linear trend y = m.t+c to a dataset, the polyfit function in MATLAB was used. The
function works by running the command yy = polyfit(t, x, d) which fits a polynomial of degree d
to the vector x using the vector t as an independent variable, generally taken to be time. In this
case d = 1. The output yy generates a vector of coefficients representing m and c from the linear
trend.
In order to generate data points for the linear trend, y = polyval(pp, yy) was used wherein the
coefficients of the polynomial in yy are used to generate a vector of values y at the vector of
time-points pp.
2.7.6 Phase space reconstruction
In order to reconstruct the phase space, a custom written program in MATLAB was used. Given a
delay of k, the program used the plot(x, y) function to map the vector x against the vector y where
y equals the vector x offset by k data points. Let N be the number of data points and x(i, 1) for
i = 1, . . . , N be equal to the data points on which the reconstruction will be based, i.e. the variable
output. Then the function plot(x(1 : (N−k), 1), y(1 : (N−k), 1)) is used where y(i, 1) = x(i+k, 1)
for i = 1, . . . , N − k. The program is reproduced in Appendix E.
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Chapter 3
Establishing Roseobacter marine
bacteria as a synthetic biology
chassis
In order to establish Roseobacter marine bacteria as a synthetic biology chassis by identifying reli-
able molecular biology procedures which enable the construction of synthetic GRNs, three strains
from the clade were used throughout the investigation: Roseobacter denitrificans (R. denitrifi-
cans), Oceanobulbus indolifex (O. indolifex) and Dinoroseobacter shibae (D. shibae). The strains
were selected firstly because they are dispersed along the Roseobacter phylogenetic tree, thus
making it possible to check whether the procedures of interest can be applied across the whole
Roseobacter spectrum. Secondly, the strains’ genomes have been sequenced (Brinkhoff et al.,
2008) and were used by Piekarski et al. (2009) to develop a fluorescence reporter system, thus
providing a good foundation to build on. The strains were also put forward as a potential synthetic
biology chassis by the UCL team, Plastic Republic, participating in the 2012 iGEM competition,
in order to tackle oceanic bioremediation challenges (http://2012.igem.org/Team:University Col-
lege London).
3.1 Long-term viability of Roseobacter glycerol stocks
In order to establish Roseobacter strains as synthetic biology chassis, the first step was to test
the period of time over which glycerol stocks of the strains R. denitrificans and O. indolifex stored
at -80°C could be revived in static and shaken cultures. This was carried out in order to assess
whether it is possible to maintain long-term storage of cells over time and build master and working
cell banks.
3.1.1 Preparation of glycerol stocks
The first step was to prepare glycerol stocks and store them directly at -80°C. For each Roseobac-
ter strain of interest, 20ml of MB was inoculated with 100µl from a fresh glycerol stock. From this
solution, two 10ml aliquots were taken and shaken for 12-16 hours at 200rpm at 37°C. Following
this, for each of the 10ml cultures:
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• A 6ml aliquot was taken and added to 1.6ml of sterile 80% glycerol. The volume was di-
vided into 380µl aliquots and stored at -80°C. These glycerol stocks were then assessed in
subsequent weeks.
• A 50µl aliquot was taken and diluted 10,000-fold in MB. This was done by diluting the 50µl
aliquot in 50ml MB broth. From this, a 5ml aliquot was taken and added to 45ml MB. Follow-
ing this, 50µl was spread onto a non-selective MB agar plate and incubated for 12-16 hours
at 37°C, after which the first colony count readings were taken and the CFU/ml calculated,
taking into account the dilutions made. This was taken to be the initial reading for the growth
of revived Roseobacter strains within static cultures.
• A 1ml aliquot was taken and the optical density (OD) at 750nm was measured using the
Ultraspec 500 pro (GE Healthcare Life Sciences, Buckinghamshire, U.K) machine as an
initial reading of the OD’s of shaken revived cultures.
3.1.2 Measurement of long-term viability of glycerol stocks using optical
density and colony count measurements
After one week, a glycerol stock of the strain of interest was taken and allowed to thaw, after which
50µl was taken and diluted 10,000-fold in MB. From this solution, a 50µl aliquot was spread on a
non-selective MB agar plate, incubated for 12-16 hours at 37°C and colonies were then counted,
accounting for the dilutions made in the process. In parallel, a second 50µl aliquot of the solution
was inoculated into 10ml MB and grown for 12-16 hours in a shaker-incubator at 37°C at 200rpm.
Following this, the OD750 was measured. This procedure was repeated for 12 weeks in duplicates.
3.1.3 The viability of Roseobacter glycerol stocks in liquid and static cul-
tures
Figure 3.1 shows that both the culturing of revived wildtype Roseobacter strains in liquid medium
and on agar plates retains efficiency for at least 12 weeks following preparation of glycerol stocks.
This indicates that master and working cell banks can be set up, minimising preparatory work for
experiments and allowing for consistency and reproducibility throughout a batch of experiments.
Both R. denitrificans and O. indolifex had an OD750 of over 2.51 and a CFU/ml count of over
2.2×107 for the duration of the experiment. Cells grown in liquid cultures show more stability than
cells grown on agar plates, with smaller variations seen between duplicate readings and over the
weeks. R. denitrificans (Figure 3.1a), in particular, exhibit a more stable profile than O. indolifex
(Figure 3.1b).
Results show that similarly to E. coli, Roseobacter strains can be grown in a range of tempera-
tures (20°C-37°C), with increased growth noted for the higher temperatures (Bruhn et al., 2007;
Christie-Oleza et al., 2012). This improves on results from Lafay et al. (1995) who had reported
that R. denitrificans does not grow at 37°C, contrary to results in Figure 3.1a. Unless otherwise
specified, the culturing of Roseobacter strains in a temperature of 37°C was applied as a measure
to simplify the culturing process in subsequent investigations.
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(a) Roseobacter denitrificans
(b) Oceanobulbus indolifex
Figure 3.1: Long-term viability of a) R. denitrificans and b) O. indolifex glycerol stocks stored at
-80°C and revived in shaken and static cultures over a period of 12 weeks. Readings for shaken
cultures were taken via OD750 measurements (right axis of plots) while readings for static cultures
were taken via CFU/ml measurements (left axis of plots). Readings were taken after 12-16 hours
from initiation of culture. Error bars show standard deviation for duplicate readings.
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3.2 Growth of Roseobacter strains in response to varying Chlo-
ramphenicol concentrations in the culture medium
Antibiotics are essential for the maintenance of plasmids equipped with antibiotic resistance genes
(Vandermeulen et al., 2011). The following study was carried out to determine whether non-
transformed wildtype Roseobacter cells are susceptible to growth inhibition in the presence of
antibiotics, and if so, the threshold concentration of antibiotics which enables a distinction be-
tween transformed and non-transformed cells. The synthetic BioBrickTM plasmid that was used
throughout transformation experiments had a Chloramphenicol resistance gene, hence, this study
was carried out with Chloramphenicol antibiotic.
The Chloramphenicol concentrations chosen for testing (Table 3.1) were based on previous work
carried out in Piekarski et al. (2009). All three Roseobacter strains (R. denitrificans, O. indolifex
and D. shibae) were used. The assay was also carried out on E. coli, to use as a reference point.
Chloramphenicol concentrations tested
Strain 0µg/ml 3.4µg/ml 7µg/ml 17µg/ml 34µg/ml
R. denitrificans X X - X X
O. indolifex X X X X -
D. shibae X X X X -
E. coli X - - - X
Table 3.1: The different Chloramphenicol concentrations which each of the three Roseobacter
strains and E. coli were cultured in, in order to assess cell growth inhibition by Chloramphenicol.
3.2.1 Preparation of Roseobacter strains in culture medium with varying
Chloramphenicol concentrations
To analyse Chloramphenicol sensitivity of R. denitrificans, O. indolifex and D. shibae, the first step
was to inoculate 100ml of MB with 100µl of cells from a glycerol stock and incubate it for 12-16
hours at 37°C at 200rpm. Four aliquots of 20ml were taken and each was supplemented with
20ml MB plus freshly prepared Chloramphenicol at a different concentration for a total of 40ml.
Four Chloramphenicol concentrations were used for each of the different strains, as listed in Table
3.1.
Following this step, each 40ml volume was divided into sixteen 2ml volumes. The remaining vol-
ume was discarded. The 2ml aliquots were incubated at 37°C at 200rpm. 2ml volumes were
taken out of incubation at hourly intervals at 0-6 hours and 8 hours post-incubation. OD600 mea-
surements were made in order to quantify cell growth. Two samples were measured at each time
point in order to carry out the experiment in duplicate. Samples were then discarded. E. coli was
taken through a similar protocol, replacing the use of MB with LB.
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3.2.2 The Chloramphenicol concentration threshold for cell growth inhibi-
tion of Roseobacter strains
A selectivity of 3.4µg/ml Chloramphenicol for R. denitrificans (Figure 3.2b) and 7µg/ml for both
D. shibae (Figure 3.2a) and O. indolifex (Figure 3.2c) resulted in minimal growth inhibition over a
span of eight hours. Selectivity of 17µg/ml or over resulted in severe growth inhibition over eight
hours for all three strains. Cells cultured in medium with Chloramphenicol concentrations higher
than 17µg/ml did not recover growth over this span of time. This study confirmed that there ex-
ists a Chloramphenicol concentration threshold above which Roseobacter cell growth is inhibited.
Hence, antibiotic selective screening can be used throughout all processes to promote growth
of antibiotic resistant transformed Roseobacter strains while inhibiting growth of non-transformed
cells.
The growth profiles of the three Roseobacter strains show a different susceptibility to Chloram-
phenicol. The growth profiles of D. shibae cultured in 3.4µg/ml or 7µg/ml Chloramphenicol are
similar to each other. The strain only showed growth inhibition when 17µg/ml Chloramphenicol
was applied. R. denitrificans and O. indolifex showed more distinct profiles when cultured in differ-
ent antibiotic concentrations. R. denitrificans, in particular, started to show distinct weak growth
when as little as 3.4µg/ml Chloramphenicol was applied. It showed acute growth inhibition at
17µg/ml, which is lower than the minimal inhibitory Chloramphenicol concentration (30µg/ml) re-
ported for this strain in Piekarski et al. (2009).
E. coli was used in order to verify that Chloramphenicol remains effective over the time span
over which observations were made. All optical density measurements were made at 600nm, as
is standard for E. coli, instead of at 750nm as used previously. This modification is based on
Roseobacter studies (Kalhoefer et al., 2011; Giebel et al., 2011) who similarly take optical density
readings at 600nm. As when culturing Roseobacter in 37°C instead of 30°C, this was undertaken
as a simplification measure in order to facilitate and standardise culturing of Roseobacter.
3.3 Transformation of Roseobacter clade bacteria using chem-
ical transformation and electroporation methods
A fundamental procedure within a cloning process and within synthetic biology is the introduction
of foreign plasmids into cell platforms. Therefore, different competence preparation and transfor-
mation protocols were implemented to analyse whether Roseobacter strains can be transformed
with plasmids, and moreover, whether they can be transformed using a simple and straightforward
technique. The selected protocols are based on established Roseobacter and E. coli methods,
with an emphasis made on the development of an electroporation based method, rather than
chemical transformation, due to the former method being more efficient in other bacterial organ-
isms (Anthony, 2001).
The synthetic plasmids used for the transformation procedures, including BioBricksTM, are listed
in Table 3.2. The BioBrickTM part pSB3C5 (EU496103) was supplied by the Registry of Stan-
dard Biological Parts (MA, U.S.A). The pA0815 plasmid was purchased from InvitrogenTM (Life
Technologies Ltd., Paisley, U.K) The pBBR1MCS1, pBBR1MCS2 and pBBR1MCS4 plasmids
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(a) Dinoroseobacter shibae
(b) Roseobacter denitrificans
(c) Oceanobulbus indolifex
(d) Escherichia coli
Figure 3.2: Growth of Roseobacter strains in liquid culture in response to varying Chloramphenicol
concentrations for a) D. shibae, b) R. denitrificans, c) O. indolifex and d) E. coli. Each plot shows
OD600 readings versus Time in hours. Error bars show standard deviation for measurements
carried out in duplicate.
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Plasmid Ori Selectivity
1 BioBrickTM pSB3C5 p15A Chloramphenicol
2 pA0815 pBR322 Ampicillin
3 pHD1313 pUC, F1 Ampicillin
4 pRPGFPSIR2rp3 pUC, 2µ Ampicillin
5 pUBeK pUC Ampicillin
6 pBBR1MCS1 pBBR1 Chloramphenicol
7 pBBR1MCS2 pBBR1 Kanamycin
8 pBBR1MCS4 pBBR1 Ampicillin
Table 3.2: BioBrickTM and engineered plasmids used in the chemical and electro transformation
of Roseobacter strains.
were purchased from CBS-KNAW Fungal Biodiversity Centre (Utrecht, Netherlands). pHD1313,
pRPGFPSIR2rp3 and pUBeK were provided as listed in Section 2.2.1. Transformation were also
carried out on E. coli to help inform results.
3.3.1 Transformation based on variations of electrocompetence and elec-
troporation methods
3.3.1.1 Efficiency of electroporation-based transformation as a function of plasmid mass
Cells were transformed using an electroporation protocol based on Piekarski et al. (2009). The
authors present the protocol as ‘a fast and easy method to transfer plasmids into Roseobacter
cells’ which gives transformation efficiencies up to the 107 CFU/µg range. This is in line with the
aims of this Roseobacter investigation to develop standardised straight-forward methods for the
use of Roseobacter cells as a synthetic biology platform. Minor modifications were made to the
protocol for simplification purposes, such as incubating cells in 37°C rather than 30°C. All three
R. denitrificans, O. indolifex and D. shibae strains, along with E. coli, were transformed with the
pSB3C5 BioBrickTM.
3.3.1.1.1 Preparation and electroporation of electrocompetent cells. Roseobacter strains
were prepared by growing 50µl of non-competent cells from a glycerol stock in 50ml MB medium
at 37°C and an agitation of 200rpm for 12-16 hours to an OD600 of over 0.5. Samples were then
centrifuged for 15 minutes at 4000rpm at 4°C. The supernatant was discarded and cell pellets
were resuspended in 10ml pre-chilled 10% (v/v) sterile glycerol after which the centrifugation-and-
resuspension process was repeated another four times, with the cell pellet being resuspended in
400µl 10% (v/v) glycerol in the last step. The suspension was divided into 50µl aliquots using
pre-chilled 1.5ml eppendorf tubes. Samples were used straight away, therefore no storage was
required. E. coli cells were prepared similarly, substituting the use of MB with LB medium.
Following preparation of electrocompetent cells, 5µl plasmid-DNA at the required concentration
was added to 50µl electrocompetent cells in a pre-chilled 0.2cm pulser cuvette (Bio-Rad, CA,
U.S.A). For each strain, four electroporation reactions were carried out using pSB3C5 at a mass
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of 50-1000ng as listed in Table 3.3. Following preparation, the mixture was then pulsed in a
Gene Pulse XcellTM System (Bio-Rad, CA, U.S.A) using a field strength of 2.5kV, capacitance
of 25µF and resistance of 200Ω. Afterwards, cells were supplemented with 1ml chilled MB and
incubated for 12-16 hours at 37°C with shaking at 200rpm to allow for synthesis of the antibi-
otic resistant protein. Following this, 100µl of the culture was transferred onto MB agar plates
with antibiotic selectivity as listed in Table 3.3 and incubated at 37°C. For each strain, two dif-
ferent Chloramphenicol concentrations were used, based on Chloramphenicol resistance results
as seen in Figure 3.2; a concentration of 17µg/ml which inhibits cell growth of non-transformed
cells and a lower concentration, dependant on the strain being used, at which cell growth, albeit
not optimal, can still be observed. After plating, D. shibae and R. denitrificans plates were left to
incubate for four days at 37°C while O. indolifex plates were left to incubate at 37°C for two days.
In parallel, control transformations with E. coli were carried out as per above, replacing the use of
MB with LB and incubating plates at 37°C for a total of 12-16 hours.
Table 3.3: Electroporation based transformation using differ-
ent plasmid masses for electroporation. Reactions and con-
trols carried out in electroporation transformation of Roseobacter
and E. coli strains with the BioBrickTM pSB3C5. Each reaction
lists the strain which was transformed, the plasmid mass used,
whether cells were pulsed, the Chloramphenicol concentrations
used to prepare transformation plates and the colony counts fol-
lowing incubation times. ‘Lawn’ refers to +250 small, non-isolated
colonies.
Strain Plasmid
Mass (ng)
Pulse Chloramphenicol
(µg/ml)
Colony
Count
1 R. denitrificans 50 Y 7, 17 0, 0
2 R. denitrificans 250 Y 7, 17 0, 0
3 R. denitrificans 750 Y 7, 17 0, 0
4 R. denitrificans 1000 Y 7, 17 0, 0
5 R. denitrificans 500 N - 250
6 R. denitrificans 1000 N - 200
7 R. denitrificans - N - 200
8 R. denitrificans - Y - 150
9 R. denitrificans - N 7, 17 0, 0
10 O. indolifex 50 Y 10, 17 0, 0
11 O. indolifex 250 Y 10, 17 0, 0
12 O. indolifex 750 Y 10, 17 0, 0
13 O. indolifex 1000 Y 10, 17 0, 0
14 O. indolifex 500 N - ∼50
15 O. indolifex 1000 N - ∼20
16 O. indolifex - N - ∼20
17 O. indolifex - Y - ∼20
18 O. indolifex - N 10, 17 0, 0
19 D. shibae 50 Y 10, 17 0, 0
20 D. shibae 250 Y 10, 17 0, 0
21 D. shibae 750 Y 10, 17 0, 0
22 D. shibae 1000 Y 10, 17 0, 0
23 D. shibae 500 N - lawn
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Table 3.3: Continued - Electroporation based transformation
using different plasmid masses for electroporation. Reac-
tions and controls carried out in electroporation test to transform
Roseobacter and E. coli strains with the BioBrickTM pSB3C5.
Each reaction lists the strain which was transformed, the plasmid
mass used, whether cells were pulsed, the Chloramphenicol con-
centrations used to prepare transformation plates and the colony
counts following incubation times. ‘Lawn’ refers to +250 small,
non-isolated colonies.
Strain Plasmid
Mass (ng)
Pulse Chloramphenicol
(µg/ml)
Colony
Count
24 D. shibae 1000 N - lawn
25 D. shibae - N - lawn
26 D. shibae - Y - lawn
27 D. shibae - N 10, 17 0, 0
28 E. coli 50 Y 34 0
29 E. coli 250 Y 34 0
30 E. coli 750 Y 34 0
31 E. coli 1000 Y 34 ∼20
32 E. coli 500 N - 150
33 E. coli 1000 N - 500
34 E. coli - N - lawn
35 E. coli - Y - 500
36 E. coli - N 34 0
3.3.1.1.2 Effectiveness of electroporation-based approach using varying plasmid mass
for Roseobacter transformation. Colony counts from transformation plates (for example, Re-
actions 1-4), listed in Table 3.3 showed that the three marine strains did not retain the BioBrickTM
plasmid following electroporation. Competent cells which were mixed with the plasmid but not
pulsed (for example, Reactions 5-6) showed good growth, indicating that the strain was not dam-
aged by the presence of the plasmid. Similarly, growth on plates of electrocompetent cells which
were pulsed/not pulsed in the absence of the plasmid (for example, Reactions 7-8) indicated that
both the preparation of electrocompetent cells and the electroporation shock were not damaging
to the strains. No growth was observed for non-pulsed cells spread onto selective plates (for
example, Reaction 9), indicating that no antibiotic-resistance contamination was present. Similar
results were observed for E. coli reactions. In this case, the electroporation worked when using
a very large DNA mass (1µg) (20 colonies were noted). The pSB3C5 BioBrickTM had a 260/280
purity ratio of 1.9, making it unlikely that plasmid impurities contributed to the observed results.
The high colony counts from D. shibae transformation plates indicated that the strain was the
more robust of the Roseobacter strains tested. Moreover, no differences were observed in colony
counts on transformation plates which had low and high antibiotic selectivities, indicating that even
the lower concentration effectively inhibits growth for non-resistant cells grown on selective agar
plates. However, based on previous findings, the higher concentration was retained to distinguish
between plasmid-positive and plasmid-negative Roseobacter cells.
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Plasmid
Mass (ng)
Voltage
(kV)
Chloramphenicol
(µg/ml)
Colony Count
1 250 0.5 17 0
2 250 1.0 17 0
3 250 1.5 17 0
4 250 3.0 17 0
5 1000 0.5 17 0
6 1000 1.0 17 0
7 1000 1.5 17 0
8 1000 3.0 17 0
9 250 0.5 - ∼10 & lawn
10 250 1.0 - ∼20 & lawn
11 250 1.5 - ∼10 & lawn
12 250 3.0 - ∼10 & lawn
13 1000 0.5 - ∼5 & lawn
14 1000 1.0 - ∼10 & lawn
15 1000 1.5 - ∼20 & lawn
16 1000 3.0 - ∼10 & lawn
Table 3.4: Transformation using different output voltages in electroporation. Reactions and
controls used in electroporation transformation of D. shibae with the BioBrickTM pSB3C5. Each
reaction lists the BioBrickTM mass used, the voltage set during electroporation, the Chlorampheni-
col concentration with which plates were prepared and colony counts following incubation times.
‘Lawn’ refers to +250 small, non-isolated colonies.
3.3.1.2 Efficiency of electroporation-based transformation as a function of voltage
3.3.1.2.1 Preparation and electroporation of electrocompetent cells. As a means of opti-
misation, cell preparation and electroporation steps were as per the previous method, with one
main difference; cells were pulsed using an output voltage between 0.5kV and 3kV, instead of the
previously used 2.5kV voltage. The pSB3C5 BioBrickTM plasmid was used at a mass of 250ng
or 1µg for insertion into D. shibae. If shown to be successful, the modified protocol would then
be applied to R. denitrificans and O. indolifex. A list of the reactions and controls which were
prepared can be found in Table 3.4. All reactions and controls were pulsed.
3.3.1.2.2 Effectiveness of electroporation-based approach using varying voltage for Ro-
seobacter transformation. Colony counts listed in Table 3.4 show that D. shibae cells which
were mixed with BioBrickTM plasmid, pulsed and spread onto selective plates (Reactions 1-8) did
not retain the plasmid, irrespective of the plasmid mass and voltage used. Colony counts for cells
taken through the same process but spread onto non-selective plates (Reactions 9-10) indicated
that cells were not compromised by the electroporation. Controls from the previous electropo-
ration process (Table 3.3) had already shown that cells retained viability in the presence of the
plasmids and following the electrocompetence preparation procedure, and that no antibiotic resis-
tant contamination was present.
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3.3.1.3 Efficiency of electroporation-based transformation based on a modified electro-
poration protocol and a broader range of plasmid ori sequences
Based on previous results, a different electrocompetence preparation and electroporation proto-
col, widely used for E. coli, was tested on D. shibae cells. In addition, four different engineered
plasmids were utilised instead of pSB3C5; pA0815, pHD1313, pRPGFPSIR2rp3 and pUBeK.
These plasmids have different origins of replication and antibiotic resistance genes, as seen in
Table 3.2.
This E. coli based protocol (Sambrook et al., 2001) was investigated for applicability with the D.
shibae strain due to a lack of Roseobacter -specific protocols available. In one of the few related
studies, a protocol developed by D’Alvise (2013) is used to transform Ruegeria mobilis, which is
a strain in the Rhodobacteraceae family in which the Roseobacter clade is also nested. Simi-
larly, Miller and Belas (2006) transform strains from the Silicibacter genus which is also nested
in Rhodobacteraceae. Although the preparation and pulsing conditions are similar to the elec-
troporation runs discussed above, both protocols use different culturing temperatures and more
complex media which are not applicable to Roseobacter strains. This renders the Rhodobacter-
aceae-optimised methods infeasible for the purpose of the current investigation.
3.3.1.3.1 Preparation and electroporation of electrocompetent cells. 10ml of MB was in-
oculated with 10µl of cells from a D. shibae glycerol stock and incubated for 12-16 hours in a
shaker-incubator at 37°C and agitation of 200rpm. Following this, 400ml MB were inoculated with
4ml of the culture and incubated at 37°C at 200rpm until OD600 was 0.3 or higher. The culture
was chilled on ice for 30 minutes, transferred to pre-chilled centrifuge bottles and centrifuged for
15 minutes at 6000rpm at 4°C. The supernatant was discarded by decanting and the pellet was
resuspended in one volume of ice-cold sterile distilled H2O. The centrifugation, supernatant dis-
carding and pellet resuspension steps were repeated another two times, with the supernatant
being removed through aspiration instead of decanting. Additionally, in the final step, cells were
resuspended in 50ml of ice-cold sterile 10% (v/v) glycerol and transferred to a pre-chilled 50ml
centrifuge tube. A final 15 minute centrifugation step was carried out at 6000rpm at 4°C, the su-
pernatant was removed using a pipette and the pellet resuspended in 2ml of ice-cold sterile 10%
(v/v) glycerol. This was then divided into 50µl aliquots in pre-chilled PCR tubes, which were kept
on ice and used immediately.
In summary, the preparation of electrocompetent cells (Sambrook et al., 2001) differs from the pre-
vious both in the two-step inoculation process which is used to grow non-competent cells initially
and in the harvesting of cells. This includes using a different speed of centrifugation (6000rpm in-
stead of 4000rpm), resuspension volume (one volume instead of a standard 10ml), resuspension
solution (ice-cold sterile distilled H2O instead of pre-chilled 10% (v/v) sterile glycerol) and final
resuspension volume (2ml instead of 400µl).
Following the preparation of electrocompetent cells, 5µl plasmid DNA at the required concentra-
tion was added to 50µl electrocompetent cells in a pre-chilled 0.2cm pulser cuvette. A list of the
reactions and controls prepared can be found in Table 3.5. Only one plasmid mass, of 500ng,
was used for electroporation. The mixture was then pulsed in a Gene Pulse XcellTM System using
a field strength of 2.5kV, capacitance of 25µF and resistance of 200Ω. After pulsing, cells were
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Plasmid Plasmid
Mass (ng)
Ampicillin
(µg/ml)
Colony Count
1 pAO815 500 100 0
2 pHD1313 500 100 0
3 pRPGFPSIR2rp3 500 100 0
4 pUBeK 500 100 0
5 pAO815 500 - 180
6 pHD1313 500 - 190
7 pRPGFPSIR2rp3 500 - 150
8 pUBeK 500 - 140
9 - - - 170
Table 3.5: Transformation using electrocompetence protocol by Sambrook et al. (2001).
Reactions and controls used to transform D. shibae using a modified electroporation protocol and
a broader range of plasmid ori sequences. Each reaction lists the plasmid and plasmid mass
used to transform D. shibae with, the Ampicillin concentration used to prepare plates with and the
colony count following the incubation period.
supplemented with 1ml of pre-warmed MB and incubated for one hour at 37°C with shaking at
200rpm to allow expression of the antibiotic resistant proteins. Following incubation, the culture
was then centrifuged for three minutes at 8000rpm and the supernatant was removed, except for
100µl in which the pellet was resuspended in order to condense cell density. The culture was
then divided equally between selective and non-selective plates and left to incubate for four days
at 37°C.
Thus, it can be seen that this protocol is similar to the previous in the electroporation conditions
used, but differs in the treatment of cells following electroporation, allowing cells to recover for
only one hour prior to plating, instead of 12-16 hours.
3.3.1.3.2 Effectiveness of modified electrocompetence and broader plasmid range ap-
proach to Roseobacter transformation. Colony counts from transformation plates wherein
electrocompetent D. shibae cells were mixed with plasmid, pulsed and spread onto selective
plates (Reactions 1-4 in Table 3.5) indicated that cells did not retain the plasmid following elec-
troporation. Colony counts of transformation plates wherein pulsed cells were spread onto non-
selective plates (Reactions 5-8) showed good growth, indicating that the plasmids were not toxic
to the cells. Colony counts from transformation plates on which D. shibae cells which were taken
through the process using a blank instead of a plasmid (Reaction 9) indicated that cells taken
through the preparation and electroporation process retained viability.
3.3.2 Transformation using the Piekarski et al. electroporation method
In light of the above results, the next step was to apply the preparation and pulsing procedure de-
veloped by Piekarski et al. (2009) for the transformation of D. shibae and E. coli cells. The range of
plasmids used for the transformation was widened again. In addition to the ones used above, the
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electroporation was carried out using three additional plasmids which were used in Piekarski et al.
(2009): pBBR1MCS1, pBBR1MCS2 and pBBR1MCS4 (Kovach et al., 1994). The plasmids have
the same backbone but have different antibiotic resistance genes (Table 3.2). The pBBR1MCS1-4
plasmids were prepared as per supplier instructions. Only pBBR1MCS1 and pBBR1MCS2 were
used in the electroporation protocol.
3.3.2.1 Preparation and electroporation of electrocompetent cells
Plasmids were used at a mass of 50ng as per Table 3.6. Cells were prepared as per Section
3.3.1.1.1, using incubation temperatures of 30°C instead of 37°C and measuring optical density
of cells at 578nm until density is at 0.5 instead of taking optical density measurements at 600nm.
Following electroporation and incubation, instead of plating cells which were suspended in an MB
solution, cells were serially diluted once in 1.7% sea-salts (Sigma-Aldrich, Munich, Germany) to
get concentrations of 1X and 0.5X. 100µl of the cells were plated on hMB agar plates (instead
of MB agar plates) with selective drug and without, as a control measure. D. shibae plates were
then left to incubate for four days at 30°C.
When using E. coli, the same electroporation process was carried out, replacing use of MB and
hMB with LB, using 37°C instead of 30°C incubation temperatures and incubating LB agar plates
for 12-16 hours.
3.3.2.2 Effectiveness of the Piekarski et al. approach to Roseobacter transformation
Results from colony counts following incubation periods, as seen in Table 3.6, indicated that the
electroporation was successful, with colonies noted on all selective plates on which electropo-
rated cells were grown (Reactions 1-6). By comparing colony counts of D. shibae plates wherein
electroporated cells were spread onto non-selective plates (Reactions 7-12) with those spread
onto selective plates (Reactions 1-6), a larger number of colonies was observed on the former,
indicating that the antibiotics were being effective and that colony counts on selective plates re-
sulted from plasmid-positive cells.
Based on these counts, two colonies from each of the selective plates were grown for 12-16 hours
in selective LB at a temperature of 30°C and agitation of 200rpm, after which the plasmid DNA
was extracted, digested and analysed via gel electrophoresis. Gel results (not shown) of the an-
alytical digests showed no clear bands, indicating that the plasmids which were used had been
discarded or broken down by the cell. This was corroborated by the low concentration of the DNA
sample following elution.
This is in contrast to results reported in Piekarski et al. (2009) who used a similar procedure
to isolate plasmid DNA. Irrespective of this, alternative methods can be adopted to confirm the
presence of inserted plasmids in Roseobacter. One option is to add EDTA to reduce nuclease
activity which may be inhibiting the isolation process. Otherwise, a phenol-chloroform extraction
method can be tested. In order to bypass DNA extraction, a plasmid encoding a fluorescent gene
(Piekarski et al., 2009) or allowing for blue/white screening can be used, although available liter-
ature indicated that the latter has not been used with a Roseobacter culture beforehand. A third
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Strain Plasmid Plasmid
Mass (ng)
Antibiotic
(µg/ml)
Colony Count
1 D. shibae pAO815 50 Amp 100 100
2 D. shibae pHD1313 50 Amp 100 100
3 D. shibae pRPGFPSIR2rp3 50 Amp 100 100
4 D. shibae pUBeK 50 Amp 100 20
5 D. shibae pBBR1MCS1 50 Cm 17 lawn
6 D. shibae pBBR1MCS2 50 Kan 100 2
7 D. shibae pAO815 50 - lawn
8 D. shibae pHD1313 50 - lawn
9 D. shibae pRPGFPSIR2rp3 50 - lawn
10 D. shibae pUBeK 50 - lawn
11 D. shibae pBBR1MCS1 50 - lawn
12 D. shibae pBBR1MCS2 50 - lawn
13 D. shibae - - - lawn
14 E. coli pAO815 50 Amp 100 20
15 E. coli pHD1313 50 Amp 100 100
16 E. coli pRPGFPSIR2rp3 50 Amp 100 140
17 E. coli pUBeK 50 Amp 100 200
18 E. coli pBBR1MCS1 50 Cm 17 0
19 E. coli pBBR1MCS2 50 Kan 100 140
20 E. coli pAO815 50 - lawn
21 E. coli pHD1313 50 - lawn
22 E. coli pRPGFPSIR2rp3 50 - lawn
23 E. coli pUBeK 50 - lawn
24 E. coli pBBR1MCS1 50 - lawn
25 E. coli pBBR1MCS2 50 - lawn
26 E. coli - - - lawn
Table 3.6: Transformation using the method by Piekarski et al. (2009). Reactions and controls
used in the electroporation of D. shibae and E. coli cells with plasmids having a range of ori
sequences. For each reaction, the table lists the strain which was transformed, the plasmid and
plasmid mass used, the antibiotic concentrations which was used to prepare transformation plates
and colony counts following incubation times. ‘Amp’ refers to Ampicillin, ‘Cm’ to Chloramphenicol
and ‘Kan’ to Kanamycin. ‘Lawn’ refers to +250 small, non-isolated colonies.
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alternative is to colony boil PCR transformed cells (Buchan et al., 2000).
Similar results were observed for E. coli reactions (Reactions 14-25), indicating that plasmids
were not retained by the host cells. Reactions wherein D. shibae and E. coli were taken through
the electrocompetence and electroporation processes without adding any plasmids and then
plated onto non-selective plates (Reactions 13, 26 respectively) showed good growth indicat-
ing that the procedure was not compromising the cells.
3.3.3 Transformation using the heat shock method
Given the above results, an alternative strategy was adopted and a heat-shock based chemical
transformation was applied instead. A CaCl2-based chemical transformation method was used to
transform the D. shibae strain with the pSB3C5 plasmid.
3.3.3.1 Preparation and transformation using the heat shock method of chemically com-
petent marine bacterial cells
D. shibae cells were prepared and transformed as per Section 2.2.6 and 2.2.7.1 respectively,
replacing the use of LB with MB. A list of reactions carried out can be found in Table 3.7.
3.3.3.2 Effectiveness of the heath-shock method to Roseobacter transformation
Colony counts from transformation plates (Table 3.7) indicated that whereas the transformation
was successful when using E. coli hosts (Reactions 8-10), transformation of D. shibae (Reac-
tions 1-3) was ineffective. Colony counts for transformation reactions which were plated onto
non-selective plates (Reactions 4-5) showed growth, indicating that the plasmid was not toxic to
the cells. Colony counts for the reaction wherein no plasmid was added to chemically compe-
tent cells taken through transformation and plated on non-selective plates (Reaction 6) indicated
that the transformation process did not compromise D. shibae. Finally, having eliminated the
probability that the electroporation and transformation protocol were toxic, colony counts for re-
actions wherein no plasmid was added to cells taken through the transformation process and
plated onto selective plates (Reaction 7) showed that no antibiotic-resistant contamination was
present. Piekarski et al. (2009) also carried out a RbCl2 chemical transformation in their study of
Roseobacter cells. Similarly, the transformation was not successful and therefore was not repli-
cated here.
A summary of the electroporation and chemical transformations which were made can be found in
Figure 3.3, which shows colony counts from D. shibae and E. coli selective transformation plates
following incubation. The plot highlights the wide range of plasmid mass and voltage conditions
examined. Repeatedly, no positive colonies for D. shibae were detected on selective transfor-
mation plates. Based on this and controls which show that cells were consistently viable and
uncontaminated, it was concluded that the transformation of Roseobacter cells using either elec-
troporation or heat-shock based methods is a non-trivial process and that further work is required
to develop an efficient, reproducible transformation procedure for Roseobacter cells.
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Strain Plasmid Plasmid
Mass (ng)
Chloramphenicol
(µg/ml)
Colony Count
1 D. shibae pSB3C5 100 17 0
2 D. shibae pSB3C5 250 17 0
3 D. shibae pSB3C5 500 17 0
4 D. shibae pSB3C5 100 - lawn
5 D. shibae pSB3C5 500 - lawn
6 D. shibae - - - lawn
7 D. shibae - - 17 0
8 E.coli pSB3C5 100 17 ∼200
9 E.coli pSB3C5 250 17 ∼200 & lawn
10 E.coli pSB3C5 500 17 ∼200 & lawn
11 E.coli pSB3C5 100 - lawn
12 E.coli pSB3C5 500 - lawn
13 E.coli - - - lawn
14 E.coli - - 17 0
Table 3.7: Transformation using the heat-shock method. Reactions and controls used to
transform D. shibae with the pSB3C5 BioBrickTMusing chemical instead of electro transformation.
For each reaction, the table shows the strain which was transformed, the plasmid and plasmid
mass which were used, the Chloramphenicol concentration used on transformation plates and
the colony counts on plates following incubation times.
3.4 Discussion
Three strains drawn from different lineages of the Roseobacter phylogenetic tree, O. indolifex, D.
shibae, and R. denitrificans were investigated to establish fundamental molecular biology proce-
dures which enable the construction and characterisation of synthetic GRNs within Roseobacter
platforms. This investigation was the first of its kind to be carried out with the aim of establishing
Roseobacter as a chassis within synthetic biology. The following findings and conclusions were
made:
1. Demonstrated that cell banks of Roseobacter marine strains can be developed and main-
tained for at least 12 weeks, possibly more. Glycerol stocks stored at -80°C were success-
fully revived in both shaken and static culture for the duration of this period.
2. Demonstrated that antibiotic selectivity can be applied throughout cloning and transforma-
tion procedures to select for plasmid-positive cells. Wildtype Roseobacter growth was
severely inhibited in the presence of Chloramphenicol concentrations as low as 17µg/ml.
This was lower than the previously reported 30µg/ml concentration (Piekarski et al., 2009).
3. Roseobacter strains were successfully cultured in temperatures up to 37°C.
4. Mapped the region of experimental design space within which three Roseobacter species
are resistant to plasmid uptake with respect to plasmid DNA concentration, plasmid ori-
gin of replication sequence, pulsing voltage and heat-shock/electroporation method used.
Throughout, Roseobacter cells were shown to have retained viability following the addition
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Figure 3.3: Plot mapping the different electroporation and chemical transformations which were
run to insert foreign plasmids into D. shibae and E. coli strains. The colony counts from selective
transformation plates for each insertion are shown as a function of the mass of plasmid DNA in
ng used in the transformation (y-axis) against the voltage in kV used during the transformation (x-
axis). Colony counts are as per the legend on the right. Colony counts marked with an * indicate
that multiple transformations using different engineered plasmids were run under the specified
conditions.
of synthetic plasmid and the transformation process.
5. The development of a simple and rapid transformation protocol for Roseobacter strain is
non-trivial and further investigative work is required in order to both enable the development
of synthetic GRNs in Roseobacter and to develop a de-skilled practice (Tucker, 2012) which
allows for the participation of both academics and citizen scientists.
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Chapter 4
Design and construction of the
stable and unstable trypanosomal
Goodwin oscillators
In the scope of establishing T. brucei as a synthetic biology chassis by developing a Goodwin
oscillator encoded by a novel synthetic GRN, the first steps were to design and assemble the
trypanosomal synthetic plasmid. Results of this process to develop both a stable and unstable
Goodwin oscillator are presented here.
4.1 The stable and unstable Goodwin oscillators
The Goodwin oscillator was developed as a simplified mathematical model of the circadian rhythm
(Goodwin, 1963). It has two main components, as seen in Figure 4.1; a single gene (gene A)
which expresses a protein A, and an operator to which the protein A binds and inhibits further
expression. This inhibitory regulation of expression is represented by the red arrow in Figure 4.1.
In order to re-start expression, there are two options; to allow protein A to degrade via natural
processes, following which expression re-initiates autonomously or to add an inducer molecule
which causes protein A to unbind from the operator and instead bind to the inducer towards which
it has a greater affinity.
Figure 4.1: Diagram of a theoretical Goodwin oscillator showing the two main components of the
GRN; gene A and the associated operator. Gene A produces a protein A which binds to the
operator, resulting in inhibitory feedback which shuts down protein synthesis, as represented by
the red arrow.
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Figure 4.2: Diagram of the plasmid encoding the stable Goodwin oscillator which is to be con-
structed showing the main molecular species in the network: the PRRNA and PEp1 promoters; the
tet operator, Tet Op; the tetR gene; the Ub-L-eGFP fusion gene; the 5’ and 3’ UTRs for both sets
of genes; the Hygromycin (‘Hyg’) and Ampicillin (‘Amp’) selectable markers and the rRNA gene
targeting locus having a NotI restriction site.
4.1.1 The GRN which encodes the stable Goodwin oscillator
The novel synthetic GRN which encodes the stable Goodwin oscillator, pStable (Figure 4.2), has
singular dominant negative feedback. The device has four main sets of components; the regu-
latory gene and operator equivalent to gene A and the operator in Figure 4.1 respectively plus
additional parts which allow for correct recombinant DNA and assembly procedures and facilitate
characterisation efforts, as discussed below:
1. Genes & Proteins. One of the main features of the network is the tetR gene which ex-
presses the Tetracycline Repressor (TetR) protein. This protein binds to the tetracycline
operator (Tet Op/tet operator) and inhibits its own expression and that of all genes within
the same operon, based on the inhibiting mechanism found on the E. coli Tn10 transposon
(Hillen & Berens, 1994). The tetR gene is equivalent to gene A in Figure 4.1 and is respon-
sible for regulation of gene expression. The tetracycline regulated system was chosen not
only because of its relative simplicity but also because it is a tightly regulated system across
several species (Gossen & Bujard, 1992; Kamionka et al., 2004) and has been shown to
work well in trypanosomes in multiple expression regulation studies (Alibu et al., 2005; Pea-
cock et al., 2005).
A modified Green Fluorescent Protein (eGFP) which acts as a reporter protein to indirectly
reflect TetR levels in the network (Zhang et al., 1996) is expressed within the same operon
and is therefore under the influence of the tet operator. Thus, the GRN is a proof-of-principle
construct which uses a fluorescing protein as an output to enable straightforward character-
isation.
The N-terminus of the eGFP gene is fused to a mutated Ubiquitin gene, a Ubiquitin degron,
wherein the 76th (and final) amino acid is changed to Leucine (Ub-L) as seen in Dantuma
et al. (2000). The fusion serves to flag up eGFP for ubiquitin-proteasome dependant degra-
dation. The final amino acid replacement is based on the N-end rule which states that a
protein’s half-life is determined by the amino acid at its terminus (Bachmair et al., 1986).
Leucine is calculated to result in a protein half-life of 5-6 hours in HeLa cells (Dantuma
et al., 2000; Gonda et al., 1989). Failing this destabilisation step, regulation through TetR
feedback is masked as the wildtype eGFP reporter protein does not have a sufficiently fast
turnover to reflect changes from TetR inhibition (Li et al., 1998). This means that the trans-
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fected organism would fluoresce irrespective of whether expression is ongoing or not.
The network has an Ampicillin gene used during E. coli assembly stages to select for trans-
formants and a Hygromycin gene which serves to select stable T. brucei transfectants.
2. Operators, Promoters & Selectable Markers The plasmid has one operator, the tet op-
erator, which lies downstream of the trypanosomal, class I, tetracycline-dependant PRRNA
promoter (Schimanski et al., 2004) and to to which the TetR protein can bind and inhibit
expression. The tetR and Ub-L-eGFP genes are under the influence of the PRRNA promoter.
Apart from this, the network has a PEP1 promoter from the EP procyclin locus (Alibu et al.,
2005) which drives expression of Hygromycin and a PAmp promoter (not shown in Figure
4.2) which drives expression of the Ampicillin resistance gene in E. coli.
3. Untranslated regions The tetR gene is flanked by two untranslated region sites (UTRs),
EP1-5’ and4ALD-3’, which are regions in mRNA which influence gene expression and sta-
bility (Drozdz & Clayton, 1999; Clayton, 1999). The former is an EP1 procyclic 5’-UTR, while
the latter is a truncated fructose biphosphate aldolase 3’-UTR. The EP1 UTR contains both
activating and inhibiting sequences which control stability and translation (Schurch et al.,
1997). 4ALD-3’ has been shown to increase expression levels in BSF trypanosomes (Clay-
ton & Shapira, 2007). The aldolase UTR can be truncated since specific sites such as the
initial 136 bases are not required for regulation (Hug et al., 1993; Hotz et al., 1995).
The eGFP gene is flanked by a 4ALD -5’ and a 4ALD 3’ region, which serve similar pur-
poses.
4. rRNA targeting region The rRNA region contains a NotI restriction site at which the plas-
mid can be linearised. The plasmid is then introduced into the trypanosomal genome via
transfection, wherein the plasmid is inserted via recombination at a non-transcribed rRNA
spacer loci (Alsford & Horn, 2008, 2005).
4.1.2 Emergence of oscillations in protein production in the stable Good-
win oscillator
Figure 4.3 explains how oscillatory protein production within the stable GRN results from auto-
inhibitory transcriptional regulation by the TetR protein. There is no positive feedback within the
GRN. In terms of protein expression dynamics, it is assumed that at time zero there is no ongoing
protein production (Figure 4.3a). The PRRNA promoter initially drives expression of tetR and eGFP,
resulting in increasing TetR and fluorescence levels (Figure 4.3b). Once dimerised (not shown),
TetR protein can bind to the tet operator and this leads to a halt in expression (Figure 4.3c). TetR
and eGFP levels then decline due to natural degradation processes (Figure 4.3d). Once TetR
protein bound to the operator is degraded, the pathway for expression is re-activated and the os-
cillation process repeats itself (Figure 4.3a). This increase, peak and decrease in protein levels is
considered to be an oscillation.
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(a) Step 1: The Goodwin oscillator at time 0. (b) Step 2: Protein synthesis occurs. tetR and Ub-L-
eGFP genes express TetR and Ub-L-eGFP protein.
(c) Step 3: TetR binds to the tet operator and inhibits
expression of the tetR and Ub-L-eGFP genes.
(d) Step 4: TetR and Ub-L-eGFP degrade, after which
protein synthesis re-starts from Step 1.
Figure 4.3: Diagram explaining how oscillatory protein production dynamics in the Goodwin oscil-
lators occur as a result of the negative feedback loop within the GRN. The negative feedback loop
results from the binding of TetR to the tet operator.
4.1.3 Theoretical design principles implemented in the stable Goodwin os-
cillator which enable oscillations
The Goodwin oscillator incorporates a set of fundamental design principles, discussed in Section
1.2.1.5 which allow for oscillations to occur: negative feedback, time-delay and non-linearity. A
dominant negative feedback loop is implemented through the auto-inhibition of tetR synthesis,
wherein a TetR dimer binds to the tet operator and represses expression. No positive loops are
present in the network. Although this is not expected to have an effect on the nature of the dy-
namics it is likely to have an effect on the quality of the oscillations, in that oscillations will be less
consistent (Tsai et al., 2008; Stricker et al., 2008).
The second necessary design feature, time-delay, is implemented due to natural synthesis pro-
cesses (transcription, translation, post-translation) within eukaryotes which result in a delay be-
tween when expression of a protein is initiated and when the protein becomes functional. A
time-delay implies that the system output (TetR and eGFP) reflects the amount of system input
(tetR and eGFP expression) at a previous time, rather than the input’s current state, thus pre-
venting the network system from stabilising. The third design feature, non-linearity, is inherently
present in transcription which is dependant on the amount of TetR present, although not linearly
so since the relation depends on the number of operator-bound TetR within the cell. In mathemat-
ical modelling, this is represented by a Hill function. Similarly to time-delay, this serves to cause
instability within the system.
4.1.4 The unstable Goodwin oscillator
The unstable Goodwin oscillator, pUnstable, builds on the stable design and retains all the main
characteristics and components. Two main sets of changes were applied, as represented in Fig-
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(a) Unstable Goodwin oscillator, showing the two main modifications which were applied to the stable oscillator; the
fusion of a Myc tag and Ub-L destabilising gene to the tetR gene (Edit 1) and the change of the UTRs flaking the Myc-Ub-
L-tetR moiety to Tubulin 5’UTR and 3’UTR (Edit 2).
(b) Stable Goodwin oscillator
Figure 4.4: Diagram of the plasmids encoding the: a) unstable and b) stable Goodwin oscillator
constructs. Edit 1 and Edit 2 highlight the changes applied to the stable device in order to develop
the unstable network.
ure 4.4a and as discussed below. These include the insertion of a Myc tag and Ub-L destabilising
gene upstream of the tetR gene (but downstream of the EP1-5’UTR) to form a moiety, and the
replacement of the EP1 5’ UTR and 4ALD 3’ UTRs flanking the tetR gene with Tubulin UTRs.
Oscillations within the unstable Goodwin oscillator occur via the same mechanisms as the stable
Goodwin device (Section 4.1.2). The same design principles implemented in the stable Goodwin
oscillator (Section 4.1.3) are also implemented here.
4.1.4.1 Modification 1: Addition of a c-Myc tag peptide and modified Ubiquitin gene up-
stream of the tetR gene
In the first modification, a c-Myc tag and Ub-L destabilising gene were fused upstream to the tetR
gene. The c-Myc tag (Evan et al., 1985) was added in order to allow for an easier characterisa-
tion process when quantifying proteins via use of antibodies, to detect for the c-Myc tag instead
of the tetR protein directly. Although there are other methods for quantifying TetR (Hillen et al.,
1982), this was considered to be a more straightforward, tried-and-tested quantification technique.
The Myc epitope was added upstream of the tetR gene rather than at the C-terminus since TetR
dimerisation occurs at the α7-α10 structures (Rossi et al., 1998) which are located in the C-
terminus half of a TetR monomer. Fusing the Myc tag at the C-terminus results in the compromis-
ing of the TetR structure and a leaky expression as seen in Dragosits et al. (2012). Research has
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Figure 4.5: Diagram highlighting the different nucleotides between the original 228bp Ub-L se-
quence (excluding the start codon) found upstream of eGFP (top row of each line) and the codon
optimised Ub-L sequence to be inserted upstream of the tetR ORF (bottom row of each line) in
the unstable oscillator. The original Ub-L sequence is in black, while the codon optimised Ub-L
sequence is in blue, with nucleotides which do not correspond to the original highlighted in red.
The numbers on top at the beginning of each line represent the base pair number.
shown that the N-terminus of the TetR (dimer) protein plays a role in the binding of the protein to
the tet operator (Berens et al., 1992). Based on this information, it was decided to append the tag
at the N-terminus so as not to compromise TetR stability and structure (Berens et al., 1992). The
effect of the appendage on the binding properties of TetR will be discussed during characterisa-
tion.
The second addendum to the tetR gene was the destabilising Ub-L gene in order to destabilise
the TetR protein (Bachmair et al., 1986), hence why this GRN is labelled as the unstable oscillator.
This was added at the N-terminus of the tetR gene, downstream of the Myc tag. The TetR pro-
tein was destabilised to increase the frequency of oscillations and thus develop a tuned oscillator
plasmid. In order to facilitate identification of the unstable plasmid a HindIII restriction site was
inserted between the Ub-L and tetR genes.
The Ub-L codon usage was optimised for the T. brucei platform. Optimisation was carried out in
order to increase translational efficiency of the moiety and reduce the risk of recombination due
to the homologous (original) Ub-L sequence which is present upstream of the eGFP gene (Men-
zella, 2011). Optimisation was carried out using an application by Integrated DNA Technologies,
Inc. (Leuven, Belgium, http://eu.idtdna.com/CodonOpt). The edited nucleotides were scattered
throughout the Ub-L sequence in order to decrease long stretches of homology with the original
Ub-L sequence. See Figure 4.5 for a comparison of the original and optimised Ub-L genes. In
total, 49 nucleotides were changed, meaning that there is a 21% discrepancy between the origi-
nal and modified Ub-L sequences. Note that the start codon in the optimised Ub-L sequence was
removed, since Ub-L was preceded by the Myc-tag.
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Figure 4.6: Diagram representing the silencing of genes by active genes at sub-telomeric loci via
inhibitive cross-talk between homologous 3’ UTRs.
4.1.4.2 Modification 2: Change of UTRs flanking tetR
In the second main modification applied to the stable oscillator, the UTRs flanking the tetR gene
were changed from the EP1 5’ UTR and4ALD 3’ UTR to the Tubulin 5’ and 3’ UTRs, represented
as the Tub 5’ and 3’ UTRs (Figure 4.4a). The Tubulin 5’ and 3’ UTRs have been shown to allow for
higher expression levels than other UTR options (McLatchie et al., 2013). The KpnI sites flanking
the previous UTRs were retained, to facilitate plasmid identification during cloning.
The decision to change the UTRs is based on findings on proteins at telomeric or sub-telomeric
locations by Hutchinson et al. (2014). A telomere is a repetitive region at the end of a chro-
matid. The authors found that VSG proteins at telomeric or sub-telomeric loci are inhibited and
kept inactive by active proteins using cross-talk between homologous 3’ UTRs of the active and
inactive proteins, as represented in Figure 4.6. Although the result has not yet been proved for
non-telomeric regions, the homologous 4ALD 3’ UTR region downstream of the tetR gene in the
Goodwin oscillator was edited nonetheless to remove the possibility of inhibiting cross-talk.
4.2 Construction of the stable Goodwin oscillator
Four assembly strategies, each using different recombinant DNA techniques for the construction
of the stable oscillator plasmid pStable were developed and taken forward in parallel. A brief
outline of the strategies, labelled the Non-directional, Three-fragment, TetR-first and eGFP first
strategies, is found in Figure 4.7 which serves to show the main cloning steps and plasmids used
in each assembly. This approach was developed as a time-efficient strategy which acknowledges
that recombinant DNA assembly strategies are not fail-safe (Perkel, 2014) and with the aim of
using the construct first past the post. These assembly strategies will be discussed next.
4.2.1 Outline of the principle cloning steps
The plasmid pRPeGFPSIR2rp3 (Figure 4.8a) was used as a backbone to construct the stable os-
cillator which has size 8.8kb. All cloning was carried out in E. coli cells, so as to take advantage
of standard and time-efficient cloning protocols. Each assembly entailed three main steps, as
represented in Figure 4.8b and as explained below:
1. Insert the EP1 5’ UTR-tetR-4ALD 3’ cassette (1.27kb), extracted from pHD1313, into pRPeGFP
SIR2rp3 at the unique KpnI site.
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Figure 4.7: Summary of the four Assembly strategies developed to construct the plasmid encoding
the Goodwin oscillator. The strategies make use of single and double preparative digests, PCR
amplifications, directional, non-directional, three-fragment and Gibson ligation techniques. The
strategies make use of the pUBeK, pRPeGFPSIR2rp3, pBC037, pConstitutive, pUbSir and ptetR -
UbSir plasmids during the assembly steps. The letters K, H, X, X* and B represents the restriction
sites KpnI, HindIII, XbaI, in-frame XbaI and BamHI used in digest and ligation steps.
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(a) pRPeGFPSIR2rp3 plasmid having the pRP backbone used as the basis for the assembly
of the stable oscillator
(b) The stable oscillator highlighting the three main cloning steps which are required for assembly
using pRP as a backbone; the insertion of the UTR-tetR-UTR cassette at the KpnI site (Step
1), the insertion of Ub-L at the HindIII/XbaI sites (Step 2) and the insertion of eGFP at the
XbaI/BamHI sites(Step 3).
Figure 4.8: Diagram showing: a) the pRPeGFPSIR2rp3 plasmid having the pRP backbone used
as a backbone for the construction of the stable oscillator and b) the stable oscillator device
highlighting the three main construction steps required for assembly.
2. Replace eGFP gene site on pRPeGFPSIR2rp3 with the Ub-L gene (0.36kb), extracted from
pUBeK.
3. Replace the Sir2rp3 gene on pRPeGFPSIR2rp3 with the eGFP gene (0.72kb) extracted from
the same pRPeGFPSIR2rp3 plasmid.
4.2.2 Oscillator assembly strategy using non-directional ligation
4.2.2.1 Introduction
The first assembly strategy using non-directional ligation is detailed in Figure 4.9. The aim of
this strategy was to ligate the eGFP gene into the pUBeK backbone, downstream of the Ub-L
gene so as to create the Ub-L-eGFP moiety via an XbaI/BamHI directional ligation (Ligation 1 in
Figure 4.9), with the XbaI/BamHI ligation scar designed to be in-frame throughout all ligations.
In parallel, the tetR gene would be inserted in the pRP backbone of pRPeGFPSIR2rp3 via a KpnI
non-directional ligation (Ligation 2). Once completed, the Ub-L-eGFP genes would be ligated into
the latter to give the stable oscillator via a HindIII/BamHI ligation (Ligation 3). The diagram omits
details such as purification and other treatments which are referred to further on if valid to the
discussion.
122
Figure 4.9: Oscillator assembly strategy using non-directional ligation.
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Figure 4.10: Analysis of the XbaI and BamHI restriction sites on pUBeK. Diagrams on the left
show the pUBeK plasmid cut with XbaI (top), XbaI & BamHI (middle) and BamHI (bottom). Gel
results on the right of XbaI and BamHI single and double digests show:
1) 10µl pUBeK, XbaI cut,
2) 10µl pUBeK, XbaI/BamHI cut,
3) 10µl pUBeK, BamHI cut,
4) 5µl pUBeK, uncut.
4.2.2.2 Restriction site mapping of the pUBeK backbone
Prior to ligation steps, analytical digests were carried out in order to confirm identity of the pUBeK
plasmid. Specifically, digests were carried out to assess whether XbaI and BamHI sites, used
during the assembly stages, were unique. Digest results seen in Figure 4.10 indicated that the
sites were not unique, as seen in Lane 1 which shows two bands for a single XbaI digest.
Following this, sequencing was carried out using the forward primer (5’-3’) ATAAGGAGGGTATC-
CCTCCGG and reverse primer (5’-3’) AATCAGTCGCTGCTGATCCGG. The primers annealed to
the middle of the Ub-L gene (Figure 4.11a), such that the gene itself and its surrounding region
were sequenced. Interest lay in sequencing the nucleotides immediately upstream and down-
stream of the gene which might have been inserted during construction of pUBeK. As a back-
bone, the commercially available pUC57 backbone was used and hence, its sequence was easily
available. Results in Figures 4.11b and 4.11c show a diagram of the known restriction sites prior
to and after sequencing. In addition to the known XbaI site downstream of Ub-L, there is a second
XbaI site upstream of the gene which was previously undetected and which is in agreement with
analytical digest results in Figure 4.10. This compromised the ligation strategy wherein the eGFP
gene was to be inserted into the pUBeK plasmid via an XbaI/BamHI ligation (Ligation 1 in Figure
4.9). This is because if the backbone is cut with XbaI and BamHI in preparation of the ligation,
the Ub-L gene is cut out of the backbone in the process. Thus an alternative strategy was adopted.
4.2.2.3 Preparation of eGFP for insertion downstream of the Ubiquitin degron region
Apart from the digestion of pUBeK, the first step of the assembly strategy required the preparation
of the eGFP insert by PCR amplifying the gene from pRPeGFPSIR2rp3 using the forward primer (5’-
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(a) Diagram showing the pUBeK plasmid and the primers
used to map restriction sites immediately upstream and
downstream of the Ub-L gene.
(b) Known restriction sites prior to sequencing. (c) Known restriction sites post sequencing.
Figure 4.11: Diagram showing: a) Primers used in the sequencing of pUBeK plasmid to map
region surrounding the Ub-L gene, b) Known restriction sites surrounding Ub-L gene prior to
sequencing, c) Known restriction sites surrounding Ub-L gene post sequencing.
3’) TCTAGAGTGAGCAAGGGCGAGGAGCTGTTCACCGGGG to add the XbaI site and remove
the start codon and reverse primer (5’-3’) GGATCCGCCTTCAAGACTTGTACAGCTCGTCC to
add the BamHI restriction site and stop codon. This results in a cassette of size c. 730bp which
includes the eGFP gene plus flanking XbaI and BamHI sites to be used in ligation.
Results of PCR reactions showed no amplified DNA regions (not shown). The first step in trou-
bleshooting this issue was to repeat the PCR as per supplier instructions using different recipes
wherein four different variables were tested for optimisation:
Addition of dimethyl sulfoxide (DMSO) - As per manual instructions, to a final concentration of
3% which serves to optimise template denaturation by removing DNA supercoils.
Addition of 0.5mM magnesium chloride (MgCl2) - Two different concentrations were tested,
0.5mM MgCl2 and 1mM MgCl2, to act as a cofactor to the magnesium-dependant Phusion
polymerase.
Annealing temperature - A 45°C instead of a 55°C annealing temperature was tested, in order
to facilitate binding.
Buffer - The use of GC instead of the standard HF buffer. GC buffer can be used in GC-rich
templates. Four different experiments were carried out, two at an annealing temperature
of 55°C using either no additional MgCl2 or an additional 0.5mM MgCl2, and two reactions
using an annealing temperature of 45°C following the same recipes.
Throughout, positive controls always showed a clear band, indicating that the PCR reagents were
working and the thermocycling process allowed for PCR (images not shown). However, no bands
were observed when a sample of the PCR on pRPeGFPSIR2rp3 was run on a gel. Therefore, three
complementary primers were designed: a forward primer (5’-3’) GAGTGGTACCCTGCACGC-
CGC, a second forward primer (5’-3’) ATGGTGAGCAAGGGCGAGGAG and a reverse primer
(5’-3’) AATCATACGATTGGGCCGCC.
These primers served to amplify cassettes of size 745bp or 844bp which include the eGFP cas-
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sette. Each of the forward complementary primers were tested and both were successful, as seen
in Figure A.1a in Appendix A which contains images of gel electrophoresis results run with PCR,
ligation and digest DNA samples. Subsequent amplifications of these strands using the original
mutagenic primers were then applied to amplify the eGFP gene and add the necessary overhangs
(See Figure A.1b). Bands had a size of c. 730bp, as expected.
Thus, amplification and addition of XbaI/BamHI restriction sites to eGFP was achieved in a se-
ries of two steps, the first using complementary primers to extract a DNA fragment including the
eGFP gene which then serves to minimise probability of non-specific annealing when the second
PCR using mutagenic primers to introduce the necessary nucleotides was applied. This ligation
step was suspended due to the non-unique restriction sites present in pUBeK as discussed above.
4.2.2.4 KpnI non-directional ligation of tetR into pRPeGFPSIR2rp3
In parallel to the above, Ligation 2 of the assembly was taken forward.
Preparation of tetR insert. PCR was carried out using the forward mutagenic primer (5’-3’)
GGTACCGTCTTGGTGTGTCGACCTTGCAGGC and reverse mutagenic primer (5’-3’) GGTACC-
TTGTACATATTGTCGTTAGAACGCGGC to extract the EP1 5’UTR-tetR-4ALD 3’UTR cassette
from the pHD1313 plasmid, add KpnI sites upstream and downstream of the cassette and prepare
it for ligation into the pRPeGFPSIR2rp3 plasmid backbone. This PCR product will be referred to as
the tetR cassette and is expected to be 1241bp long. No optimisation measures for PCR were
required, with gel electrophoresis results in Figure A.2a. Amplified DNA was purified and identity
again confirmed via gel electrophoresis (not shown).
In preparation of the ligation, a preparative KpnI digest was carried out on the tetR cassette. Two
digests were carried out in parallel, one using the digestive enzyme and another where in addition
to it, CIP-treatment was applied to dephosphorylate 5’ ends of the insert and minimise chances of
re-ligation. Following plasmid identification via gel electrophoresis, the DNA was gel purified and
a final sample taken to confirm identity via gel electrophoresis (results not shown).
Preparation of the pRPeGFPSIR2rp3 backbone. The pRPeGFPSIR2rp3 backbone was taken
through a KpnI digest and dephosphorylation reactions, as with tetR (Figure A.2b). Gel-purification
steps were swapped for purification using the QIAquick PCR Purification Kit (Qiagen) for a more
efficient process.
Ligation of fragment encoding TetR ORF into pRPeGFPSIR2rp3 backbone. Following prepa-
ration of the tetR insert and pRPeGFPSIR2rp3 backbone, ligation reactions were carried out (see
Table A.1, which also lists colony counts observed on transformation plates).
Transformation of the ligations was carried out in both W3110 and commercial TOP10 cells. In
the TOP10 cells growth was noticed on all plates, however, this was limited to small non-isolated
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colonies. In the W3110 cells, on the other hand, a small number of isolated large colonies were
noticed surrounded by small non-isolated colonies indicating suboptimal growth. When comparing
the ligations using CIP-treated inserts to those using non-CIP-treated inserts, no clear distinction
was made, indicating that CIP was not having a discernible effect. Controls also showed that the
digest was suboptimal, since no difference was observed between reactions using cut plasmid
wherein ligase was added or omitted. Two colonies were picked from the ligation plates and a
sample taken for a KpnI analytical digest and run on a gel (image not shown). Bands showed that
no insert was present.
4.2.2.5 Appraisal of non-directional ligation strategy
Following the implementation of this assembly strategy using non-directional ligation to construct
the pStable oscillator, the following findings and observations were made:
1. The amplification of eGFP from the pRPeGFPSIR2rp3 backbone requires a two-step PCR.
The first PCR uses complementary primers to extract a DNA segment including the eGFP
gene from the backbone. This reduces the probability of the second set of primers mis-
annealing along the backbone. Mutagenic primers are then applied to the segment to extract
the eGFP gene and add restriction sites, remove the start codon and add the stop codon.
2. Digests and sequencing to map restriction sites of the pUBeK backbone revealed unknown
restriction sites which prevent the use of the pUBeK backbone for cloning purposes to insert
the eGFP gene downstream of the Ub-L gene and develop the Ub-L-eGFP moiety.
3. Results of the non-directional KpnI ligation to insert tetR into the pRPeGFPSIR2rp3 back-
bone indicated that the backbone had re-ligated to itself. Additionally, the colonies ob-
served on transformation plates on which chemically transformed W3110 or TOP10 cells
were spread, were small and non-isolated. Thus, alternative chemically competent XL10-
Gold® cells available commercially will be used.
4.2.3 Oscillator assembly strategy using three-fragment ligation
4.2.3.1 Introduction
The second cloning strategy, as outlined in Figure 4.12, was adopted as an alternative approach
of fusing the eGFP gene to Ub-L on the pUBeK backbone via an XbaI/BamHI ligation given that
the XbaI site on pUBeK is not unique. The first step (Ligation 1 in Figure 4.12) was to insert the
Ub-L and eGFP genes into the pRP backbone via a three-fragment HindIII/XbaI/BamHI ligation
to get the pConstitutive plasmid. This avoids the use of pUBeK as a backbone. The pConstitu-
tive plasmid has the Ub-L-eGFP moiety but not the regulating tetR gene, resulting in constitutive
eGFP expression. Following this, the tetR cassette was to be inserted via a non-directional KpnI
ligation in pConstitutive to construct pStable (Ligation 2 in Figure 4.12). The diagram leaves out
details such as purification and other treatments which are referred to further on if valid to the
discussion.
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Figure 4.12: Assembly strategy using three-fragment ligation.
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4.2.3.2 Ligation 1: Assembly of pConstitutive plasmid by ligation of Ub-L and eGFP frag-
ments into pRPeGFPSIR2rp3 backbone
HindIII/BamHI digest of pRPeGFPSIR2rp3 backbone. The first step was to carry out a HindII-
I/BamHI preparative digest on pRPeGFPSIR2rp3, after which the reaction was run on gel (Figure
A.3a). The backbone was extracted via gel purification and an aliquot run on a gel (not shown) to
confirm DNA is still intact.
XbaI/BamHI digest of eGFP insert. To amplify the eGFP gene from pRPeGFPSIR2rp3, the two-
step PCR process using complementary primers followed by mutagenic primers as outlined in the
previous strategy was used (Figure A.3b). Following this, the DNA was purified, digested with
XbaI and BamHI and purified. A sample was run on a gel to confirm plasmid identity (not shown).
HindIII/XbaI digest of Ub-L insert. In order to extract the Ub-L gene from pUBeK, an XbaI/HindIII
digest was carried out. A sequential digest was carried out instead of a simultaneous digest as an
optimisation measure. The digest was run on a gel (Figure A.3c) which showed the required 0.4kb
Ub-L band and the discarded 2.7kb backbone band, after which it was gel purified and a small
aliquot run on a second gel to confirm plasmid remained intact throughout purification (not shown).
Three-fragment ligation. Following preparation of inserts and backbone, ligations were pre-
pared (data not shown) and transformed using XL10-Gold® cells. Colony counts from control
plates were indicative of uncut backbone and a suboptimal purification process which did not
eliminate unwanted DNA cassettes. Moreover, colonies which were picked from ligation plates
and analysed indicated that only re-ligated backbone plasmid was present.
A second three-fragment ligation was carried out using a larger plasmid mass of better quality,
eluted via a maxiprep protocol rather than a miniprep kit. DNA stocks were at least twice as
dense as stocks eluted from minipreps. In all subsequent steps, DNA eluted from a maxiprep will
be used unless otherwise specified. The inserts and backbone were prepared as per the previous
methods (images from gels not shown) and ligations were carried out (Table A.2).
Control reactions were indicative of a successful digest but a suboptimal purification of the back-
bone following digestion. Colonies were picked from the ligation plates, grown for 12-16 hours
in LB medium, purified and an aliquot taken for HindIII/XbaI, HindIII/BamHI and XbaI/BamHI an-
alytical digests to distinguish between the inserts. Results can be seen in Figure 4.13. Of the
clones picked and digested using both HindIII and BamHI (Figure 4.13a), only one clone (clone
10) shows the required bands; one at 1.1kb representing the Ub-L-eGFP fused insert and one at
6.5kb representing the pRPeGFPSIR2rp3 backbone. When the same clones were run through an
XbaI and BamHI digest (Figure 4.13b), none of the clones show the required bands at 0.72kb for
the eGFP insert and 6.8kb for the backbone. The final analytical HindIII and XbaI digest (Figure
4.13c) was only carried out on clone 10, using the pRPeGFPSIR2rp3 backbone as a control. The
resultant bands are as expected showing the 0.36kb Ub-L insert and the remaining 7.2kb back-
bone.
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(a) HindIII/BamHI analytical double digest: Diagram on the left shows pConstitutive cut with HindIII/BamHI. The right
panel shows digest results. Lanes show 10µl aliquots of 16 different clones analysed via HindIII/BamHI digest.
(b) XbaI/BamHI analytical double digest: Diagram on the left shows pConstitutive cut with XbaI/BamHI. The right panel
shows digest results. Lanes show 10µl aliquots of 16 different clones analysed via XbaI/BamHI digest.
(c) HindIII/XbaI analytical double digest: Diagram on the left shows
pConstitutive cut with HindIII/XbaI. The right panel shows digest results.
Lanes:
1) 10µl from clone 10 seen in above images, HindIII/XbaI cut,
2) 10µl pRPeGFPSIR2rp3, uncut.
Figure 4.13: Assembly strategy using three-fragment ligation - Assessing success of ligation:
Analytical double digests using: a) HindIII/BamHI, b) XbaI/BamHI and c) HindIII/XbaI on clones
picked from ligation plates to assess success of the second HindIII/XbaI/BamHI three-fragment
ligation attempt to insert Ub-L and eGFP in pRPeGFPSIR2rp3 to get pConstitutive.
Clone 10 was sequenced using primers from Table C.1 in Appendix C. Results showed that
whereas Ub-L was successfully inserted into the pRP backbone, the eGFP gene was not inserted
and instead the Sir2rp3 gene remained present. The resultant plasmid was named pUbSir and
used in subsequent assembly strategies. See Figure 4.7 for reference.
XbaI/BamHI ligation of eGFP into pRPeGFPSIR2rp3. As an alternative to the three-fragment
ligation, both inserts could be inserted via a series of standard ligations; the first to insert Ub-L via
a HindIII/XbaI ligation and the second using an XbaI/BamHI ligation to insert eGFP, or vice-versa.
For the insertion of eGFP into the pRP backbone, DNA was prepared as per above. Gel results
of the prepared material are not shown. Once the DNA was prepared, ligations were carried out
(Table A.3).
Controls again indicated that the digest worked as expected but showed a suboptimal purification
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process which did not successfully remove all unwanted Sir2rp3 DNA. Colonies were picked from
the ligation plates and analysed via gel electrophoresis following an ApaI/HindIII analytical digest.
The ApaI enzyme was chosen because the ApaI site is present in the Sir2rp3 cassette but not
the eGFP one. Thus, different bands will be observed depending on whether the eGFP or Sir2rp3
is present. Bands corresponded to the pRP backbone having the Sir insert rather than eGFP,
similarly to previous cases, indicating that the issue lies with the digestion reactions. Thus, the
Gibson ligation method was adopted as an alternative assembly method, as will be discussed in
subsequent assembly strategies.
4.2.3.3 Ligation 2: KpnI non-directional ligation of the tetR cassette into pRPeGFPSIR2rp3
In parallel to the above ligations, a non-directional ligation for the insertion of the tetR cassette
into pRPeGFPSIR2rp3 was carried out. The backbone and insert were prepared as per Section
4.2.2.4 but using higher quality backbone DNA eluted via maxi-preps. Moreover, the digest and
CIP-treatment of the tetR gene were carried out in separate reactions so as to maximise efficiency
as previous results has shown both reactions to be inefficient when carried out simultaneously.
Gel results of the prepared material are not shown.
Following ligation (Table A.4), transformations were carried out using XL10-Gold® cells. Colony
counts are indicative of an inefficient digest and CIP-treatment. Colonies were picked for further
analysis, grown in selective LB medium for 12-16 hours, purified and a KpnI analytical digest
carried out on eluted DNA. The digest was then run on a gel (not shown). All colonies showed
re-ligated pRPeGFPSIR2rp3 backbone, once again highlighting the challenge of performing a non-
directional ligation.
The first step was to test the effectiveness of different dephosphorylation enzymes on the pUbSir
backbone. Thus, instead of the previously used CIP, Calf Intestinal Alkaline Phosphatase (CIAP,
Promega) and Shrimp Antarctic Phosphatase (SAP, NEB) were used. Three volumes of 10µg
of pUbSir backbone were taken through three different preparation steps respectively as listed
in Table 4.1. Ligation reactions using only digested pUbSir backbone were then carried out as
per Table 4.2. No insert DNA was used, as the aim of this exercise was to assess whether the
dephosphorylation enzymes could prevent re-ligation. If successful, colony counts should be 0.
Non-dephosphorylated pUbSir backbone was used as a positive control in Ligation 7.
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Dephosphorylation enzyme
Reaction 1 Reaction 2 Reaction 3
CIAP (Promega) SAP (NEB) -
Steps
1 KpnI digest KpnI digest &
SAP
KpnI digest
2 PCR purification PCR purification PCR purification
3 CIP-treatment
(Promega)
- -
4 PCR purification - -
Table 4.1: Assembly strategy using three-fragment ligation - Dephosphorylation: Steps used in
the preparation of pUbSir backbone for non-directional ligation by making use of different de-
phosphorylation enzymes. In the first reaction, Calf Intestinal Alkaline Phosphatase (CIAP) by
Promega is used. In the second reaction, Shrimp Antarctic Phosphatase (SAP) by NEB is used,
while the third reaction is a control.
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Colonies were observed on all three transformation plates for Ligations 1-3 in spite of the ap-
plication of the dephosphorylation enzymes to the digested backbone. This indicates that the
tested dephosphorylation enzymes are not removing phosphate groups of DNA ends effectively.
Colony counts from transformation plates corresponding to Ligation 6 (ligation carried out using
cut backbone, no ligase) showed that the KpnI digest was successful when carried out separately
from the dephosphorylation reaction, with no growth observed on transformation plates, but did
not work as well when applied in conjunction with the dephosphorylation enzyme, as seen in the
other ligations.
4.2.3.4 Appraisal of three-fragment ligation strategy
The second assembly strategy to construct the pStable device featured the use of a three-
fragment ligation to insert Ub-L and eGFP into the pRP backbone and the repeat of a non-
directional ligation to insert the tetR cassette. Following implementation, the following devel-
opments and observations were made:
1. The pUbSir plasmid, in which ubiquitin-tagged Sir2rp3 protein is constitutively expressed,
was developed as a by-product of a three-fragment ligation implemented to insert the Ub-
L and eGFP genes into the pRP backbone. The plasmid will be used as a backbone in
subsequent cloning steps. The three-fragment ligation was twice attempted, using a larger
DNA mass of better quality the second time. In both cases, the Sir2rp3 gene was re-ligated
into the pRP backbone, instead of the eGFP gene. A Gibson assembly will be used in the
next strategy to address this.
2. In parallel to the three-fragment ligation, a non-directional KpnI ligation to insert the tetR cas-
sette into the pRP backbone was performed. In spite of using DNA material of higher quality,
modified protocols and different dephosphorylation enzymes, results repeatedly showed de-
phosphorylation to be an ineffective process, leading to the re-ligation of the pRP backbone.
As with above, a Gibson assembly will be implemented to bypass the use of a non-directional
ligation.
3. In both sets of ligations, DNA eluted from a maxiprep kit instead of a miniprep kit was used
since it is of better quality. Moreover, preparative double digests were prepared sequentially
rather than simultaneously to allow for a more effective digest.
4.2.4 Oscillator assembly strategy inserting the tetR cassette followed by
the eGFP gene via Gibson assembly
4.2.4.1 Introduction
In the third assembly strategy, the pUbSir plasmid, constructed during the previous assembly
strategy, replaced the use of pRPeGFPSIR2rp3 as a backbone. The second main feature of this
strategy is the incorporation of the Gibson ligation method (Gibson et al., 2009) as an alternative
to standard and non-directional ligation techniques. The Gibson ligation allows for the addition
of specific overhangs to the insert, which overhangs correspond to the backbone of interest, au-
tomatically making the ligation directional. This bypasses the requirement for CIP-treatment and
digestion of the insert, which results in less preparation steps and hence, a smaller loss of DNA
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Figure 4.14: Assembly strategy using Gibson assembly to insert the tetR cassette followed by the
eGFP gene into pUbSir.
material during preparative and purification steps. The backbone, on the other hand, can be pre-
pared via either PCR amplification or preparative digest. In addition, the Gibson cloning technique
requires fewer ligation controls. For example, there is no need to control for the CIP-treatment.
Once again, this makes for a simpler cloning process.
The main cloning steps of the strategy are represented in Figure 4.14. The first step was to
insert the tetR cassette into the pUbSir backbone via a Gibson ligation in order to get the ptetR -
UbSir plasmid. The insert was amplified using Gibson primers while the backbone was digested
at the unique KpnI site. Note that the insertion site was still to be made at the KpnI site on
the backbone, similarly to the previous strategies. The second step was to amplify the eGFP
insert and ptetR UbSir backbone, wherein the insert was amplified using Gibson primers which
attached complementary overhangs to ptetR UbSir while the backbone was amplified minus the
Sir2rp3 gene. Following this, the eGFP gene was to be inserted into the ptetR UbSir plasmid
between the XbaI and BamHI sites, again via Gibson ligation, in order to get the final pStable
construct. The diagram leaves out details such as purification and other treatments which are
referred to further on if valid to the discussion.
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(a) Forward Gibson primer used to amplify the tetR cassette and add pUbSir complementary over-
hangs.
(b) Reverse Gibson primer used to amplify the tetR cassette and add pUbSir complementary over-
hangs.
(c) tetR-amplifying Gibson primers with respect to pHD1313 showing the region which they amplify.
Figure 4.15: TetR-first assembly strategy: Representation of Gibson primers used for the ampli-
fication of the tetR cassette to be inserted into the pUbSir backbone: a) The upstream Gibson
primer (middle) in relation to the tetR cassette on pHD1313 (top) and pUbSir backbone (bottom),
b) The downstream Gibson primer (middle) in relation to the tetR cassette on pHD1313 (top) and
pUbSir backbone (bottom). The primers are outlined in red and attach to and amplify the tetR
cassette (orange) while adding overhangs corresponding to the pUbSir backbone (grey) where
the cassette will be inserted via Gibson assembly. c) shows the Gibson primers with respect to
pHD1313 indicating the region of amplification.
4.2.4.2 Ligation 1: Gibson assembly of ptetR UbSir by insertion of the tetR cassette into
pUbSir
Design of Gibson primers. The main preparation step in the Gibson assembly technique was
the design of plasmids which attach overhangs to the tetR insert, which overhangs correspond
to DNA sequences upstream and downstream of the insertion site on the pUbSir backbone as
represented in Figure 4.15.
Preparation of DNA and ligation process. The tetR insert was prepared via PCR amplifi-
cation using the forward Gibson primer (5’-3’) CAATGATAGAGTGGTACCGTCTTGGTGTGTC-
GACCTTG and reverse Gibson primer (5’-3’) GCGCGTGCAGGGTACCTTGTACATATTGTCGT-
TAGAACGCC. The pUbSir backbone, on the other hand, was prepared by a KpnI digest. Once
the preparative digest and amplification were completed, aliquots were run on a gel to confirm
DNA identity (Figure A.4a shows the 7.5kb pUbSir backbone linearised at the KpnI site and Fig-
ure A.4b shows the amplified 1.2kb tetR cassette). Afterwards, PCR purification was carried out
and quality was confirmed via gel electrophoresis (not shown).
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Figure 4.16: TetR-first assembly strategy - Assessing success of ligation: Diagram on the left
shows ptetR UbSir cut with KpnI. The right panel shows gel results for digest of DNA eluted from
clones picked from ligation plates following the Gibson ligation to insert tetR into pUbSir. Lanes:
1-4) 10µl clones, KpnI cut,
5) 5µl pUbSir, uncut,
6-7) 10µl clones, KpnI cut,
8) 5µl pUbSir, uncut.
The Gibson assembly and ligation controls were carried out (Table A.5), after which reactions
were transformed into XL10-Gold® cells. Colony counts showed that the positive control supplied
by the NEB supplier did not work, although this was not considered to be an issue. Colony counts
for negative controls indicated that while the Master Mix was working, the digest had not been
efficient. Six colonies were picked from the transformation plates for further analysis, grown in
selective LB medium for 12-16 hours, the DNA purified and aliquots taken for a KpnI analytical
digest. Each of the digests was then run on a gel, with results as observed in Figure 4.16. Of the
six colonies analysed, those in wells 2, 3, 4 and 7 showed the required bands which represent the
1.2kb tetR insert and 7.5kb backbone. Glycerol stocks were then prepared and samples sent for
sequencing. The presence of the tetR gene was confirmed in all the clones, although only one
had no mutations present. This was labelled the ptetR UbSir plasmid and taken forward for DNA
purification using a maxiprep.
4.2.4.3 Ligation 2: Gibson assembly of pStable plasmid by insertion of eGFP into ptetR -
UbSir backbone
In order to construct the Goodwin oscillator, the insertion of the eGFP gene into the ptetR Ub-
Sir backbone was required as a final step. The Gibson assembly technique was used as an
alternative to standard ligation since this had previously led to the re-ligation of the Sir gene.
In this Gibson assembly, both the backbone and insert were amplified. During the amplification
process of the insert, overhangs corresponding to the ptetR UbSir backbone were added as per
Gibson assembly requirements. The forward Gibson primer (5’-3’) CTAGACAAGTTTCTAGAG-
GTGAGCAAGGGCGACGAG and reverse Gibson primer (5’-3’) GCCAACTAAATGGGCAGGATC-
CGCCTTCAAGACTTG were used.
The backbone was amplified rather than XbaI/BamHI digested, as the restriction sites were not
unique due to the presence of the tetR gene. A digest using XbaI and BamHI enzymes would have
led to the fragmentation of the ptetR UbSir plasmid rather than the required linearisation. The for-
ward primer (5’-3’) TGCCCATTTAGTTGGCTT and reverse primer (5’-3’) CTCTAGAAACTTGTC-
TAGCCAATTG were used.
Whereas amplification of the eGFP insert did not require optimisation (Figure A.5a), PCR condi-
tions for ptetR UbSir required optimisation as per the following:
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Figure 4.17: TetR-first assembly strategy - Assessing success of ligation: Diagram on the left
shows pStable cut with ApaI to assess success of Gibson ligation to insert eGFP into ptetR -
UbSir. The right panel shows gel results of the digest. Lanes:
1-8) 10µl clone, ApaI cut,
9) 10µl ptetR UbSir, ApaI cut,
10) 5µl clone, uncut,
11) 5µl ptetR UbSir, uncut.
Addition of 0.5mM MgCl2 to act as a cofactor to the magnesium-dependant Phusion polymerase.
Addition of DMSO to a final concentration of 3% which serves to optimise template denaturation
by removing DNA supercoils.
Using lower annealing temperatures as low as 45°C instead of 50-65°C, in order to facilitate
binding.
Using higher annealing temperatures as high as 73°C, contrary to the above approach, in or-
der to minimise chances of mis-annealing.
Using longer extension times up to 2min/kb instead of the protocol’s suggested 30s/kb so as
to ensure completion of synthesis of DNA strands.
Using GC buffer instead of the standard HF buffer. GC buffer can be used in GC-rich templates.
Using a combination of the addition of 1mM MgCl2, 2mM DMSO and a 2min/kb extension time, the
PCR was partially successful when using an annealing temperature of 58°C or 65°C, in that the
correct band appeared at c. 8kb along with an incorrect band at c. 0.8kb indicating non-specific
annealing of primers (Figure A.5b). Gel purification was carried out on the 8kb backbone band.
Ligations were then carried out (Table A.6).
Ligations were transformed using XL10-Gold® cells. No non-amplified, circular backbone DNA
was detected in reactions run without ligase using cut backbone indicating successful amplifica-
tion and purification procedures. Colonies from the ligation plate were picked and grown in 2ml
selective LB medium for 12-16 hours, after which the DNA was purified, a 5µl aliquot taken for an
ApaI digest and run on a gel. The ApaI enzyme was used so as to distinguish between plasmids
which have the Sir2rp3 present which will show two bands, and those where the gene has been
replaced by eGFP which show one band only. Results in Figure 4.17 indicate that while clones
2-8 have only one band, it is smaller than the expected 8.7kb. The clones were taken forward for
sequencing using primers from Table C.1 in Appendix C. Sequencing showed that the inserted
DNA did not match the required eGFP DNA.
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4.2.4.4 Appraisal of tetR-first ligation strategy
The following findings and conclusions were made regarding the assembly strategy which uses
Gibson ligation as an alternative to standard ligation methods, in order to insert the tetR cassette
and eGFP gene into the pRP backbone to get pStable:
1. Standard and non-directional ligation methods were replaced with the Gibson assembly
method. This requires extensive primer design but results in a directional ligation and a
more streamlined process which requires fewer insert and backbone preparation steps.
2. The Gibson ligation to insert the tetR cassette into pUbSir was successful where a non-
directional ligation had not been on multiple modified previous trials. The backbone was
prepared via digest, while the tetR cassette insert was prepared via amplification, which
also served to add backbone-complementary overhangs.
3. A new construct, ptetR UbSir, was developed via the above Gibson assembly. The plasmid,
having the pRP backbone, has a a regulatory tetR gene and a Ub-Sir2rp3 moiety which
results in the TetR-regulated expression of ubiquitin-tagged Sir2rp3.
4. In the second Gibson ligation to insert eGFP into the ptetR UbSir, results showed that the
insert was not present in the backbone. Both backbone and insert were prepared via am-
plification, due to the presence of non-unique restriction sites in the ptetR UbSir backbone
which did not allow for backbone linearisation via digest. This required extensive optimisa-
tion which resulted in non-specific bands being amplified alongside the backbone. In order
to address this, the same assembly strategy will be carried out, but the two ligation steps
will be switched, as discussed next.
4.2.5 Oscillator assembly strategy inserting eGFP gene followed by the
tetR cassette via Gibson assembly
4.2.5.1 Introduction
The strategy uses Gibson assembly methods to construct the pStable oscillator in two main steps
as seen in Figure 4.18. In Ligation 1, the eGFP gene is inserted into the pUbSir backbone at
the unique XbaI and BamHI sites to get plasmid pConstitutive. In Ligation 2, the tetR cassette
is inserted into pConstitutive at the KpnI sites to get the final pStable construct. The strategy
is similar to the previous strategy but reduces the probability of primer mis-annealing by ligating
eGFP first and the tetR cassette secondly since it has XbaI and BamHI sites which can affect
amplification and ligation steps. The diagram leaves out details such as purification and other
treatments which are referred to further on if valid to the discussion.
4.2.5.2 Ligation 1: Gibson assembly of pConstitutive by inserting eGFP gene into pUbSir
The pUbSir backbone could be prepared via an XbaI/BamHI sequential preparative digest but
BamHI digestion has been shown to be suboptimal in previous strategies (Section 4.2.3.2). Hence,
the backbone was prepared through PCR-amplification using forward primer (5’-3’) GGATCC-
TGCCCATTTAGTTGGC and reverse primer (5’-3’) TCTAGAAACTTGTCTAGCC. Similarly, the
eGFP insert was prepared via PCR-amplification using forward Gibson primer (5’-3’) CTAGA-
CAAGTTTCTAGAGGTGAGCAAGGGCGAGGAG and reverse Gibson primer (5’-3’) GCCAACT-
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Figure 4.18: Assembly strategy to insert eGFP followed by the tetR cassette via Gibson ligation.
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Figure 4.19: eGFP-first assembly strategy, Assessing success of ligation: The left panel shows
pConstitutive digested with BseRI. The right panel shows gel results of digests of clones picked
following Gibson ligation to insert eGFP into pUbSir to get pConstitutive. Lanes show 10µl of
BseRI analytical digest of different clones.
AAATGGGCAGGATCCGCCTTCAAGACTTG which also served to add pUbSir complementary
nucleotides.
Although the primers used for the amplification of eGFP in the previous strategy could have been
used, new primers which added XbaI and BamHI restriction sites upstream and downstream of
eGFP were designed so as to increase the size of the complementary regions between the ampli-
fied insert and backbone. Amplification of both DNA sequences was straightforward and required
no optimisation. Once insert and backbone were successfully prepared (Figure A.6), ligations
were set-up (Table A.7), after which transformations were carried out using XL10-Gold® cells.
Since the insertion of eGFP has been a repeated challenge in the construction process, a 10:1
insert-to-backbone ratio was used to maximise chances of ligation. However, this resulted in only
one colony. It is possible that the excess of insert DNA interfered with the enzymes and thus
decreased ligation efficiency. Growth was noted on the negative transformation plate correspond-
ing to the ligation wherein no ligase was added, indicating the presence of non-amplified, circular
backbone DNA.
Nonetheless, six colonies were picked, grown in selective LB medium for 12-16 hours and the
DNA purified, after which a BseRI digest was carried out to distinguish between clones which
have the original Sir2rp3 insert which should show one band, and those which have successfully
ligated eGFP which should show two bands at c. 7.3kb and 0.22kb. This was adopted as an
alternative to the use of ApaI (used in the previous strategy) which only informed whether Sir2rp3
is present or not. BseRI, on the other hand, indicated whether eGFP is present or not. As seen in
Figure 4.19, clones 1, 3, 5 and 6 appear to have the eGFP insert, showing both required bands al-
though there are also unexplained bands present which can be due to uncut plasmid. Each clone
was sequenced using primers from Table C.1 in Appendix C. Results confirmed the presence of
the eGFP insert and showed no mutations present within the plasmid, confirming the success-
ful construction of pConstitutive. Clone 1 was taken forward for use in the next step of the strategy.
4.2.5.3 Ligation 2: Gibson assembly of pStable oscillator by inserting the tetR cassette
into pConstitutive
The next step was to carry out a second Gibson ligation in order to insert the tetR gene into the
pConstitutive backbone to get the Goodwin oscillator construct. The tetR insert was prepared via
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Figure 4.20: eGFP-first assembly strategy - Assessing success of ligation: Diagram on the left
shows pStable cut with KpnI to assess success of Gibson ligation to insert tetR into pConstitutive
to get pStable. The right panel shows gel results of digest. Lanes:
1-12) 10µl clones, KpnI cut,
13) 5µl clone, uncut.
amplification, using the primers (5’-3’) CAATGATAGAGTGGTACCGTCTTGGTGTGTCGACCTTG
and (5’-3’) GCGCGTGCAGGGTACCTTGTACATATTGTCGTTAGAACGCC as used in the previous
strategy when the tetR cassette was amplified for insertion into pUbSir (instead of pConstitutive).
This was viable since both pUbSir and pConstitutive have the same pRP backbone. Following
amplification, a sample was run on a gel after which DNA was purified and a second aliquot run
on a gel to confirm DNA is not compromised (Figure A.7a).
The pConstitutive backbone was linearised at the unique KpnI restriction site at which the tetR
cassette was to be inserted, bypassing the need for PCR amplification. In addition, in order to
remove unwanted circular non-ligated backbone, a DpnI reaction was added in order to break
down circular DNA. Following this, a sample of the reaction was run on a gel, the DNA purified
and a second sample run on a gel to confirm DNA identity (Figure A.7b). Once the insert and
backbone were prepared, ligations were carried out as per standard Gibson assembly protocols
(Table A.8). Reactions were transformed using XL10-Gold®.
Colony counts showed that reactions using DpnI had fewer colony counts than those which did
not, indicating that the enzyme was being effective in breaking up non-digested DNA. However,
for the corresponding negative control wherein a ligation was run using cut and DpnI treated
backbone but no ligase, one colony was observed on the transformation plate, indicating uncut
plasmid. 12 colonies were picked for further analysis from the transformation plates, grown in se-
lective LB Medium for 12-16 hours and purified, after which an aliquot was taken for a KpnI digest
to assess whether the tetR insert was present. As seen in Figure 4.20, clones 1, 2, 3, 4, 8 and 11
appear to have the insert, showing the correct bands at 1.2kb for the tetR cassette and 7.5kb for
the pConstitutive backbone. Hence, the clones were sequenced using primers from Table C.1 in
Appendix C, at which stage it was confirmed that the tetR cassette was present and hence, the
plasmid encoding the Goodwin oscillator, pStable, was successfully constructed.
4.2.5.4 Appraisal of eGFP-first ligation strategy
Following the use of Gibson ligation to insert the eGFP and tetR cassette into pUbSir to get
pStable, the following observations can be made:
1. The Gibson assembly was used to successfully construct pStable.
2. The strategy had the same steps as those used in the previous strategy but in reverse order,
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Figure 4.21: Diagram showing main cloning step required to construct the unstable oscillator
plasmid, pUnstable, by inserting the UTR-Myc-Ub-L-tetR-UTR cassette at the KpnI site on the
pConstitutive GRN in one step.
i.e. inserting the eGFP gene into pUbSir and then inserting the tetR cassette to get pStable.
This allowed for the preparation of the DNA and inserts using a series of amplification and
digestion steps which bypassed reactions which had previously been inefficient.
3. In the first step to ligate the eGFP gene into pUbSir, both insert and backbone were prepared
via PCR. The backbone could have been prepared via XbaI/BamHI digest but since digest
of the BamHI site had proved temperamental in previous attempts, amplification was used
instead. In the final step to ligate tetR into pConstitutive, the insert was prepared via PCR
while the backbone was prepared via KpnI digest, since the KpnI restriction site was unique.
4. The construction process also resulted in the development of the pConstitutive plasmid,
which has a pRP backbone and a Ub-eGFP moiety which results in the constitutive expres-
sion of ubiquitin-tagged eGFP.
4.3 Construction of the unstable Goodwin oscillator
In order to assemble the plasmid encoding the unstable Goodwin oscillator, pUnstable, a DNA
sequence was designed to encode the unstable oscillator features as depicted in Figure 4.21.
Eurogentec Ltd. (Hampshire, U.K) successfully synthesized the DNA fragment, highlighted as
‘Ligation 1’ in Figure 4.21, and subcloned it into pConstitutive.
4.4 Transfection of T. brucei cells with DNA encoding the sta-
ble and unstable Goodwin oscillators
Following the successful assembly of both the pStable and pUnstable plasmids, the next step was
to insert the two oscillator networks into T. brucei via transfection, as discussed below. The net-
works were transfected into both BSF and PCF forms of T. brucei in order to profile the network
in both platforms and so as to analyse whether it performs better in one of the forms. PCF strains
are more robust than their BSF counterparts and do not require a CO2 incubator for maintenance.
However, they need to be cultured at densities of over 1×106cells/ml in order to survive, which
results in longer transfection and thawing processes (see Sections 2.3 and 2.4).
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4.4.1 Transfection of BSF and PCF T. brucei cells with DNA encoding the
stable Goodwin oscillator
BSF trypanosomes transfected with pStable had a transfection efficiency of 7.5×10-7 cells, which
is in line with expectations, while PCF trypanosomes had a transfection efficiency of 3.5×10-7
cells, which is considered to be low for PCF strains (MacGregor et al., 2013). Following trans-
fection and incubation, all positive clones (15 for BSF cells, 4 for PCF transfection) were picked,
grown to sufficient concentrations (1×106cells/ml for BSF and 1×107cells/ml for PCF) and glyc-
erol stocks prepared.
The next step was to analyse which of the clones expressed protein the strongest. This is because
transfection of exogenous (linearised) DNA in T. brucei is based on integration by homologous re-
combination at a ribosomal spacer which serves to separate foreign DNA from native sequences
(Alsford et al., 2005). However, there are multiple copies of ribosomal spacers in the genome,
therefore, it follows that the linearised pStable plasmid was integrated randomly in one of the 18
non-transcribed rRNA loci. Strength of protein expression depended on which loci integration
occurred at. It was important to select the clone with the strongest signal in order to allow for
clear-cut fluorescent observations of the plasmid’s phenotype.
In order to assess which of the clones gave the strongest signal and also to ensure there was
no leaky expression, protein samples were prepared for each clone. In addition, each clone
was induced with 1µg/ml tetracycline for 24 hours, after which protein was also prepared and
uninduced/induced samples were run via a western blot to detect for the eGFP reporter protein.
eGFP was selected for detection over the TetR protein due to the more established and reliable
antibody products which are available.
Results from the western blot and the corresponding coomassie stain of eight induced/uninduced
BSF clones can be found in Figure 4.22. At a protein band size of 27kDa, which corresponds to
the eGFP protein, clones 1 and 5 have the strongest signals when induced. In addition, no leaky
expression was observed, in that none of the uninduced clones had detectable eGFP signals.
The coomassie stain showed that differences in observed signal strengths were due to protein
expression rather than incorrect sample preparation. Based on this data, subsequent analysis
was carried out on clone 1. The clone will be referred to as the BSF pStable clone.
For the transfection of PCF clones with pStable, the signal strength evaluation procedure as used
for BSF pStable clones was implemented. Results from the western blot and corresponding
coomassie stain can be seen in Figure 4.23, which shows tetracycline-induced protein samples
alongside uninduced samples of four PCF T. brucei clones bearing the pStable GRN. The 27kDa
eGFP signal was strongest for tetracycline induced clone 2. In addition, no leaky expression was
noted and the coomassie showed correct sample preparation. Hence, clone 2 was used in sub-
sequent analysis. It will be referred to as the PCF pStable clone.
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(a) Western Blot
(b) Coomassie Stain
Figure 4.22: Assessing the strength of protein expression of eight different BSF T. brucei clones
bearing the pStable plasmid and uninduced (-) or induced (+) with 1µg/ml tetracycline. Following
protein preparation, analysis is carried out via a) western blot detecting for the eGFP signal and b)
corresponding coomassie stain. Clones labelled as ‘-1’, ‘-2’, etc. are uninduced. Clones labelled
as ‘+1’, ‘+2’, etc. are induced. The control is a protein sample of the constitutively expressed
pConstitutive plasmid.
(a) Western Blot (b) Coomassie Stain
Figure 4.23: Assessing the strength of protein expression of four different PCF T. brucei clones
bearing the pStable plasmid and uninduced (-) or induced (+) with 1µg/ml tetracycline. Following
protein preparation, analysis is carried out via a) western blot detecting for the eGFP signal and b)
corresponding coomassie stain. Clones labelled as ‘-1’, ‘-2’, etc. are uninduced. Clones labelled
as ‘+1’, ‘+2’, etc. are induced.
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(a) Western Blot
(b) Coomassie Stain
Figure 4.24: Assessing the strength of protein expression of eight different BSF T. brucei clones
bearing the pUnstable plasmid and uninduced (-) or induced (+) with 1µg/ml tetracycline. Follow-
ing protein preparation, analysis is carried out via a) western blot detecting for the eGFP signal
and b) corresponding coomassie stain. Clones labelled as ‘-1’, ‘-2’, etc. are uninduced. Clones
labelled as ‘+1’, ‘+2’, etc. are induced.
4.4.2 Transfection of BSF and PCF T. brucei with DNA encoding the unsta-
ble Goodwin oscillator
The unstable Goodwin oscillator, pUnstable, was transfected into both BSF and PCF trypanosomes.
The BSF transfection had an efficiency of 5.5×10-6. Following incubation, eight positive clones
were picked into appropriate media, glycerol stocks prepared and the strength of protein expres-
sion of each clone analysed to pick the clone with the strongest fluorescent signal, as per the
stable oscillator analysis.
Results, seen in Figure 4.24, show that there is basal constitutive transcription, as seen in eGFP
signals detected even when transfected BSF T. brucei clones were not induced with tetracycline.
The corresponding coomassie stain indicates that protein samples were prepared consistently.
This is in clear contrast to pStable clones, wherein eGFP was only detected via western blots
when tetracycline was present. However, there is a consistently clear difference in signal strength
between induced and uninduced pUnstable clones. This indicates that an element of repression
via TetR protein is still taking place.
Based on signal strength, the first BSF T. brucei clone bearing the pUnstable plasmid was taken
forward for further analysis. Although there is a basal level of protein synthesis, it is still possible
for oscillatory protein production to occur. The oscillator can function as a tuned GRN when com-
pared to pStable, as per mechanisms in Section 4.1.2. The detected eGFP signals in uninduced
clones can be attributed to the appended Myc tag and Ub-L sequences preventing the correct
binding of TetR to the operator or to the protein sample being harvested during a peak phase
of the oscillatory cycle. Further investigation via protein analysis and microscopy carried out to
analyse this will be discussed later.
Following the insertion of pUnstable to PCF T. brucei cells, four positive clones were picked, trans-
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(a) Western Blot (b) Coomassie Stain
Figure 4.25: Assessing the strength of protein expression of four different PCF T. brucei clones
bearing the pUnstable plasmid and uninduced (-) or induced (+) with 1µg/ml tetracycline. Follow-
ing protein preparation, analysis is carried out via a) western blot detecting for the eGFP signal
and b) corresponding coomassie stain. Clones labelled as ‘-1’, ‘-2’, etc. are uninduced. Clones
labelled as ‘+1’, ‘+2’, etc. are induced. The control is a protein sample of the constitutively ex-
pressed pConstitutive plasmid.
(a) Western Blot (b) Coomassie Stain
Figure 4.26: Assessing the strength of protein expression of eight different BSF T. brucei clones
bearing the pConstitutive control plasmid which express protein constitutively. Following protein
preparation, analysis is carried out via a) western blot detecting for the eGFP signal and b) corre-
sponding coomassie stain.
lating to an efficiency of 2×10-6 cells. Glycerol stocks were prepared and the strength of protein
expression of each clone analysed via western blot and a coomassie stain, with results seen in
Figure 4.25. No eGFP signal was detected, either in the presence or absence of tetracycline, in
spite of correct protein sample preparation (as seen by coomassie results). The plasmid was suc-
cessfully transfected since the consistent use of antibiotic selection throughout the experiments
would have resulted in poor cell growth. The lack of eGFP protein can either be attributed to
the mechanisms of the plasmid itself not functioning within a PCF setting or the plasmid being
inserted at a weakly expressing recombinant locus. Nonetheless, a clone was picked at random
for microscopy imaging and phenotype characterisation.
4.4.3 Transfection of BSF T. brucei with the pConstitutive control plasmid
In parallel to the above transfections, the pConstitutive plasmid, which expresses Ub-L-eGFP
constitutively, was transfected into BSF cells. This was done so as to use pConstitutive clones
as positive controls throughout experiments and to check whether the PRRNA promoter (which is
also present in the stable and unstable oscillator plasmids) is functional and allows for constitutive
and uniform gene expression. Following transfection, of the nine clones which were analysed for
eGFP signal strength via western blot and coomassie stain, as seen in Figure 4.26, clone 7 gave
a strong signal and hence was used in all subsequent analysis.
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4.5 Discussion
Assembly and transfection of the stable Goodwin oscillator.
Following the assembly and transfection of the plasmid encoding the stable Goodwin oscillator
GRN, the following conclusions can be made:
1. Successfully constructed the stable oscillator device, pStable, using a combination of four
assembly strategies which involved multiple recombinant DNA and ligation techniques. Through-
out, standard, three-fragment, non-directional and Gibson ligations were used to assemble
the TetR-regulated plasmid, with the Gibson ligation method proving to be the more efficient
approach.
2. Developed three other engineered plasmids as a result of the assembly process; pUbSir
(resulting in constitutive expression of Ub-Sir2rp3 fusion protein), ptetR UbSir (resulting
in TetR-regulated expression of Ub-Sir2rp3 fusion protein) and pConstitutive (resulting in
constitutive expression of Ub-eGFP fusion protein), all having the same pRP backbone as
pStable. Progress can be seen throughout the assembly process in that a more standard-
ised cloning practice was adopted as the four different strategies were implemented. Thus,
for example, DNA prepared from a miniprep elution was replaced by DNA eluted via a
maxiprep which results in higher quality material. Similarly, in later strategies, restriction
enzymes in double digests were applied sequentially rather than simultaneously so as to
increase digest efficiency.
3. Successfully integrated by recombination the stable Goodwin oscillator, pStable, into the
genome of both BSF and PCF T. brucei strains. In order to maximise the probability of
observing fluorescent oscillations, the clone with the strongest eGFP signal when induced
with 1µg/ml tetracycline was selected for the phenotyping of the oscillator.
Assembly and transfection of the unstable Goodwin oscillator.
Following the assembly and transfection of the plasmid encoding the unstable Goodwin oscillator
GRN, the following conclusions can be made:
1. The unstable Goodwin oscillator, pUnstable, was synthesised at Eurogentec Ltd. The plas-
mid was delivered in less than six weeks following the placement of the order. The construc-
tion of the stable device, on the other hand, took eighteen months. In light of the difference in
timescales and the increasingly low costs for purchasing bespoke plasmids (Carlson, 2014),
the practicality of assembling plasmids externally is highlighted.
2. Transfected the plasmid encoding the unstable oscillator into both BSF and PCF T. brucei
strains. Analysis of transfected BSF clones showed that eGFP was detected even when
no tetracycline was present. This can be either due to leaky expression, indicating that the
appended Myc and Ub-L genes are preventing the correct binding of TetR to its operator or
due to protein being prepared during a peak phase of the oscillatory cycle.
3. Demonstrated that, in theory, oscillations can still take place in pUnstable protein expression
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dynamics. When transfected cells were induced with tetracycline, the eGFP signal flagged
up was stronger than that in uninduced protein samples, indicating that an element of non-
linear TetR repression is still being effected in a GRN with time-delay present, thus allowing
for oscillations to manifest.
4. Transfected BSF T. brucei cells with pConstitutive, which expresses eGFP protein constitu-
tively. This will be used as a control during phenotyping investigations.
5. The assembly of the pStable and pUnstable plasmids encoding for the Goodwin oscillator
and the insertion of these plasmids within a T. brucei host is a novel development, with
no similar engineered network constructs available. This will enable the investigation of T.
brucei as a synthetic biology chassis.
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Chapter 5
Establishing an experimental
framework for measurement of
oscillating fluorescence levels in
viable T. brucei cells
Given the successful assembly of the stable and unstable Goodwin oscillators, the next objective
was to develop an experimental set-up for the live cell imaging of single motile T. brucei cells.
Imaging is to be done via brightfield and fluorescent microscopy, with images taken at regular in-
tervals so as to enable the analysis of fluorescence levels of individual cells over time. Moreover,
the imaging framework needs to allow for the imaging of cell populations, while also allowing for
the tracking and identification of individual cells.
The challenge lies in that trypanosomes are motile cells going through swim-and-tumble phases
and travelling up to 5.6µm/s (Weisse et al., 2012). Thus, unless their motility is constricted, cells
will move in and out of focus and the field of vision during imaging and their paths will overlap
with each other, as seen in Figure 5.1 which shows a series of images of BSF trypanosomes
at 30 second intervals. This makes it difficult to distinguish between the paths of two cells over
consecutive images.
The development of a framework for the imaging of isolated cells, rather than one which allows for
the imaging of cell populations and tracking at the single cell level as in this case, was not consid-
ered as an option. Firstly, a single motile cell can still move in and out of focus resulting in poor
quality images. Secondly, novel GRN characterisation within synthetic biology involves scanning
a large number of cells. Imaging cells one at a time would make for an infeasible investigation in
terms of time.
No similar studies have been undertaken in either the field of synthetic biology or the study of
trypanosomes. Previous work in synthetic biology has focused mainly on the use of E. coli and
mammalian chassis, with no emphasis made on the immobilisation of the cells. In trypanosome
studies, on the other hand, cells are generally fixed, lysed, examined as a population or analysed
in vivo in mice (see MacLean et al. (2013) for a review). More recently, a microfluidic device
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Figure 5.1: Images taken at 30 second intervals showing how free-swimming T. brucei mounted
on 5mm multiwell slides move across the plane and in and out of focus, which limits cell tractability
when comparing images. Images were taken using brightfield microscopy with an objective of
40X. Scale bar = 100µm.
has been developed for live cell imaging which embeds pillars of polydimethylsiloxane (PDMS)
(Heddergott et al., 2012) which mimic red-blood cells, interfering with the cells’ swimming route.
However, this only results in stilted movement.
Table 5.1 lists the different methods and set-ups developed in this chapter. These can be cate-
gorised into two frameworks; those wherein cells are immobilised by encasing them within gel-like
substances and those wherein cell movement is constricted through the use of a rigid microflu-
idic trapping chamber. Throughout, knowledge was drawn from imaging techniques used for
trypanosomes and other live organisms such as zebrafish and roundworms, and then applied to
wildtype BSF T. brucei cells. Each set-up was developed with the aim of satisfying three require-
ments:
1. Minimise motility of cells across the x-, y- and z- planes.
2. Maintain viability of cells for maximum amount of time. This is a challenge because BSF
trypanosomes start to lose viability if they become immobilised (Price et al., 2010). They
lose the ability to perform cytokinesis even though they continue to progress through multiple
cell cycles (Broadhead et al., 2006). This results in misshapen clumps.
3. Be able to distinguish between cells within and between time-frames and avoid clumping of
cells.
In order to assess each set-up, WT BSF cells which are less robust than their PCF counterparts
(Price et al., 2010) were embedded accordingly and hourly cell-counts were taken to categorise
the observed trypanosomes in one of three tracks, as seen in Figure 5.2:
1. Healthy cells which are motile or undulating at a fixed spot
2. Unhealthy cells which are clumped together but are still undulating (Kulkarni et al., 2013)
3. Shrunken, non-viable cells (Wang et al., 2010; Marinho et al., 2014)
Cells were observed using an inverted microscope at a 250X magnification, until the cell popula-
tion was non-viable. At each time-point the number of motile/undulating cells, clumped but viable
cells and non-motile shrunk cells within the field of vision were counted. The microscope was only
switched on during counts so as to avoid overheating of cells.
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Material/ Technology used Description Section
1 Microfluidic cage devices Use of microfluidic technology to
develop trapping devices
Section 5.1
2 Agarose blocks Use of agarose blocks to constrict
movement
Section 5.2
3 Glass slides, Petri dishes
and multiwell plates
Testing of different platforms to
mount cells on
Section 5.3
4 Agar, agarose and xanthan
gum solutions
Testing solutions as immobilisation
agents
Section 5.4-5.6
5 CygelTM Use as an immobilisation solution Section 5.7
Table 5.1: Summary of the different set-ups, solutions and technology used to develop a frame-
work for the measurement of fluorescence levels in viable T. brucei cells.
(a) Healthy Cells (b) Clumped Cells (viable) (c) Shrunk Cells (non-viable)
Figure 5.2: Images showing different BSF morphologies: a) Healthy viable cells, b) Unhealthy
viable cells which clump together and undulate at a fixed spot and c) Non-viable cells which
remain isolated but shrink and lose their original morphology. Images were taken using brightfield
microscopy with an objective of 40X.
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(a) Design A: Traps are placed consecutively, have
width of 300µm and a centre-to-centre distance of
500µm.
(b) Design B: Traps are alternating, have width of
300µm and a centre-to-centre distance of 1000µm.
Figure 5.3: Microfluidic cage devices: CAD design of two different layouts of microfluidic cage
devices used to trap trypanosomes.
5.1 Microfluidic cage devices
The technology of microfluidics is being merged with synthetic biology to address characterisation
efforts in a resource-efficient way. Research has shown the potential of using microfluidic devices
in precise analytical and chemical studies (San-Miguel & Lu, 2013) and for use as mechanical
traps (Zhang et al., 2010; Aufderheide, 2008).
5.1.1 Design and fabrication of microfluidic traps
Microfluidics technology was used to develop a trapping device (Figure 5.3), consisting of multiple
‘cages’ which entrap single trypanosome cells while still allowing for the imaging of small popu-
lations of cells at once. Moreover, cells could be tracked since they were trapped within a bound
area. In theory, cells would retain viability for a longer span of time due to unrestricted motility
(Price et al., 2010). Although it is also implied that cells can swim in and out of focus, this can be
controlled by making the traps shallow.
Trypanosomes measure 6-42µm in length by 1-3µm in width. Therefore, each cage required a
surface area less than 150µm2. However, laser technology available was not capable of satisfying
these requirements. Instead, square traps of width 50µm, 100µm, 150µm and 300µm were de-
signed and developed, as per Figure 5.3, which shows two different CAD designs using a square
width of 300µm. In Design A cages were placed consecutively next to each other, while in Design
B cages were placed in an alternating pattern. The traps could be manufactured using a laser
mark speed of 200 or 300mm/s, resulting in two different well depths.
Both types of design were taken forward and manufactured as per Section 2.4.3.1. The designs
were ablated onto PMMA, which is a widely used polymer for the use of microfluidic devices in
cell culture (Ni et al., 2009). Figure 5.4 shows images of the manufactured products. Traps placed
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(a) Design A: Manufactured microfluidic devices having a square width of 50µm, 100µm or 150µm. Wells are placed
consecutively next to each other. Scale bar = 300µm.
(b) Design B: Manufactured microfluidic device having a square width of 300µm and a centre-to-centre distance of 1mm.
Wells are alternatting with empty squares to allow for better definition. Scale bar = 2mm.
Figure 5.4: Microfluidic cage devices: Images of different microfluidic cage devices constructed
having a) a consecutive pattern with square width of 50µm, 100µm or 150µm or b) an alternating
pattern with square width of 300µm. In both cases, laser mark speed is of 300mm/s.
consecutively to each other (as per Design A, Figure 5.4a) with a square width of 50µm have cage
walls which are not clearly defined. This is a consequence of the heat from the laser beam which
causes an element of melting around the path it etches. However, the effect is less noticeable
when etching larger wells with a width of 150µm. Moreover, definition is improved when using an
alternating well pattern as in Design B (Figure 5.4b).
Based on the above images, traps developed as per Design B were taken forward for testing with
BSF cells. Specifically, traps with individual cages having width 50µm, 100µm or 150µm and
centre-to-centre distance of 1mm were used. Traps with individual cells having width 300µm were
considered to be too large for the scope of this study. Moreover, both traps ablated with a laser
speed of 200mm/s and 300mm/s were tested. Since the duration of ablation is unknown, the
depth of the traps can not be calculated. In total, six devices were tested with BSF cells in order
to assess which design satisfied the set-up criteria.
5.1.2 Testing of microfluidic traps using live T. brucei cells
BSF cells were grown to a density of 1×106cells/ml. Following this, 50-100µl of cells was pipetted
over the wells and left to stand for two minutes. Following this, a coverslip was placed on top and
sealed using nail varnish. In all six devices tested, over 50% of trypanosomes retained viability
for 8-9 hours, after which lack of oxygen and CO2, and pH changes led to cell death.
This period of cell viability is longer than that recorded for other tested methods and can be at-
tributed in part to the cells retaining full motility and the larger volume of media, oxygen and CO2
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Figure 5.5: Microfluidic cage devices: The image on the left shows the device with wells having
square width of 50µm. The circled wells are amplified in the middle and right images using a
magnification of 400X. Visibility is hampered due to the thick border around the perimeter of the
well, the bubbles and small dark spots which are present. Scale bars = 20µm.
supply available to trapped cells. The large wells also meant that multiple cells were inserted into
each trap. This could be resolved by diluting the cells sufficiently so as to increase probability of
having one or less cells per well. Images taken at 400X magnification showed surfaces of wells to
be rough, dark and uneven, which makes the distinguishing of cells from the dark patches in the
well difficult. Figure 5.5 shows an example of this, with images showing thick cell borders, dark
patches and air bubbles.
5.2 Agarose blocks for entrapping live T. brucei cells
In the above method, microfluidic cages were used to trap cells within a bound area. The following
method by Huang et al. (2014) adopts a different approach wherein cells are both trapped and im-
mobilised between an agarose block and a glass slide. Similar experiments using ‘agarose pads’
(Kim et al., 2013) have been successfully carried out to entrap the roundworm Caenorhabditis
elegans.
Following set-up as per Section 2.4.3.2, the device was incubated at room temperature. The set-
up was assembled with no difficulties. Although cells were easy to distinguish due to low density,
the cell population lost viability within two hours of preparation. With respect to the other frame-
work criteria, the set-up did not restrict trypanosome motility sufficiently as to be able to track
individual cells over time.
5.3 The use of glass slides, petri dishes and multiwell slides
as bases for experimental set-up to immobilise live T. bru-
cei cells
In a modified approach to the above method, cells can be encased within liquid substances having
different viscosities and properties, which substances solidify to different degrees after incubation
at room temperature to form encasing and immobilising gel matrices around the cells. For this
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(a) Glass-slide base (b) Petri dish base
(c) 5mm multiwell plate base
Figure 5.6: Diagram representing the experimental set-up to test the optimal base for the mainte-
nance and imaging of viable T. brucei cells. The set-up consisted of: a) a glass slide, b) petri dish
or c) 5mm multiwell slide, on top of which cells suspended in media were pipetted, covered with a
cover slip and sealed to prevent spills.
purpose, the first requirement was to determine which of glass slides, Petri dishes or 5mm mul-
tiwell slides served as the best base for experimental set-ups. Cells were suspended in media
with no immobilising agent applied, and constricted between two solid barriers; a coverslip and a
glass slide or Petri dish or 5mm multiwell slide, as seen in Figure 5.6. In addition to determining
the span of time over which cells retained viability, observations were made on ease of handling
of each set-up.
Cells grown to a density of 1×106cells/ml in 10ml media were pelleted for 10 minutes at 2000rpm,
the supernatant was removed and the cells were resuspended in media to a concentration of
1×107 cells/ml. 5µl of resuspended cells were pipetted onto a clean glass slide or 9cm Petri dish
or multiwell slide, covered with a coverslip and sealed with nail varnish to comply with Health and
Safety regulations.
Results of cell counts can be found in Figure 5.7 which plots the percentage of viable and non-
viable cells mounted onto a Petri dish (Figure 5.7a) or glass slide (Figure 5.7b) over time. Results
show that cells retained viability for a maximum of four hours when using either platform. In both
cases, over 50% of cells show signs of being unhealthy (clumped) within the first hour. This can
be attributed to a change in pH levels, insufficient supply of nutrients, oxygen and CO2 and sub-
optimal incubation conditions. Since no immobilising agent was applied, cells were unrestricted
in their movement. Duplicates were not carried out, due to the short lifespan of cells. Even if ad-
ditional runs of the study resulted in a longer lifespan, the variability made the method unreliable.
The multiwell slide set-up showed similar results(data not shown). However, the use of multiwell
slides made for easier focusing under the microscope than when using Petri dishes and glass
slides. Therefore, 5mm multiwell slides were used for subsequent studies.
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(a) Set-up using a 9mm petri dish as a base
(b) Set-up using a glass slide as a base
Figure 5.7: Petri dish and glass slide set-up: Plot showing the percentage of viable healthy cells,
viable unhealthy (clumped/misshapen) cells and non-viable cells over time which were encased
using a) a Petri dish and coverslip set-up and b) a glass slide and coverslip set-up.
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Time post-preparation
Concentration 0 mins 3 mins 7 mins
1% agarose Good Good Good. Material ismore viscous.
0.5% agarose Good Good Good. Materialslightly more viscous.
0.25% agarose Good Good Good. Material’sviscosity not affected.
Table 5.2: Agarose as an immobilisation agent: Handling properties of different concentrations of
liquid agarose solutions at room temperature at 0, 3 and 7 minutes post preparation.
5.4 Agarose solutions as live T. brucei cell immobilisation agents
Agarose was the first immobilising agent to be tested on trypanosomes using the multiwell slide
set-up. Agarose is a traditional cell-embedding method and is recommended by Price et al.
(2010), who use 3% agarose, for long-term live trypanosome imaging. It has also been used in the
imaging of live motile zebra fish embryos (Kaufmann et al., 2012; Renaud et al., 2011). Agarose
has been used in the study of trypanosomes, although often in a different context, wherein cells
are spread on it and are motile (Oberholzer et al., 2010; Carruthers & Cross, 1992) or else em-
bedded in agarose for lysing (Inverso et al., 2010) or pulsed field gel electrophoresis (Leech et al.,
2004).
5.4.1 Handling and viscosity properties of agarose solutions
Prior to assessing the effect of agarose solutions on motile trypanosomes, different agarose di-
lutions were prepared and their handling properties assessed. This was done in order to select
those solutions which could be easily handled with pipettes, thus preventing technical barriers
when setting up. 2% agarose was prepared in dH20 and autoclaved. The solution was briefly
heated until liquid, after which 1ml 1% agarose, 0.5% agarose and 0.25% agarose dilutions were
prepared in media.
After preparation, each solution was pipetted up and down using P200 pipettes to see how easy
it is to handle the material. This was done at 0, 3 and 7 minute intervals post preparation, to
see how the solution changes over time and whether it solidifies. The 3 minute time point, in
particular, is important because during the experiment involving cells, preparation and pipetting
of the cells and agarose solution onto the multiwell slide is expected to take a similar amount of
time. Results can be found in Table 5.2. The 0.25%, 0.5% and 1% agarose concentrations are
relatively easy to handle at all time points. Viscosity of the 1% and 0.5% agarose concentrations
was observed to increase over time. The 0.25% dilution, on the other hand, retained very low
viscosity. This would be ineffective in immobilising T. brucei. Based on these results, the 1% and
0.5% agarose solutions were taken forward to assess how these concentrations affected cells in
terms of motility, viability and tractability.
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5.4.2 Effect of agarose solutions on T. brucei cell motility and viability
To analyse the effect of the 1% and 0.5% agarose solutions on trypanosomes, 10ml of cells at
1×106cells/ml was centrifuged for five minutes at 2000rpm, after which the supernatant was re-
moved and the cells were resuspended in media to a concentration of 1×107cells/ml. The required
agarose solution was then prepared, mixed gently and allowed to cool for two minutes. Immedi-
ately after this, 2µl of cells was pipetted onto a multiwell slide and overlaid with 2µl of the agarose
solution to form an encasing dome, after which a coverslip was placed on top, and the edges
sealed using nail varnish. The assembly was then incubated at room temperature and hourly cell
counts taken to categorise cells as motile and viable or unhealthy but viable or non-viable. The
experiment was carried out in duplicates.
Figure 5.8 shows that over 50% of trypanosomes embedded in 0.5% agarose (Figure 5.8a) lose
healthy viability by the two hour time-mark. All cells lose healthy viability by the three hour time-
mark due to suboptimal nutrient supply and aeration conditions.
Over 90% of cells overlaid with 1% agarose (Figure 5.8b) lose healthy viability after the three
hour time point. Cells are sensitive to the preparation and fixing process, with less than 70% of
cells being viable at the first observation time-point. A large element of variability was observed
between duplicate readings (over 65% in some cases).
5.5 Agar solutions as live T. brucei cell immobilisation agents
The embedding of T. brucei cells within agar is a less common practice than the use of agarose.
It has, however, been used to embed other motile and non-motile organisms as diverse as the
bacterial Pseudomonas aeruginosa (Pitt & Bradley, 1975) and Lactococcus lactis (Floury et al.,
2013) and the trypanosomal strain Trypanosoma cruzi (Wittner et al., 1982). In these studies,
agar was used at a concentration of 0.4-0.6% (Pitt & Bradley, 1975; Wittner et al., 1982).
5.5.1 Handling and viscosity properties of agar solutions
In order to avoid technical barriers during the cell mounting process, different agar dilutions were
tested for ease of handling, similarly to the previous cases. 2% agar was prepared in dH20 and
autoclaved, after which it was briefly heated until liquid and 1ml 1% agar, 0.5% agar and 0.25%
agar dilutions were prepared in media.
Following preparation, volumes were pipetted using P200 pipettes at 0, 3 and 5 minute intervals.
Table 5.3 shows that the 1% agar solution solidifies too quickly for use within a real-time setting.
Based on this, the two lower concentrations (0.5% and 0.25% agar) were taken forward to be
tested with T. brucei to assess how these concentrations affected cells in terms of motility, viabil-
ity and tractability.
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(a) 0.5% agarose
(b) 1.0% agarose
Figure 5.8: Agarose as an immobilisation agent: Plot showing the percentage of viable healthy
cells, viable unhealthy (clumped/misshapen) cells and non-viable cells over time which were over-
laid with a) 0.5% agarose and b) 1% agarose. Error bars represent standard deviation. The
experiment was carried out in duplicates.
Time post-preparation
Concentration 0 mins 3 mins 7 mins
1% agar Good Medium has solidified.Can not be pipetted.
Viscosity is unchanged.
Can not be pipetted.
0.5% agar Good Material starts to solidify.Requires slow pipetting.
Viscosity is unchanged.
Requires slow pipetting.
0.25% agar Good Good Good. Material’sviscosity not affected.
Table 5.3: Agar as an immobilisation agent: Handling properties of different concentrations of
liquid agar at room temperature at 0, 3 and 7 minutes post preparation.
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(a) 0.25% agar
(b) 0.5% agar
Figure 5.9: Agar as an immobilisation agent: Plot showing the percentage of viable healthy cells,
viable unhealthy (clumped/misshapen) cells and non-viable cells over time which were overlaid
with a) 0.25% agar and b) 0.5% agar. Error bars represent standard deviation. The experiment
was carried out in duplicates.
5.5.2 Effect of agar solutions on T. brucei cell motility and viability
To observe the effect of agar on embedded trypanosomes, cells were set-up as per Section 5.4.2,
replacing the use of agarose with agar at the appropriate dilution. Cell count results are repre-
sented in Figure 5.9 which shows that over 50% of cells fixed in 0.25% agar retained healthy
viability for three hours. This was followed by a one hour period during which the biggest per-
centage (39%) of cells were unhealthy (clumped/misshapen) but motile and viable. After this, the
majority of cells (over 60%) turned non-viable, but it took over six hours for all cells to lose via-
bility. For T. brucei fixed in 0.5% agar, a high percentage (over 80%) maintained healthy viability
for a three-hour time-frame, after which there was a sharp drop over a one hour period. A small
percentage of cells (5%) retained (unhealthy) viability for over seven hours.
Error bars representing standard deviation indicate a large element of variability following Hour 4.
However, prior to this, an error of less than 10% was recorded for almost all time-points across
the three tracks. This adds an element of reliability to the agar method. As with agarose solutions,
over 7% of cells lost viability during the preparation and fixing process. Although cells embedded
in 0.5% agar were more sensitive to the setting-up process than when using 0.25% agar, the
former outperforms the latter due to the high percentage of cells (+ 80%) which retain viability for
the first three hours of the experiment. In conclusion, the agar set-up addresses the criteria for
long-term viability with cells viable for up to five hours post-immobilisation. Cell motility, however,
was not fully restricted, resulting in limited cell tractability.
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5.6 Xanthan gum solutions as live T. brucei cell immobilisa-
tion agents
Xanthan gum is a polysaccharide which retains stability over a range of temperatures and pH
values (Pace Pereira Lima et al., 2012). It has been used as an encasing agent in plant tissue
imaging as an alternative to agar (Jain & Babbar, 2006).
5.6.1 Handling and viscosity properties of xanthan gum solutions
Prior to testing its effect on trypanosome cells, different concentrations of xanthan gum were pre-
pared to assess viscosity and handling properties. The research by Jain and Babbar (2006) did
not provide information on the concentration of xanthan gum used. 1% xanthan gum solution
was prepared in media and diluted to 0.5% and 0.25% solutions in media for 1ml volumes. No
heating of xanthan gum was required prior to dilutions, since the solution does not solidify at room
temperature. This also implies that there was no need for observations of pipetting properties
at multiple time points following preparation, since the viscosity is not expected to change with
time as in the previous cases. When pipetted using P200 pipettes, the 1% xanthan gum solution
was too viscous to pipette well. However, both 0.5% and 0.25% xanthan solutions were easy to
handle, with viscosity being neither too low as for the solution to be too liquid and neither too high
as to prevent correct pipetting. Hence, both solutions were taken forward to test on trypanosomes.
5.6.2 Effect of xanthan gum solutions on T. brucei cell motility and viability
In order to observe the effect of xanthan gum on embedded trypanosomes, cells were prepared
as per Section 5.4.2, replacing the use of agarose with xanthan gum and omitting heating steps.
Hourly cell count results can be seen in Figure 5.10, which shows the percentage of viable and
non-viable trypanosomes over time.
The plots for the percentage of viable cells overlaid with 0.25% xanthan gum (Figure 5.10a) and
0.5% xanthan gum (Figure 5.10b) show that in both cases, cells were sensitive to the preparation
and embedding process, with c.90% and 71% of cells encased in 0.25% and 0.5% xanthan gum
respectively being viable and healthy on the first count. Less than 50% of cells immersed in 0.25%
xanthan gum were viable after one hour of incubation, however, they then retained the same level
(c. 40%) of healthy viability for a period of roughly four hours, after which there was a rise in the
number of unhealthy (clumped/misshapen) but motile and viable cells for a period of one hour, be-
fore the population became non-viable. This pattern was not noted in the other solutions (except
when using 40% CygelTM), wherein cells tended to lose healthy viability at a roughly steady rate.
On the other hand, over 50% of cells embedded in 0.5% xanthan gum lost viability after the two
hour time-mark and no healthy cells were observed after the three hour mark. A large variability
is present across all tracks and time-points, as represented by plot error bars.
In conclusion, the 0.25% xanthan gum set-up satisfies the criteria for maintaining long-term vi-
ability but not the criteria for minimal motility and maximal tractability, with unrestricted cellular
movement observed throughout. 0.5% xanthan gum does not satisfy any of the three criteria.
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(a) 0.25% xanthan gum
(b) 0.5% xanthan gum
Figure 5.10: Xanthan gum as an immobilisation agent: Plot showing the percentage of healthy and
unhealthy (clumped/misshapen) motile viable and non-viable cells over time which were overlaid
with a) 0.25% xanthan gum and b) 0.5% xanthan gum. Error bars represent standard deviation.
The experiment was carried out in duplicates.
5.7 CygelTM as a live T. brucei cell immobilisation agent
CygelTM is a clear thermoreversible product which is liquid below room temperature and solid oth-
erwise. Price et al. (2010) used two different CygelTM solutions, one in its original format and the
other supplemented with 10mM glucose to immobilise both BSF and PCF T. brucei for up to three
hours. The former was found to be less toxic to cells and hence was selected for use in this study.
5.7.1 Handling and viscosity properties of CygelTM solutions
Handling properties and viscosity of various CygelTM dilutions were assessed to select two con-
centrations to be tested on cells, based on the ease of handling with pipettes at different time-
points following preparation. This would ensure that preparation and pipetting technical difficulties
would not compromise the set-up. Initially, CygelTM was placed on ice for two minutes as per
supplier instructions, after which 1ml 100%, 80%, 60%, 40% and 20% CygelTM dilutions were
prepared in dH20. 40X PBS was supplemented to a 2.5% (v/v) concentration. The diluted vol-
umes were kept on ice.
Once all solutions were prepared, each was pipetted up and down using P200 pipettes to observe
how easy it is to handle the material after two and five minute intervals of incubation at room tem-
perature. Results, as seen in Table 5.4 show that all solutions can be pipetted without difficulty on
ice, although the 100% and 80% concentrated solutions require slow handling due to a high vis-
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Time post-preparation
Concentration On ice 2 mins 7 mins
100% CygelTM Good. Required
slow pipetting.
Good. Required slow
pipetting. Material is solidified.
80% CygelTM Good. Required
slow pipetting.
Good. Required slow
pipetting. Material is solidified.
60% CygelTM Good Good
Good. Material more
viscous due to minor
solidifying.
40% CygelTM Good Good
Good. Material more
viscous due to minor
solidifying.
20% CygelTM Good Good Good. Material’sviscosity not affected.
Table 5.4: CygelTM as an immobilisation agent: Handling and pipetting properties of different
concentrations of CygelTM solutions when placed on ice, after two minutes of incubation at room
temperature and after seven minutes of incubation at room temperature.
cosity. All liquids retained a similar viscosity after two minutes of incubation at room temperature.
After a further five minute interval, the 100% and 80% solutions were solidified and had a gel-like
consistency. The 60% and 40% solutions were noticeably more viscous than before, while the
20% consistency retained low viscosity.
Based on this knowledge, the 80% and 40% CygelTM solutions were taken forward for testing with
BSF T. brucei. The two solutions had a different consistency and viscosity, yet could both be han-
dled after two minutes of incubation time. The next step was to assess how these concentrations
affected cells in terms of motility, viability and tractability.
5.7.2 Effect of CygelTMsolutions on T. brucei cell motility and viability
Cells were prepared as per Section 5.4.2, replacing the use of agarose with 80% and 40%
CygelTM, which was prepared as per supplier instructions. Cell count results can be seen in Figure
5.11, which shows the percentage of viable and non-viable trypanosomes over time when they
are encased in either 80% or 40% CygelTM. Results show that the application of 80% CygelTM
(Figure 5.11b) is unreliable due to two main factors: there is a large variability present between
duplicate runs as seen from the error bands representing standard deviation, and cells remain
healthy for only one hour. This is in line with observations from Price et al. (2010) who report a
90% drop in BSF viability after just one hour. In terms of minimising motility, trypanosomes were
not observed to move freely, instead undulating within a fixed spot.
Cells embedded in 40% Cygel (Figure 5.11a) retained viability for a six hour period with over 50%
of cells viable for the first four hours. In addition, there is a smaller amount of variability than
when cells were fixed with 80% Cygel (maximum variability between duplicate readings is 50%
when using 80% CygelTM and 20% when using 40% CygelTM). When comparing the effect of 40%
CygelTM on T. brucei motility with the effect of the previous immobilisation agents, trypanosomes
were noticeably more restricted in movement, resulting in increased cell tractability. The same
process was carried out using CygelTM dilutions prepared in media instead of dH20. No changes
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(a) 40% CygelTM
(b) 80% CygelTM
Figure 5.11: CygelTM as an immobilisation agent: Plot showing the percentage of viable healthy
cells, viable unhealthy (clumped/misshapen) cells and non-viable cells over time which were over-
laid with a) 40% CygelTM and b) 80% CygelTM. Error bars represent standard deviation. The
experiment was carried out in duplicates.
were noted from the previous results.
In conclusion, the 40% CygelTM immobilisation solution satisfied the three framework criteria of
minimising motility while retaining cell viability and tractability. The solution had the best perfor-
mance out of the investigated entrapping and immobilisation agents. The 40% CygelTM set-up
was taken forward for further screenings, as will be discussed next.
5.7.3 Optimal cell density of live T. brucei cells in CygelTM
The above investigations focused on the use of different materials, set-ups and technologies to
establish an experimental framework by which live cell microscopy imaging of trypanosomes can
be carried out while maintaining cell viability and tractability plus minimising cell motility. The
following assay was developed to complement this framework by optimising the cell preparation
method used prior to assembling the set-up. Specifically, the assay aims to determine the opti-
mal density to which cells are resuspended during preparation. An optimal cell density selection
improves tractability conditions and maximises the number of cells imaged while preventing over-
crowding and the inability to distinguish between cells due to an overly dense population.
BSF cells were grown in 50ml media to 1×106cells/ml, after which the culture was centrifuged
for 10 minutes at 2000rpm, the supernatant removed and the pellet resuspended to a concentra-
tion of 10×107cells/ml. From this, dilutions of 5×107 cells/ml, 2×107 cells/ml, 1×107 cells/ml and
5×106 cells/ml were prepared in media and embedded in 40% CygelTM. Afterwards, cells were
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observed at 250X magnification and imaged with a Nexus 5 phone (Google Inc., CA, U.S.A). The
images were used to take cell counts.
Figure 5.12 shows that cells at a density of 5×106cells/ml (Figure 5.12a) and 1×107cells/ml (Fig-
ure 5.12b) are too sparse, with less than 40 cells noted within each frame. Cells at a density of
2×107cells/ml (Figure 5.12c), on the other hand, increase sharply in number from an average of
36 cells or less within the field of view to 235±18 cells. For cells at a density of 5×107cells/ml
(Figure 5.12d), the average number of cells in the field of view was 393±24 cells. For cells at
a density of 10×107cells/ml (Figure 5.12e), cells were dense and clumped together with large
sparse patches in between, making it difficult to count and distinguish the cells from each other.
A non-linear increase between cell counts for cells at a density of 1×107cells/ml and 2×107cells/ml
was noted. Further analysis was carried out to compare observed cell counts to expected counts.
The expected number of cells within the field of view was calculated as follows:
• A well on a 5mm multiwell slide has a 5mm diameter and hence, total surface area is calcu-
lated to be 19.63mm2.
• When viewing the slide at a 250X magnification, the field of view of the above images was
estimated to be roughly 0.99mm×1.67mm or 1.65mm2, as based on specifications of the
SP-95-1 Inverted microscope (Brunel Microscope Ltd., Wiltshire, U.K.).
• Based on the above calculations, the field of view amounts to 8.4% of the total surface area
of the well.
• The expected number of cells which should be within the field of view amount to 8.4% of the
cell population pipetted.
Calculations are based on a number of assumptions. Firstly, it was assumed that all volumes used
were exact and no pipetting errors were made. Secondly it was assumed that the resuspended
cell solution following centrifugation was homogeneous. Results are presented in Table 5.5, which
shows a large difference between expected and observed cell counts. This can be attributed to
a number of reasons. The pipetted volume is too large for the well and is pushed out when the
coverslip is placed on to the slide. Moreover, CygelTM has a higher viscosity than the cell solution,
which means that it sinks to the bottom, resulting in a non-homogeneous CygelTM and cell solu-
tion such that a larger proportion of the cell solution than CygelTM is pushed out by the coverslip.
One solution is to mix cells with the CygelTM solution prior to pipetting onto the slide. This will help
to retain more cells within the well area. This method was adopted when imaging trypanosomes,
as will be seen in the coming chapter. Pipetting a lower volume than 4µl of cell and CygelTM solu-
tions was not considered a viable option, since it leads to rapid drying of the well, compromising
cell viability in less than an hour.
Following assessment of the optimal cell density of trypanosomes embedded in CygelTM, T. bru-
cei at a concentration of 5×107cells/ml were used for live cell microscopy efforts. This leads to a
dense field of view but prevents cell clumping.
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(a) Cells at a density of 5×106cells/ml. Average cell count is 25±1 cells.
(b) Cells at a density of 1×107cells/ml. Average cell count is 36±4 cells.
(c) Cells at a density of 2×107cells/ml. Average cell count is 235±18 cells.
Figure 5.12: Cell density screening assay: Images of live BSF T. brucei embedded in 40%
CygelTM at a concentration of a) 5×106cells/ml, b) 1×107cells/ml, c) 2×107cells/ml. Cells were
observed at 250X magnification. The experiment was carried out in duplicates. Scale bar =
250µm.
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(d) Cells at a density of 5×107cells/ml. Average cell count is 393±24 cells.
(e) Cells at a density of 10×107cells/ml. Cells are clumped together. An accurate cell count of the number of cells within
vision can not be carried out.
Figure 5.12: (Continued) Cell density screening assay: Images of live BSF T. brucei embedded
in 40% CygelTM at a concentration of d) 5×107cells/ml, e) 10×107cells/ml. Cells were observed
at 250X magnification. The experiment was carried out in duplicates. Scale bar = 250µm.
5.8 Discussion
Following investigations to develop an experimental framework which enables the measurement
of fluorescence levels in viable T. brucei cells, the following conclusions can be made:
1. Established an experimental framework using 40% CygelTM to form an encasing and immo-
bilising matrix among the cells. This set-up will be used in the microscopy imaging of live
T. brucei cell populations bearing the stable and unstable Goodwin oscillators in order to
analyse oscillations in fluorescence at the single cell level.
2. Out of the two sets of frameworks tested to either entrap or immobilise T. brucei, the use of
CygelTM satisfied the three framework criteria best. The experimental set-up was required to
minimise cell motility while maximising tractability and maintaining cell viability. In the 40%
CygelTM set-up, T. brucei were viable for up to eight hours post-embedding and cell motility
was observed to be reduced, thus allowing for increased cell tractability.
3. Established that the CygelTM set-up can be optimised by using T. brucei at a concentration
of 5×107cells/ml. When looked at via the microscope this results in a dense field-of-view
but prevented clumping of cells.
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Density
(cells/ml)
Number of
cells pipetted
Expected number of
cells within the field
of view
Average number of
cells observed within
the field of view
5×106 10,000 840 25
1×107 20,000 1,681 36
2×107 40,000 3,361 235
5×107 100,000 8,403 393
10×107 200,000 16,807 N.A
Table 5.5: The cell density assay: Analysis of the expected and observed cell counts of T. brucei
embedded in 40% CygelTM, depending on the cell density being used.
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Chapter 6
Characterisation of the unstable
Goodwin oscillator phenotype in T.
brucei cells
6.1 Preliminary investigations of the unstable Goodwin oscil-
lator
Following the transfection of BSF and PCF T. brucei with the unstable oscillator, pUnstable, pre-
liminary characterisation was carried out in order to parameterise gene network components and
assess whether they are functioning as expected. This, in turn, will inform both mathematical
modelling and microscopy imaging. The studies implemented are outlined in Table 6.1. Analysis
was primarily done using BSF T. brucei bearing the pUnstable network. Results are assumed to
hold for PCF clones since the pUnstable GRN does not use mechanisms which are dependent
on the form (BSF or PCF) of the trypanosome.
6.1.1 Growth profile of T. brucei cells bearing the unstable Goodwin oscil-
lator
The first characterisation assay carried out on transfected T. brucei was to map a growth profile
for BSF and PCF clones in order to analyse whether the unstable Goodwin oscillator plasmid im-
Assay Section
1 Establish whether the pUnstable plasmid inhibits trypanoso-
mal cell growth
Section 6.1.1
2 Establish functional activity of TetR regulator Section 6.1.2
3 Determine the half-life of the TetR and eGFP protein and de-
termine whether Ub-L moiety leads to destabilised TetR and
eGFP protein
Section 6.1.3
Table 6.1: List of preliminary characterisation assays carried out to investigate function of the
main components in the pUnstable oscillator in its T. brucei host.
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pacts on cell growth. This is important because a slower cell growth compromises the potential of
the host cell as a viable synthetic biology chassis, since the insertion of more complex plasmids
would result in increasingly poor growth and unstable lines.
The assay was carried out over 72 hours on both induced and uninduced BSF and PCF try-
panosomes, since T. brucei doubling times vary depending on the form (Lee et al., 2007). Wild-
type T. brucei cells were used as a control. Initially, cells were diluted to the required density
(1×106 cell/ml for BSF and 2×106 cells/ml for PCF cells) in 10ml of media. If required, 1µg/ml
tetracycline was added as an inducer. Cells were then left to incubate for 24 hours, after which
cell counts were taken and the dilution-(induction)-growth-count process was repeated twice. The
experiment was carried out in duplicates. The growth profile was plotted as both a saw-tooth
curve with standard deviation error bars and as a cumulative growth curve of the mean growth.
6.1.1.1 Growth profile of BSF T. brucei cells bearing the unstable Goodwin oscillator
Following a 72-hour growth profiling, growth patterns of BSF pUnstable trypanosomes (Figure
6.1) do not show a clear distinction between wildtype and induced/uninduced transfected BSF T.
brucei. This is also reflected in the corresponding estimated cell doubling times and exponential
growth functions as calculated from the mean cumulative growth curves, seen in Figure 6.1c.
6.1.1.1.1 Use of Mann-Whitney statistical analysis for comparison of growth rate data.
Following these observations, further in-depth analysis was carried out to assess whether the
observations hold under statistical and scientific scrutiny. In order to evaluate whether the BSF
cumulative growth rates are statistically significantly different from each other, the Mann–Whitney
U test was implemented (Mann & Whitney, 1947). This test is used to compare two indepen-
dent and non-parametric datasets (i.e. datasets which are not normally distributed) and deduce
whether they are significantly different from each other, as seen in Wang and Bushman (2006),
Vardi et al. (2001) and Hamamoto et al. (2015) who use the test to compare the growth patterns
of different populations. The test works by rejecting one of two hypothesis which are set; the
null hypothesis (H0) which states that the difference between the median growth rates of the two
populations is zero and the alternative hypothesis (H1) which states that the difference is not zero.
In this case, the test was used to compare the median growth of induced or uninduced transfected
T. brucei to wildtype cells. The following two sets of hypothesis were tested, to compare the me-
dian of cumulative growth of uninduced transfected cells to wildtype cells (Test 1) and to compare
the cumulative growth of induced transfected cells to wildtype cells (Test 2):
Test 1
H0: The difference in median between the cumulative growth of BSF wildtype cells
and uninduced BSF cells transfected with pUnstable is zero
H1: The difference in median between the cumulative growth of BSF wildtype cells
and uninduced BSF cells transfected with pUnstable is not zero
Test 2
H0: The difference in median between the cumulative growth of BSF wildtype cells
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(a) Saw-tooth growth rate profile of BSF T. brucei
(b) Cumulative growth rate profile of BSF T. brucei. x is the time in hours.
Strain Cell doubling time Exponential fitted curve
Wildtype BSF 7.53 hrs y = 103318.e0.092t
Uninduced, transfected BSF 7.87 hrs y = 70824.e0.088t
Induced, transfected BSF 7.70 hrs y = 85585.e0.09t
(c) Cell doubling time for BSF T. brucei: Estimated cell doubling times and exponential fitted curves for
wildtype and pUnstable-transfected BSF T. brucei. t is the time in hours.
Figure 6.1: Growth rate profiles and doubling times of induced/uninduced BSF T. brucei bearing
pUnstable represented by a: a) saw-tooth curve profile, b) semi-logarithmic cumulative growth
profile, c) doubling times and fitted exponential curves based on cumulative growth data. Induced
cells were treated with 1µg/ml tetracycline. The plot axes show Density in cells/ml versus Time in
hours. Error bars represent standard deviation. The experiment was carried out in duplicates.
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and induced BSF cells transfected with pUnstable is zero
H1: The difference in median between the cumulative growth of BSF wildtype cells
and induced BSF cells transfected with pUnstable is not zero
The test requires that the sample data from both populations is ranked in a single monotonic
order. For each population, the ranks are added up and a test statistic U is calculated using the
formula:
U = N1.N2 +NL.
NL + 1
2
− T L
where N1 is the sample size of the first population, N2 is the sample size of the second population,
NL is the number of samples in the population which had the largest sum of ranks and TL is the
largest sum of ranks from the two populations’ sums. The U statistic is then compared to a critical
U value, Ucrit, the value of which depends on the population size. For this test to hold, there must
be more than five data points per population (Sheskin, 2003). Given that the growth curve assay
was carried out over 72 hours, only four cumulative growth data points were deduced from exper-
iment data. In order to generate more values, a data point representing cell concentration at the
92nd hour was inferred from the fitted exponential curve for each track (Figure 6.1c), for a total of
five data points, after which the Mann-Whitney U test was applied.
The data points used and test results are presented in Table 6.2 which shows that for Test 1, the
U statistic was larger than Ucrit=2, indicating that there is not enough evidence to reject the null
hypothesis that the median growth rates of the wildtype and uninduced pUnstable BSF cells are
not different from each other. A similar analysis was carried out for wildtype cells and induced
pUnstable clones in Test 2 (Table 6.2). The U statistic was calculated to be 10.5 which is again
bigger than Ucrit=2, indicating there is not enough evidence to reject the hypothesis that growth
profiles of wildtype BSF cells and induced pUnstable BSF clones are not different from each other.
Hence, the pUnstable oscillator plasmid does not have a negative impact on BSF cell growth.
6.1.1.2 Growth profile of PCF T. brucei cells bearing the unstable Goodwin oscillator
Growth profiling was also carried for PCF T. brucei transfected with pUnstable over a 72-hour
period. The growth curves for PCF wildtype and induced/uninduced transfected cells (Figure 6.2a
and 6.2b) highlight a difference between the uninduced pUnstable-transfected cells and the re-
mainder of the tracks. In fact, estimated doubling times (Figure 6.2c) have a wide range of values.
In order to test whether these differences hold under statistical scrutiny, the following two hypoth-
esis were tested using the Mann-Whitney U test:
Test 3
H0: The difference in median between the cumulative growth of PCF wildtype cells
and uninduced PCF cells transfected with pUnstable is zero
H1: The difference in median between the cumulative growth of PCF wildtype cells
and uninduced PCF cells transfected with pUnstable is not zero
Test 4
H0: The difference in median between the cumulative growth of PCF wildtype cells
and induced PCF cells transfected with pUnstable is zero
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Test 1:
Comparing the cumulative growth of BSF wildtype cells with that of
uninduced cells transfected with pUnstable
Data Wildtype (Cells/ml) Uninduced, transfected (Cells/ml)
1×105 1×105
1.05×106 4.05×105
1.26×107 3.62×106
1.4×108 5.58×107
1.39×109 (Estimated) 3.3×108 (Estimated)
U statistic 11.5
H0 rejected No
Test 2:
Comparing the cumulative growth of BSF wildtype cells with that of
induced cells transfected with pUnstable
Data Wildtype (Cells/ml) Induced, transfected (Cells/ml)
1×105 1×105
1.04×106 6.45×105
1.26×107 5.26×106
1.4×108 6.68×107
1.39×109 (Estimated) 4.84×108 (Estimated)
U statistic 10.5
H0 rejected No
Table 6.2: Comparison of growth rates of BSF T. brucei cells bearing the uninduced/induced
unstable Goodwin oscillator expression cassette and unmodified wildtype cells via the Mann-
Whitney U test, which tests whether cumulative growth rates for transfected cells are significantly
different from wildtype BSF cells. The table shows the experiment and estimated data points of
the cell counts in Cells/ml which were used for the analysis to calculate the U statistic. This is
compared to Ucrit at the 0.05% confidence level which has value 2. The table also prints the
outcome whether to reject the Null hypothesis, H0.
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(a) Saw-tooth growth rate profile of PCF T. brucei
(b) Cumulative growth rate profile of PCF T. brucei. x is the time in hours.
Strain Cell doubling time Exponential fitted curve
Wildtype PCF 15.07 hrs y = 1804827.e0.046t
Uninduced, transfected PCF 34.66 hrs y = 2231223.e0.02t
Induced, transfected PCF 16.50 hrs y = 2045045.e0.042t
(c) Cell doubling times and exponential fitted curves for PCF T. brucei: Estimated cell doubling times
for wildtype and pUnstable-transfected PCF T. brucei. t is the time in hours.
Figure 6.2: Growth rate profiles and doubling times of induced/uninduced PCF T. brucei bearing
pUnstable represented by a: a) saw-tooth curve profile, b) semi-logarithmic cumulative growth
profile, c) doubling times and fitted exponential curves based on cumulative growth data. Induced
cells were treated with 1µg/ml tetracycline. The plot axes show Density in cells/ml versus Time in
hours. Error bars represent standard deviation. The experiment was carried out in duplicates.
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Test 3:
Comparing the cumulative growth of PCF wildtype cells with that of
uninduced cells transfected with pUnstable
Data Wildtype (Cells/ml) Induced, transfected (Cells/ml)
2×106 2×106
4.25×106 4.03×106
2.02×107 6.59×106
4.79×107 8.4×106
1.49×108 (Estimated) 1.15×108 (Estimated)
U statistic 9.5
H0 rejected No
Test 4:
Comparing the cumulative growth of PCF wildtype cells with that of
induced cells transfected with pUnstable
Data Wildtype (Cells/ml) Uninduced, transfected (Cells/ml)
2×106 2×106
4.25×106 4.9×106
2.02×107 2.15×107
4.79×107 3.77×107
1.49×108 (Estimated) 1.52×107 (Estimated)
U statistic 11.5
H0 rejected No
Table 6.3: Comparison of growth rates of PCF T. brucei cells bearing the uninduced/induced
unstable Goodwin oscillator expression cassette and unmodified wildtype cells via the Mann-
Whitney U test, which tests whether cumulative growth rates for transfected cells are significantly
different from wildtype PCF cells. The table shows the experiment and estimated data points
of the cell counts in Cells/ml which were used for the analysis to calculate the U statistic. This
is compared to Ucrit at the 0.05% confidence level which has value 2. The table also prints the
outcome whether to reject the Null hypothesis, H0.
H1: The difference in median between the cumulative growth of PCF wildtype cells
and induced PCF cells transfected with pUnstable is not zero
Calculations of the U statistic from the Mann-Whitney test based on experimental and inferred
data-points, as seen in Table 6.3, show that both null hypotheses, which state that the differ-
ence in median growth between wildtype and induced/uninduced transfected PCF trypanosomes
is zero, should not be rejected, indicating that observed divergent growth patterns were outliers.
Thus, similarly to BSF pUnstable-transfected cells, PCF pUnstable clones were found to have no
impact on cell growth. Note that the cell doubling time for PCF cells is much larger than for BSF
cells, in line with expectations (Pays, 1999).
6.1.2 Functional activity of the TetR regulation - Expression dynamics of
the unstable Goodwin oscillator expression cassette in T. brucei cells
following tetracycline addition and removal
This study focuses on the effect of tetracycline on pUnstable. In particular, the study establishes
the length of time over which tetracycline remains effective as an inducer. This serves to confirm
whether protein expression inhibition is regulated by TetR or otherwise, since protein expression
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(a) Western blot (b) Coomassie Stain
(c) Densitometry Plot
Figure 6.3: eGFP expression levels over a 72-hour period of BSF T. brucei bearing pUnstable
following 1µg/ml tetracycline induction and removal. Analysis is carried out via a a) western
blot detecting for the eGFP signal, b) corresponding coomassie stain and c) densitometry plot
quantifying the amount of eGFP protein detected in the western blot using the positive control as
a reference point of intensity 1.0. The positive control is a pConstitutive protein sample, while the
negative control is an uninduced pUnstable protein sample.
should be suspended as the tetracycline molecule degrades, TetR binds to the operator instead
of tetracycline and inhibition resumes.
1µg/ml tetracycline was applied to a BSF culture at a concentration of 1×105cells/ml and incu-
bated until the population has grown to a density of 1×106cells/ml, after which cells were har-
vested at 2000rpm for 10 minutes, the supernatant removed and the pellet resuspended in an
equal volume of pre-warmed media. The harvest, removal of supernatant and resuspension pro-
cess was then repeated. This step removes extracellular tetracycline while intracellular tetracy-
cline remains and diffuses back out of cells at an unknown rate. Following resuspension, samples
were taken and protein prepared at the following time-points: 0hr, 1hr, 3hr, 6hr, 24hr, 48hr and
72hr. Samples were analysed via a western blot detecting for the eGFP protein and a correspond-
ing coomassie stain.
Results, as seen in Figure 6.3, show that following the removal of extracellular tetracycline, the
fluorescent signal from the pUnstable GRN loses strength over time. In particular, there is a pro-
nounced decrease in signal strength following the three hour time-point with another significant
decrease in signal strength between the 24 and 48 hour time-point. This serves to confirm the
functional activity of the TetR regulator.
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6.1.3 Half-life of the destabilised TetR and eGFP proteins in T. brucei cells
bearing the unstable Goodwin oscillator
The next assay to be carried out was a cycloheximide-based assay to determine the half-lives
of the destabilised TetR and eGFP proteins and input the data into mathematical modelling. In
addition, knowledge of the eGFP half-life will help inform whether the protein is sufficiently desta-
bilised as to exhibit oscillations due to TetR inhibition or whether it is too stable to reflect regulatory
influence within the network.
Cycloheximide serves to disrupt translation processes and hence, synthesis. However, degrada-
tion reactions remain unaffected. Thus, following the addition of cycloheximide to a sufficiently
dense BSF culture, the number of TetR and reporter proteins within the cells remain constant ex-
cept for those which are degraded via natural processes. It follows that the period over which the
protein signal in strength decreases by half corresponds to the protein half-life. The assay was
carried out using transfected BSF cells which had been induced with tetracycline for a 24-hour pe-
riod so as to counteract inhibitive regulation and allow for maximal constitutive protein expression
to occur. This implies that decrease in protein signal reflects only degradation processes and not
oscillatory cycles.
6.1.3.1 Half-life of the destabilised, Myc-tagged TetR protein in T. brucei cells bearing the
unstable Goodwin oscillator
In the pUnstable design, a Myc tag was added upstream of the TetR protein to quantify TetR indi-
rectly and avoid using anti-TetR antibodies. Results from the western blot detecting the Myc-tag
were blank (results not shown). The positive control used in the western blot, however, did flag up
a signal, indicating that the blot was performed correctly. The coomassie stain showed that sam-
ples were prepared correctly. The lack of Myc-tag detected is unlikely to be due to no Myc protein
being synthesised. The difference in signal strength between induced and uninduced samples
(Figure 4.24, Figure 6.3) indicate that tetracycline is binding to TetR protein and, by proxy, that
TetR protein is being synthesised. It follows that the Myc tag, which is within the same cassette
as TetR and shares the same start and stop codons, is also being expressed.
Note that detecting for the Ub-L protein which is upstream of TetR would flag up Ubiquitin signals
from the organism itself and not just the pUnstable plasmid. The use of TetR-binding antibodies
proved ineffective, as will be discussed in more detail in Section 7.1.4.1. No conclusions were
made regarding the half-life of TetR and the destabilising effect of Ub-L.
6.1.3.2 Half-life of the destabilised eGFP protein in T. brucei cells bearing the unstable
Goodwin oscillator
In order to determine the half-life of the Ub-L destabilised eGFP protein in pUnstable, a western
blot and coomassie stain were run using cycloheximide-treated protein samples, with results as in
Figure 6.4 indicating that the destabilised eGFP protein has a half-life of 2-3 hours. A clear differ-
ence can be seen between eGFP signals of cycloheximide-treated and untreated samples (Figure
6.4a and 6.4b respectively), indicating that the change in the treated samples is either due to the
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effect of cycloheximide or incorrect protein samples. However, the corresponding coomassie
stains show consistent samples, indicating that the decrease in protein quantity detected in Fig-
ure 6.4a is due to the effect of cycloheximide rather than incorrect sample preparation. Due to
basal expression levels within pUnstable this data was not plugged into mathematical modelling
and instead, data gathered from pStable was used. Further investigation concerning the eGFP
half-life is discussed in Section 7.1.4.2.
6.1.4 Evaluation of the unstable oscillator phenotype following preliminary
investigations
Following the above phenotyping assays, the following findings and observations were made:
1. Preliminary characterisation of the pUnstable oscillator via western blots and coomassie
stains has shown that the main components of the pUnstable network are functional and
that TetR and eGFP protein is successfully synthesised. Promoters successfully initiate tran-
scription: detected eGFP levels indicate that the PRRNA promoter is functional while clones
cultured in the presence of Hygromycin indicate that the PEP1 promoter is also working.
There is a basal constitutive expression such that the pUnstable network can be used as a
partial replacement for tetracycline molecules since it allows for TetR and eGFP continuous
expression.
2. BSF T. brucei transfected with pUnstable and induced with tetracycline flag up a stronger
eGFP protein signal than uninduced transfected T. brucei, indicating that TetR regulation is
being implemented and that the tetracycline operator is functional.
3. Intracellular tetracycline can induce maximal expression within the plasmid for over three
hours, after which inhibition resumes as the tetracycline molecules degrade.
4. The pUnstable plasmid does not impair cell growth in transfected BSF or PCF T. brucei.
5. The Ub-L gene upstream of eGFP has a destabilising effect. The half-life of eGFP within
pUnstable is c. 3 hours long when it usually is over 24 hours long (Corish & Tyler-Smith,
1999). Quantitative mathematical modelling work concerning this will be discussed later.
6. The Ub-L gene was added upstream of the tetR gene in order to destabilise the TetR protein,
while the Myc tag was added upstream of this fusion in order to quantify TetR protein more
easily when using western blots. Further investigation is needed to determine how Myc and
Ub-L are affecting TetR.
7. In conclusion, the components of the pUnstable GRN allow for oscillations to take place.
Since the cell population is unlikely to oscillate in synchrony (Elowitz & Leibler, 2000; Stricker
et al., 2008; Danino et al., 2010; Tigges et al., 2010) and since western blots have limited
sensitivity, oscillations are unlikely to be detected via protein sample analysis. Therefore
fluorescent microscopy imaging was carried out in order to observe fluorescent patterns, as
will be discussed next.
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(a) Western blot detecting for eGFP in protein sam-
ples from induced pUnstable-transfected BSF T. brucei
treated with cycloheximide
(b) Control: Western blot detecting for eGFP in protein
samples from induced pUnstable-transfected BSF T. bru-
cei not treated with cycloheximide
(c) Coomassie stain for protein samples from in-
duced pUnstable-transfected BSF T. brucei treated
with cycloheximide
(d) Control: Coomassie stain for protein samples
from induced pUnstable-transfected BSF T. brucei
not treated with cycloheximide
(e) Densitometry plot showing the signal intensity extracted from the western blots
above of eGFP protein from pUnstable-transfected cells either treated or untreated
with cycloheximide.
Figure 6.4: Deducing the half-life of the destabilised eGFP protein in BSF T. brucei bearing
pUnstable and induced with 1µg/ml tetracycline. Protein samples were prepared at specific time-
points following cycloheximide addition and then analysed via western blot (a) detecting for eGFP
and a corresponding coomassie stain (c). In parallel, a control assay (b, d) was carried out
wherein no cycloheximide was added to the culture. e) shows a densitometry plot quantifying
the amount of eGFP in both treated and untreated pUnstable-transfected cells detected in the
western blots. The plot uses the eGFP intensity from the measurement taken prior to the addition
of the cycloheximide or blank (‘pre’) as value 1.0.
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Strain Plasmid introduced aaConditions Section
1 BSF pConstitutive aaaaaa- Section 6.2.1
2 BSF pUnstable aaUninduced Section 6.2.2
3 BSF pUnstable aaInduced with tcthres Section 6.2.2
4 PCF pUnstable aaUninduced Section 6.2.3
5 PCF pUnstable aaInduced with tcthres Section 6.2.3
Table 6.4: The pConstitutive and pUnstable-transfected BSF and PCF T. brucei clones which were
imaged using live-cell fluorescent and brightfield microscopy to observe fluorescent patterns and
characterise the phenotype of pUnstable. ‘tcthres’ is the tetracycline concentration above which
protein expression across the cell population is induced.
6.2 Characterisation of the phenotype of the unstable Good-
win oscillator
Following assessment of the main pUnstable components, the next step was to observe fluores-
cent patterns in pUnstable-transfected BSF and PCF T. brucei populations via live-cell fluorescent
microscopy. Cells were immobilised in 40% CygelTM at a density of 5×107cells/ml as per Section
5.7. Microscopy was carried out in two hour segments at two minute intervals, using an objective
of 20X. Brightfield microscopy was used as a control, with fluorescent and brightfield images taken
consecutively. This was done firstly to confirm that observed fluorescence peaks are a result of
protein dynamics within the cells rather than debris and secondly so as to facilitate manual cell
tracking.
After imaging, fluorescent background correction was applied uniformly across all image stills.
The relative fluorescence between stills was not affected. Images of the cell populations were
then collated and analysed as a video in order to detect and quantify changes in fluorescence
levels over time in individual cells. Quantification was initially done via Volocity, which uses a
combination of thresholding (Pal & Pal, 1993), edge detection (Gonzalez & Woods, 2002) and
watershed segmentation (Beucher & Lantuejoul, 1979, September) algorithms in order to select
fluorescing cells (Hand et al., 2009). After, each quantified cell was tracked manually over the
stills to check none had been misidentified. This was necessary due to an element of cell motility
which can lead to incorrect cell tracking by Volocity. Table 6.4 lists the strains which were imaged
and the conditions under which they were imaged.
6.2.1 Phenotype of pConstitutive cells in BSF T. brucei
Fluorescent microscopy imaging was carried out using pConstitutive control cells to analyse
whether eGFP expression levels were detectable with fluorescent microscopy. Imaging showed
that all observed cells were producing eGFP protein constitutively at detectable levels as seen in
Figure 6.6 which shows stills of fluorescing pConstitutive cells at intermittent time intervals.
The next step was to quantify the effect of cell undulations on the strength of the fluorescent sig-
nal. Cells can undulate across the plane or within a fixed spot (Ralston et al., 2009), leading to
changes in focus and hence, fluorescent intensity. Three cells were selected and their fluores-
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Figure 6.5: Images of pConstitutive-transfected BSF T. brucei over five consecutive time-points
taken using a 20X objective. The top row shows fluorescent microscopy images while the bottom
row shows corresponding brightfield microscopy images. The encircled cell is pConstitutive Cell
1 which was used to quantify variation in the fluorescent profile due to cell undulations. Scale bar
= 100µm.
cence quantified over five time-points. Readings were taken over five time-points because cell
motility meant that the cells moved out of the plane of vision after this period. As an example,
Figure 6.5 shows brightfield and fluorescent images of pConstitutive Cell 1, one of the three cells
used for this analysis. The mean and standard deviation of the fluorescent signal intensity within
each cell were calculated as per Table 6.5. The range of mean fluorescent signals (32.6-74.3) in
cells is attributed to cell-cell variability, which is a variation in the phenotypic output (for example,
protein synthesis) of monoclonal cells due to intrinsic noise or deterministic processes (Snijder &
Pelkmans, 2011; Pelkmans, 2012).
Although in theory, BSF cells bearing pConstitutive have a uniform fluorescent signal, the ob-
served and quantified variation in signal strength (Table 6.5) indicates that cell undulations and
intracellular sources of stochasticity are having an impact on the detected signal. The percentage
of standard deviation varies between cells (2-28%). This results in an average 17% variation.
Similar levels of GFP variation (up to 20%) were detected in control cells in Tigges et al. (2009).
Although the effects of internal processes on cell output (Haupts et al., 1998; Vilar et al., 2002) are
well documented, no information was found on the effect of cell motility (and microscope focus)
on the detected output, making it difficult to distinguish between the effect of noise and motility.
In a final observation made, it was noted that photobleaching, temperature and cell environment
during fluorescence microscopy affected trypanosomes differently when compared to observa-
tions made when using optical microscopy in Chapter 5. Specifically, the fluorescent microscopy
environment led to decreased cell viability and increased motility.
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Cell Mean fluorescent
signal
% standard
deviation
pConstitutive Cell 1 73.84 22
pConstitutive Cell 2 74.29 2
pConstitutive Cell 3 32.57 28
Average 60.23 17
Table 6.5: Mean fluorescent signal intensity and percentage of standard deviation of three
pConstitutive-transfected BSF T. brucei cells over five time-points. The fluorescent signal has
no units.
6.2.2 Phenotype of the unstable Goodwin oscillator in BSF T. brucei
6.2.2.1 Imaging of uninduced BSF T. brucei bearing the unstable Goodwin oscillator
pUnstable-transfected BSF cells were imaged as per the above method to observe fluorescent
patterns and establish whether pUnstable-transfected cells were producing eGFP protein period-
ically. Imaging and subsequent analysis showed cells to be fluorescing at a basal level, as seen
in Section 6.1. No significant changes were detected in the fluorescence intensity levels (results
not shown) over the two hour span. This is attributed in part to cell motility and low cell density,
making for limited cell tracking. This will be further discussed in the coming chapter. Throughout,
brightfield microscopy confirmed that cells were not shrunk or burst.
6.2.2.2 Imaging of BSF T. brucei bearing the unstable Goodwin oscillator and induced
with tcthres to increase the probability of detecting oscillations
A second image acquisition study was carried out on pUnstable-transfected BSF cells wherein,
prior to microscopy, cells were induced with tetracycline at the threshold tetracycline concentra-
tion, tcthres = 10fg/ml for 24 hours. This is the threshold concentration such that when cells are
induced with tcthres, only a proportion of cells fluoresce. If used at a higher concentration, tetra-
cycline induces detectable expression across the whole population. See Section 7.1.2 for the
original assay. Following this, cell preparation and imaging was as described above. This was
done in order to control for the possibility that changes in fluorescence were too weak to be de-
tected via microscopy and quantitation.
The hypothesis behind the addition of tetracycline works as follows, with reference to Figure 6.7.
When no tetracycline (Tetracycline = 0) is added to the culture of transfected T. brucei cells, TetR
and eGFP protein is synthesised. TetR then binds to the operator, Tet Op, resulting in inhibition.
As TetR degrades via natural processes, the cycle restarts itself. This oscillatory cycle has been
described in more detail in Section 4.1.2. Due to low eGFP quantity, fluorescence is not detected
by microscopy. On the other hand, if the culture of transfected T. brucei is induced with a high con-
centration of tetracycline (Tetracycline > tcthres), TetR and eGFP is synthesised and TetR binds to
the tetracycline molecules, to which it has a greater affinity than Tet Op. This results in constitutive
expression until the tetracycline molecules are degraded. Thus, no oscillations occur during this
period.
184
Finally, if tetracycline is added at a concentration of tcthres (Tetracycline = tcthres), tetracycline
molecules applied to the cell culture are dispersed among the cells and a proportion of them be-
comes intracellular (Step 1 in bottom box in Figure 6.7). Thus, when expression occurs (Step 2)
and a TetR protein is synthesised, it binds to the tetracycline molecules present instead of the op-
erator (Step 3), thus allowing for further expression of both tetR and eGFP genes and an increase
in fluorescent levels (Step 4). This process is repeated until the number of TetR proteins exceeds
the number of tetracycline molecules (Step 5).
At this stage, TetR binds to the tet operator and expression is inhibited (Step 6). This is followed
by a period where TetR and eGFP proteins degrade due to natural processes (Step 7), after which
the oscillatory cycle re-initiates. Thus, tetracycline at the tcthres concentration serves to increase
fluorescence levels, the amplitude of oscillations and in turn the probability of observing oscilla-
tions via microscopy. Although the above explanation does not take basal levels of transcription
into account, the hypothesis still holds.
Following imaging of tcthres induced pUnstable-transfected BSF T. brucei, quantified cells showed
no significant change in fluorescence intensity (results not shown). Similarly to results for unin-
duced pUnstable-transfected BSF cells, trypanosomes retained an element of motility, making for
limited tractability. This does not disprove the hypothesis behind adding tetracycline to the culture,
but is in indication that further cells need to be imaged under increased immobilisation conditions.
6.2.3 Phenotype of the unstable Goodwin oscillator in PCF T. brucei
Apart from pUnstable-transfected BSF cells, induced and uninduced pUnstable-transfected PCF
clones were also imaged over a two hour segment in order to observe fluorescence patterns.
Fluorescence was not detected in individual cells (images not shown). This reflects findings in
transfection results in Section 4.4 wherein western blot results did not flag up eGFP signals in
pUnstable-transfected PCF clones, even when induced. Further studies, including assessing the
point of insertion of the plasmid on the genome following transfection, are required to analyse
these results.
6.2.4 Evaluation of the unstable oscillator phenotype following live cell mi-
croscopy imaging
Following the imaging of T. brucei cells having the pConstitutive and pUnstable plasmids, the fol-
lowing results and observations were made:
1. BSF T. brucei transfected with pConstitutive express eGFP continuously and at detectable
levels. The fluorescence signal varies by an average of 17% over five readings due to
cell motility, undulations and intracellular stochasticity. This will be used when analysing
changes in fluorescence levels in cells having the pUnstable or pStable plasmid, to help in-
dicate whether observed fluctuations were true oscillations or noise. However, the imaging
of pConstitutive transfects over a time span of two hours would allow for better comparability
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Figure 6.7: Diagram explaining how different concentrations of tetracycline molecules affect pro-
tein dynamics in T. brucei cells bearing the Goodwin oscillator, leading to either undetected fluo-
rescence oscillations, detected fluorescence oscillations or increasing fluorescence levels. PRRNA
is the promoter, Tet Op is the tetracycline dependant operator, tetR is the tetR gene, Ub-L-eGFP
is the Ub-L and eGFP gene moiety, TetR is the TetR protein, eGFP is the eGFP protein, tc is
tetracycline and tcthres is the threshold tetracycline concentration.
Tetracycline = 0: When no tetracycline is added to the culture (Step 1), TetR and eGFP protein is
expressed at time 0 (Step 2). TetR binds to Tet Op, resulting in protein synthesis inhibition (Step
3). TetR and eGFP degrade naturally (not shown), after which the cycle re-starts. Throughout,
eGFP levels are not sufficiently high to be detected.
Tetracycline > tcthres: When tc at a higher concentration than tcthres is added to the culture (Step
1), TetR and eGFP is expressed at time 0 (Step 2). TetR binds to tc, towards which it has a
greater affinity than Tet Op (Step 3). Due to an excess of tc, all TetR proteins bind to it, preventing
inhibition and resulting in increasing fluorescence levels but no oscillations.
Tetracycline = tcthres: When tc at a concentration of tcthres is added to the culture (Step 1), TetR
and eGFP is expressed at time 0 (Step 2). TetR binds to tc (Step 3). This continues until all tc is
bound (Step 4), at which stage TetR binds to Tet Op (Step 5,6) and inhibits further synthesis. TetR
and eGFP degrade via natural processes (Step 7), after which the oscillatory cycle re-starts. The
increase in eGFP quantities prior to inhibition increases the probability that fluorescence levels
are detected.
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of results to pStable and pUnstable transfects, wherein imaging is taken over two hour seg-
ments. Thus, results can only be used as an indication and it is recommended that further
imaging of pConstitutive is carried out.
2. Imaging of induced and uninduced T. brucei bearing pUnstable showed non-significant
changes in fluorescence signals, in part due to motility issues and due to the PCF pUn-
stable clones not issuing a signal. The optimisation of the imaging set-up will go a long
way towards controlling this issue as it would enable the imaging of a larger number of
transfected clones at lower motility.
3. pUnstable components are functioning and interacting as expected, as seen in characteri-
sation assays carried out on BSF and PCF T. brucei transfectants. Moreover, simulations
of protein dynamics (discussed further on) indicate that the GRN dynamics are fluctuating.
This indicates that observations from microscopy imaging do not eliminate that pUnstable
functions as an oscillator and that further work should be carried out.
6.3 Discussion
Following characterisation of the unstable Goodwin oscillator phenotype in T. brucei cells via
protein analysis and microscopy imaging, the following conclusions can be made:
1. Characterised a novel synthetic GRN encoding an unstable Goodwin oscillator within a T.
brucei chassis. This is the first synthetic oscillator to be characterised within a trypanosomal
platform.
2. Assessed functionality of the main pUnstable network components. Promoters and opera-
tors were functional and the network successfully synthesised destabilised eGFP, TetR and
antibiotic resistant protein.
3. Deduced that the pUnstable network has a basal level of tetR and Ub-L-eGFP transcription.
This implies that the pUnstable network can be used in alternative applications to pStable
where basal transcription levels are required or as an alternative to induction by low levels
of tetracycline. This results in a more efficient and feasible process while still allowing for
oscillations to occur.
4. Confirmed that the pUnstable network is regulated via autonomous TetR regulation which
can be reversed via the addition of tetracycline. When added at a 1µg/ml concentration,
tetracycline has a lasting effect of over three hours.
5. Established that the pUnstable network does not impact on either BSF or PCF cell growth.
This is important in the assessment of T. brucei as a synthetic biology platform as it shows
that the cells retain stability following the integration of extracellular plasmid.
6. Characterised the pConstitutive plasmid phenotype in BSF T. brucei via microscopy imaging
and quantitation. Although based on a limited data set, cells were shown to express eGFP
constitutively.
7. Quantified variation in fluorescent signal due to cell undulations and intracellular stochastic-
ity over a ten minute time-span as 17% of mean observed fluorescent signal.
8. Imaged and analysed induced and uninduced BSF and PCF T. brucei bearing the unstable
Goodwin oscillator. Fluorescent oscillations were not observed under the conditions stud-
ied. This does not exclude pUnstable from functioning as an oscillator, especially since
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preliminary analysis and mathematical modelling have indicated that the GRN can function
as an oscillator (irrespective of whether it is genuine or stochastic). Further development of
the experimental set-up and imaging technology will enable a wider set of conditions to be
scanned for observable oscillatory behaviour.
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Chapter 7
Characterisation of the stable
Goodwin oscillator phenotype in T.
brucei cells via experimentation
and mathematical modelling
Following characterisation of the pUnstable plasmid, the next step was to characterise the pStable
oscillator (Figure 7.1) phenotype in T. brucei cells. This involved parameterising gene network
components and dynamics via protein analysis and microscopy imaging and the development of
a mathematical model for the synthetic trypanosomal Goodwin oscillator.
7.1 Preliminary investigation of the stable Goodwin oscillator
Prior to the imaging of transfected T. brucei clones, characterisation was carried out to analyse
function of the main components of the pStable plasmid. An overview of these studies can be
found in Table 7.1. Analysis was mainly carried out on BSF T. brucei bearing the pStable network.
Results are assumed to hold for PCF clones since the pStable GRN does not use mechanisms
Figure 7.1: Diagram showing the stable Goodwin oscillator, pStable. The main components within
the network are the PRRNA and PEp1 promoters, the tetR cassette, the Ub-L-eGFP fusion gene, the
tetracycline operator Tet Op; the 5’ and 3’ UTRs for both tetR and Ub-L-eGFP; the Hygromycin
(Hyg) and Ampicillin (Amp) selectable markers and the rRNA gene targeting fragment having the
NotI restriction site.
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Assay Section
1 Establish whether the pStable plasmid inhibits trypanosomal
cell growth
Section 7.1.1
2 Establish the minimum tetracycline induction threshold for
pStable
Section 7.1.2
3 Establish functional activity of TetR regulator Section 7.1.3
4 Determine the half-life of the TetR and eGFP protein and deter-
mine whether Ub-L-eGFP moiety leads to destabilised eGFP
protein
Section 7.1.4
Table 7.1: List of preliminary characterisation assays carried out to investigate function of the
main components of the pStable oscillator network in transfected T. brucei.
which are dependent on the form (BSF or PCF) of the trypanosome.
7.1.1 The growth profile of T. brucei transfected with the Goodwin oscilla-
tor
The first study was a growth assay to determine whether trypanosomes transfected with pStable
have stunted growth when compared to wildtype T. brucei. The assay was carried out as per
Section 6.1.1, using wildtype T. brucei as a control. The experiment was carried out in duplicates
and the growth profile represented in both the saw-tooth and cumulative growth curve format.
7.1.1.1 Growth profile of BSF T. brucei cells bearing the stable Goodwin oscillator
Following a 72-hour growth profiling, the saw-tooth growth curve (Figure 7.2a) shows no distinct
patterns for the growth rate of the three different BSF tracks (uninduced pStable-transfected clone,
induced pStable-transfected clone, control wildtype). However, a significant amount of variety is
observed between the duplicate counts within each track with the standard deviation being as
large as 44% of the mean cell count (see the 72 hour count, uninduced cell line). The estimated
cumulative growth curves (Figure 7.2b) and cell doubling time estimates (Figure 7.2c) of the mean
values of the three tracks also indicate undistinctive growth patterns.
7.1.1.1.1 Use of Mann-Whitney statistical analysis for comparison of growth rate data.
In order to test whether these observations hold under mathematical scrutiny, the Mann-Whitney
U test was used to compare the wildtype growth patterns to growth patterns of induced/unin-
duced pStable-transfected trypanosomes. The test was previously described and used in Section
6.1.1.1.1 for the analysis of growth rates of T. brucei cells having the unstable Goodwin oscillator
cassette. The Mann-Whitney test serves to check whether the similarity, or lack thereof, of median
growth rates of transfected and non-transfected cells hold under statistical scrutiny. The following
tests were carried out:
Test 1
H0: The difference in median between the cumulative growth of BSF wildtype cells
and uninduced BSF cells transfected with pStable is zero
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(a) Saw-tooth growth rate profile of BSF T. brucei
(b) Cumulative growth rate profile of BSF T. brucei. x is the time in hours.
Strain Cell doubling
time Exponential fitted curve
Wildtype BSF 9.90 hrs y = 125471.e0.07t
Uninduced, transfected BSF 9.12 hrs y = 100071.e0.076t
Induced, transfected BSF 8.77 hrs y = 103008.e0.079t
(c) Cell doubling time of BSF T. brucei: Estimated cell doubling times and exponential fitted growth
curve functions, where t is the time in hours, for BSF wildtype and pStable-transfected T. brucei.
Figure 7.2: Growth rate profiles and doubling times of induced/uninduced BSF T. brucei bearing
pStable represented by a: a) saw-tooth curve profile, b) semi-logarithmic cumulative growth pro-
file, c) doubling times and fitted exponential curves based on cumulative growth data. The axes
show Density in cells/ml versus Time in hours. Error bars represent standard deviation.
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Test 1:
Comparing the cumulative growth of BSF wildtype cells with that of
uninduced BSF T. brucei transfected with pStable
Data Wildtype (Cells/ml) Uninduced, pStable clone (Cells/ml)
1×105 1×105
1.015×106 6×105
3.654×106 3.99×106
2.192×107 2.254×107
1.040×108 (Estimated) 1.475×108(Estimated)
U statistic 11.5
H0 rejected No
Test 2:
Comparing the cumulative growth of BSF wildtype cells with that of
induced BSF T. brucei transfected with pStable
Data Wildtype (Cells/ml) Induced, pStable clone (Cells/ml)
1×105 1×105
1.015×106 6.65×105
3.654×106 3.39×106
2.192×107 1.78×107
1.040×108 (Estimated) 2.026×108(Estimated)
U statistic 11.5
H0 rejected No
Table 7.2: Comparison of growth rates of BSF T. brucei cells bearing the uninduced/induced stable
Goodwin oscillator expression cassette and unmodified wildtype cells via the Mann-Whitney U
test, which tests whether cumulative growth rates for transfected cells are significantly different
from wildtype BSF cells. The table shows the experiment and estimated data points of the cell
counts in Cells/ml which were used for the analysis to calculate the U statistic. This is compared to
Ucrit at the 0.05% confidence level which has value 2. The table also prints the outcome whether
to reject the Null hypothesis, H0.
H1: The difference in median between the cumulative growth of BSF wildtype cells
and uninduced BSF cells transfected with pStable is not zero
Test 2
H0: The difference in median between the cumulative growth of BSF wildtype cells
and induced BSF cells transfected with pStable is zero
H1: The difference in median between the cumulative growth of BSF wildtype cells
and induced BSF cells transfected with pStable is not zero
In order to implement the Mann-Whitney test, five data points per population were required. Thus,
an additional data point was inferred using the exponential fitted curve to estimate cell growth at
the 96th hour, as seen in Table 7.2 which also shows the test outcome. In both cases, the U
statistic is larger than the critical U value. Hence, there is not enough evidence to reject the null
hypothesis (H0) that the difference between wildtype and pStable transfected cells is zero.
The doubling time of the wildtype BSF trypanosomes was estimated to be 9.90 hours in this assay
and 7.53 hours in the previous growth assay for BSF T. brucei bearing the pUnstable oscillator
(Section 6.1.1.1). In both studies, the same methods and wildtype strains were used. This is
indicative of cell-cell variability (Snijder & Pelkmans, 2011).
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7.1.1.2 Growth profile of PCF T. brucei cells bearing the stable Goodwin oscillator
A similar study to the above was carried out on PCF T. brucei to determine a growth profile for
induced and uninduced pStable-transfected PCF clones. Results for the saw tooth and cumulative
growth curve can be seen in Figures 7.3a and 7.3b, both of which indicate that uninduced trans-
fected cells have a higher growth rate than the other tracks. This is also reflected in the estimated
doubling times (Figure 7.3c). In order to analyse whether this divergence is statistically signifi-
cant, the Mann-Whitney U test was applied to the PCF cumulative data set to analyse statistically
whether the median growth rate of PCF wildtype cells differs significantly from the median growth
of induced and uninduced transfected PCF cells, as per the following hypothesis:
Test 3
H0: The difference in median between the cumulative growth of wildtype PCF cells
and uninduced PCF cells transfected with pStable is zero
H1: The difference in median between the cumulative growth of wildtype PCF cells
and uninduced PCF cells transfected with pStable is not zero
Test 4
H0: The difference in median between the cumulative growth of PCF wildtype cells
and induced PCF cells transfected with pStable is zero
H1: The difference in median between the cumulative growth of PCF wildtype cells
and induced PCF cells transfected with pStable is not zero
Experimental and inferred values used and test results for the U statistic can be found in Table
7.3. As with the above BSF results, the U statistic for both tests is larger than the critical U statis-
tic, Ucrit=2. Thus, both induced and uninduced transfected PCF cumulative growth profiles do
not differ significantly from the wildtype PCF cumulative growth rate, indicating that the observed
difference in PCF growth rates was due to outliers.
7.1.2 The minimum tetracycline induction concentration, tcthres, required
to induce pStable in T. brucei cells
Following transfection, pStable-transfected BSF and PCF clones were shown to be inducible using
1µg/ml tetracycline (Figures 4.22a and 4.23a). In this assay, the minimum tetracycline concentra-
tion, tcthres, which induces pStable was established for use during microscopy imaging of pStable
(and pUnstable) clones, as discussed in further detail in Section 6.2.2 and 7.3.
Initially, four flasks of pStable-transfected BSF T. brucei were diluted to 1×105cells/ml in HMI-9
media. Each volume was induced with 0-1µg/ml tetracycline and incubated for 24 hours, after
which protein was isolated. Samples were analysed via a western blot detecting for the eGFP
signal and a corresponding coomassie stain, as seen in Figure 7.4. eGFP signal is detected
when the culture is induced with 2.5ng/ml tetracycline or higher. The antibody flagged up both a
∼27kDa band corresponding to the eGFP signal and an unknown ∼37kDa band. This band was
not noted in other blots.
In order to confirm results, a second titration assay was carried out wherein the eGFP signal was
analysed in vivo via fluorescent microscopy instead of western blots. This also served to investi-
193
(a) Saw-tooth growth rate profile of PCF T. brucei
(b) Cumulative growth rate profile of PCF T. brucei. x is the time in hours.
Strain Cell doubling
time Exponential fitted curve
Wildtype PCF 15.00 hrs y = 1804827.e0.0462t
Uninduced, transfected PCF 10.66 hrs y = 1601671.e0.065t
Induced, transfected PCF 14.44 hrs y = 1937994.e0.048t
(c) Cell doubling time of PCF T. brucei: Estimated cell doubling times and exponential growth rates,
where t is the time in hours, for wildtype and pStable-transfected PCF T. brucei.
Figure 7.3: Growth rate profiles and doubling times of induced/uninduced PCF T. brucei bearing
pStable represented by a: a) saw-tooth curve profile, b) semi-logarithmic cumulative growth pro-
file, c) doubling times and fitted exponential curves based on cumulative growth data. Induced
cells were treated with 1µg/ml tetracycline. The plot axes show Density in cells/ml versus Time in
hours. Error bars represent standard deviation. The experiment was carried out in duplicates.
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Test 3
Comparing the cumulative growth of PCF wildtype cells with that of
uninduced PCF transfected with pStable
Data Wildtype (Cells/ml) Uninduced, transfected (Cells/ml)
2×106 2×106
4.25×106 6.23×106
2.02×107 3.46×107
4.79×107 2.57×108
1.49×108 (Estimated) 8.21×108(Estimated)
U statistic 9.5
H0 rejected No
Test 4
Comparing the cumulative growth of PCF wildtype cells with that of
induced PCF transfected with pStable
Data Wildtype (Cells/ml) Induced, transfected (Cells/ml)
2×106 2×106
4.25×106 5.75×106
2.02×107 1.52×107
4.79×107 4.91×107
1.49×108 (Estimated) 1.94×108(Estimated)
U statistic 11.5
H0 rejected No
Table 7.3: Comparison of growth rates of PCF T. brucei cells bearing the uninduced/induced
stable Goodwin oscillator expression cassette and unmodified wildtype cells via the Mann-Whitney
U test, which tests whether cumulative growth rates for transfected cells are significantly different
from wildtype PCF cells. The table shows the experiment and estimated data points of the cell
counts in Cells/ml which were used for the analysis to calculate the U statistic. This is compared to
Ucrit at the 0.05% confidence level which has value 2. The table also prints the outcome whether
to reject the Null hypothesis, H0.
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(a) Western Blot (b) Coomassie Stain
(c) Densitometry Plot
Figure 7.4: Titration assay carried out to deduce the tetracycline induction threshold, tcthres, of
the pStable network. Analysis was carried out via a) western blot detecting for the eGFP signal
and b) corresponding coomassie stain of a pStable-transfected BSF clone induced with different
levels of tetracycline in the 0-1µg/ml range. c) shows a densitometry plot quantifying the amount
of eGFP detected in the western blot using the positive control as a reference point of intensity
1.0. The positive control shows protein from the constitutively expressed pConstitutive network.
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(a) Cells induced with 2.5ng/ml tetracycline. (b) Cells induced with 2ng/ml tetracycline.
(c) Cells induced with 1.5ng/ml tetracycline. (d) Cells induced with 1ng/ml tetracycline.
Figure 7.5: Second titration assay carried out to deduce the tetracycline induction threshold,
tcthres, for pStable. Analysis is carried out via live cell imaging of a pStable-transfected BSF clone
induced with a) 2.5ng/ml b) 2ng/ml c) 1.5ng/ml d) 1ng/ml of tetracycline. Each image shows
brightfield (left) and fluorescent (right) images of the same plane using a 40X objective. Scale bar
= 50µm.
gate whether the 37kDa band observed in the western blot was due to contamination. Similarly
to the previous titration assay, cells were induced with 1-2.5ng/ml of tetracycline and incubated
for 24 hours. Following this, cells were embedded in 40% Cygel as per Section 5.7. Fluorescent
microscopy was carried out using a 40X objective. In parallel, brightfield microscopy using a 40X
objective was used as a control measure to verify that observed fluorescence is being emitted
from cells rather than debris. Microscopy results in Figure 7.5 show that whereas induction us-
ing 1ng/ml tetracycline gave no detectable signal when the eGFP protein was selected for on a
western blot (Figure 7.4), microscopy images showed cells induced with 1ng/ml to be fluoresc-
ing. This is due to microscopy fluorescence detection being more sensitive than western blotting.
Thus, further microscopy-based analysis using lower tetracycline concentrations was carried out
in order to deduce the tetracycline induction threshold, tcthres.
For the third titration assay, a similar process as above was implemented, inducing pStable-
transfected BSF cells with 1fg/ml-750pg/ml tetracycline. Results of brightfield and fluorescent
imaging (not presented) show that cell populations induced with over 10fg/ml tetracycline fluo-
resce, indicating an excess of tetracycline molecules relative to TetR protein numbers. However,
in populations induced with 10fg/ml of tetracycline only a margin of the cells fluoresce, with other
cells remaining uninduced.
This is attributed to intracellular stochasticity and in particular, the dispersion of tetracycline among
the population. Specifically, in some cells there are more tetracycline molecules than TetR pro-
teins, resulting in (temporary) observed fluorescence due to (temporary) constitutive expression.
This occurs because TetR proteins bind to the excess tetracycline molecules instead of the tet
operator, since they have a greater affinity for the former. This allows for protein expression. This
continues until the number of TetR proteins exceeds the intracellular tetracycline molecules, at
which stage the TetR protein binds to the tet operator and TetR inhibition takes place, as ex-
plained previously in Figure 6.7. In the remainder of the cells there is an excess of TetR proteins
rather than tetracycline molecules, resulting in no modified expression patterns and no fluores-
cence observed. In both cases, oscillatory protein production in the pStable network can still take
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place. Following these findings, the threshold induction tcthres is taken to be 10fg/ml.
7.1.3 Functional activity of the TetR regulator - Expression dynamics of
the stable Goodwin oscillator expression cassette in T. brucei cells
following tetracycline addition and removal
The next step was to establish the length of time over which tetracycline remains effective as an
inducer for pStable. This in turn serves to inform whether protein expression inhibition in the GRN
is regulated by TetR or otherwise, since protein expression should be suspended as the tetracy-
cline molecules degrade and TetR binds to the operator instead. pStable-transfected BSF clone
were induced with 1µg/ml tetracycline, incubated for 24 hours and harvested in order to remove
extracellular tetracycline molecules. Following this, protein samples were prepared at 0hr, 1hr,
3hr, 6hr, 24hr, 48hr and 72hr time-points.
Samples were analysed via a western blot detecting for the eGFP signal and corresponding
coomassie stain, as seen in Figure 7.6. Following removal of tetracycline, the eGFP signal re-
tains strength as a result of intracellular tetracycline for over 6 hours. After a 24 hour period, only
residual levels of the eGFP signal remain. After 72 hours, no eGFP was detected. The coomassie
stain confirms that protein samples were prepared correctly. Therefore, this assay has shown that
the effect of tetracycline on pStable can be reversed after a 24-hour period. Moreover, expression
patterns are in line with TetR inhibitory regulation, serving to confirm the functional activity of the
TetR regulator.
7.1.4 Half-life of TetR and the destabilised eGFP protein in T. brucei cells
having the stable Goodwin oscillator
For the final characterisation on pStable components, the half-life of TetR and eGFP proteins was
deduced in order to plug the data into mathematical modelling to develop a hypothetical profile for
the plasmid phenotype via simulations. In addition, knowledge of the eGFP half-life will help in-
form whether the protein is sufficiently destabilised as to exhibit oscillations due to TetR inhibition
or whether it is too stable to reflect regulatory influence within the network. This is similar in scope
of the cycloheximide-based assay carried out on pUnstable. The change in protein quantity over
a six hour period following cycloheximide addition was recorded via a western blot detecting for
the appropriate protein and a corresponding coomassie stain.
7.1.4.1 Half-life of the TetR protein in T. brucei cells bearing the stable Goodwin oscillator
For the detection of the TetR protein, both antibodies used (Anti-Tet Repressor Antibody (EMD
Millipore Co., MA, U.S.A) and Anti-Tet Repressor Antibody (Sigma-Aldrich, Munich, Germany))
gave inconclusive results (not shown) when samples were run on a western blot. No bands were
detected in spite of multiple runs of the experiment. The coomassie stain showed strong uniform
bands throughout, indicating that protein was prepared correctly. For mathematical modelling,
literature sources were referred to for an estimate of the TetR half-life, as will be discussed in
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(a) Western Blot (b) Coomassie Stain
(c) Densitometry Plot
Figure 7.6: eGFP expression levels over a 72-hour period of BSF T. brucei bearing pStable fol-
lowing 1µg/ml tetracycline induction and removal. Analysis is carried out via a a) western blot
detecting for the eGFP signal, b) corresponding coomassie stain and c) densitometry plot quan-
tifying the amount of eGFP protein detected in the western blot using the positive control as a
reference point of intensity 1.0. The positive control is a pConstitutive protein sample, while the
negative control is an uninduced pStable protein sample.
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Section 7.2.
7.1.4.2 Half-life of the destabilised eGFP protein in T. brucei cells bearing the stable Good-
win oscillator
In order to assess whether Ub-L was exerting a destabilising influence over the eGFP protein, an
assay was carried out to deduce the half-life of the reporter protein being expressed in pStable,
as per previous studies. Then, by comparing results to the half-life of a control plasmid which
has the non-destabilised eGFP protein, a deduction could be made as to whether Ub-L was be-
ing effective in pStable. As a control plasmid having the (non-destabilised) eGFP gene, a BSF
2T1 cell line (VSG221 expressing Tagged cell line, clone 1) was used (Alsford et al., 2005). This
comparative analysis was only carried out with the pStable network, rather than both Goodwin os-
cillators, because basal transcription within pUnstable makes for a less straightforward distinction.
Figure 7.7 shows western blot results detecting for the eGFP protein in pStable protein samples.
The protein half-life of eGFP is deduced to be between three and six hours. The corresponding
Coomassie stain confirms that the reduction in signal strength is a result of decrease in protein
quantity, rather than incorrect sample preparation. Additionally, eGFP signals of untreated protein
samples (Figures 7.7b and 7.7d) do not show a reduction in signal strength over the six-hour
timespan, indicating that the weakening signal observed in treated samples is a result of cyclo-
heximide having an effect on the cell culture, rather than a process which occurs independently.
eGFP band sizes, at c. 27kDa, indicate that the Ub-L-eGFP moiety is being cleaved in vivo as
expected, as otherwise the signal would have a size of c. 38kDa (Dantuma et al., 2000).
The next step was to analyse whether the half-life of the reporter protein in pStable was different
from that of non-destabilised eGFP expressed in the control 2T1 T. brucei. Results for the assay
carried out on the 2T1 strain are found in Figure 7.8. In clear contrast to the eGFP signal within the
cycloheximide-treated protein sample isolated from pStable-transfected BSF T. brucei, the non-
destabilised eGFP signal in cycloheximide-treated 2T1 cells retains a strong band throughout
the six hour observation period (Figure 7.8a). The corresponding coomassie stain (Figure 7.8c)
shows that protein was prepared correctly. The blank assay (Figure 7.8b and 7.8d), wherein no
cycloheximide was added to the induced 2T1 culture shows no clear difference in signal strength.
Therefore, it is unclear whether observations are a result of the cycloheximide not having an effect
in this assay run or whether they are a result of the eGFP being stable for over 24 hours, as is
expected (Corish & Tyler-Smith, 1999).
In order to control for this, a final assay was carried out wherein pStable-transfected and 2T1
BSF T. brucei were treated with cycloheximide simultaneously rather than in different runs, after
which protein was isolated at one hour, three hours and six hours post treatment and run on a
western blot to detect for the eGFP protein. Results in Figure 7.9 show a clear difference over
time between the eGFP signal strength of the cycloheximide-treated 2T1 cell line and the eGFP
signal strength of cycloheximide-treated pStable-transfected BSF clone. This indicates that the
Ub-L gene is exerting an influence in the Ub-L-eGFP moiety, reducing the half-life of eGFP from
its stable 24 hour half-life to 3-6 hours. This is in line with observations made when Ub-L was
fused to β-gal in reticulocytes red blood cells, wherein β-gal half-life was reduced to 5.5 hours,
as per the N-end rule (Gonda et al., 1989). The next step was to plug this data into a modelling
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(a) Western blot detecting for eGFP in protein samples
from induced pStable-transfected BSF T. brucei treated
with cycloheximide
(b) Control: Western blot detecting for eGFP in protein
samples from induced pStable-transfected BSF T. brucei
not treated with cycloheximide
(c) Coomassie stain for protein samples from in-
duced pStable-transfected BSF T. brucei treated
with cycloheximide
(d) Control: Coomassie stain for protein samples from
induced pStable-transfected BSF T. brucei not treated
with cycloheximide
(e) Densitometry plot showing the signal intensity extracted from the western blots
above of eGFP protein from pStable-transfected cells either treated or untreated with
cycloheximide.
Figure 7.7: Deducing the half-life of the destabilised eGFP protein in BSF T. brucei bearing
pStable and induced with 1µg/ml tetracycline. Protein samples were prepared at specific time-
points following cycloheximide addition and then analysed via western blot (a) detecting for eGFP
and a corresponding coomassie stain (c). In parallel, a control assay (b, d) was carried out
wherein no cycloheximide was added to the culture. e) shows a densitometry plot quantifying the
amount of eGFP in both treated and untreated pStable-transfected cells detected in the western
blots. The plot uses the eGFP intensity from the measurement taken prior to the addition of the
cycloheximide or blank (‘pre’) as value 1.0.
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(a) Western blot detecting for eGFP in protein isolated
from 2T1 BSF T. brucei treated with cycloheximide
(b) Control: Western blot detecting for eGFP in protein
isolated from 2T1 BSF T. brucei not treated with cyclo-
heximide
(c) Coomassie stain for protein isolated from 2T1 BSF
T. brucei treated with cycloheximide
(d) Control: Coomassie stain for protein isolated from
2T1 BSF T. brucei not treated with cycloheximide
(e) Densitometry plot showing the signal intensity extracted from the western blots
above of eGFP protein isolated from 2T1 BSF cells either treated or untreated with
cycloheximide.
Figure 7.8: Deducing the half-life of the non-destabilised eGFP protein in 2T1 BSF T. brucei.
Protein samples were prepared at specific time-points following cycloheximide addition and then
analysed via western blot (a) detecting for eGFP and a corresponding coomassie stain (c). In
parallel, a control assay (b, d) was carried out wherein no cycloheximide was added to the culture.
e) shows a densitometry plot quantifying the amount of eGFP in both treated and untreated 2T1
BSF clones detected in the western blots. The plot uses the eGFP intensity from the measurement
taken prior to the addition of the cycloheximide or blank (‘pre’) as value 1.0.
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(a) Western blot
(b) Densitometry plot
Figure 7.9: Comparing the half-life of non-destabilised and destabilised eGFP proteins in induced
control 2T1 and pStable-transfected BSF clones respectively, via: a) protein samples which were
prepared at specific time-points following cycloheximide addition and then analysed via western
blot, b) densitometry plot quantifying the detected eGFP in the western blot. The plot uses the
reading at time 0 of the non-destabilised eGFP as a reference point of value 1.0. The positive
control is a sample from the constitutively expressed pConstitutive plasmid.
frame and assess whether the protein is sufficiently destabilised as to reflect expression patterns,
as will be seen next.
7.1.5 Evaluation of the stable oscillator phenotype following preliminary
analysis
Following characterisation and parameterisation of the pStable oscillator components and its phe-
notype within the T. brucei host, the following findings and observations were made:
1. Preliminary characterisation of the pStable oscillator via western blots and coomassie stains
has shown that the main components of the network are functional and that TetR and eGFP
protein is successfully synthesised. Promoters successfully initiate transcription: detected
eGFP levels indicate that the PRRNA promoter is functional while transfectant clones cultured
in the presence of Hygromycin indicate that the PEP1 promoter is also working.
2. No eGFP signal was detected unless the pStable-transfected T. brucei culture was induced
with tetracycline. Moreover, once induced with 1µg/ml tetracycline, a strong eGFP signal
was detected for over 6 hours, after which there was a decrease in signal strength and a
resuming of expression inhibition. This indicates that TetR regulation is being implemented
and that the tetracycline operator is functional. This is similar to findings for the pUnstable
Goodwin oscillator.
3. The tetracycline induction threshold, tcthres, for pStable-transfected BSF T. brucei at a con-
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centration of 1×106cells/ml is over 10fg/ml. In cultures induced with 10fg/ml of tetracycline
only a margin of the cells fluoresce. This phenomenon allows for the tuning of expression
dynamics and was used during fluorescent microscopy.
4. There is no statistically significant difference between growth rates of wildtype cells and
pStable-transfected BSF and PCF T. brucei. This is similar to findings for T. brucei bearing
the pUnstable Goodwin oscillator.
5. The half-life of the destabilised eGFP protein is 3-6 hours, a much lower value than the
standard 24 hour half-life. This implies that the Ub-L gene fused to eGFP is flagging up
the protein for degradation. This information will be plugged into mathematical modelling to
simulate a profile for protein expression dynamics.
6. In conclusion, the components of the pStable GRN allow for oscillations to take place. Since
the cell population is unlikely to oscillate in synchrony (Elowitz & Leibler, 2000; Stricker et
al., 2008; Danino et al., 2010; Tigges et al., 2010) and since western blots have limited
sensitivity, oscillations are unlikely to be detected via protein sample analysis. Therefore
fluorescent microscopy imaging was carried out in order to observe fluorescent patterns.
7.2 Preliminary quantitative mathematical modelling and anal-
ysis of protein expression dynamics within the trypanoso-
mal Goodwin oscillator
Preliminary quantitative mathematical modelling was carried out to develop a mathematical model
of the trypanosomal Goodwin oscillator and run simulations to inform whether the network is likely
to function as an oscillator within its T. brucei host. This is the first mathematical model of a
synthetic GRN which has been developed for use within a trypanosomal platform. Previous math-
ematical analysis on T. brucei has focused on the epidemiological aspect, with studies modelling
existing pathways within T. brucei (Kerkhoven et al., 2013; Verlinde et al., 2001; Gu et al., 2013),
disease patterns (Medlock et al., 2013) and the modelling of T. brucei within a systems biology
context (Bakker et al., 2010).
The following analysis uses half-life data based on preliminary analysis of the pStable Goodwin
oscillator but does not exclude results from applying to the pUnstable network, as will be explained
further on.
7.2.1 Screening of the Goodwin oscillator’s parameter space using Gille-
spie stochastic simulations
The Goodwin oscillator was represented mathematically in terms of molecular components/species
and related biochemical reactions (Monod, 1971). The main species of interest are TetR and
eGFP protein. The model (i.e. set of species and reactions) was used to map out how TetR
and eGFP protein quantities vary over time due to the interplay of biochemical reactions, such
as transcription and degradation, which occur to and between the network components, such as
the tet operator and TetR protein. The set of components which were modelled was kept fixed
throughout the modelling process. On the other hand, reaction rates were treated as variable
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parameters (Stricker et al., 2008; Fung et al., 2005; Danino et al., 2010).
A screening assay was developed in order to deduce the parameter values which lead to peri-
odic TetR and eGFP protein expression dynamics. This is also known as parameter analysis.
By assuming that the selected set of species and biochemical reactions are representative of the
species and reactions which lead to oscillations, reaction rate parameters were varied across a
wide range of values to vet which parameter combinations, if any, led to oscillations. Thus, the
investigation consisted of multiple iterations wherein a combination of parameters was randomly
selected and input into Gillespie simulations to generate a time series of the species’ quantities
via the ABC Sysbio software. This is a Python based software which implements Bayesian pa-
rameter inference, model selection and stochastic and deterministic simulations within dynamical
systems including GRNs (Liepe et al., 2014; Filippi et al., 2013; Barnes et al., 2011b, 2011a).
In each iteration of the screening assay, each reaction rate value was selected from a uniformly
distributed range of values based on information extracted from experiments or literature sources.
T. brucei-specific data was not available in the literature available. Thus, generic uniform distribu-
tions with a wide range of values were set for each parameter, as explained further below. Once
parameters were selected, the Direct Method Gillespie algorithm (Gillespie, 1977) was imple-
mented. The Gillespie algorithm is a stochastic simulation algorithm (SSA) which uses probability
measures to map out changes in species molecule numbers due to the biochemical reactions
which occur over time. The SSA is simple in principle and has been used in various synthetic biol-
ogy settings (Elowitz & Leibler, 2000; Stricker et al., 2008). Although there are several variations
of the Gillespie algorithm which have been developed, the original SSA could be used to address
the scope of this study. Following iterations, the parameter combinations, if any, which led to an
oscillatory output for the TetR and eGFP proteins were selected.
By using the Gillespie SSA which bases the decision of when and which biochemical reaction
next takes place on a probability measure, the screening assay introduced an element of random-
ness, reflecting the stochastic nature of the biological setting. This was considered to be more
representative of the GRN than deterministic modelling, which can be considered as an average
representation of stochastic trajectories (Kepler & Elston, 2001) and which has been shown to
differ from stochastic simulations outside the thermodynamic limit (Stricker et al., 2008; Elowitz &
Leibler, 2000), which conditions are not satisfied in this case (Gillespie, 1976).
7.2.1.1 Development of the mathematical model representing protein expression dynam-
ics within the trypanosomal Goodwin oscillator
The first step was to translate the pStable Goodwin network into mathematical modules, specif-
ically, into a set of species and reactions. The model is based on the theory that the quantity of
each species within the GRN is in constant flux due to the multiple ongoing biochemical reac-
tions and processes within the network (Monod, 1971). Although the aim is to map out protein
trajectories for TetR and eGFP, several other components involved in protein synthesis have to
be considered. The species which were modelled are listed in Table 7.4. While the selected
components are not an exhaustive list of the components within pStable and pUnstable, they are
representative of the species involved in the generation of TetR and eGFP oscillations. Note that,
for example, the Myc gene in pUnstable was not modelled explicitly since it does not impact TetR
and eGFP dynamics but only serves characterisation purposes.
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Species Description
1 mRNATetR The product of tetR gene transcription
2 TetR The product of mRNATetR translation
3 TetR2 TetR dimer
4 Op The tet operator
5 TetR2.Op The complex formed when TetR2 is bound to Op
6 mRNAeGFP The product of eGFP gene transcription
7 eGFP The product of mRNAeGFP translation
Table 7.4: The species/components from the plasmid encoding for the Goodwin oscillator which
were selected for preliminary quantitative modelling and trajectory simulations.
In order to represent interactions between the TetR-associated species (Species 1-5 in Table 7.4),
biochemical reactions R1-R10 listed in Table 7.5 were selected for modelling. The reaction rate
parameters are as described per Table 7.6 which also lists the parameters’ range of uniformly
distributed values. In the model, the low binding rate of TetR to the operator in pUnstable is not
modelled explicitly and is instead modelled implicitly in the low binding rates.
The rates are primarily based on values extracted from Tigges et al. (2010), wherein the authors
developed a multi-component system based on positive and inhibitory regulation within a eukary-
otic chassis. The rate of transcription is based on data from Stricker et al. (2008). Although
detailed data of TetR systems within prokaryotic chassis is more readily available (Biliouris et al.,
2011), it is likely to be less relevant than eukaryote-based data.
As with the set of species, the list of reactions is a representative but not exhaustive list of bio-
chemical processes within the GRN. Figures 7.10a and 7.10b represent how the selected TetR
species interact with each other as per reactions R1-R10 listed in Table 7.5.
The same process as for the TetR family of components was carried out for eGFP-related species
(Op, mRNAeGFP and eGFP). The set of reactions R11-R14 modelled for the eGFP components are
listed in Table 7.5, while the corresponding reaction rates are as per Table 7.6. The degradation
rate of eGFP was determined experimentally and is set at 0.004min-1. (Section 7.1.4). Although
this data is based on pStable analysis, results are applicable to the pUnstable network as well.
Figure 7.10c represents how the selected eGFP species interact with each other as per reactions
R11-R14.
7.2.1.2 Differential equation representation of the mathematical model
Prior to Gillespie simulations, the set of species and reactions were assembled to develop a set
of ordinary differential equations (ODEs) which represent how each species evolves over time
due to the interplay of the biochemical reactions which are being modelled. This set of ODEs was
then coded in Systems Biology Markup Language (SBML) as per requirements of the ABC-Sysbio
program running Gillespie simulations. The set of ODEs is a deterministic representation of the
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Reaction aaaDescription
R1aaa ∅ k1−→a mRNAtetR aaaTranscription
R2 mRNAtetR
k2−→amRNAtetR + TetR aaaTranslation
R3 TetR+ TetR
k3−→a TetR2 aaaDimerisation
R4 TetR2
k4−→a TetR+ TetR aaaDissocation
R5 Op+ TetR2
o1−→a Op.TetR2 aaaBinding
R6 Op.TetR2
o2−→a Op+ TetR2 aaaUnbinding
R7 mRNAtetR
d1−→a ∅ aaaDegradation
R8 TetR
d2−→a ∅ aaaDegradation
R9 TetR2
d3−→a ∅ aaaDegradation
R10 Op.TetR
d4−→a Op aaaDegradation
R11 ∅ k1−→a mRNAeGFP aaaTranscription
R12 mRNAeGFP
k2−→a mRNAeGFP + eGFP aaaTranslation
R13 mRNAeGFP
d1−→a ∅ aaaDegradation
R14 eGFP
d5−→a ∅ aaaDegradation
Table 7.5: The biochemical reactions selected for quantitative modelling of network dynamics.
The species are as described in Table 7.4, while the parameter reaction rates ki, oi and di are as
described in Table 7.6.
Rate Description Distribution
k1 Rate of transcription of tetR and eGFP genes U(0.18mol.min-1, 0.54mol.min-1)
k2 Rate of translation of mRNAtetR & mRNAeGFP U(0.01min-1, 0.03min-1)
k3 Rate of dimerisation of TetR U(0.007mol-1.min-1, 0.02mol-1.min-1)
k4 Rate of dissociation of TetR2 U(0.0005min-1, 0.0015min-1)
o1 Binding rate of TetR2 to Op U(0.009mol-1.min-1, 0.027mol-1.min-1)
o2 Unbinding rate of TetR2 from Op U(0.00005min-1, 0.00015min-1)
d1 Degradation rate of mRNAtetR and mRNAeGFP U(0.008min-1, 0.026min-1)
d2 Degradation rate of TetR U(0.011min-1, 0.035min-1)
d3 Degradation rate of TetR2 U(0.011min-1, 0.035min-1)
d4 Degradation rate of TetR2 when bound to Op U(0.011min-1, 0.035min-1)
d5 Degradation rate of eGFP 0.004min-1
Table 7.6: The biochemical reaction rate parameters and their distributions, used in the modelling
of the TetR and eGFP family of components within the trypanosomal Goodwin oscillator mathe-
matical model. The rates are used as described in Table 7.5 and are based on values extracted
from Tigges et al. (2010). ‘mol’ stands for molecules.
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(a) Diagram showing the components and biochemical rates in the math model which correspond to interactions between
the TetR components when TetR2 is not bound to Op.
(b) Diagram showing the components and biochemical rates in the math model which correspond to interactions between
the TetR components when TetR2 is bound to Op. No transcription takes place during this stage.
(c) Diagram showing the components and biochemical rates in the math model which correspond to interactions between
the eGFP components when TetR2 is not bound to Op. If TetR2 is bound to Op, only eGFP and mRNAeGFP degradation
reactions take place.
Figure 7.10: Diagram showing set of mathematically modelled components and biochemical re-
actions corresponding to: a) interactions between TetR2 components when TetR2 is not bound to
Op, b) interactions between TetR2 components when TetR2 is bound to Op and c) interactions be-
tween eGFP components when TetR2 is not bound to Op. The DNA species within the Goodwin
oscillator which are modelled are mRNATetR, TetR, TetR2, Op, TetR2.Op, mRNAeGFP and eGFP.
The tetR and eGFP genes are represented in the diagram but are not modelled explicitly in the
model. k1 represents the rate of transcription, k2 is the rate of translation, k3 is the dimerisation
rate, k4 is the rate of dissociation, o1 represents the binding rate of TetR2 to Op, o2 represents the
reverse reaction rate and d1-d5 represent degradation rates.
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model. Stochasticity is then introduced via simulations, effectively transforming the equations into
the more realistic chemical master equation (Gillespie, 1976). Species are represented as [x]:
d[mRNAtetR]
dt
= k1
[Op]
S + [Op]
− d1[mRNAtetR] (7.1)
d[TetR]
dt
= k2[mRNAtetR]− 2k3[TetR] [TetR− 1]
2
+ 2k4[TetR2]− d2[TetR] (7.2)
d[TetR2]
dt
= k3[TetR]
[TetR− 1]
2
− k4[TetR2]− d3[TetR2]− o1[TetR2][Op] + o2[TetR2.Op]
(7.3)
d[Op]
dt
= −o1[TetR2][Op] + o2[TetR2.Op] + d4[TetR2.Op] (7.4)
d[TetR2.Op]
dt
= o1[TetR2][Op]− o2[TetR2.Op]− d4[TetR2.Op] (7.5)
d[mRNAeGFP]
dt
= k1
[Op]
S + [Op]
− d1[mRNAeGFP] (7.6)
d[eGFP ]
dt
= k2[mRNAeGFP]− d5[eGFP ] (7.7)
It can be seen that all reactions except for dimerisation and transcription (seen in (7.1), (7.2), (7.3)
and (7.6))are modelled as mass action laws. Dimerisation takes into account the possible combi-
nations of pairs of TetR which are used for the reaction, as seen in Gillespie (1976). Transcription
is modelled as a Hill function, as seen in Elowitz and Leibler (2000), Fung et al. (2005) and Tigges
et al. (2009) to name but a few. It has general form f =
[X]n
(S)n + [X]n
wherein X is the species of
interest (in this case, Op) and n is the cooperativity coefficient of the species which in this case
has value 1 (Sheinman & Kafri, 2012). This is based on the assumption that there is only one
operator per cell due to the efficiency, or lack thereof, of trypanosome transfection. As discussed
in Chapter 4, 2×107 cells were used per transfection. Of these, an average of 10 were success-
fully transfected and picked as clones i.e. the probability of inserting a single plasmid is 5×10-7.
It follows that the likelihood of a second plasmid being inserted into an already transfected cell
(irrespective of whether they are independent events or not) is lower still. Finally, S is taken to
be the amount of X (Op) which is required to have half of the binding sites occupied. Although
not biologically relevant this was taken to be 0.5. Thus, using this representation, transcription is
allowed only if Op is not bound to a TetR2 molecule, otherwise [Op]=0 and the reaction is shut
down. By relating transcription directly to whether Op is bound or not, rather than the amount of
inhibitive TetR2 molecules available, a direct estimate of ongoing transcription is generated.
7.2.1.3 Assumptions made for the analysis of the stable Goodwin oscillator behaviour in
T. brucei cells
Several assumptions were made during the development of the mathematical model, in addition
to those already listed above. Assumptions serve to simplify the complex biological environment,
since reflecting all biochemical processes within the network would lead to a computationally in-
feasible model. The level of detail is similar to other synthetic biology studies carried out (Fung
et al., 2005; Danino et al., 2010; Tigges et al., 2010). Firstly, gene expression was modelled using
transcription and translation, rather than a set of more complex initiation-elongation-termination
steps. Secondly, time-delay in protein synthesis was not modelled explicitly. Instead, it is in-
herently present in the transcription-translation(-dimerisation) process which results in a delay
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between initiation and finalisation of the protein products. The rate of transcription of tetR and
eGFP genes is assumed to be the same since it is initiated by the same promoter. The rate of
translation for both mRNATetR and mRNAeGFP is also considered equal. The same goes for the
degradation rate of mRNATetR and mRNAeGFP and the degradation of the TetR monomer, TetR
dimer and bound TetR dimer (Stricker et al., 2008; Tigges et al., 2010).
Assumptions made by the Gillespie SSA are as discussed in Gillespie (1976) and Gillespie (1977).
7.2.2 Results and analysis of Gillespie time series simulations to inform
screening analysis of the Goodwin oscillator parameter space
Having developed the mathematical model of the trypanosomal Goodwin oscillator, the next step
was to carry out Gillespie time series simulations for the scope of parameter screening of the
11-dimensional parameter space specified above. The following section presents results from
Gillespie simulations.
7.2.2.1 Time series trajectories of the Goodwin oscillator species
Gillespie time series simulations were set to model component dynamics over a time-span of 1000
minutes. The quantity of each species was recorded at 0.5 minute intervals. 500 simulations were
carried out, implying 500 different parameter combinations were tested based on simple random
sampling. Carrying out an exhaustive scan of the parameter space would have been infeasible
since there are over 4×10100 possible parameter combinations based on the above uniform dis-
tributions and the power of the ABC-Sysbio program. The set of simulations can be considered to
represent a population of 500 cells rather than just one cell sampled for 500 times. A decision was
taken to carry out 500 simulations (as opposed to, for example, 1000 simulations) as a represen-
tative sample of the number of cells which are in the plane of view (average of 393 cells) during
microscopy given that cells are embedded at a concentration of 5×107 cells/ml in 40% Cygel as
per Section 5.7.
Unless otherwise specified, starting molecule numbers were set at 0 for all species except for the
tet operator, Op, which was set at value 1. Figure 7.11 shows the 500 time series trajectories for
mRNATetR, TetR, TetR2, mRNAeGFP and eGFP. The time series trajectories for Op and TetR2.Op
are not presented since they have a digital profile which switches between 0 and 1 which offers
no new information. Since the plots were very dense and difficult to distinguish, 10 simulations
were selected randomly and plotted in Figure 7.12.
The plots show that species are oscillating continually. Op and TetR2.Op (not shown) switch be-
tween on and off states. On average, the tet operator, Op, is bound to a TetR2 molecule, implying
that on average, protein expression within the system is being inhibited. Protein dynamics of the
same species are not synchronised over the different simulations, except for a calibration period
at the beginning of the simulation, as reflected in the average time-series (black band). This was
calculated via MATLAB by averaging the simulated time series data under consideration.
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(a) mRNATetR (b) TetR
(c) TetR2 (d) mRNAeGFP
(e) eGFP
Figure 7.11: Time series trajectories of 500 Gillespie simulations over a time-span of 1000 minutes
for the species: a) mRNATetR, b) TetR, c) TetR2, d) mRNAeGFP and e) eGFP. The axis show
Number of molecules vs Time in minutes. The band in black represents the average number of
species molecules. Starting conditions are set to 0 for all species except Op=1.
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(a) mRNATetR (b) TetR
(c) TetR2 (d) mRNAeGFP
(e) eGFP
Figure 7.12: Time series trajectories of 10 randomly selected Gillespie simulations over a time-
span of 1000 minutes for the species: a) mRNATetR, b) TetR, c) TetR2, d) mRNAeGFP and e)
eGFP. The axis show Number of molecules vs Time in minutes. The band in black represents the
average number of species molecules over time. Starting conditions are set to 0 for all species
except Op=1.
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Figure 7.13: eGFP time series trajectories of 10 randomly selected Gillespie simulations over
a time-span of 1000 minutes. The eGFP degradation rate was set to 0.02min-1 instead of
0.004min-1. The axis show Number of molecules vs Time in minutes. The band in black rep-
resents the average number of species molecules over time. Starting conditions are set to 0 for
all species except Op=1.
The type of fluctuations differ according to species; mRNATetR and mRNAeGFP have similar pro-
files. TetR and TetR2 have a lower amplitude and shorter period than their eGFP counterpart. All
species, except for eGFP have sinusoidal oscillations. eGFP oscillations, on the other hand, are
sinusoidal with an increasing trend as seen in Elowitz and Leibler (2000). The latter is attributed
to the degradation rate of eGFP which does not allow for a sufficiently quick turnover of eGFP
protein for the oscillation to reset itself, but instead builds on previous eGFP levels. In fact, when
simulations were carried out using a higher eGFP degradation rate oscillations have a more uni-
form sinusoidal pattern and lower amplitudes, as seen in Figure 7.13. The plot shows 10 randomly
selected simulations of eGFP quantity profiles, similarly to the above, using a degradation rate of
0.02min-1 instead of the experimentally determined 0.004min-1.
7.2.2.2 Time series trajectories for different starting conditions
500 Gillespie simulations were carried out using different starting conditions, wherein initial quanti-
ties for the mRNATetR, TetR, TetR2, mRNAeGFP and eGFP species was set to 1 (not shown, results
similar to Figure 7.11), 10 (not shown, results similar to Figure 7.11), a random number between
1 and 20 (Figure 7.14) and 50 (Figure 7.15). Throughout, Op was set to 1, while TetR2.Op was
set to 0. Finally, in Figure 7.16, all species were set to 0 except for TetR2.Op which was set to 1.
Each plot shows 10 randomly selected simulations which allow for visual assessment of expres-
sion dynamics of the mRNA and protein components.
Simulated trajectories repeatedly indicate that protein dynamics are independent of initial condi-
tions. Following a brief calibration period, trajectories are similar to those observed in the original
simulations (Figure 7.12). This is a positive result as it indicates that oscillations are likely to occur
irrespective of the initial state of the population of cells.
7.2.2.3 Time series trajectories of TetR and eGFP proteins
The above sections presented results for expression dynamics throughout the device encoding
the Goodwin oscillator. However, interest lay in TetR2 and eGFP protein quantity trajectories.
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(a) mRNATetR (b) TetR
(c) TetR2 (d) mRNAeGFP
(e) eGFP
Figure 7.14: Starting molecule numbers set randomly from 1 to 20 for all species except
Op=1, TetR2.Op=0: Time series trajectories for 50 randomly selected Gillespie simulations over
a time-span of 1000 minutes for the species: a) mRNATetR, b) TetR, c) TetR2, d) mRNAeGFP and
e) eGFP. The axis show Number of molecules vs Time in minutes. The band in black represents
the average number of molecules over time.
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(a) mRNATetR (b) TetR
(c) TetR2 (d) mRNAeGFP
(e) eGFP
Figure 7.15: Starting molecule numbers set to 50 for all species except Op=1, TetR2.Op=0:
Time series trajectories for 10 randomly selected Gillespie simulations over a time-span of 1000
minutes for the species: a) mRNATetR, b) TetR, c) TetR2, d) mRNAeGFP and e) eGFP. The axis show
Number of molecules vs Time in minutes. The band in black represents the average number of
molecules over time.
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(a) mRNATetR (b) TetR
(c) TetR2 (d) mRNAeGFP
(e) eGFP
Figure 7.16: Starting molecule numbers set to 0 for all species except TetR2.Op=1: Time
series trajectories for 10 randomly selected Gillespie simulations over a time-span of 1000 minutes
for the species: a) mRNATetR, b) TetR, c) TetR2, d) mRNAeGFP and e) eGFP. The axis show
Number of molecules vs Time in minutes. The band in black represents the average number of
molecules over time.
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Analysis via MATLAB confirmed that oscillations were present in all 500 simulations of both TetR2
and eGFP protein. Analysis was based on a custom-written algorithm which detected decreas-
ing inclines and troughs within each simulation and flagged up those simulations wherein protein
quantities remained constant or almost constant or were monotonic.
Figures 7.17 and 7.18 show twelve individual randomly selected trajectories from simulations of
the TetR2 and eGFP protein respectively, using different parameters in each case. The individual
trajectories reveal a broad range of oscillation characteristics, such as frequency and amplitude,
with a linear growth trend observed in a proportion of the eGFP trajectories. The source of this
variety and whether it is of a stochastic or deterministic nature is unknown. Moreover, it is unclear
whether the fluctuations themselves are genuine or of a stochastic nature. In order to eliminate
noise sources, the protein trajectories can be simulated using deterministic methods and com-
pared to simulations derived from an SSA.
7.2.2.4 Parameter analysis based on TetR2 dynamics
Given the variety of oscillation characteristics seen in Figure 7.17 and Figure 7.18 for TetR2 and
eGFP protein quantities, analysis was carried out to better understand the source of this variation
and analyse whether specific parameter combinations led to specific characteristics. The maxi-
mum coordinate was selected as the characteristic of interest in order to help inform microscopy
results and observed fluorescence patterns. Note that the maximum coordinate is not equivalent
to the amplitude. A large maximum coordinate can be correlated to observed fluorescence, unlike
the amplitude which does not necessarily have the same correlation due to linear growth trends
which can mask the true amplitude. The maximum coordinate (in terms of protein molecule num-
ber) for each of the 500 trajectories of the TetR2 and eGFP components was recorded and plotted
as a histogram, as seen in Figure 7.19. The plot indicates that the maximum coordinate data can
be fitted to a Poisson distribution, although this was not the scope of the analysis.
Based on the information represented in Figure 7.19, maximum coordinates of TetR2 were divided
into low (proteins<3), medium (3≤proteins<5) and high (5≤proteins) as based on first and third
quartile values. Due to the Poisson distribution of the maximum coordinates, the track sizes are
unequal. The reaction rate parameter combinations which led to each set of TetR2 kinetics were
then extracted (Figure 7.20, 7.21 and 7.22), in order to assess whether specific parameter com-
binations favoured certain trajectories.
Data is represented as a matrix plot. Along the diagonal is a histogram for each of the parameters
(reaction rates) being analysed. The histograms correspond to the parameter labels and range of
values along the x-axis. The y-axis for the histograms, the frequency, is not labelled due to space
constraints. The remainder of the plot consists of scatter plots which showcase relations between
each pair of parameters. Each data point relates to a maximum coordinate which is being anal-
ysed. The rate of degradation of eGFP is not included since it has a fixed value.
A bias can be observed between the rates of transcription, translation and degradation which lead
to the three sets of maximum TetR2 coordinates, as seen in the histograms along the diagonal
of each matrix plot (Figure 7.20 - 7.22). Combinations of low transcription and translation rates
plus high mRNA, TetR and TetR2 degradation rates result in small quantities of protein with a high
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
(j) (k) (l)
Figure 7.17: TetR2 dynamics: Individual plots of 12 randomly selected TetR2 protein quantity tra-
jectories simulated with the Gillespie SSA using different parameter sets. The axis show Number
of molecules vs Time in minutes. Starting conditions were set to 0 for all species except Op=1.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
(j) (k) (l)
Figure 7.18: eGFP dynamics: Individual plots of 12 randomly selected eGFP protein quantity tra-
jectories simulated with the Gillespie SSA using different parameter sets. The axis show Number
of molecules vs Time in minutes. Starting conditions were set to 0 for all species except Op=1.
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(a) TetR2 protein (b) eGFP protein
Figure 7.19: Maximum number of molecules: Histogram plots of the maximum number of
molecules attained during the 500 simulations for the protein trajectories of: a) TetR2 and b)
eGFP.
turnover and favour low value TetR2 oscillations (Figure 7.20). There are no clear trends in the pa-
rameter values and combinations which lead to medium value oscillations (Figure 7.21). A more
pronounced trend can be seen in parameter combinations which led to high value oscillations
(Figure 7.22), with high transcription and translation rates plus low RNA and TetR degradation
rates. This combination results in larger protein quantities with a low protein turnover, leading to
a build-up of protein. It should be noted that the bias in the synthesis and degradation rates is not
pronounced. In fact, in each of the rates, over 50% of the simulated values were scattered across
the remaining range of possible values. Coupled with the fact that the other parameters analysed
did not demonstrate a clear trend, this further highlights the importance of distinguishing between
genuine and stochastic fluctuations in protein dynamics.
7.2.2.5 Parameter analysis based on eGFP dynamics
Similarly to the above analysis with TetR2, parameter combinations which led to low, medium or
high maximum coordinate eGFP oscillations were analysed in order to extract parameter trends.
The analysis was carried out on both TetR2 and eGFP related biochemical parameters within the
network rather than just eGFP-specific rates. This is because TetR2 has a regulatory influence
over eGFP and hence, TetR2 patterns have the potential to affect eGFP oscillations. Based on
first and third quartile data from Figure 7.19b, low oscillations were considered to be those where
the maximum eGFP coordinate is at less than 23 proteins (Figure 7.23a). Analysis of the his-
tograms and scatter plots of the rate parameters which correspond to this outcome (Figure 7.23b)
revealed a trend for low transcription and translation rates in addition to high mRNA degradation
rates. This is similar to results observed for low amplitude TetR2 oscillations. TetR degradation
rates tended to be low, implying that the tetracycline operator is less likely to be unbound and
hence eGFP expression is less likely to take place.
For medium level oscillations, having a maximum coordinate between 24 and 42 proteins (Figure
7.24a), parameter analysis (Figure 7.24b) was inconclusive. For high value oscillations having
a maximum coordinate of over 42 proteins (Figure 7.25a), parameter trends were the opposite
of those observed for low level oscillations, with high transcription and translation rates favoured
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(a)
(b)
Figure 7.20: Analysing the parameter space which results in low value (<3 molecules) TetR2
oscillations: a) TetR2 trajectories when the maximum coordinate is less than 3 proteins. These
were selected from the original 500 simulations carried out. The axis show Number of molecules
vs Time in minutes. b) The corresponding matrix plot showing the values of and the relations
between the eight distinguishable and non-fixed biochemical parameters which lead to the trajec-
tories in (a): the rate of transcription, rate of translation, rate of dimerisation, rate of dissociation,
rate of binding, rate of unbinding and degradation rate for the mRNA and protein components.
The histograms along the diagonal highlight the distribution of values of each parameter. The
scatter plots show the relation between each pair of parameters. The x- and y- axis show the
range of possible values for each of the parameters.
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(a)
(b)
Figure 7.21: Analysing the parameter space which results in medium value (3-4 molecules)
TetR2 oscillations: a) TetR2 trajectories when the maximum coordinate is 3-4 proteins. These
were selected from the original 500 simulations carried out. The axis show Number of molecules
vs Time in minutes. b) The corresponding matrix plot showing the values of and the relations
between the eight distinguishable and non-fixed biochemical rate parameters which lead to the
trajectories in (a): the rate of transcription, rate of translation, rate of dimerisation, rate of disso-
ciation, rate of binding, rate of unbinding and degradation rate for the mRNA and protein compo-
nents. The histograms along the diagonal highlight the distribution of values of each parameter.
The scatter plots show the relation between each pair of parameters. The x- and y- axis show the
range of possible values for each of the parameters.
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(a)
(b)
Figure 7.22: Analysing the parameter space which results in high value (>4 molecules)
TetR2 oscillations: a) TetR2 trajectories when the maximum coordinate is more than 4 proteins.
These were selected from the original 500 simulations carried out. The axis show Number of
molecules vs Time in minutes. b) The corresponding matrix plot showing the values of and the
relations between the eight distinguishable and non-fixed biochemical rate parameters which lead
to the trajectories in (a): the rate of transcription, rate of translation, rate of dimerisation, rate of
dissociation, rate of binding, rate of unbinding and degradation rate for the mRNA and protein
components. The histograms along the diagonal highlight the distribution of values of each pa-
rameter. The scatter plots show the relation between each pair of parameters. The x- and y- axis
show the range of possible values for each of the parameters.
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along with low mRNA degradation rates and high TetR degradation rates. The latter decreases
the probability of having a TetR2.Op complex, leading to expression and increasing eGFP num-
bers. Thus, similarly to conclusions made for TetR2 oscillation analysis, there is a small output
bias based on the parameter combinations which requires further analysis, especially of the noise
component.
7.2.3 Evaluation of the Goodwin oscillator parameter space following screen-
ing analysis
Following preliminary stochastic and quantitative mathematical modelling of protein expression
dynamics within the trypanosomal Goodwin oscillator, the following findings and observations
were made:
1. A mathematical model was developed to represent the pStable and pUnstable Goodwin
oscillators as a set of components, such as mRNA and proteins, which interact with each
other via biochemical reactions, such as synthesis and degradation. These biochemical
reactions govern how component quantities vary over time. Based on the available literature,
this is the first mathematical model of a synthetic GRN used to inform outcome within a
trypanosomal context.
2. A screening assay of the 11-dimensional parameter space of the model was carried out
via Gillespie stochastic simulations which used different parameter combinations at each
iteration in order to scan which combinations led to the onset of oscillations of protein quan-
tities. Results repeatedly showed that parameters from across the whole spectrum led to
low-amplitude fluctuations in TetR2 and eGFP mRNA and protein quantities.
3. Results indicated that dynamics were independent of starting conditions. Simulations showed
that in the scenarios which were tested wherein components had different numbers of
molecules at time 0, dynamics resumed their original profile following a brief calibration
period.
4. The components exhibited different types of sinusoidal oscillations; oscillations for mRNATetR
and mRNAeGFP had a similar profile which had a higher amplitude and longer period than the
oscillatory profile of TetR and TetR2. eGFP oscillations were sinusoidal with an increasing
trend, attributed to the degradation rate of eGFP which does not allow for a sufficiently quick
turnover of eGFP protein in line with the oscillation period but instead builds on previous
eGFP levels.
5. Oscillations were initially in synchrony, as indicated by the average protein trajectory cal-
culated for each component. After one oscillation, the cells (each of which was using a
different combination of parameters) became desynchronised.
6. Oscillation characteristics, such as maximum coordinate, amplitude and period, varied be-
tween simulation runs. Analysis showed that certain parameter rate values, specifically
synthesis and degradation rates, show a bias towards high or low maximum coordinates.
The remainder of the parameters do not show a clear bias. In light of this and the wide
range of trajectories which were exhibited, it becomes necessary to distinguish between
genuine and stochastic fluctuations. This can be done by developing a mathematical model
of control plasmid pBC188 to observe whether fluctuations within the system lead to similar
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(a)
(b)
Figure 7.23: Analysing the parameter space which results in low value (<24 molecules)
eGFP oscillations: a) eGFP trajectories when the maximum coordinate is less than 24 proteins.
These were selected from the original 500 simulations carried out. The axis show Number of
molecules vs Time in minutes. b) The corresponding matrix plot showing the values of and the
relations between the eight distinguishable and non-fixed biochemical rate parameters which lead
to the trajectories in (a): the rate of transcription, rate of translation, rate of dimerisation, rate of
dissociation, rate of binding, rate of unbinding and degradation rate for the mRNA and protein
components. The histograms along the diagonal highlight the distribution of values of each pa-
rameter. The scatter plots show the relation between each pair of parameters. The x- and y- axis
show the range of possible values for each of the parameters.
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(a)
(b)
Figure 7.24: Analysing the parameter space which results in medium value (24-42
molecules) eGFP oscillations: a) eGFP trajectories when the maximum coordinate is 24-42
proteins. These were selected from the original 500 simulations carried out. The axis show Num-
ber of molecules vs Time in minutes. b) The corresponding matrix plot showing the values of and
the relations between the eight distinguishable and non-fixed biochemical rate parameters which
lead to the trajectories in (a): the rate of transcription, rate of translation, rate of dimerisation, rate
of dissociation, rate of binding, rate of unbinding and degradation rate for the mRNA and protein
components. The histograms along the diagonal highlight the distribution of values of each pa-
rameter. The scatter plots show the relation between each pair of parameters. The x- and y- axis
show the range of possible values for each of the parameters.
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(a)
(b)
Figure 7.25: Analysing the parameter space which results in high value (>42 molecules)
eGFP oscillations: a) eGFP trajectories when the maximum coordinate is more than 42 pro-
teins. These were selected from the original 500 simulations carried out. The axis show Number
of molecules vs Time in minutes. b) The corresponding matrix plot showing the values of and
the relations between the eight distinguishable and non-fixed biochemical rate parameters which
lead to the trajectories in (a): the rate of transcription, rate of translation, rate of dimerisation, rate
of dissociation, rate of binding, rate of unbinding and degradation rate for the mRNA and protein
components. The histograms along the diagonal highlight the distribution of values of each pa-
rameter. The scatter plots show the relation between each pair of parameters. The x- and y- axis
show the range of possible values for each of the parameters.
227
Strain Plasmid introduced aaConditions Section
1 BSF pStable aaUninduced Section 7.3.1
2 BSF pStable aaInduced with tcthres Section 7.3.1
3 PCF pStable aaUninduced Section 7.3.2
4 PCF pStable aaInduced with tcthres Section 7.3.3
Table 7.7: The pStable-transfected BSF and PCF T. brucei clones which were imaged using live-
cell fluorescent and brightfield microscopy to observe fluorescent patterns and characterise the
phenotype of pStable. ‘tcthres’ is the tetracycline concentration above which protein expression
across the cell population is induced.
fluctuations. Moreover, a deterministic model wherein all sources of stochasticity are elimi-
nated should be simulated in order to observe whether a similar output as for the stochastic
model is achieved.
7. In conclusion, the trypanosomal Goodwin oscillator has been shown to lead to a periodic
TetR2 and eGFP output. Based on these findings, along with characterisation results, a de-
cision was taken to go ahead with microscopy fluorescent analysis.
7.3 Characterisation of the phenotype of the stable Goodwin
oscillator via live cell imaging and qualitative mathemati-
cal pattern analysis
Following assessment of the main pStable components and mathematical screening analysis,
live-cell fluorescent microscopy imaging of pStable-transfected BSF and PCF clones was carried
out. Similarly to pUnstable-transfected T. brucei, this was done in order to quantify and analyse
fluorescence pattern profiles of live trypanosome cells. Images of pStable transfectants were ac-
quired at two minute intervals over a two-hour period using fluorescent microscopy with a 20X
objective. Cells at a density of 5×107cells/ml were embedded in 40% Cygel as per Section 5.7.
Throughout, brightfield microscopy was used in tandem to fluorescent microscopy as a control.
This was done to confirm that observed fluorescence is not being emitted by debris and sec-
ondly so as to facilitate cell tracking. Once completed, the images were collated, corrected for
background fluorescence and analysed as a video in order to detect and quantify changes in fluo-
rescence levels over time in individual cells. Quantification consisted of both automated detection
by Volocity and manual tracking. The latter was necessary due to an element of cell motility which
can lead to incorrect cell tracking by Volocity. Table 7.7 lists the strains which were imaged.
7.3.1 Phenotype of the stable Goodwin oscillator in live BSF T. brucei
Fluorescent microscopy imaging was carried out on BSF T. brucei bearing the stable Goodwin
oscillator. No fluorescence was observed throughout, as confirmed by quantitation (results no
shown). Throughout, brightfield microscopy confirmed that cells were viable and healthy. This
does not disqualify pStable as an oscillator but raises the same challenges as seen in the live cell
imaging of pUnstable-transfected cells and may be an indication of the limits of sensitivity of the
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(a) Images of BSF T. brucei bearing pStable highlighting BSF cell motility over 120 minutes.
(b) Images of PCF T. brucei bearing pStable highlighting PCF cell motility over 120 minutes.
Figure 7.26: Images of: a) uninduced pStable-transfected BSF T. brucei and b) uninduced
pStable-transfected PCF T. brucei highlighting cell motility over 120 minutes. Images are taken
using a 20X objective and brightfield microscopy. Scale bar = 100µm.
imaging technology being used (Section 6.2.2 ).
Following this, a second imaging study was carried out on pStable-transfected BSF clones in-
duced with tetracycline at the tcthres level, based on the hypothesis of increasing eGFP protein
numbers while still allowing for oscillations to occur and thus controlling for the probability that
oscillations are present but too low to be detected, as discussed in Figure 6.7. The effect of tcthres
on the cell population could not be properly gauged due to cell motility. Figure 7.26a shows three
stills taken using brightfield microscopy of the induced transfected BSF cell population at time 0, 1
hour and 2 hours, which serves to highlight how the landscape changes over time. This highlights
the challenge in tracing live motile cells over multiple time-points. Thus, no conclusion was made
regarding the phenotype of pStable.
7.3.2 Phenotype of the stable Goodwin oscillator in uninduced live PCF T.
brucei cells
Following the imaging of pStable-transfected BSF clones, the same analysis was carried out on
uninduced PCF T. brucei bearing the pStable network. No fluorescent signals were detected.
However, Figure 7.26b shows stills of the PCF cell population taken throughout the two hour imag-
ing procedure, which serve to highlight two main differences from its BSF counterpart. Firstly, cell
density is higher, in spite of using the same cell preparation techniques. Secondly, cell motility
has been greatly reduced such that a proportion of the cells could be traced over the two hour
period.
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7.3.3 Phenotype of the stable Goodwin oscillator in live PCF T. brucei cells
induced with tcthres
7.3.3.1 Live cell imaging of the stable Goodwin oscillator in PCF T. brucei induced with
tcthres
Since no fluorescence was observed for uninduced PCF clones, a similar imaging procedure was
carried out using PCF T. brucei bearing the pStable network and induced with tetracycline at a
concentration of tcthres as per Section 6.2.2.2. This was done in order to control for the probability
that changes in fluorescent levels were not being detected, as seen per Figure 6.7. Automated
and manual tracking showed that the tetracycline successfully led to a proportion of the cell pop-
ulation expressing eGFP protein at detectable levels, in line with the hypothesis.
Following imaging, due to improved tractability conditions of PCF T. brucei, three cells were se-
lected which: 1) did not clump with other cells for the duration of imaging, 2) did not swim out
of the plane of vision for the duration of imaging and 3) could be tracked over the majority of the
stills. These cells, labelled Cell A, B and C, were taken forward for background correction, tracking
and quantification and are highlighted in Figure 7.27 which shows both fluorescent background
corrected and brightfield stills from the two hour imaging procedure. Figure 7.28 shows close-up
stills from fluorescent and brightfield microscopy of Cell A over 120 minutes, as extracted from
Figure 7.27. A change in fluorescence levels over time was observed in these cells, as will be
discussed next. The remainder of the cells did not satisfy the three criteria simultaneously.
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7.3.3.2 Quantification and analysis of fluorescence oscillatory trajectories at the single
cell level in T. brucei cells bearing pStable and induced with tcthres
The time series of the quantified fluorescence in each of the three cells is plotted in Figure 7.29. A
fluctuating trend, in line with oscillations, can be seen in each of the profiles. The standard devia-
tion for each cell was 22%-35% of the mean signal, indicating a trend in the variations which goes
beyond the stochasticity resulting from focusing variability and stochastic intracellular processes,
quantified at c. 17% of the mean signal in a plasmid expressing GFP constitutively (Section 6.2.1).
It needs to be taken into account that the latter calculation was based on readings over a 30 minute
period, while oscillations within pStable where taken over two hours. Therefore, fluorescence sig-
nals of the constitutive plasmid should be measured over an equivalent two hour time-span prior
to conclusions being made. This will be enabled by the development of an imaging device which
allows for better control of the organisms.
Prior to further data manipulation, missing data points were imputed using a window of size 3 i.e.
the missing data point was estimated by averaging the value of the three previous and three sub-
sequent data points. There was one missing data point per cell, attributed to cell undulations and
loss of microscope focus. Following this, the data was noise-filtered so as to extract the under-
lying trend from the stochastic environment. Two different smoothing techniques were effected:
an 8-point moving average filter (Oppenheim et al., 1999) and a cubic spline interpolation. This
allows for the visualisation of the data as a smooth, continuous curve.
There were 60 data points in total, representing the fluorescence signal of the cell at two minute
intervals over a two hour period. In the moving average filter using a window of size eight, the
average value of each data point was averaged out over the time point ti of interest and eight time
points prior and subsequent to it ti−8, . . . , ti−1, ti, ti+1, . . . , ti+8 given that i− j > 0 and i+ j < 61
for j = 1, . . . , 8. Otherwise, the time-point out of bounds was ignored. Moving average filters have
been used to smooth oscillations and eliminate the effects of noise in synthetic biology (Tigges
et al., 2009), biochemistry (Jiang et al., 2013), engineering (Johnson & Principe, 2005), astron-
omy (Bloomfield, 2004) and neurology (Azami et al., 2011). Although other filtering algorithms are
available (as seen in, for example, Stricker et al. (2008) and Tigges et al. (2010)) this technique
was selected because it allows for a tailored filtering process via the user-defined window size.
In the cubic spline interpolation, polynomials were fitted to sections of the noise-filtered data such
that connection points are smooth, to form a piecewise function known as a cubic spline. Splines
have been used in biochemistry and synthetic biology (Yang et al., 2013b; Chen et al., 2009;
Morrissey et al., 2011) to fit piecewise functions to irregular data.
The imputed, noise-filtered and smoothed functions for the three cells, as seen in Figure 7.29,
show a low-amplitude sinusoidal trajectory, having a period of 50 minutes and a small linear
growth trend. It is not yet clear how this compares to the observed half-life of destabilised eGFP
(c. 3 hours). This also highlights the need to deduce the half-life of TetR, since it will help inform
whether the fluctuations can be traced back to changes in TetR protein levels or otherwise.
The cells appear to be oscillating in synchrony. The low proportion of oscillating cells, in compar-
ison to the cell population being imaged does not automatically pose a challenge to the nature
of the GRN. For example, only 12% of the cells having the oscillator developed by Tigges et al.
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(2010) were observed to fluctuate. Further investigative work is expected to inform whether the
observed oscillations are recurrent or not, whether the synchrony holds over generations and
more importantly, whether the fluctuations are TetR-generated or stochastic.
Moreover, the oscillatory characteristics (low-amplitude, 50 minute period) need to be fitted against
a mathematical model in order to extract the parameter profile. The preliminary stochastic simula-
tions carried out yielded a wide array of fluctuations which strengthened the case for carrying out
live cell imaging but had little information to extract otherwise due to the variability. However, the
mathematical model of the trypanosomal Goodwin oscillator can be used to explain why oscilla-
tions or changes in fluorescence patterns were not observed in uninduced T. brucei bearing the
stable or unstable oscillator and in induced BSF T. brucei bearing the stable Goodwin oscillator;
based on the consistently fluctuation output, it is possible that the oscillations were present but
were too low for detection by the available technology.
7.3.3.3 Phase space reconstruction of the stable Goodwin oscillator fluorescent profile in
the T. brucei host
In order to visualise recurring patterns and establish whether the oscillations observed held un-
der mathematical scrutiny, following data quantification and smoothing, qualitative analysis of the
non-linear system was carried out by reconstructing the phase space from the smoothed cell tra-
jectories. The phase space represents all the possible states(values) of a selected variable within
the network. In this case, the phase space of the fluorescence signal was reconstructed. The
states attained by the variable were traced on the phase space. This trajectory then allowed for
underlying structures to be elicited. The phase space was reconstructed as per Taken’s time-delay
embedding method (Takens, 1981). Phase space analysis has been widely used in the study of
genetic networks for similar purposes (Gao et al., 2010b; Li et al., 2012; Fung et al., 2005).
Since the oscillatory time series profile for each cell showed a growing average linear trend (Fig-
ure 7.29), the first step prior to plotting the phase space of each cell was to de-trend the data.
Initially, the mean value of the trajectory was subtracted from each data point of the smoothed
dataset. Secondly, a linear growth line (the trend) was fitted to this smoothed dataset with mean
0. The trend was then removed by subtracting the linear growth to get de-trended oscillations.
Figure 7.30 shows the smoothed data oscillations and the fitted growth trend for each of Cells
A, B and C, along with the de-trended oscillation and the de-trended mean, which has value 0.
The linear growth trend for the eGFP signal is attributed to an accumulation of eGFP due to its
relatively low degradation rate which does not allow for all eGFP to be degraded prior to the next
wave of protein expression. This was also reflected to an extent in mathematical simulations.
The phase space was then generated using the de-trended dataset seen in Figure 7.30 and using
a delay of 8, which was chosen empirically. Although the delay could be estimated using the False
Nearest Neighbours’ algorithm (Kennel et al., 1992) or the Mutual Information scheme (Fraser &
Swinney, 1986) the phase space generated using this data was suboptimal (not shown). The gen-
erated phase planes (Figure 7.31) are indicative of a periodic limit cycle i.e. a closed trajectory,
although it does not clarify whether the observed fluorescent dynamics are oscillations result-
ing from changes in eGFP quantity and hence, the interplay between expression and inhibitory
regulation. Figure 7.31d, showing the reconstructed phase space with the three trajectories su-
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(a) Cell A
(b) Cell B
(c) Cell C
Figure 7.29: Quantified fluorescent trajectories in tcthres induced PCF cells bearing the
pStable network: Plot showing raw quantified fluorescence data (in blue) and imputed, noise-
filtered and smoothed fluorescence (in orange) time series for three PCF tcthres-induced cells
bearing the pStable network, which did not clump or move out of the plane of vision during the
two hour experiment and had detectable fluorescence levels. The axis show Fluorescence vs
Time in minutes. Fluorescence intensity has no units.
245
(a) Cell A
(b) Cell B
(c) Cell c
Figure 7.30: Smoothed and De-trended data: Diagrams showing smoothed de-trended time
series profile (purple) for the fluorescent intensity in a) Cell A, b) Cell B and c) Cell C. The axis
shows Fluorescence (no units) vs Time in minutes. Each plot also shows the imputed, noise-
filtered, smoothed data which was then detrended (blue), the linear trend which was removed
(orange) and the detrended mean which has value zero (black).
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(a) Reconstructed phase space for Cell A (b) Reconstructed phase space for Cell B
(c) Reconstructed phase space for Cell C (d) Reconstructed phase space for trajectories of Cell A,
Cell B and Cell C
Figure 7.31: Reconstructed phase space of de-trended data: Diagrams showing reconstructed
phase space of smoothed de-trended fluorescence signal trajectory of a) Cell A, b) Cell B and c)
Cell C. d) shows the reconstructed phase space using all three trajectories. A delay of 8 was
used. The axis shows Fluorescence (no units) vs Fluorescence (no units).
perimposed on each other, indicates that the trajectories are similar to each other and that there
is consistency among the oscillations. Outliers are attributed to the data points on the edge of
the data set (the first or last data points), which can not be manipulated the same as the remain-
ing points. Further investigations, using larger data sets and a second generation mathematical
model, are expected to complement these findings.
7.3.4 Evaluation of the stable oscillator phenotype following live cell mi-
croscopy imaging and qualitative mathematical analysis
Following characterisation of the phenotype of the stable Goodwin oscillator via live cell mi-
croscopy imaging, data quantification and qualitative mathematical analysis, the following results
and observations were made:
1. PCF cells bearing the stable Goodwin oscillator allow for more straightforward analysis
than their BSF counterparts, in that microscopy images showed decreased cell motility and
denser cell populations. Thus, quantification of single cell fluorescent trajectories and the
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screening of populations of cells was facilitated.
2. The preliminary mathematical model which was developed to screen biochemical param-
eter rate combinations which led to an oscillatory output can be used to explain why no
oscillations were observed in BSF T. brucei bearing the stable Goodwin oscillator and their
uninduced PCF counterparts. Simulations repeatedly showed an oscillatory output with a
low amplitude and low maximum coordinate, indicating that oscillations may be occurring
but are not being detected by the available microscopy technology.
3. A varying fluorescent pattern was observed over a two hour imaging segment in a small
proportion of PCF cells bearing the stable Goodwin oscillator and induced with tetracycline
at a threshold concentration of tcthres=10fg/ml. As hypothesised, this acted as a tuning
measure, increasing the overall quantity of eGFP while still allowing for oscillations to take
place and controlling for the probability that oscillations were present but not being detected
by the available technology.
4. The fluorescence signal profile of three induced PCF T. brucei bearing the pStable network
which retained viability and tractability over the two hour imaging procedure was quantified
using a combination of thresholding, edge detection and watershed segmentation. Follow-
ing this, results were confirmed visually. The time series trajectory was smoothed and fil-
tered using a moving-average filter and spline fitting algorithm to dampen the effect of noise
and allow for the dominant trend to be extracted. This revealed a low-amplitude oscillatory
pattern in the fluorescence trajectories of all three cells.
5. In order to better assess whether the observed and quantified oscillatory trajectories hold
under qualitative mathematical analysis, the phase space for the fluorescence intensity of
each oscillation was reconstructed. Results showed the presence of a limit cycle within each
phase space with outlier edges which correspond to the first and last smoothed data points
which are generated from smaller data points than the remainder.
6. Following characterisation and mathematical analysis, results yielded data consistent with
oscillations, the nature of which is unclear. Further investigations using larger data sets,
deterministic models and control measurements should be carried out in order to yield con-
clusive data in line with this or otherwise.
7.4 Discussion
This chapter presented results following the characterisation of the stable Goodwin oscillator phe-
notype in T. brucei cells via protein analysis, microscopy imaging and quantitative and qualitative
mathematical modelling. The following conclusions are made:
1. In line with synthetic biology principles, mathematical and wet lab analysis was used to
inform the other and build on the available knowledge in a cyclical pattern.
2. Characterised the novel pStable synthetic GRN within a T. brucei chassis. This is the first
synthetic plasmid, alongside pUnstable, to be characterised within a trypanosomal platform.
3. Assessed function of the pStable network components. Promoters, operator and antibiotic
resistance mechanism were found to be functional. Moreover, it was confirmed that TetR
and eGFP protein was expressed and that expression was regulated via TetR inhibition, the
effect of which could be reversed via tetracycline. When added at a concentration of 1µg/ml,
tetracycline induced expression for over 24 hours, after which inhibition was resumed.
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4. Deduced that when induced with tetracycline at a concentration of 10fg/ml, pStable exhib-
ited partial fluorescence in that a proportion of cells were observed to fluoresce while the
remainder did not. This was used throughout imaging in order to increase the probability of
detecting changing fluorescence patterns.
5. Established that the degradation rate of Ubiquitin tagged eGFP within a T. brucei platform is
0.004min-1. From the available data, this appears to be the first such exercise to determine
reaction rates of GRN components within a T. brucei chassis.
6. Deduced that growth rates of T. brucei bearing the pStable network are not statistically
different from wildtype T. brucei. This is similar to results for the pUnstable network.
7. Developed a mathematical model for the trypanosomal Goodwin oscillation based on the ex-
pression dynamics and interactions of the network components via biochemical rates. This
is one of the first applications of a mathematical model to a synthetic GRN as part of an
analytical package to investigate GRNs within trypanosomes. Experimental and literature
data was used to inform parameter rates within the model. In order to screen the parame-
ter space for combinations which lead to oscillatory protein expression dynamics, Gillespie
simulations were run using different parameter combinations to generate time series profiles
for the regulatory and reporter proteins, TetR and eGFP, and their associated components.
Results indicated that low-level sinusoidal oscillations occurred over a wide variety of fre-
quencies, irrespective of the parameter values selected. This brings into question whether
the oscillations are stochastic or genuine.
8. Elicited information on the influence of different parameter combinations on the oscillatory
output. Analysis of parameter rates with respect to the maximum coordinate of TetR2 oscilla-
tions showed that low protein synthesis coupled with high degradation rates led to low-level
maximum coordinates in oscillations, while high protein synthesis rates coupled with low
degradation rates led to oscillations which had a higher maximum coordinate. Analysis of
eGFP simulations showed that low protein synthesis, combined with a low degradation rate
for the TetR components and a high degradation of mRNA favoured a low level maximum
coordinate in oscillations. The reverse is true for an eGFP oscillatory output with higher max-
imum coordinates. Therefore, oscillations appear to be dependant on the protein turnover
rate. However, the relation is noisy and again brings into questions whether this is reflective
of genuine or stochastic fluctuations.
9. Characterised the phenotype of the pStable network in live T. brucei via microscopy imaging
and quantitation. PCF cells bearing the stable Goodwin oscillator and induced with tcthres
tetracycline had detectable fluorescence levels. Three cells which retained healthy viability
and remained in focus were tracked and their fluorescence levels found to correspond to an
oscillatory pattern having a period of c. 50 minutes and a varying amplitude with a linear
growth trend. This was corroborated by mathematical analysis via phase space reconstruc-
tion.
10. Data is consistent with the pStable plasmid functioning as a stable Goodwin oscillator within
a T. brucei chassis, although results are based on a small dataset. Further experiments are
expected to yield conclusive results.
11. Demonstrated the potential of T. brucei as a synthetic biology chassis, having developed,
inserted and partially characterised a novel synthetic gene network within this chassis. This
opens the door for further research regarding the use of T. brucei as a bioprocessing plat-
form.
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Chapter 8
Conclusion
Synthetic biology currently depends on the use of first generation chassis such as E. coli and
mammalian CHO cells. This may limit its ability to address challenges in areas as diverse as
bioprocessing, biotherapeutics, bioremediation and energy generation. In order to address this
gap, this multi-faceted project incorporating biochemistry, mathematics and engineering initiated
an investigative process to establish Roseobacter marine bacteria and unicellular T. brucei pro-
tozoa as synthetic biology chassis.
1. Achievements regarding the establishment of Roseobacter clade marine bacteria as a
synthetic biology chassis by identifying reliable molecular biology procedures for the de-
velopment of a synthetic gene network.
The clade of Roseobacter marine bacteria was selected for the purpose of expanding the set of
available synthetic biology chassis because strains are naturally found in various diverse oceanic
habitats and are implicated in balancing global carbon levels (Brinkhoff et al., 2008; Buchan et al.,
2005). Moreover, Roseobacter utilise mixotrophic metabolism (Sato-Takabe et al., 2014; Swing-
ley et al., 2007), employ quorum signalling (Moran et al., 2007) and are easily cultivated (Brinkhoff
et al., 2008; Buchan et al., 2005). Therefore, they hold potential as chassis for the application of
synthetic biology in addressing marine bioremediation and geo-engineering challenges.
The following achievements towards the establishment of a standardised and reliable synthetic bi-
ology practice in Roseobacter were made during the investigation on the Roseobacter strains O.
indolifex, D. shibae and R. denitrificans, drawn from across the Roseobacter phylogenetic spec-
trum:
• Established that cell banks can be developed for Roseobacter strains. Glycerol stocks of
the strains stored at -80°C were shown to revive well in both shaken and static cultures for
a period of 12 weeks.
• Demonstrated that all three marine bacterial strains could be successfully cultured at 37°C.
This enabled the adoption of a more standard practice, bypassing the requirement for differ-
ent culturing temperatures for the different strains.
• Deduced that antibiotic selectivity, which is fundamental to cloning procedures, can be used
to inhibit cell growth of the three wildtype Roseobacter strains. Cell growth was inhibited
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by Chloramphenicol concentrations as low as 17µg/ml instead of the previously reported
30µg/ml (Piekarski et al., 2009).
• Mapped the region of experimental design space within which the three Roseobacter strains
are resistant to plasmid uptake with respect to plasmid DNA concentration, origin of replica-
tion, voltage and transformation method used. This information will be of paramount impor-
tance in future research on the development of a transformation procedure for Roseobacter
clade bacteria.
• Examined the potential of Roseobacter clade bacteria as a synthetic biology chas-
sis. This was the first project of its nature. The achievements discussed above have
contributed to the development of reliable molecular biology procedures for use with
Roseobacter platforms. This study has also demonstrated that synthetic biology
within Roseobacter is non-trivial and is not sufficiently de-skilled as to allow for the
participation of citizen scientists.
Future work. In order to establish Roseobacter clade bacteria as synthetic biology host cells,
the first recommendation is to develop a reliable, simple and rapid transformation procedure which
allows Roseobacter cells to stably uptake foreign plasmid DNA. Moreover, alternative methods
such as colony PCR should be incorporated when assessing success of transformation. These
developments will allow for the participation of both professional and citizen scientists. Moreover,
this will enable the characterisation and modelling of synthetic GRNs within Roseobacter.
2. Achievements regarding the establishment of T. brucei as a synthetic biology chassis
by designing, modelling, constructing and measuring a Goodwin oscillator encoded by a
novel synthetic gene network.
The eukaryote T. brucei protozoa were selected as potential synthetic biology host cells be-
cause they combine mechanisms found in both prokaryote and eukaryote species (Palenchar
& Bellofatto, 2006; Bouvier et al., 2013), such as fast doubling times and mammalian-like post-
translational glycosylation of host proteins. T. brucei make use of sophisticated antigen variation
and genome modification mechanisms (Rudenko, 2011) to evade host immune systems. More-
over, T. brucei have been studied as a model organism for the research of protozoan biological
processes (Serricchio & Butikofer, 2011), leading to well established culturing and cloning pro-
tocols via standard genetic engineering cloning techniques (Clayton & Shapira, 2007; Clayton,
1999). Therefore, there is scope for establishing the use of T. brucei in the application of synthetic
biology within bioprocessing and to further probe its pathobiology.
The following achievements in the development of a novel synthetic GRN encoding a Goodwin
oscillator to establish T. brucei as a chassis were made:
• Designed a GRN which functions as an autonomous oscillator via the use of a TetR inhibiting
feedback loop and which made use of a green fluorescent reporter protein. Two versions of
the oscillator were constructed in order to tune protein expression dynamics; pStable and
pUnstable, one using a standard tetR gene and the other using a Ub-L destabilised tetR
gene. The GRN was specifically designed for use in T. brucei, having features such as
an rRNA sequence at which the plasmid was linearised for insertion into rRNA spacers in
the genome and UTRs to enable protein synthesis. The network architecture incorporated
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non-linear, time-delayed negative feedback which enabled oscillatory dynamics.
• Assembled the pStable oscillator plasmid using a combination of ligation techniques; stan-
dard, three-fragment, non-directional and Gibson. Throughout, the Gibson ligation method
(Gibson & Bruck, 2000) proved to be the more efficient approach for the construction of the
synthetic GRN. The pUnstable plasmid was synthesised commercially in six weeks (com-
pared to eighteen months it took for the construction of pStable). Following this develop-
ment, it is recommended that plasmid DNA is assembled and synthesised commercially to
save both on time and costs. The assembly also led to the development and construction of
three other plasmids having the same pRP backbone as the Goodwin oscillators but different
combinations of the tetR, Ub-L and eGFP genes. Thus, the construction process resulted
in five novel synthetic GRNs for use within trypanosomes. These can be provided to future
researchers on request and can therefore be used in new lines of T. brucei research within
synthetic biology, bioprocessing and pathobiology.
• Established an experimental framework for the imaging of live motile T. brucei cells. The
set-up was required to constrict cell movement and allow for single cell tracking over a span
of hours without compromising cell viability. This enables the imaging of cell populations
and the tracking and identification of single cells, making for a time and resource efficient
characterisation process. The developed set-up uses 40% CygelTM to form an encasing gel
matrix around T. brucei on a 5mm well slide base. The device restricted cell movement,
thus allowing for cells to be tracked. T. brucei maintained viability for over two hours. The
establishment of this framework from scratch has highlighted the importance of having the
appropriate technology and equipment for the purpose of the study. No other similar device
is available on the market. Therefore, this set-up can be used for the immobilisation of other
motile organisms than T. brucei.
• Developed from scratch a quantitative mathematical model of the pStable and pUnstable
Goodwin oscillator plasmids to complement characterisation studies. In line with synthetic
biology principles, mathematical and wet lab analysis were used to inform each other and to
build on the available knowledge in a cyclical pattern. The model was partly built using data
from component characterisation in the pStable network (see below).
• Carried out preliminary quantitative analysis on the mathematical model via Gillespie sim-
ulations to screen the model’s parameter space. Since T. brucei-specific biochemical rates
were not available, it was necessary to examine whether oscillations occurred under very
specific conditions or otherwise. Simulated trajectories repeatedly indicated that the GRN
functioned as a low-level amplitude oscillator, irrespective of the parameters selected. More-
over, parameter analysis showed that protein synthesis and degradation rate combinations
may be used to tune characteristics of the oscillatory output, since they show a small bias
towards a higher or a lower maximum coordinate based on their values.
• Characterised the phenotype of the pStable and pUnstable Goodwin oscillators in both BSF
and PCF T. brucei. Protein analysis was initially carried out in order to assess whether net-
work components were functional. This was carried out via growth profiling assays, west-
ern blot assays and half-life assays which also served to inform mathematical modelling.
Throughout, established molecular biology methods were used, highlighting the practicality
of using T. brucei as host cells. Afterwards, fluorescent patterns in T. brucei were imaged via
live cell population microscopy imaging and analysed at the single cell level. This allowed
for deductions on functionality and protein expression dynamics within the networks.
• Demonstrated the both BSF and PCF cells bearing pStable and pUnstable do not have
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impaired cell growth when compared to their wildtype counterparts. This implies that T.
brucei host cells retain stability following the addition of <10kb extracellular plasmid DNA.
• Demonstrated that the components of pUnstable are functional, with regulation of expres-
sion governed by TetR inhibition which could be reversed via tetracycline induction. When
tetracycline was added at a concentration of 1µg/ml, the induction effect was noticed for
over 6 hours when analysing protein sample. Throughout, protein was expressed at a con-
stitutive basal level, indicating that the pUnstable network can be used as a tuned version
of the pStable network.
• Demonstrated that the components of pStable are functional, with regulation of expression
governed by TetR inhibition. Expression could be induced via tetracycline at a concentration
of above 10fg/ml. When added at a concentration of 1µg/ml, the induction effect was noticed
for over 24 hours when analysing protein sample.
• Imaged BSF and PCF, induced and uninduced cell populations. No changes in fluorescent
patterns were observed in BSF and uninduced PCF transfectants. This does not disprove
previous characterisation carried out, but may reflect findings from quantitative mathematical
analysis which indicate that the plasmid functions as a low-level oscillator. It is also an indi-
cation of the limits of the set-up and sensitivity of the imaging technology being used. This
highlights how the production of oscillations and their detection are separate issues. How-
ever, in the images of induced PCF T. brucei bearing the pStable network, three cells were
identified as having changes in fluorescent patterns. These were successfully recorded
and quantified using a combination of computational techniques and visual confirmation. In
order to extract the dominant trajectory, the noise components were removed by applying
a smoothing filter and a cubic spline, resulting in an oscillatory eGFP trajectory for each
cell with a period of c. 50 minutes and a varying amplitude. This is in agreement with the
function of the network as an oscillator.
• Mathematically analysed the observed oscillations in fluorescence signals by reconstruct-
ing their phase space. Results showed that there was a linear growth trend within each
trajectory, attributed to the low eGFP degradation rate, which results in a proportion of the
eGFP not being degraded prior to the re-initiation of expression at the beginning of each
cycle. Protein expression dynamics were again consistent with oscillations and the pStable
network functioning as an oscillator.
• In conclusion, a novel plasmid encoding a Goodwin oscillator for implementation in a T. bru-
cei chassis was designed, assembled, characterised and modelled. Results, albeit based
on a small dataset, were consistent with the network functioning as an oscillator but also
highlight the need for further conclusive data in order to establish the source of oscillations.
The assembly process also led to the development of five novel trypanosomal synthetic
GRNs, the first mathematical model of a synthetic GRN used within a T. brucei based study
and the development of a device which allows for the imaging of live and motile cells over
two hours while being able to track a proportion of the cells individually.
• The investigation has shown that T. brucei hold potential as a synthetic biology plat-
form and has contributed towards the diversification of the synthetic biology chassis
pool by initiating the study of T. brucei as host cells. This was the first investigation
of its kind and provides a solid foundation for future research on the use of T. brucei
within the application of synthetic biology for bioprocessing and pathobiology.
Future work. Based on the above findings, the following main recommendations are set out for
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future work and the continuation of the investigation of T. brucei as synthetic biology chassis. The
current set-up for the imaging of motile T. brucei cells should be optimised so as to allow for more
limited cell motility and longer imaging times. The current device highlighted the challenge in
maintaining cells viable for over two hours while immobilising them. The set-up should draw from
microfluidics in order to allow for the constant supply of nutrients to embedded cells while con-
stricting their motility. In light of previous results, wherein findings made when using an inverted
microscope did not translate fully to when using a fluorescent microscope, all research should be
carried out within the same conditions as when imaging.
This development is important not just for the analysis of live T. brucei but for the analysis of live,
motile unicellular organisms in general. Once this is in place, it is recommended that further mi-
croscopy imaging is carried out on pStable and pUnstable in order to generate a larger dataset of
recorded and quantified fluorescence trajectories from a representative sample of the cell popu-
lation. This will allow for further characterisation of the network phenotype and the development
of a more detailed mathematical model based on parameter estimation.
The need for a second-generation mathematical model is coupled with the need for deterministic
mathematical modelling. This will help to differentiate between genuine or stochastic fluctuations
and help inform whether the low level oscillations observed in both simulations and imaging where
a result of noise or not. Moreover, a second generation model is required in order to be able to
analyse the relation between the frequencies of the observed and simulated trajectories.
Protein analysis highlighted the need for easily characterised parts within synthetic biology. Dur-
ing protein assays, for example, the TetR protein was not detected. When a Myc tag was added
upstream of the TetR gene in the pUnstable network, no protein was detected either. This was
not for lack of protein being expressed. Moreover, in adding the Myc tag upstream of the tetR
gene, the ability of the TetR protein to bind to the operator appeared to be affected. This needs to
be investigated further in order to develop systems which can be characterised more efficiently or
to develop mathematical models which allow for the calculation of an output as a function of, for
example, TetR protein.
This work has highlighted a novel challenge which synthetic biologists should seek to address
immediately. Based on the available data, there is no clearly defined set of guidelines on what
constitutes a host cell within synthetic biology. A document needs to be developed in collaboration
with leaders within the field of synthetic biology, defining the requirements for an organism to be
classified as a synthetic biology chassis. This will clarify the studies which need to be carried out
when investigating species as novel host cells in the future.
Conclusive statement.
In conclusion, this work contributed towards addressing the current limitations of first generation
synthetic biology host cells by investigating two novel potential platforms; Roseobacter marine
clade bacteria and lower eukaryote unicellular T. brucei as synthetic biology chassis. This has
opened up a novel and interesting area of investigation within synthetic biology with the potential
to influence the application of synthetic biology in fields as diverse as bioprocessing, biotherapeu-
tics and bioremediation.
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Appendix A
Ligation recipes and gel
electrophoresis results from
cloning during construction of the
stable Goodwin oscillator
This appendix lists the ligation recipes which were developed and used during each of the four
assembly strategies in the construction of the stable Goodwin oscillator. This appendix also con-
tains images of gel electrophoresis runs using amplified, digested or ligated DNA cassettes and
plasmids generated during the cloning process.
A.1 Oscillator assembly strategy using non-directional liga-
tion
The following recipes and gel images were generated during the first ligation strategy using non-
directional ligation to construct the stable Goodwin oscillator.
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(a) Diagram on top shows the segment on pRPeGFPSIR2rp3
to be amplified using complementary primers. The bottom
panel shows gel results for PCR. Lanes: 5µl
1) PCR using first forward primer and reverse primer with use
of DMSO and HF buffer,
2) PCR using second forward primer and reverse primer with
use of DMSO and HF buffer,
3) PCR using first forward primer and reverse primer with
DMSO and GC buffer,
4) PCR using second forward primer and reverse primer with
DMSO and GC buffer,
5) Positive control using M2M3 plasmid,
6) Negative control using no DNA template.
(b) Diagram on top shows the segment
on the previously amplified segment to be
PCR’d using mutagenic primers. The bot-
tom panel shows gel results for the reac-
tion. Lanes:
1-2) 5µl eGFP, amplified and purified. (Pos-
itive and negative controls not shown).
Figure A.1: Assembly strategy using non-directional ligation - Plasmid preparation: Two-step pro-
cess to amplify eGFP from pRPeGFPSIR2rp3 and add overhangs using: a) complementary primers
on pRPeGFPSIR2rp3 in the first PCR step and b) mutagenic primers on previously amplified DNA
segment in the second PCR step.
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(a) Diagram on the left shows region of pHD1313 plasmid to be amplified using mutagenic primers in order to
extract tetR cassette and add KpnI sites. The right panel shows PCR results. Lanes:
1) 5µl tetR cassette, amplified using 10ng/µl template with DMSO,
2) 5µl tetR cassette, amplified using 50ng/µl template with DMSO,
3) 5µl tetR cassette, amplified using 50ng/µl template without DMSO,
4) 5µl tetR cassette, amplified using 100ng/µl template with DMSO,
5) 5µl tetR cassette, amplified using 100ng/µl template without DMSO,
6) 5µl Positive control PCR using M2M3 plasmid with DMSO,
7) 5µl Positive control PCR using M2M3 plasmid without DMSO.
(b) Diagram on the left shows pRPeGFPSIR2rp3 cut with KpnI for non-directional ligation of the tetR cassette
into it. The right panel shows digest results. Lanes:
1-2) 5µl pRPeGFPSIR2rp3, KpnI cut & dephosphorylated & purified
3) 5µl pRPeGFPSIR2rp3, KpnI cut & purified.
Figure A.2: Assembly strategy using non-directional ligation - Plasmid preparation: Gel results
showing the: a) tetR cassette and b) pRPeGFPSIR2rp3 during preparation steps for a KpnI non-
directional ligation to insert the tetR cassette into pRPeGFPSIR2rp3.
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A.2 Oscillator assembly strategy using three-fragment liga-
tion
The following recipes and gel images were generated during the second ligation strategy using a
three-fragment ligation to construct the stable Goodwin oscillator.
(a) Diagram on the left shows pRPeGFPSIR2rp3 cut with HindIII/BamHI for three-fragment ligation of Ub-L
and eGFP into it. The right panel shows gel results of 50µl pRPeGFPSIR2rp3 backbone digested with HindIII
and BamHI.
(b) Diagram on the left shows eGFP region amplified using mutagenic primers in preparation for
three-fragment ligation of Ub-L and eGFP into pRPeGFPSIR2rp3. The right panel shows PCR
results: 1-7) 5µl eGFP, amplified using complementary and mutagenic primers.
(c) Diagram on the left shows pUBeK cut with HindIII/XbaI for three-
fragment ligation of Ub-L and eGFP into pRPeGFPSIR2rp3. The right
panel shows digest results. Lanes:
1) 50µl pUBeK, HindIII/XbaI cut,
2) 5µl pUBeK, HindIII cut.
Figure A.3: Assembly strategy using three-fragment ligation, Plasmid preparation: Gel re-
sults showing: a) pRPeGFPSIR2rp3 backbone, b) eGFP insert and c) Ub-L insert during the
preparation process for the HindIII/XbaI/BamHI three-fragment ligation of Ub-L and eGFP into
pRPeGFPSIR2rp3.
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Ligation
1 2 3 4 5
Insert:Backbone molar ratio 3:1 1:1 - - -
Ingredient Amount Amount Amount Amount Amount
1
pRPeGFPSIR2rp3 backbone
a Cut, purified
a (240ng/µl)
4µl
(148mols)
(960ng)
4µl
(148mols)
(960ng)
4µl
(148mols)
(960ng)
4µl
(148mol)
(960ng)
-
2
pRPeGFPSIR2rp3 backbone
a Uncut
a (325ng/µl)
- - - -
3.6µl
(148mols)
(1167ng)
3
Ub-L insert
a Cut, purified
a (39 ng/µl)
4.1µl
(443mols)
1.4µl
(148mols) - - -
4
eGFP insert
a Amplified, cut, purified
a (160 ng/µl)
2µl
(443mols)
0.7µl
(148mols) - - -
5 Quick T4 DNA Ligase 1µl 1µl 1µl - -
6 2X Ligase Buffer 10µl 10µl 10µl 10µl 10µl
7 dH20 to 21µl to 21µl to 21µl to 21µl to 21µl
Total 21µl 21µl 21µl 21µl 21µl
Colony Count 27 42 32 0 Lawn
Table A.2: Assembly strategy using three-fragment ligation - Ligation: Set-up of ligations and
controls for the HindIII/XbaI/BamHI three-fragment ligation using increased backbone and insert
mass to insert Ub-L and eGFP into pRPeGFPSIR2rp3 to get pConstitutive, using Quick T4 DNA
ligase. Each ligation lists the cut purified backbone or uncut backbone in volume, mols and mass,
the insert in volume, mols and mass (optional), the volume of Quick T4 DNA ligase (optional), 2X
Ligase Buffer and dH20 (optional) used for ligation. Colony counts are from transformation plates
following incubation times. ‘Lawn’ refers to +250 small, non-isolated colonies.
262
Ligation
1 2 3 4 5
Insert:Backbone molar ratio 3:1 2:1 - - -
Ingredient Amount Amount Amount Amount Amount
1
pRPeGFPSIR2rp3 backbone
a Cut, purified
a (212ng/µl)
6µl
(178mols)
(1272ng)
6µl
(178mols)
(1272ng)
6µl
(178mols)
(1272ng)
6µl
(178mols)
(1272ng)
-
2
pRPeGFPSIR2rp3 backbone
a Uncut
textcolorwhitea (325ng/µl)
- - - -
4.3µl
(178mols)
(1396ng)
3
eGFP insert
a Amplified, cut, purified
a (160ng/µl)
2.4µl
(530mols)
1.6µl
(353mols) - - -
4 Quick T4 DNA Ligase 1µl 1µl 1µl - -
5 2X Ligase Buffer 10µl 10µl 10µl 10µl 10µl
6 dH20 to 21µl to 21µl to 21µl to 21µl
to
21mul
Total 21µl 21µl 21µl 21µl 21µl
Colony Count 14 18 26 0 +250
Table A.3: Assembly strategy using three-fragment ligation - Ligation: Set-up of ligations and con-
trols for an XbaI/BamHI directional ligation to insert eGFP into pRPeGFPSIR2rp3 as an alternative
to the three-fragment ligation. Each ligation lists the cut purified backbone or uncut backbone in
volume, mols and mass, the insert in volume, mols and mass (optional), the volume of Quick T4
DNA ligase (optional), 2X Ligase Buffer and dH20 (optional) used for ligation. Colony counts are
from transformation plates following incubation times.
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A.3 Oscillator assembly strategy inserting the tetR cassette
followed by the eGFP gene via Gibson assembly
The following recipes and gel images were generated during the third ligation strategy using a
Gibson ligation to insert the tetR cassette followed by the eGFP gene to construct the stable
Goodwin oscillator.
(a) Diagram on the left shows the pUbSir plasmid digested with KpnI in preparation of Gibson
ligations to insert tetR cassette. The right panel shows digest results. Lanes:
1) 5µl pUbSir, KpnI cut,
2) 5µl pUbSir, uncut.
(b) Diagram on the left shows region of pHD1313 plasmid to be amplified using Gibson primers in
order to extract tetR cassette. The right panel shows PCR results. Lanes:
1-2) 10µl tetR cassette, amplified from pHD1313 with Gibson primers using annealing temperature
of 55°C
3-4) 10µl tetR cassette, amplified from pHD1313 with Gibson primers using annealing temperature
of 60°C
5-6) 10µl tetR cassette, amplified from pHD1313 with Gibson primers using annealing temperature
of 72°C
7) 5µl tetR, uncut.
Figure A.4: TetR-first assembly strategy - Plasmid preparation: Gel results showing the: a) pUbSir
backbone and b) tetR cassette during preparation steps for a Gibson ligation to insert the tetR
cassette into pUbSir to get ptetR UbSir.
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Ligation
1 2 3 4 5
Insert:Backbone molar
ratio
3:1 2:1 - - -
Ingredient Amount Amount Amount Amount Amount
1
pUbSir backbone
a Cut, purified
a (80ng/µl)
3µl
(0.048pmol)
(240ng)
3µl
(0.048pmol)
(240ng)
3µl
(0.048pmol)
(240ng)
3µl
(0.048pmol)
(240ng)
-
2
Positive Control (NEB)
a (325ng/µl)
- - - - 10µl
3
tetR insert
a Amplified, purified
a (20ng/µl)
8.7µl
(0.145pmol)
5.8µl
(0.097pmol)
- - -
4 Gibson Master Mix 10µl 10µl 10µl - -
5 dH20 to 20µl to 20µl to 20µl to 20µl to 20µl
Total 20µl 20µl 20µl 20µl 20µl
Colony Count 130 100 30 110 0
Table A.5: TetR-first assembly strategy - Ligation: Recipes for reactions and controls used in
Gibson ligation to insert the tetR cassette into pUbSir to get ptetR UbSir. Each ligation lists the
cut purified backbone or control backbone in volume, mols and mass, the insert in volume, mols
and mass (optional), the volume of Gibson Master Mix (optional) and dH20 (optional) used for
ligation. Colony counts are from transformation plates following incubation times.
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(a) Diagram on the left shows region of pRPeGFPSIR2rp3 plasmid to be amplified using
Gibson primers in order to extract eGFP. The right panel shows gel results of the
amplification of eGFP from pRPeGFPSIR2rp3. Lanes:
1-2) 10µl eGFP, amplified using 2µl template, 58°annealing temperature
3) 10µl eGFP, amplified using 1µl template, 58°annealing temperature.
(b) Diagram on the left shows region of ptetR UbSir plasmid to be amplified as prepa-
ration for a Gibson ligation to insert eGFP into ptetR UbSir. The right panel shows
PCR results using different recipes and conditions. Lanes:
1) 5µl ptetR UbSir, amplified using HF buffer, 58°C annealing temp,
2) 5µl ptetR UbSir, amplified using GC buffer, 58°C annealing temp,
3) 5µl ptetR UbSir, amplified using HF buffer, 65°C annealing temp,
4) 5µl ptetR UbSir, amplified using GC buffer, 65°C annealing temp,
5) 5µl ptetR UbSir, amplified using HF buffer, 72°C annealing temp,
6) 5µl ptetR UbSir, amplified using. GC buffer, 72°C annealing temp,
7) 10µl ptetR UbSir, uncut.
Figure A.5: TetR-first assembly strategy - Plasmid preparation: Gel results showing the: a) eGFP
insert and b) ptetR UbSir backbone during the preparation process for a Gibson ligation to insert
eGFP into ptetR UbSir to get pStable.
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Ligation
1 2 3 4
Insert:Backbone molar ratio 3:1 2:1 - -
Ingredient Amount Amount Amount Amount
1
ptetR UbSir backbone
a Amplified, purified
a (16ng/µl)
8.5µl
(0.026pmol)
(136ng)
8.5µl
(0.026pmol)
(136ng)
8.5µl
(0.026pmol)
(136ng)
-
2
ptetR UbSir backbone
a Uncut
a (100ng/µl)
- - -
1.4µl
(0.026pmol)
(136ng)
3
eGFP insert
a Amplified, purified
a (30ng/µl)
1.8µl
(0.077pmol)
1.2µl
(0.052pmol)
- -
4 Gibson Master Mix 10µl 10µl 10µl -
5 dH20 to 20µl to 20µl to 20µl to 20µl
Total 20µl 20µl 20µl 20µl
Colony Count 8 0 0 lawn
Table A.6: TetR-first assembly strategy - Ligation: Recipes for reactions and controls used in Gib-
son ligation to insert eGFP into ptetR UbSir to get pStable. Each ligation lists the cut purified
backbone or uncut backbone in volume, mols and mass, the insert in volume, mols and mass (op-
tional), the volume of Gibson Master Mix (optional) and dH20 (optional) used for ligation. Colony
counts are from transformation plates following incubation times. ‘Lawn’ refers to +250 small,
non-isolated colonies.
A.4 Oscillator assembly strategy inserting eGFP gene followed
by the tetR cassette via Gibson assembly
The following recipes and gel images were generated during the fourth ligation strategy using
a Gibson ligation to insert the eGFP gene followed by the tetR cassette to construct the stable
Goodwin oscillator.
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(a) Diagram on the left shows pUbSir amplified without the Sir2rp3 gene for
Gibson ligation of the eGFP into it. The right panel shows PCR results. Lanes:
1) 10µl pUbSir, amplified with Gibson primers, purified,
2) 5µl pUbSir, uncut.
(b) Diagram on the left shows region of pRPeGFPSIR2rp3 to be amplified using
Gibson primers in order to extract eGFP for ligation into pUbSir. The right panel
shows PCR results. Lanes:
1) 10µl eGFP, amplified with Gibson primers, purified
2) 5µl pRPeGFPSIR2rp3, uncut.
Figure A.6: eGFP-first assembly strategy - Plasmid preparation: a) Purified pUbSir backbone and
b) Purified eGFP insert in preparation for the Gibson ligation to insert eGFP into pUbSir to get
pConstitutive.
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Ligation
1 2 3 4
Insert:Backbone molar ratio 10:1 2:1 - -
Ingredient Amount Amount Amount Amount
1
pUbSir backbone
a Amplified, purified
a (15ng/µl)
5µl
(0.017pmol)
(75ng)
5µl
(0.017pmol)
(75ng)
5µl
(0.017pmol)
(75ng)
-
2
pUbSir backbone
a Uncut
a (50ng/µl)
- - -
1.5µl
(0.017pmol)
(75ng)
3
eGFP insert
a Amplified, purified
a (24ng/µl)
5µl
(0.175pmol)
1µl
(0.033pmol) - -
4 Gibson Master Mix 10µl 10µl 10µl -
5 dH20 to 20µl to 20µl to 20µl to 20µl
Total 20µl 20µl 20µl 20µl
Colony Count 1 10 2 lawn
Table A.7: eGFP-first assembly strategy - Ligation: Recipes for reactions and controls used in
Gibson ligation to insert eGFP into pUbSir to get pConstitutive. Each ligation lists the cut purified
backbone or uncut backbone in volume, mols and mass, the insert in volume, mols and mass (op-
tional), the volume of Gibson Master Mix (optional) and dH20 (optional) used for ligation. Colony
counts are from transformation plates following incubation times. ‘Lawn’ refers to +250 small,
non-isolated colonies.
(a) Diagram on the left shows the region on pHD1313 to be amplified to extract the tetR cassette
in preparation for a Gibson ligation to insert the cassette into pConstitutive. The right panel shows
PCR results. Lanes:
1) 10µl tetR cassette, amplified with Gibson primers & purified,
2) 5µl pHD1313, uncut.
(b) Diagram on the left shows pConstitutive digested with KpnI digest in preparation for a Gibson
ligation to insert the tetR cassette into it. The right panel shows digest results. Lanes:
1) 10µl pConstitutive, KpnI cut & purified,
2) 5µl pConstitutive, uncut.
Figure A.7: eGFP-first assembly strategy, Plasmid preparation: Gel results showing: a) tetR and
b) pConstitutive DNA amplified, digested and purified in preparation for a Gibson ligation to insert
tetR into pConstitutive to get pStable.
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Appendix B
List of primers used during PCR
amplification
This appendix lists all primers used in the PCR amplification processes in preparation for stan-
dard, three-fragment, non-directional and Gibson ligations, with mutagenic nucleotides in bold
and overhangs underlined. In addition, the primer length, direction and a brief description of the
primers is included. These have been referred to in Chapter 4. All primers were ordered from
Eurofins MWG Operon (Ebersberg, Germany).
1 Length: 37bp Direction: Forward Amplifies: eGFP gene
Sequence(5’ - 3’): TCT AGA GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG G
Notes: Replace ATG start codon with AGA codon and HindIII site with in-frame XbaI site.
2 Length: 32bp Direction: Reverse Amplifies: eGFP gene
Sequence(5’ - 3’): GGA TCC GCC TTC AAG ACT TGT ACA GCT CGT CC
Notes: Replace AGA with TGA stop codon and XbaI site with BamHI site
3 Length: 21bp Direction: Forward Amplifies: eGFP gene
Sequence(5’ - 3’): GAG TGG TAC CCT GCA CGC CGC
4 Length: 21bp Direction: Forward Amplifies: eGFP gene
Sequence(5’ - 3’): ATG GTG AGC AAG GGC GAG GAG
5 Length: 21bp Direction: Reverse Amplifies: eGFP gene
Sequence(5’ - 3’): AAT CAT ACG ATT GGG CCG CC
6 Length: 31bp Direction: Forward Amplifies: tetR cassette
Sequence(5’ - 3’): GGT ACC GTC TTG GTG TGT CGA CCT TGC AGG C
Notes: Introduces KpnI site upstream of the tetR cassette
7 Length: 33bp Direction: Reverse Amplifies: tetR cassette
Sequence(5’ - 3’): GGT ACC TTG TAC ATA TTG TCG TTA GAA CGC GGC
Notes: Introduces KpnI site downstream of the tetR cassette
8 Length: 38bp Direction: Forward Amplifies: tetR cassette
Sequence(5’ - 3’): CAA TGA TAG AGT GGT ACC GTC TTG GTG TGT CGA CCT TG
Notes: Adds pRP compatible overhangs, Used for Gibson ligation.
9 Length: 40bp Direction: Reverse Amplifies: tetR cassette
Sequence(5’ - 3’): GCG CGT GCA GGG TAC CTT GTA CAT ATT GTC GTT AGA ACG C
Notes: Adds pRP compatible overhangs, Used for Gibson ligation.
10 Length: 36bp Direction: Forward Amplifies: eGFP gene
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Sequence(5’ - 3’): CTA GAC AAG TTT CTA GAG AAG CTT ATG GTG AGC AAG
Notes: Adds pRP compatible overhangs, Used for Gibson ligation.
11 Length: 38bp Direction: Reverse Amplifies: eGFP gene
Sequence(5’ - 3’): GCC AAC TAA ATG GGC ATT CTA GAC TTG TAC AGC TCG TC
Notes: Adds pRP compatible overhangs, Used for Gibson ligation.
12 Length: 18bp Direction: Forward Amplifies: pRP backbone
Sequence(5’ - 3’): TGC CCA TTT AGT TGG CTT
Notes: Used for Gibson ligation.
13 Length: 25bp Direction: Reverse Amplifies: pRP backbone
Sequence(5’ - 3’): CTC TAG AAA CTT GTC TAG CCA ATT G
Notes: Used for Gibson ligation.
14 Length: 22bp Direction: Forward Amplifies: pRP backbone
Sequence(5’ - 3’): GGA TCC TGC CCA TTT AGT TGG C
Notes: Used for Gibson ligation.
15 Length: 19bp Direction: Reverse Amplifies: pRP backbone
Sequence(5’ - 3’): TCT AGA AAC TTG TCT AGC C
Notes: Used for Gibson ligation.
16 Length: 35bp Direction: Forward Amplifies: eGFP gene
Sequence(5’ - 3’): CTA GAC AAG TTT CTA GAG TGA GCA AGG GCG AGG AG
Notes: Adds pRP compatible overhangs, Used for Gibson ligation.
17 Length: 36bp Direction: Reverse Amplifies: eGFP gene
Sequence(5’ - 3’): GCC AAC TAA ATG GGC AGG ATC CGC CTT CAA GAC TTG
Notes: Adds pRP compatible overhangs, Used for Gibson ligation.
18 Length: 38bp Direction: Forward Amplifies: Ub-L gene
Sequence(5’ - 3’): ACC AAA AAG TAA AAT TCA CAA GCT TAT GCA GAT CTT CG
Notes: Adds pRP compatible overhangs. Not used.
19 Length: 34bp Direction: Reverse Amplifies: Ub-L gene
Sequence(5’ - 3’): CTT GCT CAC TCT AGA AAC TTG TCT AGC CAA TTG C
Notes: Adds pRP compatible overhangs. Not used.
20 Length: 27bp Direction: Forward Amplifies: eGFP gene
Sequence(5’ - 3’): AGA CAA GTT TCT AGA GTG AGC AAG GGC
Notes: Adds pRP compatible overhangs. Not used.
21 Length: 32bp Direction: Forward Amplifies: eGFP gene
Sequence(5’ - 3’): AGA TCT GCC TTC AAG ACT TGT ACA GCT CGT CC
Notes: Adds pRP compatible overhangs. Not used.
22 Length: 36bp Direction: Reverse Amplifies: eGFP gene
Sequence(5’ - 3’): GCC AAC TAA ATG GGC AAG ATC TGC CTT CAA GAC TTG
Notes: Adds BglII site, stop codon, pRP compatible overhangs. Not used.
Table B.1: List of primers used throughout the construction pro-
cess of the Goodwin oscillator. The nucleotides underlined repre-
sent overhangs. The nucleotides in bold are introduced by muta-
genic PCR.
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Appendix C
List of primers used during plasmid
sequencing
This appendix lists the primers used in sequencing reactions following cloning in order to confirm
success of the procedures. The list includes primer length, direction and which DNA segment the
primer sequences. All primers were ordered from Eurofins MWG Operon (Ebersberg, Germany).
1 Length: 21bp Direction: Forward Sequences: pUBeK
Sequence(5’ - 3’): AAG ATA AAG GGT ATC CCT CCG
2 Length: 21bp Direction: Forward Sequences: pUBeK
Sequence(5’ - 3’): ATA AGG AGG GTA TCC CTC CGG
3 Length: 21bp Direction: Reverse Sequences: pUBeK
Sequence(5’ - 3’): AAT CAG TCG CTG CTG ATC CGG
4 Length: 20bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): AAA CGC GTG CGC TAC ACA GC
5 Length: 21bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): AAT GAT AGA GTG GTA CCC TGC
6 Length: 21bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): TAA ACG GCC ACA AGT TCA GCG
7 Length: 19bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): CCA CTA CCA GCA GAA CAC C
8 Length: 26bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): TTT CTC ATA GGC GTG TGC ACC TTC CG
9 Length: 22bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): CCT GAT TCA CTC ATC GTT GAG C
10 Length: 21bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): TCT AAT TCC AGA CTA CTG GCG
11 Length: 21bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): CAA TTA TTA GGG AAG CGA CGC
12 Length: 21bp Direction: Reverse Sequences: pRP backbone
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Sequence(5’ - 3’): AGG AAA CCA ACT TGT AGT GGC
13 Length: 23bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): ATG CAC CAA CGA GAC AAC CAA GC
14 Length: 21bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): TTG AAG TTC ACC TTG ATG CCG
15 Length: 23bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): AAG CAG TTT GAG TAT TTG GAG CC
16 Length: 21bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): TCA TTG ATA GGG TGT ACG CCG
17 Length: 21bp Direction: Forward Sequences: pRP backbone
Sequence(5’ - 3’): AGT AAA AGT AGC GCT TAC GGC
18 Length: 21bp Direction: Reverse Sequences: pRP backbone
Sequence(5’ - 3’): TCC AGA GCA ATG GTT TTA CCG
19 Length: 19bp Direction: Forward Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): ACC ATA CTC ACT TTT GCC C
20 Length: 21bp Direction: Forward Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): TTC CCG GAG TAA TCT GAT GGC
21 Length: 21bp Direction: Forward Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): ACA TTC AGA AGG AGT CGA CGC
22 Length: 20bp Direction: Forward Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): ATG AAG TGG TGC AAA ACG CG
23 Length: 21bp Direction: Reverse Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): ATC CCT TGA CTC AAA CAC GCG
24 Length: 21bp Direction: Forward Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): ACT GTG TTG ATA AGG GAC GGG
25 Length: 21bp Direction: Reverse Sequences: pRP backbone & tetR insert
Sequence(5’ - 3’): CAT TAA GCA GCT CTA ATG CGC
Table C.1: List of primers used in sequencing reactions following
standard and Gibson ligations in order to confirm success of reac-
tions.
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Appendix D
MATLAB code used to apply moving
average smoothing technique
The following scripts were used in MATLAB (2012a) in order to impute data or apply the moving
average filter to a data set of interest in order to smooth data and eliminate the effects of noise
to better understand the underlying trend. The moving average filter used a window size of eight.
Through ‘CellA’ is taken to be the data set of interest with size 1 row × x columns where x is the
number of data points. In the second script, x=60.
1 %Impute data to remove the data points quantified as zero
2
3 for(i=1:x)
4 if (CellA(i,x)<0.01)
5 CellA(i,x)=mean([CellA(i-3,x),CellA(i-2,x),CellA(i-1,x),CellA(i+1,x),
6 CellA(i+2,x),CellA(i+3,x)]);
7 end;
1 %Moving average filter, which takes into account beginning and end points
2
3 %Add extra column to each data set where moving average data will be
4 %printed
5 CellA=[CellA zeros(60,1)];
6
7 for(i=1:60)
8 if(i==1 )
9 CellA(i,3)=mean([CellA(i,2),CellA(i+1,2),CellA(i+2,2),CellA(i+3,2)
10 ,CellA(i+4,2),CellA(i+5,2),CellA(i+6,2),CellA(i+7,2),CellA(i+8,2)]) ;
11 elseif (i==2 )
12 CellA(i,3)=mean([CellA(i-1,2),CellA(i,2),CellA(i+1,2),CellA(i+2,2),
13 CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),CellA(i+6,2),CellA(i+7,2),
14 CellA(i+8,2)]);
15 elseif(i==3 )
16 CellA(i,3)=mean([CellA(i-2,2),CellA(i-1,2),CellA(i,2),CellA(i+1,2),
17 CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),CellA(i+6,2),
18 CellA(i+7,2),CellA(i+8,2)]);
19 elseif(i==4 )
20 CellA(i,3)=mean([CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
21 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),
22 CellA(i+6,2),CellA(i+7,2),CellA(i+8,2)]);
23 elseif(i==5 )
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24 CellA(i,3)=mean([CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),
25 CellA(i,2),CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),
26 CellA(i+5,2),CellA(i+6,2),CellA(i+7,2),CellA(i+8,2)]);
27 elseif(i==6 )
28 CellA(i,3)=mean([CellA(i-5,2),CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),
29 CellA(i-1,2),CellA(i,2),CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),
30 CellA(i+4,2),CellA(i+5,2),CellA(i+6,2),CellA(i+7,2),CellA(i+8,2)]);
31 elseif(i==7 )
32 CellA(i,3)=mean([CellA(i-6,2),CellA(i-5,2),CellA(i-4,2),CellA(i-3,2),
33 CellA(i-2,2),CellA(i-1,2),CellA(i,2),CellA(i+1,2),CellA(i+2,2),
34 CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),CellA(i+6,2),CellA(i+7,2),
35 CellA(i+8,2)]);
36 elseif(i==8 )
37 CellA(i,3)=mean([CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),CellA(i-4,2),
38 CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),CellA(i+1,2),
39 CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),CellA(i+6,2),
40 CellA(i+7,2),CellA(i+8,2)]);
41
42 elseif(i==53 )
43 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
44 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
45 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),
46 CellA(i+6,2),CellA(i+7,2)]);
47 elseif(i==54 )
48 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
49 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
50 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),
51 CellA(i+6,2)]);
52 elseif(i==55 )
53 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
54 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
55 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2)]);
56 elseif(i==56 )
57 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
58 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
59 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2)]);
60 elseif(i==57 )
61 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
62 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
63 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2)]);
64 elseif(i==58 )
65 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
66 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
67 CellA(i+1,2),CellA(i+2,2)]);
68 elseif(i==59 )
69 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
70 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
71 CellA(i+1,2)]);
72 elseif(i==60)
73 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
74 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2)]);
75 else
76 CellA(i,3)=mean([CellA(i-8,2),CellA(i-7,2),CellA(i-6,2),CellA(i-5,2),
77 CellA(i-4,2),CellA(i-3,2),CellA(i-2,2),CellA(i-1,2),CellA(i,2),
78 CellA(i+1,2),CellA(i+2,2),CellA(i+3,2),CellA(i+4,2),CellA(i+5,2),
79 CellA(i+6,2),CellA(i+7,2),CellA(i+8,2)]);
80 end;
81 end;
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Appendix E
MATLAB code used for phase
space reconstruction
This script was used in MATLAB (2012a) in order to reconstruct the phase space of the smoothed
fluorescent trajectories as quantified from microscopy imaging data. The phase was reconstructed
by removing the mean and linear trend from the smoothed data set and then plotting the detrended
data using a delay of 8 against itself at delay 0.
1 %Key of Cell A matrix columns
2 %1=time
3 %2=original data
4 %3=smootheed data
5 %4=smoothed data with mean removed
6 %5=smoothed data with mean and trend removed
7 %6=phase space data on non-detrended data
8 %7=phase space data on detrended data
9
10 %Remove mean from smoothed data so as to make data revolve around 0
11 CellA=[CellA zeros(60,1)];
12 MeanA=mean(CellA(:,3));
13 for i=1:60
14 CellA(i,4)=CellA(i,3)-MeanA;
15 end;
16
17 %Fit linear line to the data
18 xA = CellA(:,1);
19 yA = CellA(:,4);
20 pA = polyfit(xA,yA,1);
21 x1A = CellA(:,1);
22 y1A = polyval(pA,x1A);
23
24 %Remove linear trend
25 CellA=[CellA zeros(60,1)];
26 for i=1:60
27 CellA(i,5)= CellA(i,4)-y1A(i,1);
28 end;
29
30 %Reconstruct phase space for detrended data
31 CellA=[CellA zeros(60,1)];
32 delay=8;
33 for i=1:(60-delay)
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34 CellA(i,7)=CellA(i+delay,5);
35 end;
36 h=figure;
37 plot(CellA(1:(60-delay),5),CellA(1:(60-delay),7),'LineWidth',1.5)
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